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Glossary of Terms 
Anatomy the branch of biology concerned with the study of the structure of organisms and 
their parts. 
Angiogenesis the physiological process through which new blood vessels form from pre-
existing vessels. 
Aetiology the cause, set of causes, or manner of causation of a disease or condition. 
Biochemistry sometimes called biological chemistry, the study of chemical processes within 
and relating to living organisms. 
Biopharmaceutics the study of the chemical and physical properties of drugs and the 
biological effects they produce. 
Biotechnology the exploitation of biological processes for industrial and other purposes, 
especially the genetic manipulation of microorganisms for the production of 
antibiotics, hormones, etc. 
Drug Tariff outlines what will be paid to pharmacy contractors in reimbursement for the 
cost of drugs, appliances, etc, used in providing NHS services. 
Chloramphenicol an antibiotic useful for the treatment of a number of bacterial infections. 
Epidemiology the science that studies the patterns, causes and effects of health and disease 
conditions in defined populations. 
Herceptin the brand name of a medicine called trastuzumab used to treat some types 
of breast cancer and stomach cancer. 
Opioid an opium-like compound that binds to one or more of the three opioid receptors of 
the body. 
Orlistat a drug designed to treat obesity. 
Paraneoplastic syndrome a set of signs and symptoms that is the consequence of cancer in 
the body. 
Pharmaceutics is the study of relationships between drugs formulation, delivery, disposition 
and clinical response. 
Pharmacoeconomics the scientific discipline that compares the value of one pharmaceutical 
drug or drug therapy to another. 
Pharmacogenetics the study of inherited genetic differences in drug metabolic pathways, 
which can affect individual responses to drugs in terms of therapeutic as well as 
adverse effects.  
Pharmacognosy the study of medicinal drugs derived from plants or other natural sources. 
Pharmacology the branch of medicine and biology concerned with the study of drug action. 
Pharmacovigilance the science and activities relating to the detection, assessment, 
understanding and prevention of adverse effects or any other drug-related problem. 
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Physiology the branch of biology that deals with the normal functions of living organisms 
and their parts. 
Polypharmacy the use of four or more medications by a patient, generally adults aged over 
65 years. 
Quinolones a family of synthetic broad-spectrum antibacterial drugs. 
Statins a group of cholesterol-lowering medicines. 
Simvastatin drug used to lower cholesterol and triglycerides (types of fat) in the blood. 
Telehealth the delivery of health-related services and information via telecommunications 
technologies. 
Thiazide diuretics a common treatment for high blood pressure also used to clear fluid from 
the body in conditions where it accumulates too much fluid, such as heart failure. 
Warfarin an anticoagulant normally used in the prevention of thrombosis and 
thromboembolism, the formation of blood clots in the blood vessels and their 
migration elsewhere in the body, respectively. 
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Abstract 
Introduction 
A number of UK studies have investigated the role of pharmacists in public health 
(Blenkinsopp, et al. 2002; Anderson and Blenkinsopp 2003; Agomo 2012a). However, many 
of these studies have also identified barriers in this public health role (Agomo 2012a; Agomo 
and Ogunleye 2014). My project aimed to identify strategies, which could enhance the 
public health role of community pharmacists in the UK. 
Method 
My project used a mixed methods approach, involving a content analysis of the UK 
undergraduate pharmacy curriculum, a descriptive survey of UK community pharmacists 
and interviews with healthcare practitioners to investigate strategies enhancing the public 
health role of community pharmacists in the UK. 
Results 
The majority of my survey respondents indicated that there was a need for pharmacists to 
work closely with other healthcare practitioners [93.1%, C.I. ±5.32]; pharmacy students to 
train with other healthcare students [81.4%, C.I. ±8.21]; students and pharmacists to be 
provided with advanced experience in public health [86.2%, C.I. ±7.24 and 89.8%, C.I. ±6.32 
respectively]; as well as increasing the public health content of the undergraduate pharmacy 
curriculum [64.8%, C.I. ±9.97]. Respondents from Cardiff were more likely to participate in 
local authority-run schemes than other respondents (p < .001; η2 = .296). Male respondents 
were more likely to agree that 'insufficient funding from the government’ was a barrier to 
the public health role of community pharmacists [p = .011; ρ = -.269]. The findings of my 
interviews confirmed several aspects of my survey findings, particularly as regards 
accessibility, encouraging collaboration between pharmacists and other healthcare 
professionals, and tackling a number of barriers, such as the lack of awareness of the public 
health skills of pharmacists. There were some indications from my content analysis that the 
teaching of macro-level public health activities (such as epidemiology, assessment, 
pharmacovigilance, policy development and assurance at the population-based level) in 
most UK pharmacy schools was either minimal or lacking.  
Conclusion 
There is a need to enhance the public health role of community pharmacists in the UK. This 
will help make public health services more accessible to the public, reduce healthcare costs 
and pressures on other healthcare professionals, as well as helping to elevate the image of 
community pharmacists.  
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Chapter 1 – Introduction 
 
1.1 - Context 
Supporting my project, which aimed mainly to identify strategies enhancing the public 
health role community pharmacists in the UK, is my role as a change agent. According to 
Havelock (1973), a change agent is a person who facilitates planned change or planned 
innovation. A person can act as a change agent in four primary ways. They include being a 
catalyst, a solution giver, a process helper and a resource linker (Havelock 1973). I see 
myself more as a catalyst and a solution giver, rather than as a process helper or a resource 
linker. This is because, as a catalyst, the change agent helps to overcome inertia and to prod 
and pressure the system to be less complacent and to start working on its serious problems 
(Havelock 1973). According to Havelock (1973), change agents do not necessarily have the 
answers to problems, but they are usually dissatisfied with things the way they are. By 
making their dissatisfaction known and by upsetting the ‘status quo', they energise the 
problem-solving process, and hence get things started (Havelock 1973). 
My role as an insider-researcher-practitioner is also important in my project. Not only have I 
been engaged in many of the issues concerning pharmacy practice in the UK (as described 
briefly in my Review of Learning), but my previous work on the role of community 
pharmacists in public health (Agomo, et al. 2006, Agomo 2012a) puts me in a good position 
to investigate strategies enhancing the public health role of community pharmacists in the 
UK. I believe that I am well situated to investigate strategies that can enhance the public 
health role of community pharmacists in the UK, due to my position as an insider 
practitioner-researcher and my insight into the role of community pharmacists in public 
health. Some of the attributes I bring to the project include the fact that I am an 
independent worker who does not need close supervision. At the same time, I am able to 
decide logically what should be done and work towards it steadily, regardless of 
distractions. These attributes, as well as my skills, academic qualifications and professional 
experiences, have helped me undertake the DProf project. 
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1.2 - Background 
According to the World Health Organisation (WHO 2015a), 2015 represented the target year 
for the Millennium Development Goals (MDGs). However, as some of the gains made in 
different regions of the world have been uneven; this also meant that the MDG target could 
not be achieved in most countries (WHO 2015a). WHO has noted that this uncompleted 
agenda will need to include new challenges such as the increasing impact of non-
communicable diseases, and changing social and environmental determinants (WHO 
2015a). However, the WHO has also estimated that of 56 million global deaths in 2012, 38 
million, or 68%, were due to non-communicable diseases (NCDs) (WHO 2017). The four 
main NCDs are cardiovascular diseases, cancers, diabetes and chronic lung diseases (WHO 
2017). Most of these conditions are preventable through public health initiatives involving 
community pharmacists, particularly as the literature confirms the role of pharmacists in 
alcohol screening (Brown, et al. 2014; Dhital 2004; Dhital, et al. 2015); breastfeeding 
support (Lenell, et al. 2015); chlamydia screening (Anderson and Thornley 2011; Emmerton, 
et al. 2011; Gudka, et al. 2013); falls preventation (Mott, et al. 2016); general services 
(Agomo 2012a); hepatitis C screening (D’Angelo, et al. 2015); HIV screening (Crawford, et al. 
2016; Mugo, et al. 2015) and lifestyle support (Chiazor, et al. 2015; Sabater-Hernandez, et 
al. 2016). In addition, there are some evidence that pharmacists do provide public health 
services in sexual health (Michie, et al. 2016); syringe exchange services (Janulis 2012; Torre, 
et al. 2010); TB screening (Bell, et al. 2012; Jakeman, et al. 2015); travel health (Tudball, et 
al. 2015) as well as weight management services (Um, et al. 2015; Weidmann, et al. 2015).  
In terms of contemporary policy context in the world of pharmacy it has been argued that 
pharmacy education and practice have changed from their initial narrow product-centred 
focus to the present patient-centred focus in many countries globally, although to different 
degrees (Addo-Atuah 2014). Therefore, the introduction of the Millennium Development 
Goals (MDGs), as a framework for promoting global health in relation to development, has 
made the promotion of population health as relevant as the clinical care of the individual 
patient (Addo-Atuah 2014). Hence, there is now a demand for a public health-oriented 
medical education and practice that prepares the present medical practitioner to see farther 
the individual patient to his community and society (Addo-Atuah 2014). A similar change in 
pharmacy education and practice have also been made (Bush and Johnson 1979), such that, 
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will necessitate pharmacy education to comprise the right public health orientation to 
prepare and empower pharmacists with the necessary knowledge, skills, attitudes, and 
values crucial for contributing to public health, both at the micro and macro levels, 
regardless of their practice setting (Addo-Atuah 2014). Moreover, there will an expectation 
from pharmacists to evaluate public health policies for costs and effectiveness as well as 
collaborate with government agencies in formulating public health policy (Dolinsky, et al. 
2007).  
On conditions such as human immunodeficiency virus (HIV)/acquired immunodeficiency 
syndrome (AIDs) prevention, Deas and McCree (2010) have suggested that several training 
options could be provided one of which is to expand current pharmacy curricula to include 
information and training on HIV testing and biomedical and behavioural prevention 
interventions. Another suggestion is to expand clerkship and clinical residency programs to 
include training in HIV/AIDS prevention (Deas and McCree 2010). In addition, professional 
pharmacy associations could offer workshops and/or postgraduate courses on HIV/AIDS 
prevention to practising pharmacists (Deas and McCree 2010). It is possible to extend these 
trainings to other aspects of public health involving pharmacists.  
Still, part of this overhaul in pharmacy education will be to reinforce the involvement of 
patients and the public in decisions concerning the planning, design, development and 
delivery of local services in the hope that this will result to an enhancement in public health 
services for patients (Farrell 2004; Fudge, et al. 2008). According to the Department of 
Health, “To ensure that excellent education is relevant to the needs of patients and the 
public, the workforce planning system needs to be based on the way people expect services 
to be delivered” (DoH 2013). This is also supported by the new General Pharmaceutical 
Council (GPhC) Standards (especially Standard 5.6) that outline the relevance of patient and 
public involvement (PPI) in pharmacy education, as well as highlight the need for effecting 
practical experience of working with patients, carers and other healthcare professionals 
side-by-side the theoretical and scientific features of pharmacy education (Becket, et al. 
2014). 
Although, the evolution of pharmacy practice in recent decades has been a global 
phenomenon, with remarkable changes happening in the developed world (Mossialos, et al. 
2013), there are however many barriers that will need to be overcome to ensure best 
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practice is distributed more widely on an international level (Krass 2016). Some of the 
factors which affect pharmacy’s ability to translate knowledge of evidence-based practice 
from one environment to another have been noted to include: the wealth of information 
available; wide differences in healthcare systems; government legislation on ownership of 
community pharmacy and control of medicines; the structure of the pharmacy sector; the 
power and influence of the medical profession; the availability of general practitioners 
(GPs); the education of pharmacists; and systems of pharmacist reimbursement (Krass 
2016).  
Notably, variations in pharmacy curricula and programmes around the world also have a 
role to play to the different rate of implementation of best practice models (Krass 2016). 
Yet, wide variation in the length and comprehensiveness of experiential placements in 
pharmacy degree programmes lead to variations in level of clinical (possibly, public health) 
skills of graduates in different countries (FIP 2014). Still, in countries where best practice 
models are successfully in place by “early adopters”, worryingly many practitioners have not 
always responded. Some of the reasons given for this reluctance include pharmacists often 
lack of confidence, fear new roles, are stuck when faced with ambiguity, always need 
approval and are risk averse (Krass 2016).  
In addition, some of the influences on pharmacists' role in public health have been noted to 
include, loss to follow-up and inadequate training (Dhital, et al. 2015); organisational 
obstacles, e.g. lack of time and unfamiliarity with the tool, as well as, challenges with 
engaging with clients (Brown, et al. 2014); challenges with incorporating service into normal 
work flow, staff lack of confidence in public health, and restrictions around commissioned 
services (Mackridge, et al. 2015). As well as, limited evidence of service effectiveness and 
cost-effectiveness in the community pharmacy setting (Watson and Sheridan 2011); 
attitudes towards pharmacists engaging in screening and brief intervention (SBI) for risky 
drinkers (Sheridan, et al. 2012); as well as pharmacists’ attitudes to clients, training, and lack 
of knowledge and confidence to provide a brief intervention (McCaig, et al. 2011).  
Other influences include, commitment issues relating to workload and, in some cases, no 
staff member taking responsibility for ‘driving’ the distribution of the specimen collection 
kits and the restriction of advertising to in-store posters and leaflets (Emmerton, et al. 
2011); not simplifying paper work, not using web-based system for recording, lack of 
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compensations/incentives, and not making testing universally available at all pharmacies, at 
all times (Gudka, et al. 2013); as well as, recruitment of patients, the process through which 
the intervention was delivered, the extent to which patients implemented the 
recommendations for intervention and the acceptance of pharmacists’ recommendations by 
prescribing physicians (Casteel, et al. 2011).  
Additional influences hindering the public health role of pharmacists have also been 
identified to include, lack of an adequate counselling space, lack of demand and expectation 
of a negative reaction from customers (Eades, et al. 2011); poor implementation of public 
health initiatives (Hermansyah, et al. 2016); major differences between community 
pharmacy practice in Europe (Martins, et al. 2015); challenges with pharmacists developing 
innovative practices, and schools and colleges of pharmacy including public health 
topics/courses in the curriculum to provide a fundamental knowledge and practice 
opportunities for students (Nemire, et al. 2010); the lack of qualified staff and adequate 
infrastructure which may be compromising the quality of the services offered (Gyawali, et 
al. 2014); as well as lack of appropriate policy on public health role of community 
pharmacists, inadequate training of students and pharmacists in public health, lack of time 
and lack of the concept of team work with other health care professionals (Mohamed, et al. 
2013).  
According to Brown, et al. (2016) there is also the issue of insufficient evidence to assess the 
effectiveness of community pharmacy-based interventions on health equity; as well as 
insufficient information to examine the relationship between intervention effectiveness and 
behaviour change strategies and/or models used, implementation factors, or the 
organisation and delivery of interventions. Finally, labour costs, competition and inadequate 
reimbursement levels, which threaten the sustainability of these services (Doucette, et al. 
2012); continued shortage in the pharmacist workforce and associated lack of time 
(Wibowo, et al. 2010); lack of awareness, lack of consensus, preventing  young people from 
accessing pharmacy services, and not adapting services to meet the specific needs of this 
group (Horsfield, et al. 2014), as well as, the corporation of participating organisations 
(Lecher, et al. 2015) have also been identified as other influences affecting the public health 
role of pharmacists. 
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To manage some of these challenges and as part of its global workforce development goals 
for pharmacy, the International Pharmaceutical Federation (FIP) have highlighted the need 
for distinctly identifiable elements of collaborative working and inter-professional education 
and training, which is expected to be a feature of all workforce development programmes 
and policies (FIP 2016).  
In the UK, the government has identified the importance of a multi-disciplinary public health 
workforce for handling the main causes of ill health (DoH 1999, 2010a). At the same time, 
the NHS Future Forum has recently suggested that healthcare professionals such as 
pharmacists ought to be incentivised in their national contract, as General Practitioners 
(GPs) are, to deliver health improvements and promote healthy lifestyles (News Team 
2012a). Although there are no signs that this has now happened, the closer relationship 
being developed between GPs and pharmacists by the Royal Pharmaceutical Society (RPS) 
and the Royal College of General Practitioners (RCGP) (Robinson 2015a), does give some 
hope that this aspiration will one day become a reality. The white paper ‘Choosing health 
through pharmacy: A programme for pharmaceutical public health' outlines some of the 
public health priorities for pharmacy (DoH 2005). A recent white paper (DoH 2010a) 
proposes a higher priority and dedicated resources for public health, with community 
pharmacists expected to play greater roles than before. While some of the public health 
activities provided from the community pharmacy have been successful, several have been 
unsuccessful due to various factors (Agomo 2012a; Agomo and Ogunleye 2014). 
According to the Secretary of State for Health, Britain is now the most obese nation in 
Europe (DoH 2010a). In addition, Britain has one of the worst rates of sexually transmitted 
infections (STIs), with a relatively large population of problem drug users and increasing 
levels of harm from alcohol consumption (DoH 2010a). As it pertains to STIs, some of these 
infections (e.g. chlamydia and hepatitis B), can be further managed through the wider 
involvement of pharmacists in pharmacy-based vaccination services (Rosado and Bates 
2016). Still, other health difficulties faced by Britain include smoking, which alone claims 
over 80,000 lives every year; poor mental health, tackling which could reduce the overall 
disease burden by nearly a quarter; and health inequalities between the rich and poor, 
which have been getting progressively worse (DoH 2010a). The government white paper 
‘Healthy lives, healthy people’ (DoH 2010a), which responds to Professor Sir Michael 
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Marmot's 'Fair society, healthy lives: Strategic review of health inequalities in England post 
2010' report (Marmot 2010) by adopting its life course framework for tackling the wider 
social determinants of health, uses a new approach, which aims to build people's self-
esteem, confidence and resilience right from infancy, with stronger support for early years 
(DoH 2010a). The white paper complements 'A vision for adult social care: Capable 
communities and active citizens’ (DoH 2010b) in paying more attention to personalised, 
preventative services that are focused on delivering the best outcomes for citizens and 
assist in establishing the Big Society. The white paper builds on 'Equity and excellence: 
Liberating the NHS’ (DoH 2010c) to set out the overall principles and framework for public 
health service that achieves excellent results, unleashing innovation and liberating 
professional leadership (DoH 2010a).  
In a recent white paper, 'Five year forward view', the government presented its plan to 
make greater use of pharmacists through its plan for 'Multispecialty Community Providers’ 
(MCPs), which would become the focal point for a far wider range of care needed by their 
registered patients (NHS 2014). With this arrangement, larger group practices could in 
future begin employing consultants or engage them as partners, bringing in senior nurses, 
consultant physicians, geriatricians, paediatricians and psychiatrists to work alongside 
community nurses, therapists, pharmacists, psychologists, social workers and other staff 
(NHS 2014). Public Health England supports the 'Five year forward view' through its pledge 
to develop its partnership with pharmacy, as well as enable the profession to become an 
integral part of the primary care family (Lawrence 2014). 
Nevertheless, the recent observation by the General Pharmaceutical Council (GPhC), that 
the present Master of Pharmacy (MPharm) degree offered by British universities fails to 
prepare pharmacists with the skills needed to deliver the care and services expected of 
them in the future, further problematises the situation (Anon 2015a). According to the 
GPhC, there is now a need to produce pharmacists who are competent in delivering patient-
centred care and at the same time, have people skills and are able to work in a multi-
disciplinary team (Anon 2015a). This becomes important when we also consider the results 
of a recent Ipsos/MORI poll carried out for the General Pharmaceutical Council (GPhC), 
which revealed that although the public trusts the advice given by a community pharmacist, 
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the degree of trust is lower than that afforded to other health professionals (Ipsos MORI 
2014). 
Regarding new developments in the public health agenda, the motivation for Modernising 
Pharmacy Careers Programme proposal for reform (Smith and Darracott 2011), is the need 
to develop Day 1 pharmacists who can: 
• engage patients and carry out relevant consultations, encouraging and embedding 
safe and more effective use of medicines,  
• support public health through the promotion of healthier lifestyles and the delivery 
of public health services, including aspects of behavioural change, 
• respond to a diagnosis, usually developed by a medical practitioner, formulate a 
plan for initial and ongoing treatment in partnership with the patient, carers and 
other health professionals as appropriate, applying prescribing skills where 
appropriate, 
• lead the pharmacy team and work effectively within a multi-professional team. 
Based on the authors’ review of what was then current arrangements, their ambition for the 
future of pharmacy, as well as their realistic assessment of capabilities, they suggested 
fundamental proposals for reforming pharmacist education and training as a starting point 
for discussions and action: 
• Creating a single five-year MPharm programme, which includes two periods of 
work-based learning (and assessment) and leads to graduation and registration as a 
qualified pharmacist. 
• Building an infrastructure which brings together universities and employers to 
jointly design and deliver the five-year MPharm programme including the planning 
and management of major work-based placements, and the academic and 
professional assessments necessary for satisfactory completion of training and 
registration. 
The main drawback with this document seem to lie with the authorship of the document, 
particularly as it did not include key individuals from other sectors of pharmacy practice, 
notably, the hospital, pharmaceutical industry, primary care or even public health. It is 
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therefore possible that this oversight might have biased the document in favour of mostly 
commercially-led community pharmacy practice, and to some extent, the academia, at the 
disadvantage of other key sectors, whose contribution and role in advancing and sustaining 
the public health (as well as the clinical pharmacy) role of pharmacists cannot be deemed 
insignificant. 
1.2.1 - Overall effectiveness and cost effectiveness of community pharmacists in public 
health 
In terms of the effectiveness of community pharmacists in public health, the US literature 
suggests that the essential public health service where pharmacy presence is most felt is in 
evaluating the effectiveness, accessibility, and the quality of the services they provide 
(Strand, et al. 2016). Next is to link people to needed personal health services and assure 
the provision of health care when otherwise unavailable (Strand, et al. 2016). On the other 
hand, the core competency of Health Policy and Administration was most frequently utilised 
in pharmacy practice (Strand, et al. 2016). Yet, Strand, et al. (2016) also argues that core 
competencies of biostatistics and epidemiology are vital to contribute to many of the 
essential services such as monitor health status to identify and solve community health 
problems; diagnose and investigate health problems and health hazards in the community; 
evaluate effectiveness, accessibility, and quality of personal and population-based health 
services; and research for new insights and innovative solutions to health problems. As is 
probably the case in many countries (including the UK), there is no indication until now that 
neither biostatics nor epidemiology has been high priorities in the US pharmacy curriculum 
(Strand, et al. 2016).  
In the UK, a number of studies have investigated the effectiveness of community 
pharmacists in public health. Notably, is a study that looked at the effectiveness of a 
community pharmacy weight management programme (Boardman and Avery 2014), and 
demonstrated that reductions in weight and waist circumference can be achieved in 
patients who participate in a community pharmacy weight management programme. In this 
study, 281 patients attended the programme across four Primary Care Trusts. The results of 
the study indicated that at 3 months, patients had lost weight (mean change = -3.07 kg) and 
waist circumference (mean change = -3.87 cm), but had no difference in blood pressure. 
However, after 6 months weight and waist circumference were further reduced from 
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baseline (mean change = -4.59 kg, -4.79 cm respectively) and there was a reduction in blood 
pressure (mean change systolic = -9.5 mmHg; diastolic = -4.7 mmHg) (Boardman and Avery 
2014).  
Still, in another UK study that aimed to enhance community pharmacists' involvement in 
pharmacy practice research through peer interview training, the study revealed that 
positive themes from five interviewers included the importance of the topic and their wish 
to learn skills beyond their everyday role (Morecroft, et al. 2015). The small group format of 
the training day helped to build confidence, in addition, interviewers felt that their shared 
professional background helped them to encapsulate relevant comments as well as probe 
effectively (Morecroft, et al. 2015). On the negative, there were challenges, particularly as it 
relates to interviewers balancing research activities with their daily work. Moreover, 
interviewers had trouble when it came to getting uninterrupted time with interviewees, 
which sometimes affected data quality by 'rushing' (Morecroft, et al. 2015).  
On the cost effectiveness of community pharmacists in public health, a recent report by the 
UK Pharmaceutical Services Negotiating Committee (PSNC) indicates twelve services carried 
out by community pharmacies delivered £3.0bn in savings in 2015, offsetting the £2.8bn of 
total funding from the Department of Health (Oswald and Adcock 2015). However, self-care 
support contributed the largest share of overall value, at 40%, followed by 31% for 
medicines support and 29% for public health (Oswald and Adcock 2015). In the United 
States of America, it has been estimated that total spending on healthcare grew by 7.9% in 
2004 and accounted for 16% of the gross domestic product (Tanne 2006), with this 
amounting to $6,280 (£3,520) per person (Smith, et al. 2006). However, in a study that 
estimated the cost-effectiveness of a pharmaceutical care intervention program in Dutch 
community pharmacies that improved patients' adherence to lipid-lowering therapy, it was 
noticed that patients in the MeMO (Medication Monitoring and Optimisation) program had 
a lower risk for therapy discontinuation, RR = 0.49 (0.37 to 0.66), while the effectiveness was 
found to be similar in primary and secondary prevention (Vegter, et al. 2014). The study also 
reported that in a cohort of 1,000 primary and secondary prevention patients, the MeMO 
program led to a reduction of 7 nonfatal strokes, 2 fatal strokes, 16 nonfatal myocardial 
infarctions (MIs), 7 fatal MIs, and 16 revascularizations over patients' lifetime (Vegter, et al. 
2014). While additional medication, disease management, and intervention costs in the 
  
 
26 
MeMO program were €411,000, the cost savings that came from reduced CVEs were found 
to be €443,000. In terms of quality-adjusted life, the MeMO program resulted in 84 quality-
adjusted life-years (QALYs) gained and net cost savings of €32,000, while the clinical benefits 
and cost savings were found to be highest in the secondary prevention population (Vegter, 
et al. 2014). 
Similarly, in another study that performed an economic analysis from the Belgian healthcare 
payer’s perspective, the average overall costs in the base-case analysis per patient for the 
PHARMACOP-intervention and usual care were €2,221 and €2,448, respectively within the 
1-year time horizon (van Boven, et al. 2014). According to the authors, this reflects cost 
savings of €227 for the PHARMACOP-intervention. The PHARMACOP-intervention resulted 
in the prevention of 0.07 hospital-treated exacerbations per patient (0.177 for PHARMACOP 
versus 0.244 for usual care), and at the same time, revealed robust cost-savings in various 
sensitivity analyses (van Boven, et al. 2014). 
In a UK study that screened patients potentially at risk of chronic obstructive pulmonary 
disease (COPD) with validated tools, it was reported that smoking cessation initiation gave a 
project gain of 38.62 life years, 19.92 quality-adjusted life years and a cost saving of £392.67 
per patient screened (Wright, et al. 2015a). In a related study (Wright, et al. 2015b) that 
evaluated the effect of a community pharmacy-based COPD service on patient outcomes, 
that there were significant improvements in patient reported adherence, utilisation of 
rescue packs, quality of life and a reduction in routine general practitioner (GP) visits. The 
intervention cost was estimated to be offset by reductions in the use of other NHS services 
[GP and accident and emergency (A&E) visits and hospital admissions] (Wright, et al. 2015b). 
These savings in the public health activities provided by community pharmacists are also 
supported by the findings of another study (RPS 2014a; Watson, et al. 2014) which reports 
that the cost of treating common ailments (e.g. head lice, threadworms, athlete’s foot, etc.) 
in community pharmacies was about £29.30 per patient. However, when A&E were used for 
the same ailments, the cost was found to be nearly five times higher at £147.09 per patient 
and nearly three times higher at GP practices at £82.34 per patient (Watson, et al. 2014).  
In sum, in the USA, the effectiveness of community pharmacists in public health is felt most 
in evaluating the effectiveness, accessibility, and the quality of the services they provide 
(Strand, et al. 2016). In a Dutch study that looked at adherence to lipid-lowering therapy, 
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the MeMO program resulted in 84 quality-adjusted life-years (QALYs) gained and net cost 
savings of €32,000 (Vegter, et al. 2014).  
In the UK, there is evidence that it is possible to achieve reductions in weight and waist 
circumference in patients who participate in a community pharmacy weight management 
programme (Boardman and Avery 2014). In addition, it is also possible to build community 
pharmacists’ confidence in public health through a small group format training (Morecroft, 
et al. 2015). In another UK study it was reported that smoking cessation initiation gave a 
project gain of 38.62 life years, 19.92 quality-adjusted life years and a cost saving of £392.67 
per COPD patient screened (Wright, et al. 2015a). Still, in a related study it was revealed 
that there were significant improvements in patient reported adherence, utilisation of 
rescue packs, quality of life and a reduction in routine general practitioner (GP) visits 
(Wright, et al. 2015b). To support the argument for community pharmacists’ enhanced role 
in public health, the Watson, et al.  (2014) reveals that the cost of treating minor ailments in 
community pharmacies was almost three to five times lower than when GP practices or A&E 
departments were used. 
1.3 - Defining Public Health 
The definition of public health has changed and developed since the term first appeared in 
the nineteenth century (Baum 2008), with definitions varying between times and contexts 
(Hamlin 2002). The health of populations rather than individuals is often thought to be the 
concern of Public health; therefore, it frequently refers to wider determinants of health 
(DoH 2010a). Unlike other healthcare services, public health is mainly concerned with long-
term health issues and trends (Hunter, et al. 2007). Based on Acheson's (1988) initial 
definition, Wanless has defined public health as: 
 ‘The science and art of preventing disease, prolonging life and promoting health 
 through the organised efforts and informed choices of society, organisations, 
 public and private, communities and individuals.' (Hunter, et al. 2007, p.22) 
The monograph published by the Canadian Federal Minister of Health ‘A new perspective on 
the health of Canadians' (Lalonde 1974), enormously influenced the definition of public 
health as fundamentally different from medicine, and stated that health did not depend 
mostly on medical care but on non-medical factors such as socio-demographic, lifestyle and 
environmental influences (Baum 2008). According to Hunter, et al. (2007), since the end of 
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the 1970s there has been a broad political movement focused on developing what later 
became ‘the new public health’ (Ashton and Seymour 1988) (see Figure 1). 
Nevertheless, for the purpose of my project, I prefer the following definition of public health 
from the UK's Faculty of Public Health: 
 ‘The science and art of promoting and protecting health and well-being, preventing 
 ill health and prolonging life through the organised efforts of society.' (FPH 2010). 
The Faculty of Public Health definition is unique, in that it sees public health as population-
based; it focuses on collective responsibility for health, its protection and disease 
prevention (FPH 2010). In addition, it recognises the important role of the state, as well as 
socio-economic and wider determinants of health; and it stresses partnerships with all those 
whose actions contribute to the health of the population (FPH 2010). According to the FPH 
(2010), there are three key domains of public health practice, namely: Health Improvement 
(inequalities, education, housing, employment, family/community, lifestyles, and 
surveillance and monitoring of specific diseases and risk factors); Improving Services (clinical 
effectiveness, efficiency, service planning, audit and evaluation, clinical governance and 
equity); and Health Protection (infectious diseases, chemicals and poisons, radiation, 
emergency response and environmental health hazards). 
1.4 - Definition of Health and Determinants of Health 
The World Health Organisation (WHO) has defined health as a 'state of complete physical, 
mental and social well-being and not merely the absence of infirmity' (Hunter, et al. 2007, 
p.5). According to Dahlgren and Whitehead (1991) (see Figure 2), the main determinants of 
health include non-modifiable factors (age, sex, hereditary factors) and modifiable ones 
(individual lifestyle factors, social and community influences, living and working conditions 
and general socio-economic, cultural and environmental conditions). Since the determinants 
of health were identified by Dahlgren and Whitehead (1991), there has been increased 
awareness of health as a global issue, with the present threats to global health including 
bioterrorism, climate change and potential pandemics such as the severe acute respiratory 
syndrome (SARS) and Ebola outbreaks (Hunter, et al. 2007). This awareness has also led to 
an enhanced understanding of the factors that can control people’s well-being and positive 
health (see Figure 3).  
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1.5 - The Concept of Advanced Practice 
The United Kingdom Central Council (UKCC), defines advanced practice as, 
 ‘Adjusting the boundaries for the development of future practice, pioneering and 
 developing new roles responsive to changing needs and with advancing clinical 
 practice, research and education to enrich professional practice as a whole.’ (UKCC 
 1994: 20; McGee and Castledine 2003: 18) 
In the case of nursing (which is relevant to pharmacy), it was widely agreed that formal 
preparation beyond the level of initial registration was a necessity, and that advanced 
practice should contain a clinical component that included advanced assessments, ordering 
diagnostic tests, treating patients and referring them to other sources of help, as well as 
acting as a source of professional advice to colleagues (McGee and Castledine 1998, 1999; 
Wilson-Barnett, et al. 2000). Interestingly, several developments in healthcare delivery in 
the UK have been the driving force for advancing professional practice (Por 2008; McGee 
and Castledine 2003). They include, the reduction in junior doctors' hours (Por 2008; McGee 
and Castledine 2003), development of user involvement and consumer groups, patient 
demands for greater choice and accessibility of healthcare, recruitment and retention of 
staff in some specialities, new personal medical services initiatives in primary care, national 
frameworks and government targets for health outcomes (Por 2008). Other demands have 
come from new initiatives in the organisation of care such as, ‘re-engineering' (Humphreys 
1996), ‘patient-focused care' (Department of Health NHS Management Executive 1994), and 
the need to streamline the health service to make it more efficient and more acceptable to 
patients. The additional influences driving the advanced practice agenda in the UK are 
health policies and reforms introduced by the Labour government during the late 1990s and 
early 2000s, designed to improve the quality of services based on local needs and to reduce 
health inequalities (McGee and Castledine 2003; Bradshaw and Bradshaw 2004). However, 
the term ‘advanced practice' hardly existed in the pharmacy literature until recently 
(Meadows, et al. 2004). In the UK, the limited engagement of community pharmacists in 
advanced practice, no doubt, has had huge implications for community pharmacists' ability 
to enhance their public health role from the basic activities with which they have always 
been associated, e.g. smoking cessation, emergency oral contraception provision and health 
advice (Agomo 2012a; Anderson 1998; Anderson and Blenkinsopp 2003) to more advanced 
roles, such as emergency preparedness and response to bioterrorism, climate change and 
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Figure 1. International Milestones in the Development of the New Public Health (Adapted from Baum 2008: 32) 
 
         21st century 
 Ecological health 
 Responses to 
globalisation 
 Global governance 
for health 
 
            Turn of the 21st century 
 Jakarta Conference 
 Healthy settings (cities, villages, 
islands, markets, workplaces) 
 Partnerships 
 Role of private for-profit sector 
 Environmental health more 
pressing 
 
                Early to mid 1990s 
 1991 Sunsvall Health Promotion 
Conference on Supportive 
Environments for health 
 UN Rio Earth Summit - Agenda 21 
 Global Healthy Cities Program 
 
                Mid to late 1980s 
 Ottawa Charter for Health 
Promotion 
 European Healthy Cities 
Program launched 
 Adelaide statement on Healthy 
Public policy 
 
             Early 1980s 
 Goals and targets 
established for HFA 2000 in 
Europe and North America 
 Behavioural risk factor 
programs proliferate 
                  1970s 
 Canadian Lalonde report 
 WHO Alma Ata Health for 
All 2000 strategy 
 Behavioural risk factors 
recognised  
 Heart health programs 
            19th-century roots 
 Local Medical Officers of Health 
 Public health legislation 
 State intervention to provide 
sanitation and clean water 
 Snow removes Broad Street pump 
 Germ theory accepted 
 Improved standard of living (e.g. 
better nutrition and housing) 
 Trade unions established - 
employment conditions improved 
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Figure 2. Main Determinants of Health (Hunter, et al. 2007: 5) 
 
 
 
Figure 3. Global Determinants of Health (Hunter, et al. 2007: 7) 
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potential pandemics, tackling inequalities, and surveillance and monitoring of specific 
diseases and risk factors (Agomo 2012a; Patterson 2008). 
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Chapter 2 – Terms of Reference/Objectives and Review of Relevant 
Literature 
 
2.1 - Terms of Reference 
In my service-focused study (Agomo 2012a); I identified a wide range of roles that 
community pharmacists around the globe were providing in public health. They included, 
smoking cessation services; infection control and prevention; promoting cardiovascular 
health and blood pressure control; provision of emergency hormonal contraception (EHC); 
prevention and management of drug abuse, misuse and addiction; and healthy eating and 
lifestyle advice. This study contributed to the decisions of an important UK public health 
paper (Public Health England 2014). In the same study (Agomo 2012a), I also noted that 
despite the input from various governments to enhance the public health agenda for 
pharmacy, and the numerous opportunities that exist in public health services for 
community pharmacists (DoH 2010a, 2010c; Bjorkman, et al. 2008), UK community 
pharmacy public health practice still remains at a basic level (Agomo 2012a; Anderson 1998; 
Anderson and Blenkinsopp 2003). This observation is supported by Truong and Patterson 
(2010), who argue that although the pharmacy profession has evolved from product-
orientated to patient-centred care, with pharmacists contributing to micro-level public 
health activities (e.g., disease management, health and wellness screening, immunisations, 
medication therapy management), there remain unmet needs for pharmacists in macro-
level public health functions (i.e., assessment, policy development, and assurance at the 
population-based level). 
However, it has been recognised that community pharmacists are in a prime position to 
help combat health issues, many of which are identified risk factors for chronic diseases 
(DoH 2008). This is particularly important, as community pharmacies are easily accessible 
and provide a convenient and less formal environment for those who cannot or do not wish 
to visit other kinds of health services (DoH 2008; McGuire, et al. 2007). 
2.2 - Ontological Reflection 
Reflecting on my ontology, values such as ethics (Fox, et al. 2007), accountability, hard work 
and perseverance guided me. Although I am able to locate the source of my values mainly 
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from my Christian and cultural upbringing, over the years my values have been influenced 
by both my formal and informal education, and my empathy for the unwell. In my role as a 
community pharmacist, I strive to ensure that my values do not influence adversely the 
services I provide to the public. This is in line with the General Pharmaceutical Council's 
standards of conduct, ethics and performance that stipulate the behaviours, attitude and 
values expected of pharmaceutical professionals (GPhC 2012). Guiding these behaviours, 
attitude and values are the seven principles set out by the GPhC. They include: ensuring that 
patients are my first concern; using professional judgement in the interest of patients and 
the public; showing respect to others; encouraging patients and the public to participate in 
decisions about their care; developing my professional knowledge and competence; being 
honest and trustworthy; and taking responsibility for my working practices. However, living 
and working in the UK and experiencing practice that is hugely different from what I 
experienced earlier in Nigeria (in terms of advanced practice), has also changed my practice 
and influenced my values in a positive way. 
2.3 – My Professional Journey  
Briefly, my career as a pharmacist started in Nigeria in 1991 after I had completed a five-
year undergraduate pharmacy programme at the University of Benin, Benin City, Nigeria. 
The unique point about the University of Benin pharmacy programme was its clinical 
orientation, which is slightly different from the science-based pharmacy curriculum offered, 
for example, in the UK. I was later to use this experience to enter the pharmaceutical 
industry in Nigeria as a medical representative, to register and work in the UK as a 
pharmacist, and to develop my role as a freelance pharmaceutical writer and a postgraduate 
student.  
On arrival in the UK in 2000, I went through a conversion programme that involved studying 
independently and taking pharmacy examinations at the University of Sunderland (2001), 
taking another internship programme, this time in a community pharmacy practice in 
London (2001–2002), and taking the Royal Pharmaceutical Society of Great Britain’s                     
pre-registration examination. Essentially, my role as a community pharmacist revolves 
around dispensing patients' prescriptions, counselling patients, answering queries from 
doctors and other healthcare providers, providing minor ailment, smoking cessation and 
emergency hormonal contraception services. Moreover, I am also involved in stock control 
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and ordering, training and mentoring pre-registration pharmacists, technicians and counter 
staff, providing medicine use reviews (MURs) and the new medicines service (NMS), 
providing health checks that involve blood pressure, cholesterol and basal metabolic index 
monitoring, and other general duties.  
Using the MUR or the NMS as an example, my role as a community pharmacist involves 
identifying, during the dispensing process, patients who are on long-term medication, such 
as medicines used in asthma (MUR), or identifying those who are using long-term 
medication for certain conditions for the first time (NMS). I follow this identification of 
patients with discussions that try to establish patients' knowledge and understanding of 
their medicines, how compliant they are with the regimen and any signs of side effects. 
MURs also provide an opportunity for me to give lifestyle advice (on healthy diets, exercise, 
etc.) to patients. In situations where, for example, patients are taking asthma inhalers for 
the first time, I often use this opportunity to teach them how to use and maintain their 
inhalers correctly.  
However, the area that I have found the most challenging as well as motivating in my role as 
a community pharmacist has been in the support of patients with drug addiction problems. 
Normally the role of the community pharmacist in drug addiction lies in the dispensing, and 
sometimes supervision of the consumption of methadone and buprenorphine to drug 
addicts. In the many years I have worked as a community pharmacist in the UK, I have 
noticed that often most community pharmacists do not consider counselling drug addicts to 
get them to quit drug addiction as part of their role. It is therefore not unusual to find many 
addicts taking the same dose (sometimes, high doses) of methadone or buprenorphine for a 
number of years, without any sign of them making an effort to reduce the dose or even quit 
drug addiction entirely. My engagement in a community pharmacy in London, where several 
drug addicts (including a patient with a suicidal tendency) were served, therefore provided 
the opportunity for me to apply indirectly some of the things I learnt with the behavioural 
change models at St. George's Hospital Medical School, Tooting, London (now St. George's, 
University of London).  
In terms of learning, my experience with drug addicts has also strengthened my conviction 
about the role of community pharmacists in public health (Agomo 2006, 2012a). My DProf 
project, which investigates strategies enhancing the public health role of community 
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pharmacists in the UK (excluding Northern Ireland), enables me to advance this learning.   
2.4 - Reflecting on my Role as a Change Agent  
In addition to my role as a community pharmacist, I am also actively engaged in 
pharmaceutical writing, for example dealing with the restructuring of the UK undergraduate 
pharmacy curriculum to enhance both the clinical (Agomo 2004, 2006, 2011) and managerial 
skills (Agomo 2007, 2008a) of pharmacists. I have also published papers on the role of the 
community pharmacist in public health (Agomo, et al. 2006; Agomo 2012a; Agomo and 
Ogunleye 2014), which have contributed immensely to the conceptualisation and development 
of my DProf project. 
In the MSc dissertation I conducted while studying at St. George’s Hospital Medical School 
(now St. George's, University of London) (2005), I looked at 'the current provision of smoking 
cessation services by community pharmacists in an inner-city area’. This was a descriptive, 
cross-sectional survey, in which I mailed questionnaires to all 62 participating community 
pharmacists in Wandsworth PCT. A total of 44 usable responses were collected, a response 
rate of 72%. The results of the survey indicated that the majority of respondents (86%) were 
involved in the management of Nicotine Replacement Therapy (NRT), with most (71%) of 
the NRT services being funded by the Primary Care Trust (PCT) – now replaced by the 
Clinical Commissioning Group (CCG). In that study, I noted that the main difficulties with the 
then pharmacy-based NRT schemes were the pharmacists’ lack of freedom to prescribe 
NRT, the recruitment of patients, high dropout rates and low success rates reported by 
many respondents (Agomo, et al. 2006). 
However, in my service-focused study (King's College, London); I used the scoping review of 
the literature to identify 'the role of community pharmacists in public health'. My main 
objectives for the study were to identify relevant literature from the UK and overseas 
regarding the role of community pharmacists in public health, through electronic database 
searches and grey literature. I limited the search period from January 1985 to November 
2010. In terms of findings, I identified a wide range of roles that community pharmacists 
were providing in public health. The dominant themes being in the areas of smoking 
cessation services, healthy eating and lifestyle advice, provision of emergency hormonal 
contraception, infection control and prevention, promoting cardiovascular health and blood 
pressure control and prevention and management of drug abuse, misuse and addiction. In 
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addition, I also identified several barriers and gaps in the UK evidence base. The gaps were 
significant in themes with no identified UK studies, such as preventing falls in the elderly, 
emergency preparedness and response to bioterrorism, climate change and potential 
pandemics, immunisation and vaccination services and prevention and risk assessment of 
osteoporosis.  
2.5 - Motivation to Study for the DProf 
In terms of my motivation, I will however argue that it was the Population Health module I 
studied during my MSc programme at St. George’s Hospital Medical School (now St. 
George's, University of London), that actually kick-started my interest to investigate further 
the role of pharmacists in public health. Hence, my area of focus in the MSc dissertation - 
smoking cessation, the Service-Focused Study (SFS) and then the DProf programme. In the 
Population Health module, I learnt about a number of public health topics, such as 
measuring the health of populations; sources of information; epidemiological methods; 
patterns of disease; planning and provision of healthcare; effects of health care 
interventions; prevention and screening; and communicable disease control.  
At the same time, the preparatory materials on statistics and research methods enabled me 
to understand research issues such as the main types of study design, their advantages and 
disadvantages. Also, how to select appropriate designs in practice and the importance of 
study design issues, for example, random sampling, random allocation, placebos, blind 
assessment, intent to treat analysis, and eliminating sources of bias. I consider that bringing 
some of these topics (particularly with regard to Public Health) into the undergraduate 
pharmacy curriculum could help to enhance both the knowledge base and the role of 
community pharmacists in public health.  
In 2012, I published a summary of my SFS at King's in the Journal of Pharmaceutical Health 
Services Research (Agomo 2012a). I am extending this work through the opportunity created 
by my DProf programme.  
2.6 - Enhancing the Study’s Viability 
For my project to be viable I believe I need to address both the quantitative and qualitative 
aspects and that by combining the post-positivist and constructivist paradigms; the project 
will deliver results that are more meaningful. While the post-positivist approach will allow 
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for hypothesis testing, through the constructivist approach I will be able to give voice to the 
experiences and perceptions of the other participants (IWBL 2011). Hence, a mixed methods 
approach incorporating both quantitative and qualitative elements creates a significantly 
more coherent project which both analyses the past and develops solutions for the future in 
a sufficiently robust manner to represent a piece of work to be assessed at doctoral level. In 
addition, by integrating qualitative and quantitative data collection methods, it is possible to 
develop a better understanding of the strategies needed to enhance the public health role 
of community pharmacists in the UK (Creswell and Plano Clark 2007). Using these methods, 
my project will therefore involve a postal survey of UK community pharmacists, content 
analysis of UK pharmacy schools’ curricula and semi-structured telephone interviews with 
community pharmacists and other healthcare professionals. 
2.7 - Theoretical Framework 
Regarding the application of social theories to pharmacy practice, there is agreement on the 
role played by the social sciences in pharmacy and pharmacy education (ACPE 2006). 
According to Davies (2010), a good theory not only helps to prevent overlooking of factors 
that may be important determinants of practice, when you link theory to outcomes, it is 
possible to explore why, or why not, any intervention was effective. The Theoretical 
Domains Framework (TDF) is an integrative framework, which is as a vehicle to help apply 
theoretic approaches to interventions aimed at behavioural change (Cane, et al. 2012; 
Duncan, et al. 2012). According to Cane, et al. (2012) behaviour change is vital to improving 
healthcare and health outcomes. Such behaviours may be those of healthcare workers, for 
example, implementation of evidence-based practice of patients, medication adherence of 
the general population, or even smoking cessation and increasing physical activity (Cane, et 
al. 2012). While it has been noted that the TDF enables a wide range of possible theoretical 
explanations for behaviours to be considered (Duncan, et al. 2012), yet McKenzie, et al. 
(2008) argues that the framework is not a theory, as it does not propound relationships 
between its elements. Notwithstanding, the TDF been used to identify barriers to quality 
improvement in healthcare in order to develop interventions (McKenzie, et al. 2008). 
To enable implementation of health care interventions, the TDF can be used prospectively 
(Dyson, et al. 2013; French, et al. 2013; Tavender, et al. 2014) as well as retrospectively in 
theory-based process evaluation (Cane, et al. 2012; Curran, et al. 2013; French, et al. 2013). 
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According to Dyson, et al. (2013), to facilitate the use of theory in implementation research 
and practice, it requires the use of a tool to permit researchers and practitioners to measure 
prospectively the theoretical determinants that represent barriers and levers to practice 
change. It is then possible to use this knowledge to design appropriate theory-informed 
strategies to support change (Dyson, et al. 2013). Hence, the Theoretical Domains 
Framework (TDF), which I chose for my study, brings together the models and theories of 
behavioural change (Jones, et al. 2015). According to Jones, et al. (2015), Susan Michie and 
team at University College London (UCL) developed the TDF. It had 12 domains originally, 
later this was increased to 14 domains – each domain obtained from the constructs of many 
behavioural change theories (Jones, et al. 2015). A domain is defined as comprising, a set of 
similar theoretical constructs (Michie, et al. 2005). The TDF is however intended to be used 
in changing professional behaviour (Jones, et al. 2015). 
In terms of development, experts – theorists, researchers/implementers and health 
psychologists who generated 33 theories and 128 constructs and then grouped constructs 
into domains (Jones, et al. 2015), created the TDF. There was also an interdisciplinary 
validation process by health psychologists, with further validation involving the use of the 
TDF in a number of settings with a variety of topics (Jones, et al. 2015). The fourteen 
domains include the following: knowledge; skills; social influences; memory, attention and 
decision processes; behavioural regulation; professional/social role & identity; beliefs about 
capabilities (self-efficacy); beliefs about consequences; optimism; intentions; goals; emotion; 
environmental context and resources (environmental constraints); and reinforcement (Jones, 
et al. 2015).  
According to Lipworth, et al. (2013), in the TDF, “knowledge” refers to an awareness of the 
existence of something”. “Knowledge” therefore is seen to be important as a person’s 
perceived awareness of the scientific rationale, procedure(s), and task environment related 
with a desired behaviour is likely to determine whether or not a person implements it 
(Lipworth, et al. 2013). “Skills” refer to “an ability or proficiency acquired through practice”, 
and considered important, as a person’s perceived sense of their own competence in 
carrying out a desired behaviour is likely to determine whether they will be interested to 
implement it (Lipworth, et al. 2013). In TDF, “beliefs about capabilities” refers to 
“acceptance of the truth, reality, or validity about an ability, talent, or facility that a person 
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can put into constructive use” (Lipworth, et al. 2013). Again, this is relevant as the level of 
confidence a person has about their ability to carry out a particular behaviour is also likely to 
influence whether or not they execute it (Lipworth, et al. 2013). In regard to “beliefs about 
consequences”, this refers to an “acceptance of the truth, reality, or validity about the 
outcomes of a behaviour in a given situation” (Lipworth, et al. 2013). Hence, the beliefs a 
person has about the outcomes of a particular behaviour will influence if or not they decide 
to conform (Lipworth, et al. 2013). On the other hand, “social and professional role and 
identity” refers to a “coherent set of behaviours and displayed personal qualities of an 
individual in a social or work setting (Lipworth, et al. 2013). Here, it argues that the extent to 
which someone believes that a particular behaviour evens up with his or her 
social/professional identity will determine whether he or she will implement it (Lipworth, et 
al. 2013). 
In the TDF, “social influences” refer to “those interpersonal processes that can cause 
individuals to change their thoughts, feelings, or behaviours”. Hence, factors such as 
pressure, encouragement, or support from others can frequently affect the performance of 
a desired behaviour (Lipworth, et al. 2013). In regard to “environmental context and 
resources”, this domain refers to “circumstances of a person’s situation or environment that 
discourages or encourages the development of skills and abilities, independence, social 
competence, and adaptive behaviour” (Lipworth, et al. 2013). Therefore, the nature of the 
environment in which a person is expected to carry out a specific behaviour is likely to 
influence their ability and willingness to perform it (Lipworth, et al. 2013). 
On “optimism”, this refers to “the confidence that things will happen for the best or that 
desired goals will be attained”. Here, it argues that the extent to which a person believes a 
goal will be attained, will influence the probability of the individual carrying out the 
behaviour(s) that will lead to that goal (Lipworth, et al. 2013). Concerning “emotion”, it 
concerns “a complex reaction pattern, involving experiential, behavioural, and psychological 
elements, by which an individual attempts to deal with a personally significant matter or 
event”. Hence, it is believed that negative emotions such as fear and anxiety, as well as 
positive emotions for example joy and pride, linked with a desired behaviour, are expected 
to influence whether or not a person chooses to do it (Lipworth, et al. 2013).  
According to the TDF, “reinforcement” relates to “increasing the probability of a response 
  
 
41 
through a dependent relationship, or contingency, between the response and a given 
situation” (Lipworth, et al. 2013). Reinforcement is also important as perceived rewards and 
punishments affiliated with performance or non-performance of a specific behaviour can 
determine whether a person decides to perform it (Lipworth, et al. 2013). On “intention”, 
this is “a conscious decision to perform a behaviour or a resolve to act in a certain way” 
(Lipworth, et al. 2013). Therefore, the level of motivation or commitment a person has to 
behave in a specific manner will determine whether they carry it out (Lipworth, et al. 2013). 
On the other hand, “goals” refer to “mental representations of outcomes or end states that 
an individual wants to achieve” (Lipworth, et al. 2013). Here, the presence of a goal and the 
value set on it in regards to a particular behaviour, is likely to determine whether or not the 
behaviour will be performed (Lipworth, et al. 2013).  
Yet, in the TDF, “memory, attention and decision processes” refer to “the ability to retain 
information, focus selectively on aspects of the environment, and choose between one or 
more alternatives” (Lipworth, et al. 2013). In this case, it argues that remembering to 
execute a particular behaviour or remaining focused on it, is likely to influence whether or 
not the individual performs the behaviour (Lipworth, et al. 2013). Finally, “behavioural 
regulation” refers to “anything aimed at managing or changing objectively observed or 
measured actions” (Lipworth, et al. 2013). This is considered relevant as the availability of 
an action plan or monitoring progress towards a behaviour is likely to affect whether or not 
a behaviour is implemented or an outcome is attained (Lipworth, et al. 2013).  
Although the TDF is known to have a number of strengths that might include, the fact that it 
provides a clear structure as well as has multidisciplinary application, however, it is known 
to have a number of limitations that might include, the fact that it is still on trial; the 
confusion surrounding if it is a theory of itself or just a framework of theories, and the 
challenge associated with the large number of constructs it has (Jones, et al. 2015). In 
addition, many consider the operationalization of the TDF challenging, due to a perceived 
lack of familiarity with the framework, hence, considerable variations in the reported 
understanding of the framework (Phillips, et al. 2015). Still, the lack of clear operational 
definitions can complicate the development of a clear understanding of the domains and 
associated constructs for each domain (Phillips, et al. 2015).  
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While, for example, through the survey questionnaire, it is possible for me to assess 
community pharmacists’ knowledge, attitude and behaviour regarding enhancing their 
public health role and determine their perceived barriers or facilitators to enhancing this 
role; through the interview of UK healthcare professionals and content analysis of UK 
undergraduate pharmacy curriculum, I am also able to determine any perceived social 
pressure, etc., against this role.  
Regarding public health interventions, Blenkinsopp, et al. (2002) have argued that during 
the last decade, the Transtheoretical Model (TTM) has become pre-eminent in health 
promotion in the UK. This is significant, as TTM is a theoretical model of behaviour change, 
which used in interventions to encourage the cessation, for example, of smoking and drug 
misuse or the adoption of specific behaviours such as exercise and healthy eating 
(Blenkinsopp, et al. 2002). Anyway, as some of the anticipated strategies in enhancing the 
role of community pharmacists in public health might also involve changing their attitudes 
and behaviours towards the public health role, one would therefore anticipate that a 
greater appreciation and application of these behavioural change models   by pharmacists, 
their trainers and possibly employers, will lead to better outcomes in public health practice. 
Having said that, the motivational theories are not without limitations, particularly as many 
of them tend to give little consideration to the social, economic and cultural environments 
in which people’s behaviours occur (Baum 2008), hence, my choice for the TDF. For this 
project, I have used the TDF throughout to underpin the research. My research project 
focused throughout on public health. 
2.8 - Review of Literature and Information 
2.8.1 - Introduction 
In a service-focused study (Agomo 2012a), I identified smoking cessation services; infection 
control and prevention; promoting cardiovascular health and blood pressure control; 
provision of emergency hormonal contraception (EHC); prevention and management of 
drug abuse, misuse and addiction and healthy eating and lifestyle advice as the main roles 
provided by community pharmacists in public health. There were, however, gaps in 
methodological issues, and in the UK evidence base, particularly as it relates to preventing 
falls in the elderly, immunisation and vaccination services, and prevention and risk 
assessment of osteoporosis. 
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In that study, I also noted that despite the input from various governments to enhance the 
public health agenda for pharmacy and the numerous opportunities that exist in public 
health services for community pharmacists (DoH 2010a, 2010c; Bjorkman, et al. 2008), UK 
community pharmacy public health practice still remains at a basic level (Agomo 2012a; 
Anderson 1998; Anderson and Blenkinsopp 2003). This observation is supported by Truong 
and Patterson (2010), who argue that although the pharmacy profession has evolved from 
product-orientated to patient-centred care, with pharmacists contributing to micro-level 
public health activities (e.g., disease management, health and wellness screening, 
immunisations, medication therapy management), there remain unmet needs for 
pharmacists in macro-level public health functions (i.e., assessment, policy development 
and assurance at the population-based level).  
2.8.2 - Search Strategy 
In 2012, I conducted a literature search by searching five databases: Google Scholar, 
CINAHL, Biomedical Reference Collection database, MEDLINE and International 
Pharmaceutical Abstracts. The aim of my literature search was to determine what earlier 
work on strategies enhancing the public health role of community pharmacists had already 
been conducted. The search terms I used were: ‘enhancing’ or ‘enhance’ or ‘enhanced’ or 
‘advancing’ or ‘advance’ or ‘advanced’ and ‘public health’ and ‘community pharmacy’ or 
‘pharmacy’ or ‘community pharmacists’ or ‘pharmacists’. I limited the search dates from 
January 2007 to May 2012 to ensure that I used only recently published materials. I also 
limited the search to full text, experiments on humans and English language. Most of the 
papers I identified originated from outside the UK (mainly from the USA). I considered all 
citations, read abstracts of interest, and selected final references. I only included original 
papers, excluding materials published before 2007 or studies not related to enhancing the 
public health role of community pharmacists. In addition, I excluded publications in foreign 
languages due to the cost and time involved in translating materials, as well as Bachelor’s 
and taught MSc dissertations and book reviews. The initial search using the search terms 
and before using the filters, generated 1.3 million references, most of which were unrelated 
to my topic of interest. I then used the filters above and removed all duplicates: the 
searches performed for the five electronic databases generated 36 usable references, which 
are summarised in Tables 1a and 1b. 
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2.8.3 - Results 
In terms of distribution, I found that 27 of my 36 identified papers were empirical studies 
(75%), one paper was a literature review (2.8%) and eight papers were reviews (reports and 
commentaries, 22.2%). While the majority of the papers I identified originated from the USA 
(21, 58.3%), I however noticed a significant gap in the UK evidence base (7 papers, 19.4%), 
particularly for those themes where I identified no UK papers (see Table 1a and 1b; for 
definition of categories, see Table 2). In terms of the composition of the empirical studies, I 
noticed that the majority of the papers used a quantitative approach in their study, while 
only three papers (8.3%) used a mixed method approach (Trapskin, et al. 2009; McDaniel 
and Malone 2011; Johnson, et al. 2009). There was also a significant gap in the quality of 
evidence of the papers I reviewed, as I identified only one literature review study (Eades, et 
al. 2011).  
Following my review of knowledge and information on strategies for enhancing the public 
health role of community pharmacists, a number of themes emerged (see Tables 1a and 1b). 
2.8.3.1 - Use of Social Media in Public Health Education 
According to Cain, et al. (2010), it is now possible to use social media through, for example, 
facilitating the organisation of people and distribution of content, to enhance the public 
health role of community pharmacists. Hence, through evolutions in social media (e.g., 
Facebook, Text messaging, Skype, Twitter, YouTube, etc.) (Cain, et al. 2010; Lam 2013), we 
are beginning to see a change in the way society communicates. While the authors 
acknowledge that implementing health interventions via social media poses challenges, they 
also highlight the fact that several examples exist that display the potential for pharmacists 
to use social media in health initiatives. The only concern I have with the paper was that it 
provides no information about how the provision of public health services by pharmacists 
through social media will be funded. This paper, however, strengthens my position on the 
adoption of new technologies in UK pharmacy practice (Agomo 2008b, 2012b).  
Considering the impact which the use of social media could have in helping pharmacists 
deliver education and public health content,  as well as its ability to enable pharmacists 
deliver public health activities at a distance, particularly to those individuals who are not 
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able to visit pharmacies in person, the use of these tools in practice could be seen as an 
enabler in the public health role of the pharmacist. 
2.8.3.2 - Developing Good Adherence Strategies for Patients 
In a retrospective study, evaluating the factors associated with compliance with thiazide 
diuretics in a Chinese hypertensive population, Wong, et al. (2011a) show that paying fees 
and follow-up visitors are significantly associated with better anti-hypertensive compliance. 
However, patients who were newly prescribed thiazide diuretics and those with poorer 
socio-economic status are more likely to be non-compliant with anti-hypertensive therapies. 
The identified link between fee paying and compliance is helpful in tackling medicine 
wastage, with recent estimates in England currently in the order of £300 million per year 
(Trueman, et al. 2010). Community pharmacists developing good compliance strategies will 
help minimise medicine wastage, as well as guaranteeing better health outcomes for 
patients. However, closely related to this, is the findings of a US cross-sectional mail survey 
that investigated the influence of pharmacists’ attitudes to their intention to report serious 
adverse drug events (ADEs) to the Food and Drug Administration (Gavaza, et al. 2011). 
While 90% of the respondents felt that reporting serious ADEs would improve patient 
safety, 72.6% indicated that reporting serious ADEs was time-consuming. Over half (55.5%) 
of the respondents felt that reporting serious ADEs would disrupt the normal workflow 
(Gavaza, et al. 2011). Developing good adherence strategies for patients (such as, paying 
fees, follow-ups, reporting serious ADEs and simplifying regimens) is an enabler in the public 
health role of pharmacists, particularly as it concerns minimising medicines wastage and 
ensuring that patients take their medicines correctly, as prescribed. 
2.8.3.3 - Enhancing the Public Health Content of Pharmacy Curricula 
According to Brown-Benedict (2008), doctorally prepared public health officials design, 
implement and evaluate health programmes and policies, translate research and 
communicate for policy and health system change (Drexel University 2015). In an 
investigation of the public health content of US pharmacy schools, through a web-based 
survey, DiPietro, et al. (2011) found that about 21% of respondents offered a joint Master of 
public health degree (PharmD/MPH), while approximately 14% indicated that a minor in 
public health was available. While the PharmD programmes offered by most US pharmacy 
schools tended to include more curricular elements related to assessment and assurance 
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than policy development, the public health topics offered were most often reported to be 
part of a broader course rather than stand-alone courses. The Doctor of Public Health 
(DrPH) degree is not yet popular with UK pharmacists (Anderson 2012). However, one of the 
objectives of my project will be to assess if a change in the UK undergraduate pharmacy 
curriculum (Agomo 2012c) to increase its public health content could help enhance the 
public health role of community pharmacists in the UK. It has been argued that one possible 
reason for the low popularity of the DrPH degree in the UK might be that universities 
offering the programme have yet to ‘define a market for the graduates’ of the programme 
(Paccaud, et al. 2011), unlike in the USA where the market for DrPHs is fully developed. 
Also related to this is the finding of a UK systematic review study (Eades, et al. 2011) that 
investigates pharmacist and consumer views concerning public health in community 
pharmacy. According to Eades, et al. (2011), to improve public health services in community 
pharmacy, there will be a need to increase pharmacists’ confidence in providing public 
health services through enhancing their training. Still, in a US study in which Brown, et al. 
(2007) evaluate the effectiveness and impact of an elective service-learning course, it is 
noted that by exposing students to issues affecting individuals and the community, brought 
about a positive change in the students’ perception of their knowledge and understanding 
of broader issues facing the community. Enhancing the public health content of pharmacy 
curricula will help wide the knowledge base and skills of students/pharmacists in public 
health, irrespective of the practice setting of the graduating pharmacists (Addo-Atuah 
2014). This is therefore an enabler in the public health role of the pharmacist, as enhancing 
the public health content of the UK pharmacy curricula will widen and enhance the 
knowledge base of graduates in public health, as well as give pharmacists the confidence to 
collaborate actively with other public health practitioners. 
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Table 1a. Overview of Papers Included in the Review of Knowledge and Information - Demonstrating Strategies that can Enhance the Public Health Role of 
Community Pharmacists  
 
Theme 
No. of 
papers 
per 
theme 
Countries of origin and type 
 
 
*No and categories 
of papers  
No. of 
empirical 
studies 
No. of lit. 
reviews 
No. of 
guidelines 
No. of 
reviews  
(reports and 
commen-
taries) 
Total no. of 
UK papers 
Minimising the spread 
of infections 
1 1 Ghana, empirical 
 
1 B3 1 0 0 0 0 
Use of social media 1 1 USA, review 
 
1 D 
 
0 0 0 1 0 
Developing good 
adherence strategies for 
patients 
2 2 USA, empirical 
 
2 B3 2 0 0 0 0 
Promoting patients’ 
self-management 
capacities 
3 1 UK, review 
2 Hong Kong, empirical 
1 D 
2 B3 
2 0 0 1 1 
Enhancing 
communication 
techniques 
5 2 USA, empirical 
2 Australia, empirical 
1 Thailand, empirical 
 
1 B1, 1 B3 
2 B3 
1 B3 
 
5 0 0 0 0 
Promoting 
interdisciplinary 
initiatives 
2 1 USA, review 
1 UK, empirical 
1 D 
1 B3 
1 0 0 1 1 
Strengthening safe 
medication disposal 
methods 
1 1 USA, empirical 
 
1 B3 
 
1 0 0 0 0 
Enhancing the 
management of 
polypharmacy and long-
term conditions  
1 1 USA, review 1 D 0 0 0 1 0 
  
 
48 
Remunerating 
pharmacists directly for 
providing public health 
services 
2 1 USA, empirical 
1 UK, empirical 
 
1 C1 
1 B3 
2 0 0 0 1 
*See Table 2 for the definition of categories. 
 
Table 1b. Overview of Papers Included in the Review of Knowledge and Information - Demonstrating Strategies that can Enhance the Public Health Role 
of Community Pharmacists (contd.) 
Theme 
No. of papers 
per theme 
Countries of origin and type 
No. and  categories 
of papers 
No. of 
empirical 
studies 
No. of lit. 
reviews 
No. of 
guidelines 
No. of 
reviews 
Total no. of 
UK papers 
Innovating smoking 
cessation activities of 
pharmacists 
2 1 Finland, empirical 
1 USA, empirical 
1 B3 
1 C2 
2 0 0 0 0 
Advancing pharmacy 
practice experience of 
students in public health 
6 5 USA, empirical 
1 USA review 
 
3 B2, 2 B3 
1D 
 
5 0 0 1 0 
Managing legitimate 
medication needs to 
prevent drug-related 
problems 
3 1 USA, review 
1 USA, empirical 
1 Australia, review 
1 D 
  1 B1 
1 D 
1 0 0 2 0 
Enhancing the public 
health content of 
pharmacy curricula 
4 2 USA, empirical 
1 USA, review 
1 UK, literature review 
 
2 B3 
1 D 
1 A2 
2 1 0 1 1 
Other identified studies 3 2 UK, empirical 
1 NZ/England, empirical 
2 B3 
1 B3 
3    3 
Total number of 
studies  
36   27 1 0 8 7 
  *See Table 2 for the definition of categories. 
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Table 2. Evidence Categories used by the Department of Health in the National Service Frameworks 
(Anderson, et al. 2004: 194) 
Evidence from research and other professional literature  
A1 Systematic reviews which include at least one Randomised Controlled Trial                 
(RCT), e.g. systematic reviews from Cochrane or NHS centre for reviews and 
dissemination. 
 
A2 Other systematic and high-quality reviews, which synthesise references. 
 
B1 Individual RCTs. 
 
B2 Individual non-randomised, experimental/intervention studies. 
 
B3 Individual well-designed non-experimental studies, controlled statistically if 
appropriate. Includes studies using case control, longitudinal, cohort, 
matched pairs or cross-sectional random sample methodologies, and well-
designed qualitative studies; well-designed analytical studies including 
secondary analysis. 
 
C1  Descriptive and other research or evaluation not in B (e.g. convenience 
samples). 
 
C2 Case studies and examples of good practice. 
 
D Summary review articles and discussions of relevant literature and conference 
proceedings not otherwise classified. 
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2.8.3.4 - Enhancing the Effectiveness of Students’ and Pharmacists’ Communication 
Techniques 
In a survey that explores the self-reported techniques used by health care professionals to 
enhance communication with patients with low health literacy, Schwartzberg, et al. (2007) 
found that using simple language (94.7%), handing out printed materials (70.3%) and 
speaking more slowly (67.3%) were the most commonly used strategies. While the most 
frequently used techniques were basic in nature, there was little attempt made by health 
care professionals to assess patient understanding. Of the more advanced techniques 
examined, none were used by a majority of those surveyed. In a related study, Emmerton, 
et al. (2010), through structured interviews, explored the health literacy competencies of a 
sample of community pharmacy consumers. According to their study findings, 87% of 
respondents recognised a sample prescription, while 20% could not readily match the 
prescription to a labelled medicine box. Although 82% of respondents interpreted ‘three 
times a day’ appropriately, the interpretation of a standard ancillary label was highly 
variable. Independently related to lower performance in some variables were, advanced 
age, less formal education, non-English-speaking background and male gender were. Also 
confirmed in a recent study in England, is the need for healthcare practitioners to improve 
their communication techniques (Rowlands 2012).  
The findings of an Australian study also supported this need for enhanced communication 
techniques for pharmacy students and pharmacists (Roughead, et al. 2011). According to 
the paper, enhanced communication and transfer of information between healthcare 
providers and healthcare settings can reduce medication and healthcare errors post-
hospital discharge (Roughead, et al. 2011). Still, in a separate study conducted in Thailand 
(Sookaneknun, et al. 2009) that reported the results of providing health information through 
a university community pharmacy to its surrounding community, it is noted that the 
community living near the community pharmacy responded positively to the health 
information centre service provided by pharmacists or PharmD students, especially with 
reference to chronic diseases. Finally, a US study (Carter, et al. 2008) looks at the 
background and methods of an on-going study to determine the effects of hospital 
pharmacists’ enhanced communication with patients and their community providers; the 
study hoped to address the value of a pharmacist case manager in improving the 
communication of care plans between the inpatient and community settings, hence 
 51 
 
optimising the use of medication. 
One of my project objectives is to assess the opinion of practitioners on the teaching of 
content-specific/advanced communication techniques to undergraduate pharmacy students 
and pharmacists. Enhancing the effectiveness of communication techniques is an enabler in 
the public health role of the pharmacist, in the sense that assessing patients’ understanding, 
enhancing communication and transfer of information between healthcare providers and 
healthcare settings can reduce medication and healthcare errors post-hospital discharge 
(Roughead, et al. 2011).  
2.8.3.5 - Promoting Interdisciplinary Initiatives in Pharmacy Education and Practice 
There is now an emphasis in the UK on interdisciplinary initiatives in the management of 
many causes of ill health (News Team 2012b). In the USA, inter-professional education is 
driven by health professional education associations such as the Association of American 
Medical Colleges, the American Association of Colleges of Pharmacy and so on (AAMC 
2012). However, in a commentary provided in another study, Sampselle, et al. (2010) 
summarise current clinical research directives, as well as other interdisciplinary initiatives. 
According to the authors, the National Institutes of Health Clinical and Translational Science 
Award (CTSA) initiative is driven by the ‘urgent need to transform health and medicine from 
the curative and onerous paradigm of today to the vision of a more predictive, personalized, 
and pre-emptive world of health care’ (Zerhouni 2006: 1090). To accomplish this paradigm 
shift, a mandate for greater interdisciplinarity has been issued (Zerhouni 2003). Supporting 
the interdisciplinary initiative are the findings of a UK study that investigates the community 
pharmacy ‘minor ailment scheme’ (MAS) across three primary care trusts in the North East 
of England (Baqir, et al. 2011). During the observation period, 396 patients used the MAS, of 
whom 230 (58.1%) indicated they would have made an appointment with their general 
practitioner (GP) if the MAS was not in place. In addition, there was an estimated reduction 
in local healthcare costs by £6739 per month through MAS. The authors therefore conclude 
that the MAS released National Health Service (NHS) resources (especially in relation to GP 
consultations) by preventing (or minimising) patient use of alternative and costlier branches 
of the NHS (Baqir, et al. 2011). This study is also complemented by the findings of a fairly 
recent study (RPS 2014a; Watson, et al. 2014) that reports that the cost of treating common 
ailments (e.g. head lice, threadworms, athlete’s foot, etc.) in community pharmacies was 
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about £29.30 per patient, however, when the same ailments were treated at A&E, the cost 
was found to be nearly five times higher at £147.09 per patient and nearly three times 
higher at GP practices at £82.34 per patient. In total, the study estimated that 3% of all A&E 
consultations and 5.5% of GP consultations for common ailments could be managed in 
community pharmacies (Watson, et al. 2014). This translated to over 650,000 visits to A&E 
and over 18 million GP consultations per year that could be diverted, with a total annual 
cost saving of over £1billion (RPS 2014a; Watson, et al. 2014). My project hopes to enhance 
interdisciplinarity by assessing if pharmacy students training closely with other healthcare 
students and, later, graduates working closely with other healthcare providers could help to 
enhance the public health role of community pharmacists in the UK. Due to its ability to 
bring considerable savings and better health outcomes to the NHS, as well as encouraging 
collaborative practice, promoting interdisciplinary initiatives in pharmacy education and 
practice is also an enabler in the public health role of the pharmacist. 
2.8.3.6 - Supporting Efforts Aimed at Preventing the Development of Antimicrobial 
Resistance and the Spread of Infections 
Antibiotic resistance continues to be a global problem. However, in my service-focused 
study (Agomo 2012a); I identified the role of community pharmacists in infection control. In 
a structured questionnaire conducted in the Ashanti region of Ghana, Buabeng, et al. (2007) 
found that the majority of severe malaria cases (89%) were in children aged five years or 
less. In terms of sourcing, medicines came from licensed chemical sellers (50%), pharmacies 
(21%), neighbouring clinics (9%), or ‘other’ sources (20%), including leftover medicines at 
home. Some of the identified limitations in the paper included 247 (49%) of the study 
participants being lost to follow-up for outcomes assessment at the health facilities due to 
untraceable addresses or living too far from the facilities, and the study targeting only one 
region in the country and two facilities within that region. In the UK, there has been an 
active effort to encourage prescribers to minimise the way they prescribe antibiotics to 
patients, to reduce the development of resistant bacteria (Parkes 2014). Pharmacists 
supporting this initiative is an enabler in the public health role of pharmacists, as it 
promotes a healthier society. It is also possible for pharmacists to support other healthcare 
practitioners to minimise the spread of various communicable diseases, such as, human 
immunodeficiency virus (HIV), tuberculosis, herpes, chlamydia through educational activities 
and public awareness. 
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2.8.3.7 - Promoting Patients' Self-Management Capacities 
According to Taylor and Bury (2007), there are three areas relevant to enhancing NHS 
patients’ self-management capacities. They include the policy formation process leading up 
to the Expert Patients Programme's (EPP) present stage of development; the evidence base 
supporting claims made for its effectiveness; and the significance of psychological concepts 
such as self-efficacy in approaches to improving public health. However, some of the issues 
raised in the paper that concern funding would no longer be valid, particularly as new 
bodies - the NHS Commissioning Board Authority and the Clinical Commissioning Groups 
(CCGs), now control NHS funding. 
In a cross-sectional phone survey, You, et al. (2011) examine Hong Kong public knowledge, 
attitudes and behaviours regarding self-medication, self-care and the role of pharmacists in 
self-care. Although in this study, the majority of respondents supported the idea that 
patients with chronic illness can self-manage their diseases, the revelation that less than 
half agreed to use a pharmacist-led approach in self-care is an issue that should concern EPP 
development in the UK. However, in related work, Wong, et al. (2011b) explore the 
perspectives of physicians, pharmacists, traditional Chinese medicine (TCM) practitioners 
and dispensers on the self-management of patients with chronic conditions, in addition, 
they explore the possibilities of developing pharmacist-led patient self-management in Hong 
Kong. Similar to the findings of You, et al. (2011), UK pharmacists ought to be worried about 
the concerns of some professionals who believed that pharmacists were drug experts only 
and could therefore only play an assisting role. This perception of pharmacists having 
insufficient training in disease management highlights once again my view that there is a 
need to strengthen both the clinical and the public health training of UK pharmacists 
(Agomo 2004, 2006, 2011, 2012c). As promoting patients’ self-management capacities can 
empower patients to take greater control of their health and wellbeing, as well as save 
money to the NHS, by minimising day-to-day involvement of other healthcare practitioners 
in patients’ care, this theme is an enabler in the public health role of pharmacists. 
2.8.3.8 - Strengthening Patients' Education in Safe Medication Disposal Methods 
In a US, cross-sectional survey to determine the public’s current method of medical disposal 
and knowledge of the environmental impact of inappropriate medication disposal, Abrons, 
et al. (2010) found that respondents frequently flushed medications down the toilet (27.2%) 
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or incorrectly dumped medications in the trash (34.6%). While only 30.9% had received 
previous advice on safe medication disposal, post-education survey results indicated that 
80.1% of respondents were willing to change their disposal methods, and increased 
numbers of respondents viewed inappropriate medication disposal as a moderate to 
substantial problem (from 57.2% pre-education to 83.9% post-education). There is evidence 
suggesting that the trend may not be much different in the UK (Fradgley and Smith 2012). 
Strengthening patients’ education in safe medication disposal methods is an enabler in the 
public health role, as contamination and injury (from sharp items) are minimised. As many 
patients (including addicts) may not even be aware that their local pharmacies have facilities 
for safe medication disposal practices, awareness is important for better uptake and 
outcome. 
2.8.3.9 - Enhancing the Management of Polypharmacy and Long-term Conditions 
According to a US study that looks at polypharmacy and combination therapy (Munger 
2010), the risks of polypharmacy and the potential for inappropriate therapy must be 
considered and balanced against the possible benefits of multiple drug therapies. The paper 
suggests that an optimal approach to reducing the risks and maximising the benefits of 
polypharmacy should include regular reviews of patients’ medication lists, which can then 
be changed to include, where appropriate, combination therapy and the use of single-pill 
combinations (Munger 2010). This is similar to what community pharmacists now do in 
England, known as the ‘Medicines Use Review’ - a service that may require further overhaul 
to make it more relevant to patients. Interestingly, The Scottish Government has recently 
published guidance on tackling polypharmacy at a national level (NHS Scotland and The 
Scottish Government 2012). Deviating from the widely accepted definition of polypharmacy, 
which is ‘the taking of four or more medicines’, the Scottish solution is to redefine 
polypharmacy to ‘mean when a patient is taking more drugs than needed’ (NHS Scotland 
and The Scottish Government 2012). Considering the several benefits associated with the 
management of polypharmacy and long-term conditions, such as, regular reviews of 
patients’ medication lists to minimise drug-drug interaction, non-compliance and side 
effects, this theme is enabler in the public health role of the pharmacist. 
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2.8.3.10 - Managing Legitimate Medication Needs to Prevent the Accidental use of Banned 
Substances 
According to a US study that looks at the educational opportunities and anti-doping roles 
and responsibilities of pharmacists (Ambrose 2011), pharmacists can assist in anti-doping 
activities by managing the legitimate medication needs of athletes to prevent them from 
accidentally using a banned substance, as well as educating athletes and the public about 
the health consequences of using performance-enhancing substances. While pharmacists 
can also work with anti-doping agencies, the main barrier to pharmacists’ involvement in 
anti-doping activities is that there are presently very few established educational 
opportunities for pharmacists and pharmacy students; hence the need to develop 
educational programmes in sports pharmacy and doping control for postgraduate training 
and for experiential (internship) programmes (Ambrose 2011).  
The findings of another US study (Lee, et al. 2009) support the role of pharmacists in 
managing the legitimate medication needs of the public. This study determined the 
effectiveness of TIMER (Tool to Improve Medications in the Elderly via Review) in helping 
pharmacists and pharmacy students to identify drug-related problems during patient 
medication reviews. According to the paper, TIMER resulted in an increase in the number of 
drug-related problems identified by practising pharmacists and pharmacy students during 
medication reviews of hypothetical patient cases (Lee, et al. 2009). Chaar, et al. (2011) have 
also argued for a need to highlight the role of pharmacists in opioid substitution therapy 
(OST), as well as the scope for expanding this role in the future. In terms of advantages, 
Chaar, et al. (2011) also note that for public clinics, patient transfer to community 
pharmacies eases workload and costs and increases capacity for new OST patients. From a 
patient's perspective, they argued that OST dispensing at a pharmacy is more flexible and 
often preferred compared to other service providers. Pharmacists are well placed to gain 
clientele, profit and receive small incentives from state governments in Australia for their 
involvement. Managing legitimate medication needs to prevent the accidental use of 
banned substances can extend the role of pharmacists in sports medicine and anti-doping 
activities. Pharmacists can become the first point of contact for advice, thereby enabling 
specialist role in this area of practice. This theme is definitely an enabler in the public health 
role of the pharmacist. 
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2.8.3.11 - Remunerating Pharmacists Directly for Providing Public Health Services 
In earlier studies I conducted, I identified inadequate remuneration as a major barrier to 
pharmacists’ involvement in public health services (Agomo, et al. 2006; Agomo 2012a). A 
pilot project that described the Wisconsin Pharmacy Quality Collaborative (Trapskin, et al. 
2009) demonstrated that collaboration among payers and pharmacists is possible; 
moreover, this can result in the development of an incentive aligned programme that 
stresses quality patient care, standardised services and professional service compensation 
for pharmacists. Hence, there is a need to change the present community pharmacy model 
(Agomo 2012e), as well as contract and remunerate individual pharmacists/groups of 
pharmacists (partners) directly for providing public health/pharmacy services, as is being 
proposed in Scotland (The Scottish Government 2013). This may not only save money for 
funding organisations, but could also become a huge incentive for pharmacists to engage 
actively in public health services. 
Related to this is the impact the corporation of community pharmacy has on pharmacists’ 
general well-being, as well as on their willingness to provide public health services. Hence, a 
UK paper (Bush, et al. 2009) notes that the level of provision of EHC on patient group 
direction (PGD), supervised administration of medicines and needle-exchange schemes 
were lower in supermarket pharmacies than in other types of pharmacy. While 
supermarkets and multiple pharmacy chains were better in their ability to raise finance for 
service development, the premises of such pharmacies may not be the most suitable for the 
provision of such services (Bush, et al. 2009). Hence, the study argues that there is a need 
for a mixed market in community pharmacy to maintain a comprehensive range of 
pharmacy-based public health services for maximum benefit to all patients. As remunerating 
pharmacists directly for providing public health services can serve an incentive for enhanced 
role in public health, this is also an enabler in the public health role of the pharmacist. This 
can also act as a catalyst for the development of independent pharmacist practitioners 
(IPPs) – pharmacists who are able to work independently or alongside health-visitors to 
handle medicine related challenges faced, for example, by elderly patients, those with 
learning difficulties or disabilities. 
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2.8.3.12 - Innovating Smoking Cessation Activities of Pharmacists 
Several studies have confirmed the role of pharmacists in smoking cessation (SC) (Sinclair 
and Lennox 2001; Hudmon, et al. 2001; West, et al. 2005; Agomo, et al. 2006; Agomo 
2012a). A mail survey that explores the familiarity and implementation of the national SC 
guidelines in Finnish community pharmacies (Kurko, et al. 2010) found that almost half 
(47%) of respondents (n = 1190) were familiar with the SC guidelines and that familiarity 
enhanced guideline implementation. Familiarity was associated with the respondents' 
perceptions of their personal SC skills and knowledge (OR 3.8), the value customers placed 
on counselling on nicotine replacement therapy (NRT; OR 3.3) and regular use of a pocket 
card supporting SC counselling (OR 3.0) (Kurko, et al. 2010). In addition to recommending 
NRT, pharmacists familiar with the guidelines more frequently used other guideline-based 
SC methods, such as recommended non-pharmacological SC aids, compared with unfamiliar 
respondents (Kurko, et al. 2010). However, the association identified in the study (Kurko, et 
al. 2010) between professional self-esteem (Agomo 2012f) and SC activities is a possible 
barrier to the service, which service planners/developers will need to be aware of. The main 
limitation of the study was that the survey was conducted between 2006 and 2007, almost 4 
years before the paper was published. Many aspects may have changed since then. 
In a case study conducted in the USA, the investigators seek to understand what motivated 
retailers to discontinue tobacco sales and what employees and customers thought about 
their decision (McDaniel and Malone 2011). For independent pharmacies, the only reason 
given for the decision to end tobacco sales was that tobacco caused disease and death 
(McDaniel and Malone 2011). Grocers listed health among several other factors, including 
regulatory pressures and wanting to be seen to be ‘making a difference’. While pharmacy 
employees were delighted to no longer be selling a deadly product, grocery store 
management saw the decision to end tobacco sales as enhancing the stores’ image and 
consistent with their inventory of healthy foods. It might be of interest to those pharmacy 
retailers that continue to sell tobacco products that many customers said that knowing that 
retailers were no longer selling tobacco products made them more likely to shop at the 
store. I hope that the recent announcement by CVS Caremark Corp (owners of CVS 
Pharmacy) to stop selling tobacco products at its 7600 stores should encourage other retail 
pharmacies in the UK and globally to follow suit (Wahba and Steenhuysen 2014). The main 
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drawback of the study (McDaniel and Malone 2011) is that it excludes those who could not 
speak English in a state (California) with many Spanish-only speakers. Nonetheless, the 
recent interest shown by the public in the use of e-cigarettes (Hogenboom 2013) has 
created the need for pharmacists to recognise the existence and possibly the effectiveness 
of other non-traditional methods in smoking cessation. This line of thought is supported by 
a recent expert independent evidence review published by Public Health England (PHE), 
which concluded that e-cigarettes are significantly (about 95%) less harmful to health than 
tobacco, with the potential to help smokers quit smoking (McNeill, et al. 2015). The role of 
community pharmacists in smoking cessation is huge, in that they can supply a wide range 
of nicotine products to patients (Agomo, et al. 2006; Agomo 2012a). However, evidence 
from a UK study (West, et al. 2000) also suggests that enhancing the training of community 
pharmacists in the behavioural sciences means that they will be better equipped to use 
behavioural change methods in their counselling sessions. As smoking cessation can help 
minimise the onset of a number of conditions such as, asthma, chronic obstructive 
pulmonary disease (COPD), emphysema, cancers, etc., pharmacists’ enhanced role in 
smoking cessation is an enabler in the public health role of the pharmacist. 
2.8.3.13 - Advancing Pharmacy Practice Experience of Students in Public Health 
However, as the education of future pharmacists in the provision of public health expands, 
so, too, will there be a need for colleges and Schools of Pharmacy to provide opportunities 
for students to develop public health skills through experiential learning (Patterson 2008). 
Supporting this need, the findings of a US intervention study/survey (Patterson 2008) 
identify high satisfaction with the advanced pharmacy practice experience (APPE) in a 
variety of different domains, including provision of pharmaceutical care, providing patient 
education, exercising cultural competency, referring to community resources and utilising 
medication assistance programmes. Interestingly, because of their community experience, 
the students recognised that working behind a pharmacy counter does not give an accurate 
picture of health care beyond the pharmacy (Patterson 2008). Another US intervention 
study (Whitley 2010) observes that post-APPE discussion definitions were broader and more 
accurate. Unsolicited comments about the discussion series documented in post-APPE 
reflections described students’ initial lack of knowledge, improved knowledge base and 
improved interest in participating in public health initiatives (Whitley 2010). The paper 
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concludes that time devoted to public health discussions during an APPE can substantially 
affect student pharmacists’ knowledge base and interest in public health (Whitley 2010). 
While there is presently no pharmacy school in the UK offering the undergraduate PharmD 
programme, it is hoped that introducing a dual pharmacy/MPH degree, or at least 
enhancing the public health content of UK pharmacy curricula, will go a long way towards 
raising the confidence of UK pharmacists as public health practitioners. 
Closely related to this, the findings of another US study (Johnson, et al. 2009) determine, 
among other things, the availability of experiential learning opportunities in culturally 
diverse areas. The paper argues that exposure to diverse populations during advanced 
community practice experiences has parallels with the strategic college objectives of 
expanding and diversifying experiential sites to enhance pharmacy students’ abilities to 
meet emerging patient-care challenges and opportunities. However, the small number of 
faculty participants (two), who were involved in the interview, limits the generalisability of 
their findings. However, in a review paper (Truong and Patterson 2010) that aims to identify 
existing professional and educational initiatives for the pharmacist’s expanded role in public 
health, it was noted that some of the strategies and opportunities for pharmacists to pursue 
advanced educational training in public health will include residency programmes with an 
emphasis on public health, fellowship programmes in healthcare policy or public health 
policy, and graduate degree programmes such as the Master of public health (MPH) and 
public health certifications. Nonetheless, in 2006, the American Pharmacists Association put 
forward a policy statement on the role of the pharmacist in public health, with a call for an 
increase in PharmD/MPH dual degree programmes (Truong and Patterson 2010). This policy 
statement might also benefit UK pharmacy education and practice, and my call for a dual 
pharmacy degree programme in the UK strengthens it (Agomo 2012c). Again, a US study 
(Westrick, et al. 2009) notes that pharmacy college/school-affiliated community pharmacies 
were more likely than non-affiliated pharmacies to participate in immunisation and 
emergency preparedness. Furthermore, a US intervention study (Cerulli and Malone 2008) 
observes that there was an enhancement of women’s awareness about health issue through 
the APPE and health promotion interventions, while guiding students also to achieve the 
desired curricular outcomes. Advancing pharmacy practice experience of students in public 
health can enable students to learn from other healthcare practitioners, as well as widen 
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and enhance their knowledge base and skills in public health, including provision of 
pharmaceutical care, providing patient education, exercising cultural competency, referring 
to community resources and utilising medication assistance programmes. This theme is also 
an enabler in the public health role of the pharmacist. 
2.8.3.14 - Other Identified Studies 
Other identified papers include those that look at supporting community pharmacy-based 
services for alcohol misuse (Horsfield 2011) and community pharmacy travel medicine 
services (Hind, et al. 2008), as well as a study that investigate the general public’s and health 
providers’ perspectives on public health utilisation in community pharmacies (Saramunee, 
et al. 2012). On travel medicine services, a UK paper (Hind et al, 2008) is of the view that 
community pharmacists in the UK presently provide limited travel medicine services. 
However, community pharmacists can enhance this service by offering the travelling public 
general advice on various issues such as bite prevention, provision of immunisations and 
malaria prophylaxis, with the public in many cases also willing to pay for some of the 
services. This willingness to pay for community pharmacy public health services seems to 
agree with the findings of my pre-registration pharmacy audit (Agomo C, unpublished 
observation, 2002). According to a UK paper that looks at how to enhance public health 
service utilisation in community pharmacy (Saramunee, et al. 2012), all four groups of 
participants (the general public, community pharmacists, general practitioners, other 
stakeholders of pharmacy-based public health services) agreed that community pharmacies 
are a good source of advice on medicines and minor ailments, but were less supportive of 
public health services. On barriers, some of the identified factors affecting utilisation of 
pharmacy services, hence, barriers to the public health role of the pharmacist include the 
community pharmacy environment, the pharmacist and support staff, service publicity, the 
public, GP services, and the healthcare system and policies (Saramunee, et al. 2012). Also 
disturbing for service planners and funders (barrier) is the perception of both the general 
public and other health care providers of pharmacists’ competencies, privacy and 
confidentiality in pharmacies, the high dispensing workload and inadequate financial 
support (Saramunee, et al. 2012).  
There is little empirical evidence of the effectiveness of community pharmacy-based 
services for alcohol misuse (Dhital 2004; Fitzgerald and Stewart 2006; Watson and 
 61 
 
Blenkinsopp 2009). However, a New Zealand/England study (Horsfield 2011) that explored 
the views of 40 pharmacists on the prospect of providing screening and brief intervention 
(SBI) for alcohol health promotion purposes, found that there appears to be potential for 
alcohol SBI services in community pharmacy. Nonetheless, for this service to be successful, 
the authors argue that interventions designed to reduce barriers such as apprehension 
about implementing SBI services due to concerns about offending or alienating customers, 
lack of experience and confidence, problems faced with other health promotion initiatives, 
time constraints, privacy and the need for enhanced incentives will need to be addressed 
and evaluated (Horsfield 2011). Enhancing the role of pharmacists in travel medicine and 
alcohol misuse are both enablers in the public health role of pharmacists, as both roles can 
reduce medicines and alcohol related harms (respectively) to the public.  
2.8.3.15 - Conclusions 
In a service-focused study (Agomo 2012a); I identified a wide range of roles that community 
pharmacists were providing in public health. There were, however, gaps in methodological 
issues and in the UK evidence base. In my review of literature and information, I identified a 
wide range of strategies that could help enhance the public health role of community 
pharmacists in the UK. The dominant themes included strategies to enhance the public 
health role community pharmacists through Expert Patients Programme; enhanced 
communication techniques; smoking cessation activities; advanced pharmacy practice 
experience in public health; and the enhancement of the public health content of pharmacy 
curricula. On communication, a study shows that assessing patients’ understanding, 
enhancing communication and transfer of information between healthcare providers and 
healthcare settings can reduce medication and healthcare errors post-hospital discharge 
(Roughead, et al. 2011). On the other hand, Eades, et al. (2011) notes that to improve public 
health services in community pharmacy, there will be a need to increase pharmacists’ 
confidence in providing public health services through enhancing their training.  
There were, however, gaps in the evidence base, particularly instances where there were no 
indications that the studies were piloted (e.g. Patterson 2008; Kurko, et al. 2010; Whitley 
2010; McDaniel and Malone 2011), and ethical considerations (e.g. Patterson 2008; 
DiPietro, et al. 2011) and consent approval (e.g. Schwartzberg, et al. 2007; Patterson 2008; 
Kurko, et al. 2010; Whitley 2010; DiPietro, et al. 2011) were not discussed. In addition,  
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instances where either the sample size was not stated (e.g. Whitley 2010) or the response 
rate was low (e.g. DiPietro, et al. 2011). However, in some of the papers, the outcome 
measures (e.g. Emmerton, et al. 2010; DiPietro, et al. 2011; McDaniel and Malone 2011; 
You, et al. 2011; Wong, et al. 2011b), recommendations for further studies (e.g. Patterson 
2008; McDaniel and Malone 2011) and limitations of the study (e.g. Patterson 2008; 
Trapskin, et al. 2009; Whitley 2010; Wong, et al. 2011b) were not discussed. The fact that 
most of the identified studies originated from outside the UK, with findings that often could 
not be generalised to the UK, due to differences in health systems, practices and laws, to 
some extent justifies a need for my study.  
2.9 - Aims, Objectives and Outcomes 
Title: Strategies enhancing the public health role of community pharmacists in the UK. 
2.9.1 - Assumptions  
It is widely assumed that because community pharmacies are extensively and conveniently 
located, they are better placed than other healthcare professionals to provide public health 
services to patients (DoH 2008). There is also an assumption that pharmacists are highly 
educated in drugs, diseases and their management, and that patients can easily visit their 
community pharmacists without making any prior arrangements. However, several barriers, 
such as time pressure and workload (O’Loughlin, et al. 1999; Ursell, et al. 1999; Agomo, et 
al. 2006; Agomo 2012a; Agomo and Ogunleye 2014); the training of pharmacists and their 
staff (Kotecki, et al. 2000; Watson, et al. 2003; Agomo 2012a; Agomo and Ogunleye 2014); 
inadequate remuneration and lack of support from stakeholders (Le and Hotham 2006; 
Kotecki, et al. 2000; Agomo, et al. 2006; Agomo 2012a; Agomo and Ogunleye 2014); safety 
concerns (Peterson, et al. 2007; Agomo and Ogunleye 2014); and lack of documentation 
(Hogue, et al. 2006; Saramunee, et al. 2012; Agomo and Ogunleye 2014) have also been 
recognised as hindering the provision of public health services from community pharmacies. 
Based on these and earlier identified gaps, this study seeks to investigate strategies 
enhancing the public health role of community pharmacists in the UK using a mixed 
methods approach.  
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2.9.2 - Aims of my Project 
A number of UK studies (for example, Anderson 1998; Blenkinsopp, et al. 2002; Anderson 
and Blenkinsopp 2003; Agomo 2012a) have looked at the role of pharmacists in public 
health. However, the focus of these studies has been mainly on identifying the different 
types of public health service provided by pharmacists; investigating the attitude of patients 
or service providers towards the public health role of pharmacists; or identifying barriers 
hindering the public health role of pharmacists. There seem to be no studies that focus 
specifically on identifying strategies that can enhance the public health role of community 
pharmacists in the UK. To contribute to the public health agenda of the UK government for 
community pharmacists (DoH 1999, 2010a; Watson, et al. 2014; NHS 2014) and to address 
gaps in the evidence base, my project aims mainly at identifying strategies enhancing the 
public health role of community pharmacists in the UK (Table 3). 
2.9.3 - Objectives of my Project 
Table 3. Relation between aims, objectives, and methods 
  Aims Objectives Data collection 
tools 
To review the literature about strategies enhancing the 
public health role of community pharmacists in the UK 
 
To review the literature about strategies 
enhancing the public health role of 
community pharmacists 
Review of literature and 
information 
To identify strategies enhancing the public health role of 
community pharmacists in the UK 
To examine why the public health role of 
community pharmacists in the UK remains 
basic in the 21st century 
Questionnaire 
To assess community pharmacists’ knowledge, 
attitude and behaviour regarding enhancing 
their role in public health and determine the 
perceived barriers to enhancing this role 
Questionnaire  
To assess the opinion of practitioners on 
changing the UK undergraduate pharmacy 
curriculum to increase its public health 
content and, maybe, UK pharmacy schools 
offering dual MPharm/MPH degrees 
Interview 
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Table 3. Relation between aims, objectives, and methods (contd.) 
 
To assess the opinion of practitioners on 
pharmacy students training closely with other 
healthcare students and, later, graduates 
working closely with other healthcare 
providers (for example GPs and nurses) to 
enhance the public health role of community 
pharmacists in the UK 
Interview 
To identify strategies enhancing the public health role of 
community pharmacists in the UK 
To assess the opinion of practitioners on the 
teaching of content-specific/advanced 
communication techniques to undergraduate 
pharmacy students and pharmacists, as well 
as, the adoption of new technologies in 
community pharmacy practice to enhance the 
public health role of community pharmacists 
in the UK 
Interview 
To examine the pattern of UK undergraduate 
pharmacy curriculum, teaching and learning 
policy 
Content analysis 
 
2.9.4 - Research Questions 
Based on my project objectives, my research (project) questions were: 
1. What are the identified themes and gaps from my review of literature and 
information on strategies enhancing the public health role of community 
pharmacists in the UK? 
2. Why is the public health role of community pharmacists in the UK still basic in 
the 21st century? 
3. What is the knowledge, attitude and behaviour of community pharmacists 
regarding enhancing their role in public health and their perceived barriers to 
enhancing this role? 
4. What is the opinion of practitioners on changing the UK undergraduate 
pharmacy curriculum to increase its public health content and, maybe, UK 
pharmacy schools offering dual MPharm/MPH degrees? 
5. What is the opinion of practitioners on pharmacy students training closely with 
other healthcare students and, later, graduates working closely with other 
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healthcare providers (for example GPs and nurses) to enhance the public health 
role of community pharmacists in the UK? 
6. What is the opinion of practitioners on the teaching of content-specific/advanced 
communication techniques to undergraduate pharmacy students and 
pharmacists, as well as the adoption of new technologies in community 
pharmacy practice to enhance the public health role of community pharmacists 
in the UK? 
7. What is the pattern of UK undergraduate pharmacy curriculum, teaching and 
learning policy? 
2.9.5 - Outcomes of the Project 
The findings of my project will be of interest to relevant stakeholders, for example, the UK 
pharmacy/health schools, the NHS Commissioning Board, the Clinical Commissioning Groups 
(CCGs), the General Pharmaceutical Council (GPhC), the Royal Pharmaceutical Society (RPS), 
the Department of Health (DoH) and the Faculty of Public Health, in terms of public health 
commissioning and funding of community pharmacies, the regulation and training of 
pharmacists and the development of collaborative (interdisciplinary) initiatives between the 
various health professions in the UK. I plan to produce and distribute to relevant 
stakeholders, a summary of my project with key findings. In addition, I also plan to publish 
refereed journal articles (and possibly, a book/book chapter), as well as convey my project 
findings to the research community through the presentation of papers at relevant 
conferences.  
2.10 - Resources  
The findings of my project can also contribute to the public health agenda of the UK 
government for community pharmacists (DoH 1999, 2010a; NHS 2014) and hence enable 
community pharmacists in the UK to deliver health improvements and promote healthy 
lifestyles. I am able to control or gain access to the resources needed in this study, and this 
includes any contingency plans needed. As a teacher-practitioner at the UCL School of 
Pharmacy, London, as well as a member of both the General Pharmaceutical Council and the 
Royal Pharmaceutical Society, I am able to recruit for my project, without much difficulty, 
readily available and accessible participants and relevant stakeholders. 
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Chapter 3 - Methodology 
3.1 - Introduction 
In my review of knowledge and information, I identified a wide range of strategies needed 
to enhance the public health role of community pharmacists in the UK (see Tables 1a and 1b 
and Figure 4). The dominant themes included strategies enhancing the public health role of 
community pharmacists through the Expert Patients Programme, enhanced communication 
techniques, smoking cessation activities, advanced pharmacy practice experience in public 
health, and the enhancement of the public health content of pharmacy curricula. Most of 
the studies I identified in my review of knowledge and information however originated from 
outside the UK, with findings that often could not be generalised to the UK, due to 
differences in health systems, practices and laws. To make some of these findings relevant 
to the UK, there was therefore a need for me to conduct a survey of UK community 
pharmacists. In addition, examine the pattern of UK undergraduate pharmacy curricula, 
teaching and learning policy through a content analysis of the curricula of UK Schools of 
Pharmacy, and interview healthcare professionals to identify strategies enhancing the public 
health role of community pharmacists in the UK. 
The findings of my survey of UK community pharmacists largely confirmed many of the key 
findings from my review of knowledge and information. At the same time, the majority of 
my survey respondents also confirmed most of the barriers identified in my review of 
knowledge and information. I either confirmed various barriers or identified new ones in the 
free text comments, including commercial pressure, difficulty following up with patients, 
conflict of interest, lack of awareness, community pharmacists being under-utilised, etc.  
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Figure 4. Themes identified from my review of knowledge and information 
 
3.2 - Project Design: Methodologies 
Supporting my project proposal is my role as a change agent (Havelock 1973). Since 2004, I 
have been engaged in many of the issues concerning pharmacy practice in the UK (as 
described briefly in my Review of Learning). My interest in the role of community 
pharmacists in public health (Agomo, et al. 2006; Agomo 2012a; Agomo and Ogunleye 
2014), as well as my role as an insider-researcher-practitioner, put me in a good position to 
investigate and identify strategies enhancing the public health role of community 
pharmacists in the UK. My guide are values such as ethics (Fox, et al. 2007), accountability, 
hard work and perseverance. In addition, the General Pharmaceutical Council's standards of 
conduct, ethics and performance that stipulate the behaviours, attitude and values 
expected of pharmaceutical professionals (GPhC 2012) guides my professional practice. 
3.3 - Plan of Investigation 
My research project focused throughout on public health. In order to achieve the aims of 
my project, I used a mixed methods approach. I divided my project into three phases: Phase 
1, 2 and 3. By using the combined method, qualitative approaches can assist quantitative 
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work in a number of ways, such as providing hypotheses to be tested by quantitative 
research; validating survey data; interpreting statistical relationships and deciphering 
puzzling responses; helping to construct scales and indices for survey items; and offering 
case study illustrations (Burton 2000). Moreover, survey data can identify individuals for 
qualitative study, as well as representative and unrepresentative cases (Bryman 1993; 
Fielding and Fielding 1986). Cohen and Manion (1989) suggest further advantages of 
combining methods, such as when a complex phenomenon requires analysis, when some 
controversial aspects require investigation and when an established approach provides a 
limited and perhaps distorted picture. Again, using more than one method to study the 
same research question provides researchers with the additional advantage of being able to 
support the validity of their findings, particularly if both methods can give mutual 
confirmation (Bryman 1993). Although Fielding and Fielding (1986) support the mixed 
methods approach, they also warn that the use of multiple methods is not an absolute 
guarantee of the validity of the results, as using multiple sources can also increase the 
chance of error.  
3.4 - Phase 1: Survey 
3.4.1 - Study Population 
In 2014, there were around 50,000 pharmacists in the UK, of which approximately 70% were 
community pharmacists (population size, 35,000) (NHS England 2013). I calculated the study 
sample size needed for my postal survey (at 95% confidence level and ±7.5 confidence 
interval - margin of error) to be around 170 community pharmacists. Because I was 
expecting a minimum response rate of 50%, I needed to send out at least 340 (170 x 2) 
questionnaires to achieve that sample size. However, in my actual project, I selected 385 
community pharmacies randomly from the lists of community pharmacies (total eligible 
population, 456) in Barnet, London, and its surrounding area, Cardiff and Edinburgh, as 
listed on yell.com. My assumption was that each community pharmacy as listed on yell.com 
would employ one permanent pharmacist. I determined the sample size needed for my 
survey (170) using a sample size calculator (CRS 2012), and then generated the individual 
numbers (community pharmacies) to be included in my survey using a random integer set 
generator (RANDOM.ORG 2015). The target response rate for my survey was between 50–
60%. 
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3.4.2 - Design 
This phase of my project took the form of a descriptive, cross-sectional survey that 
generated mostly quantitative data. I selected this study method as can easily be repeated 
in different locations and at different times (Hakim 1987). In addition, it enables researchers 
to identify associations between factors (Hakim 1987). The main disadvantage with this type 
of design is that the structured nature of the questionnaire may have an effect on the 
quality of information obtained (Bowling 1997). I selected and included items in the 
questionnaire based on the themes identified in my review of literature and information, 
with assistance from my academic adviser and academic consultant (content or face 
validity) (Oparah and Arigbe-Osula 2002). I designed the questionnaire to take 
approximately 20 minutes to complete with assurance of the confidentiality of responses.  
To address the issues of the validity and reliability of the instrument, I pilot tested the 
questionnaire for content, clarity and format of the questions on a group of 150 randomly 
selected community pharmacists in the Bedfordshire area, England, as listed on the NHS 
Choices website (eligible population, 517) (NHS Choices 2015). I explained the purpose of 
the study, and my response rate for the pilot study was 39% (59/150), after two reminders 
(three weeks apart).  According to Fink (2003), for a pilot test, one usually requires 10 or 
more individuals who are willing to complete the survey. In addition, I calculated Cronbach’s 
alpha to estimate the internal consistency of my pilot survey questionnaire. Based on the 56 
items tested on my pilot questionnaire, my SPSS reliability test indicated that the Cronbach's 
alpha was 0.787 (see Appendix 1). As this number was greater than 0.7, there was no need 
to alter the questionnaire (Nunnaly 1978).  
The pilot study enabled me to determine the adequacy of the sampling frame; assess non-
response rates; evaluate the appropriateness and effectiveness of my chosen data collection 
method; establish the adequacy of my questions and determine whether they worked; and 
determine whether the questions and responses were understood (Burton 2000). In 
addition, it enabled me to determine whether some questions needed be removed; assess 
whether my questionnaire ‘flowed’ and questions ‘fitted’ together; assess whether the 
transition from one section to another was smooth and whether my question filters actually 
worked and did not lead to subjects skipping more questions than necessary (Burton 2000). 
The pilot study also helped me to assess the layout of the questionnaire, hence provided a 
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clear idea of how long it took to complete the questionnaire in order to advise potential 
respondents correctly and judge respondents’ interest and attention to questions (Burton 
2000). I studied the responses from my pilot questionnaires carefully, and since the pre-
testing did not result in major modification of the instrument, I used the instrument in my 
final study (Oparah and Arigbe-Osula 2002). 
I designed the questionnaire to collect demographic characteristics of respondents, such as 
gender, age, role and years of post-qualification experience (Oparah and Okojie 2005). I also 
requested respondents to describe their involvement in public health services. Hence, 
respondents were asked to tick ‘Yes’ or ‘No’ on three sub-questions: offering over-the-
counter advice; participating in a local authority-run scheme (e.g. immunisation) for 
pharmacists; and collaborating with a local practice in a shared care kind of scheme? 
Furthermore, respondents were requested to give their opinion on the strategies enhancing 
the public health role of community pharmacists in the UK as well as the perceived barriers, 
using a scale of 1-5 (1 = disagree, 2 = strongly disagree, 3 = neither agree nor disagree, 4 = 
agree, 5 = strongly agree) (Oparah and Okojie 2005). I balanced the questions by including 
questions that concerned the negative and positive aspects of strategies enhancing the 
public health role of community pharmacists in the UK. My academic adviser (Dr. James 
Ogunleye) and academic consultant (Prof. Jane Portlock) approved my questionnaire before 
use.  
I chose a postal survey for Phase 1 of my project to save time and cost, ensure anonymity, 
and minimise social desirability and interviewer bias (Bowling 1997). According to Cline 
(2011), a single researcher can conduct this type of data collection. Moreover, mail surveys 
are self-administered, increasing anonymity (Cline 2011). Hence, respondents are more 
likely to respond truthfully to sensitive questions (Cline 2011). However, the main 
disadvantages of the mail questionnaire are its limited usefulness in populations with low 
literacy as well as in groups who are homeless (Cline 2011). When compared against other 
methods of self-reports, e.g., structured face-to-face interviews and telephone interviews, 
response rates for mail surveys are generally low (Cline 2011). However, Dillman (2000) 
reports that close adherence to techniques known to increase response rates (e.g., multiple 
contacts, financial incentives) can boost response rates to 70-80%.  
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For my postal survey, I used self-addressed envelopes (SAEs) to improve the response rate 
and reduce the financial burden on participants. I then mailed the questionnaires (Appendix 
2) with covering letters (see Appendix 3) to 385 randomly selected community pharmacists 
from Barnet, London, and its surrounding areas, Cardiff and Edinburgh. The covering letter 
introduced the researcher and the academic adviser, summarising the purpose of the study 
and guaranteeing confidentiality. Finally, I sent two reminders at three-weekly intervals to 
non-responders to enhance the response rate. 
 3.4.3 - Data Analysis 
My initial assumption was that I was collecting parametric data. I performed all statistical 
analyses using the Statistical Package for the Social Sciences (SPSS version 19.0). Tests for 
significance of variables were included in my analysis. In addition, I used the statistical 
procedure correlation (Diamond and Jeffries 2001) to ascertain any association and its 
strength between variables. According to Diamond and Jefferies (2001), correlation 
measures the association between two continuous variables, that is, the strength of the 
relationship between the values of two variables. In situations where both variables (x or y) 
are not normally distributed, Spearman’s correlation is tested (Reid 1996). 
3.4.4 - Justification for Effect Size Calculation 
According to Wright (2003), effect sizes tell the reader how big the effect is, something, 
which the p value does not do. Hence, the purpose of reporting the effect size is to 
communicate to the reader the size of the effect and to allow comparisons with other 
effects (Wright 2003). It is, therefore, simply a way of quantifying the difference between 
two groups; hence, it is mathematically expressed as the difference between the mean 
values of the two groups, divided by the standard deviation (Equation 1) (Coe 2000). 
                            Mean of experimental group – Mean of control group 
  Effect size =                              Standard deviation 
 
      
      Equation 1 
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Hence, an effect size of 1.0 is equivalent to a change of one standard deviation in the study 
sample (Bowling 2002). However, according to Cohen's table of effect size magnitude [r] 
(Cohen 1992):  
 <.10: trivial 
 .10 - .30: small to medium 
 .30 - .50: medium to large 
 >.50: large to very large                                                                                               
For Eta squared, η2, with Anova, effective size magnitude is as follows (Nandy 2012),  
 0.01 = small 
 0.06 = medium 
 0.14 = large  
According to Wright (2003), it is important to report the units of measurement of the effect 
size. The American Psychological Association’s ‘Publication Manual’ has highlighted the 
importance of reporting the effect size, which identified ‘failure to report effect sizes’ as one 
of the ‘defects in the design and the reporting of research’ (APA 2001: 5). Moreover, the 
British Psychological Society now has a statement in its ‘Notes for contributors’, which 
requires for all its journals under normal circumstances to incorporate effect size in their 
reports (Clark-Carter 2003). Clark-Carter (2003) also warns of the dangers of not reporting 
the effect size when only the probability is reported, for example, the risks of making a Type 
I error – rejecting the null hypothesis when it is true, and the introduction of an alternative 
hypothesis, which could lead to the possibility of making a second type of error (a Type II 
error) of rejecting the alternative hypothesis when it was true.  
One advantage of effect size over an inferential statistic, such as the t test is that the effect 
size is relatively unaffected by the sample size (Clark-Carter 2003; Abelson 1995). Hence, 
effect size can be used to compare studies that have used different sample sizes, unlike 
their test statistics and probabilities, which can only sensibly be compared if the sample 
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sizes are the same (Clark-Carter 2003). Another advantage of effect size is that it is 
expressed directly in the units of the scale of the dependent variable, and sizes of difference 
along the scale are supposed to be meaningful to the researcher (Abelson 1995). Although 
Cohen’s d (Cohen 1988) is one of the most popular effect sizes, and measures the difference 
between the means of the two groups compared, Spearman’s rho, ρ, can be treated as a 
measure of effect size - as ranks are involved and not measurements (McDonald 2014). 
Limitations of the correlation coefficient include the following (Reid 1996): 
1. As the correlation coefficient is a measure of the linear (i.e. straight-line) relationship 
between two variables, it therefore means that if some kind of non-linear 
relationship exists, then the correlation coefficient will not be appropriate, and it 
may even be misleading. It is therefore important to check the data on a scattergram 
first, before calculating a correlation coefficient.  
2. Extreme or outlying observations can have an overwhelming effect on the size of the 
correlation coefficient, thereby creating an artificially low value of r. 
3. Care needs to be taken when the data relate to two separate underlying groups, as 
the overall relationship may be distorted by the different relationships. 
4. Correlation is a measure of association, not causation. Just because two variables 
are highly correlated, this does not imply that one causes the other. There are 
usually many factors involved.  
3.5 - Phases 2 and 3: Content Analysis and Interviews 
3.5.1 - Methods and Sample 
Phase 2 of my study (content analysis) employed aspects of both the quantitative and 
qualitative methods of analysis. Phase 3 of my study (interviews) involved the use of mainly 
qualitative methods. First, I used content analysis to examine the pattern of UK 
undergraduate pharmacy curricula, teaching and learning policies. This involved choosing 
concepts for examination, and then quantifying and tallying their presence as well as 
exploring the relationships between the concepts identified (Busch, et al. 2012). Following 
the analysis of my survey (Phase 1) as well as the content analysis (Phase 2), I identified a 
sample of healthcare practitioners (eleven pharmacists, three general practitioners and a 
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nurse) and then invited them to participate in the interviews (Phase 3). The aims of my 
interviews were to assess the opinion of practitioners on changing the UK undergraduate 
pharmacy curriculum to increase its public health content and, maybe, UK pharmacy schools 
offering dual MPharm/MPH degrees; to assess the opinion of practitioners on pharmacy 
students training closely with other healthcare students and, later, graduates working 
closely with other healthcare providers (for example GPs and nurses) to enhance the public 
health role of community pharmacists in the UK. In addition, to assess the opinion of 
practitioners on the teaching of content-specific/advanced communication techniques to 
undergraduate pharmacy students and pharmacists, as well as the adoption of new 
technologies in community pharmacy practice to enhance the public health role of 
community pharmacists in the UK. I determined the sample size during the process, hence 
continued with the interviews until they yielded no new information, or the data became 
saturated (Morse 2000; Cline 2011). I outlined the nature and format of the study to 
participating practitioners. 
I selected individual participants purposively from a list of interested respondents, and 
based on their willingness to participate in the study. I obtained informed consent prior to 
inclusion in the study. The qualitative design of my interview enabled the objectives of my 
project to be met (Maxwell 1996); particularly as it enabled me to explore the different 
issues surrounding strategies enhancing the public health role of community pharmacists in 
the UK. I collected my data through interviews conducted by telephone (supported by 
Skype) using an interview guide (Appendix 4), together with open-ended questions, to both 
frame the interviews and probe for additional information (Miles and Huberman 1994). I 
recorded my interviews using 'HD Call Recorder for Skype', and each lasted approximately 
20 to 30 minutes. I facilitated these interviews and remained consistent with the method 
suggested for in-depth interviews (McCracken 1988). I compiled the interview guide from 
the identified themes in my review of knowledge and information as well as the findings of 
my survey (Phase 1). 
I asked my academic adviser and academic consultant to review the potential topics to 
determine their suitability, as this ensured that the proposed methods were workable, 
acceptable to the subjects and manageable (Burton 2000). Participation was voluntary, with 
confidentiality guaranteed (Fox, et al. 2007). During the interviews, I ensured that relevant 
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issues were clarified and understood. To ensure the validity of the study, my interview 
questions were open-ended; these enabled respondents to raise issues they believed were 
important to the study area, as well as enabling me to explore these in detail (Smith 2002). 
Furthermore, this ensured that what guided the content and direction of the interviews 
were the responses of the interviewees rather than merely following my agenda, with the 
data truly reflecting respondents’ perspectives on the issue of interest (Smith 2002).  
3.5.2 - Justification and Limitations of Qualitative Methods 
The qualitative research methodology was included in my project as it is a method of 
naturalistic enquiry, which is normally less obtrusive than quantitative investigations and 
does not manipulate the research setting (Bowling 2002). The qualitative method therefore, 
enabled me to explore in depth strategies enhancing the public health role of community 
pharmacists in the UK. By adopting this method, the findings of my survey were enhanced, 
as the qualitative study focused on the meanings that participants in the study setting 
placed on their social world (Bowling 2002), something that could not be achieved with 
quantitative research. Bowling (2002) also argues that qualitative research has advantages 
over quantitative research in areas where the issues being studied are sensitive in nature or 
complex, when there is minimal pre-existing knowledge and where the need for exploration 
and inductive hypothesis generation is vital (Bowling 2002). 
However, I was also mindful of the possibility of bias entering my data collection process 
(Smith 2002). These biases include the preconceptions of the interviewer (Weiss 1994) and 
the fact that the issues raised may be a reflection of the interviewees’ pressing concerns at 
the time of the data collection (Cotter and Mckee 1997). The interviewer’s pre-knowledge 
of the respondent may also affect both the issues raised (Anderson 1998) and the 
respondent’s willingness to share certain views (De Young 1996).  
The main weaknesses in qualitative research are that it is usually more difficult to analyse 
qualitative data, and that these studies are only possible with small samples (Bowling 1997). 
This then leads to the questionable representativeness of the data (Bowling 1997). There is 
also the problem of knowing whom to recruit, knowing which people will fit the research 
aims and objectives most appropriately, and how to convince participants that participating 
is pertinent and worthwhile, as the entire process is very time-consuming (Burton 2000). 
Devising an interview guide can also be difficult (Burton 2000). Another important weakness 
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with qualitative research is that it is difficult for researchers to accommodate the interactive 
nature of interviewing (Burton 2000). 
3.5.3 - Content Analysis 
According to Cole (1988), content analysis is a method of analysing written, verbal or visual 
communication messages. Content analysis as a research method is a systematic and 
objective means of describing and quantifying phenomena (Krippendorff 1980; Sandelowski 
1995). Content analysis enables the researcher to test theoretical issues to improve 
understanding of the data (Elo and Kyngäs 2008), at the same time, it is a research method 
for making replicable and valid inferences from data to their context, with the aim of 
providing knowledge, new insights, a representation of facts and a practical guide to action 
(Krippendorff 1980). Often, the main purpose of those concepts or categories is to develop a 
model, conceptual system, conceptual map or categories (Elo and Kyngäs 2008). Content 
analysis as a research method also has received some criticisms, particularly in the 
quantitative field, where it is perceived as a simplistic technique that does not involve 
detailed analysis, as well as criticism that it is not sufficiently qualitative in nature (Morgan 
1993).  
Content analysis is popular in nursing research, and its advantages include the fact that it is 
a content-sensitive method (Krippendorff 1980), which also offers some flexibility in terms 
of research design (Harwood and Garry 2003). In terms of process, content analysis can be 
used with either qualitative or quantitative data, and the analytical method used is either 
inductive or deductive (Elo and Kyngäs 2008). According to Lauri and Kyngäs (2005), the 
inductive approach is ideal where there is not enough former knowledge about the 
phenomenon or if this knowledge is fragmented. Other the other hand, we use the 
deductive approach when the structure of analysis is operationalised based on previous 
knowledge and the goal of the study is theory testing (Kyngäs and Vanhanen 1999). While 
there are no systematic rules for analysing data; however, for both methods the analysis 
process is said to involve three main phases: preparation, organising and reporting, with the 
main attribute being that the many words of the text are grouped together into much 
smaller content categories (Weber 1990; Burnard 1996). 
According to Guthrie, et al. (2004), the preparation phase begins with selecting the unit of 
analysis, which can be a word or a theme (Polit and Beck 2004). Cavanagh (1997) notes that 
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the decision on what to analyse in what detail and sampling considerations are vital factors 
prior to choosing the unit of analysis. Concerning sampling Krippendorff (1989) notes that 
sampling units enable the drawing of a statistically representative sample from a population 
of potentially available data. Moreover, Krippendorff (1989) also argues that while the 
process of drawing representative samples is not indigenous to content analysis, it is still 
important to eliminate the statistical biases intrinsic in much of the symbolic material 
analysed and to make sure that the often-conditional hierarchy of selected sampling units 
becomes representative of the organisation of the symbolic phenomena being investigated.   
According to Elo and Kyngäs (2008), a unit of meaning can constitute more than one 
sentence, and at the same time have several meanings. This means that using it as a unit of 
analysis makes the analysis process hard and demanding (Catanzaro 1988; Graneheim and 
Lundman 2004). According to Graneheim and Lundman (2004), the most appropriate unit of 
analysis is whole interviews or observational protocols that are large enough to be seen as a 
whole and small enough to be remembered as a context for a meaning unit during the 
analysis process. To decide the contents to be analysed, Robson (1993) therefore argues 
that researchers are more often than not guided by the aim and research question of the 
study. 
For my project, the aim of my content analysis was to examine the pattern of UK 
undergraduate pharmacy curricula teaching and learning policies. I obtained copies of the 
UK pharmacy schools’ curricula from the various schools’ websites, where available, or 
directly (by email) from the respective pharmacy school officers. I then uploaded these 
documents to NVivo for analysis. In the analytic process, I immersed myself in the data by 
reading through the written materials (curricula) several times, enabling new 
insights/theories to emerge (Polit and Beck 2004). The process of content analysis of the 
curricula of UK pharmacy schools involved open coding, creating categories and abstraction 
(Elo and Kyngäs 2008). With NVivo, which I utilised for my study, open coding meant writing 
notes and headings through NVivo memos and annotations while reading the data (Elo and 
Kyngäs 2008). I read the written materials through again, writing down as many headings as 
needed in NVivo memos and annotations to describe all aspects of the content (Burnard 
1991, 1996; Hsieh and Shannon 2005). With the headings and notes in NVivo, I was able to 
generate categories freely at this stage (Burnard 1991).  
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With my open coding completed, I then grouped the list of categories under higher order 
headings (McCain 1988; Burnard 1991). I grouped data mainly to reduce the number of 
categories by collapsing those that were similar or dissimilar into broader higher order 
categories (Burnard 1991; Dey 1993). According to Dey (1993), the idea of creating 
categories is not simply to bring together observations that are similar or related; rather, 
data are being classified as ‘belonging’ to a particular group and this means that it is 
possible to make a comparison between these data and other observations that do not 
belong to the same category. Still, Cavanagh (1997) also notes that the purpose of creating 
categories is to have a way of describing the phenomenon, to enhance understanding and 
to generate knowledge. With NVivo, it was also possible for me to present some numerical 
(Seale and Silverman 1997) as well as visual representations in my analysis. 
Regarding trustworthiness, GAO (1996) advises that there is a need to describe the analysis 
process and the results in sufficient detail to inform readers properly on how the analysis 
was conducted, together with its strengths and limitations. Also, as the results of the 
content analysis often reflect the contents or meanings of the categories (Elo and Kyngäs 
2008); Dey (1993) also notes that creating categories is both an empirical and conceptual 
challenge, because categories must be conceptually and empirically grounded. Nonetheless, 
the credibility of the research finding relates also, to how well the categories cover the data 
(Graneheim and Lundman 2004). On the other hand, showing how well the results relate to 
the data can enhance the reliability of the study (Polit and Beck 2004). As it pertains to 
transferability of findings, Graneheim and Lundman (2004) also suggest that the researcher 
describing clearly the context, selection and characteristics of participants, as well as the 
process of data collection and analysis can achieve this. Nevertheless, it is possible to 
enhance the trustworthiness of the analysis through authentic citations that indicate to 
readers from where or from what kinds of original data the categories are contrived (Patton 
1990; Sandelowski 1993).  
Regarding confidentiality, Ford and Reutter (1990) also note the importance of not 
identifying informants by quotes from the data. Weber (1990) suggests that it is possible to 
assess the internal validity of content analysis as face validity or by using agreement 
coefficient. However, Graneheim and Lundman (2004) highlight some of the differing 
opinions regarding seeking agreement, particularly as each researcher interprets the data 
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depending on their subjective perspective, not forgetting the fact that co-researchers could 
bring forth alternative interpretations (Sandelowski 1995). Bazeley and Jackson (2013: 93) 
seem to agree with Graneheim and Lundman (2004), when they argue: 
‘While we support the need to check for reasonable consistency across coders in 
team research, driven by their need to work towards a common goal, we question 
the value of doing so in a project with a solo investigator. Each person approaching 
the data will do so with their own goals and perspective, and so each will see and 
code differently. Coding is designed to support analysis – it is not an end in itself. 
What becomes important, then, is that the coder records the way he or she is 
thinking about the data, keeps track of the decisions made, and builds a case 
supported by the data for the conclusions reached. The alternative is to train 
someone, like a machine, to apply the same codes to the same data – but all this 
proves is you can train someone, not that your codes are ‘valid’ or useful. What can 
be of value is to have someone else review your data and some of your coding for 
the purpose of having a discussion about what you are finding there, especially if you 
are new to the task of qualitative coding.’ 
According to James (2008), authenticity is an important part of establishing trustworthiness 
in qualitative research, so that the research findings become relevant to society. Having said 
that, authenticity also means getting away from concerns about the reliability of research to 
concerns about its impact on members of the culture or community being researched 
(James 2008). In my project, I have followed the approach suggested by Bazeley and Jackson 
(2013), hence, utilised the input of my academic adviser and my academic consultant in 
order to validate my content analysis process. 
On the other hand, content analysis is not without its limitations, which include its sheer 
quantity, which can be daunting, and even overwhelming; during the analysis, it is possible 
to come up with many fascinating points, which are not related to the topic under study (Elo 
and Kyngäs 2008). Moreover, reporting the study and presenting its results can be tasking, 
particularly as the results are developed through a process constituting a number of phases 
(Elo and Kyngäs 2008). Content analysis also has other limitations (Krippendorff 1989), one 
of which comes from its commitment to scientific decision-making. Statistically significant 
findings need many units of analysis, and an attempt to derive such findings means a 
commitment to be quantitative, which can also prevent the analysis of unique 
communications (Krippendorff 1989). The next limitation stems from the replicability 
requirement - this implies fixed and observer-independent categories and procedures that 
must be codified without reference to the analyst and the material being analysed 
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(Krippendorff 1989). One of the resultant effects is computer content analysis, which 
favours the use of data in contexts that entail stable and unambiguous interpretations and 
leaves little room for those whose meanings evolve in the process of communication and in 
ways characteristic of the different communicators or social groups involved (Krippendorff 
1989). The last limitation is the expectation of content analysis to contribute to social theory 
(Krippendorff 1989). If categories are obtained from the very material being analysed, the 
findings are not generalisable much beyond the given data. On the other hand, if they are 
derived from a general theory, the findings tend to ignore much of the symbolic richness 
and uniqueness of the data in hand (Krippendorff 1989). 
Finally, Elo and Kyngäs (2008) also warn that compressing qualitative data too much can 
prevent the integrity of the narrative materials from being maintained during the analysis 
phase. Still, in situations where conclusions are just summarised without including several 
sustaining excerpts, the wealth of the original data may fade away (Elo and Kyngäs 2008).  
3.5.4 - Data Analysis for Interviews 
I used the qualitative data software package NVivo (version 10) for the storage, retrieval, 
and analysis of data. I transcribed the interviews verbatim. I also ensured that I checked all 
transcripts independently against the original recordings. As a validity check on the 
interpretative process, I requested the coding procedure to be independently verified by an 
experienced researcher. To further enhance the validity of my project, I returned to 
respondents to request their views and comments on the preliminary findings (Smith 2002), 
mainly by sharing my interpretations of the categories or themes that emerged with the 
informants; conducting a second brief interview with respondents to clarify or verify various 
issues emerging from the data; and asking informants to read the analysis and share their 
reactions to my interpretations (De Young 1996).  
In order to become familiar with the collected data, I read the transcribed interviews 
through carefully several times and then summarised them. I used NVivo in the 
condensation stage for category development (Pope, et al. 2000). In the analysis, I used 
thematic analysis (Braun and Clarke 2006; Caulfield and Hill 2014). According to Braun and 
Clarke (2006), thematic analysis (TA) is a poorly demarcated and rarely acknowledged, still 
widely used qualitative analytic method within and beyond psychology. However, the main 
benefit of thematic analysis lays with its flexibility (Braun and Clarke 2006). It is possible to 
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use TA in a realist or descriptive way; still, it is not limited to that (Braun and Clarke 2014). 
There are presently different variants of TA. While the Braun and Clarke method offers a 
theoretically flexible approach; others (for example, Boyatzis 1998; Guest, et al. 2012; Joffe 
2011) locate TA implicitly or explicitly within more realist/post-positivist paradigms (Braun 
and Clarke 2014). Yet, the version of TA they developed offers a strong, systematic 
framework for coding qualitative data, and for then using that coding to identify patterns 
across the dataset in relation to the research question (Braun and Clarke 2014). The 
questions of what level to seek patterns, and the interpretations given to those patterns, 
are therefore up to the researcher to decide, the reason being that techniques are distinct 
from the theoretical positioning of the research (Braun and Clarke 2014).  
As noted, thematic analysis is a method for identifying, analysing, and reporting patterns 
(themes) within data, therefore, minimally organises and describes data set in (rich) detail 
(Braun and Clarke 2006). Although, Braun and Clarke (2006) have argued that there is no 
clear agreement about what thematic analysis is, how to go about doing it; however, they 
have also noted that some of the phases of thematic analysis are similar to the phases of 
other qualitative research. Essentially, the phases include familiarising yourself with your 
data; generating initial codes; searching for themes; reviewing themes; defining and naming 
themes and producing the reports (Braun and Clarke 2006). 
In terms of the advantages of thematic analysis, it is not a complex method (Braun and 
Clarke 2006; Bryman 2008; Caulfield and Hill 2014). It is flexible, and a relatively easy and 
quick method to learn and do; it is accessible to researchers with minimal or no experience 
of qualitative research; results are generally accessible to educated general public; and 
useful method for working within participatory research paradigm, with participants as 
collaborators. In addition, it can usefully summarise main features of a large body of data, 
and/or give a ‘thick description’ of the data set; can highlight similarities and differences 
across the data set; can generate unanticipated insights; allows for social as well as 
psychological interpretations of data; and can be useful for producing qualitative analyses 
suited to informing policy development (Braun and Clarke 2006).  
Yet, thematic analysis is not without some disadvantages (Kvale 2007; Bryman 2008; 
Caulfield and Hill 2014), many of which depend more on poorly conducted analyses or 
inappropriate research question, than on the method itself (Braun and Clarke 2006). While 
 82 
 
the flexibility of the thematic analytic method allows for a wide range of analytic options - 
such that potential range of things that can be said about one’s data is broad; this 
advantage can also be a disadvantage as it makes developing specific guidelines for higher-
phase analysis difficult (Braun and Clarke 2006). This can be potentially paralysing to the 
researcher aiming to decide what aspects of their data to focus on (Braun and Clarke 2006). 
Another disadvantage is that thematic analysis has limited interpretative power beyond 
basic description if it is not used within an existing theoretical framework that connects the 
analytic claims that are made (Braun and Clarke 2006).  
Still, unlike narrative or other biographical approaches, it is not possible to preserve a sense 
of continuity and contradiction through any one individual account, and these 
contradictions and consistencies across individual accounts may be revealing (Braun and 
Clarke 2006). Also, unlike discourse analysis (DA) and conversation analysis (CA), a simple 
thematic analysis does not allow the researcher to make claims about language use, or the 
fine-grained functionality of talk (Braun and Clarke 2006), or to analyse what patterns of 
speech tell us about the power relationships between individuals (Caulfield and Hill 2014). 
Another disadvantage is the time it takes to do a thematic analysis well (Caulfield and Hill 
2014). Finally, thematic analysis currently has no fame as an analytic method, reasons being 
that it is poorly demarcated and claimed, though widely used (Braun and Clarke 2006).  
For this project, I used throughout the TDF to underpin the research. For my analysis, I 
assigned initial codes to data of interest for the analytical framework through a process of 
repeated reading, with the emphasis on including all relevant data. Further re-reading and 
analysis of subsequent transcripts led to my refinement of the initial codes, thereby 
ensuring that I took into account the contexts of any extracts. As the analysis progressed, 
the number of new initial codes reached a maximum, with the process of refinement taking 
precedence. I aligned pieces of text to a particular code across the transcripts, grouped 
them together as individual reports and then printed them out to aid further analysis. 
Afterwards, I reflected these reports back to the transcripts to identify connections involving 
the index codes. Next, I considered the initial codes together to identify patterns and 
connections to form what became sub-categories, which I then connected across higher 
order categories (Burnard 1991). I considered the emerging categories with the transcripts 
to establish whether the categories were related to the data and their contexts. Through the 
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process of refinement and identifying relationships between categories, theme areas 
emerged.  
I also reviewed the emerging themes for counter-themes (Abu-Omar et al 2000), as well as 
presenting some numerical data in the analysis to assure the reader that the findings 
presented are representative of the full data set, thereby ensuring that attention has been 
given to rare events and deviant cases (Seale and Silverman 1997). Concerning the reliability 
of the study, Smith (2002) argues that the aim of the researcher is not to ensure consistent 
interpretations or responses. Rather, the aim is to understand the underlying contexts and 
reasons for the differences (Smith 2002). Such differences and inconsistencies, which may 
merit further exploration, may then be illuminated in terms of the study objectives (Smith 
2002). This will be valuable in terms of informing the analysis and development of 
hypotheses or theories (Smith 2002).  
To enhance reliability and hence tackle some of the biases mentioned earlier, my project 
employed various methods, such as ensuring consistency in data processing, analysis and 
coding procedures; the use of open and non-leading questions to ensure success in the 
interviews; and digital recording (HD Call Recorder for Skype) of interviews, which enabled 
my practices to be reviewed (Smith 2002). In addition, I kept meticulous records on the 
research process, which required keeping a separate diary of feelings and interpretations 
(Bowling 2002).  
3.5.5 - Improving data reliability 
I improved data reliability by comparing data from phases 1, 2 and 3 of my project; by 
consulting participants to agree or refute my interpretation of the information they 
provided; and including a ‘critical friend’ as part of my research design, with whom I also 
checked data, especially interpretative data (IWBL 2011). 
3.5.6 - Ethical Considerations 
I have already discussed some of the issues concerning ethical considerations above. As an 
insider-researcher-practitioner, my project is likely to influence and, I hope, enhance the 
public health practice of community pharmacists in the UK (Costley, et al. 2010). This project 
will be of benefit to my own development, not just as a pharmaceutical writer, community 
pharmacist and researcher, but also in my role as a teacher-practitioner at the UCL School of 
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Pharmacy, London. In addition, as an insider-researcher-practitioner, I take responsibility 
for, recognise and understand the ethical codes of practice and principles that exist within 
the context in which my project is being researched (Darley, et al. 2001). 
In terms of personal and professional perspectives, I privately funded this project hence; I 
was not constrained as such to fulfil any particular stakeholder’s expectations other than 
those of the university (Murray 1997). The main responsibility therefore lay with me: to 
carry out a project which was right for me and for my professional area, as well as adopting 
an appropriate approach to collecting data from colleagues that felt right for me and did not 
impose on others (Costley, et al. 2010). Again, as an insider-researcher, I proceeded 
carefully in negotiating with colleagues, ensuring that I followed research protocols 
designed for insider-researchers (if they were available) rather than researchers coming new 
to a particular situation (Costley, et al. 2010). To avoid the risks of exploitation and betrayal 
(Griffiths 1998), I made clear to the participants what was expected of them in terms of both 
the project itself and the research element of the project, as well as ensuring that I 
explained exactly what I meant by anonymity and confidentiality (Fox, et al. 2007; Costley, 
et al. 2010). I clearly stated to participants the purpose of my project, which is part of my 
DProf degree, as well as the objectives of my project and what I intended to do with the 
information they provided. 
Again, due to my close familiarity with my research and the micro-politics of my community 
of practice (pharmacy), as well as the power I have in interpreting and writing up my 
findings using my own constructions, I minimised this power imbalance by calling on others 
to verify or contest my accounts (Costley, et al. 2010). My interests, particularly what I 
believed would benefit community pharmacy practice in the UK based on evidence 
dominate my project. I own the intellectual property rights to this academic work and was 
therefore the person who decided about the nature of the project, the research and the 
output. However, the development process and implementation of my project will require 
some input from UK pharmacy bodies, the DoH and Schools of Pharmacy. I also ensured that 
I did not put participants in a difficult position because they were friends or colleagues. In 
addition, I ensured that the interviewing process with senior and junior colleagues was fair 
and balanced, and took due care to ensure that interviews with colleagues (participants) did 
not act as a kind of ‘therapy’ and a ‘venue to air grievances’ (Costley, et al. 2010).  
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The General Pharmaceutical Council's standards of conduct, ethics and performance that 
stipulate the behaviours, attitude and values expected of pharmaceutical professionals 
guided my ethical considerations (GPhC 2012). Guiding these behaviours, attitude and 
values are the seven principles set out by the GPhC. They include ensuring that patients are 
my first concern; using professional judgement in the interest of patients and the public; 
showing respect to others; encouraging patients and the public to participate in decisions 
about their care; developing my professional knowledge and competence; being honest and 
trustworthy; and taking responsibility for my working practices. According to the GPhC, ‘It is 
important that you (pharmacy professionals) meet our standards and that you are able to 
practise safely and effectively. Your conduct will be judged against the standards and failure 
to comply could put your registration at risk. If someone raises concerns about you we will 
consider these standards when deciding if we need to take any action’ (GPhC 2012). The 
GPhC goes further to state, ‘If you are a pharmacy professional these standards apply to 
you, even if you do not treat, care for or interact directly with patients and the public’ (GPhC 
2012). 
In addition, I submitted a Research Ethics form (REf) to the programme approval panel (PAP) 
and research ethics sub-committee (RESC) of Middlesex University, for approval. They 
approved the project. Participation in the study was voluntary, with informed consent 
obtained from participants. I coded the data to make participants unidentifiable, and stored 
in a password-protected personal computer. Questionnaires, coding sheets and other 
confidential materials were stored in different secured cabinets. 
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Chapter 4 - Project Activities and Findings 
 
4.1 - Introduction 
The main aim of my project was to identify strategies enhancing the public health role of 
community pharmacists in the UK. Following my project activity, which involved a survey of 
147 UK community pharmacists, content analysis of the curricula of 28 UK pharmacy schools 
and interviews with 15 healthcare professionals, I identified several key findings on 
strategies enhancing the public health role of community pharmacists in the UK. I report 
some of these below. I linked my project findings throughout to public health. 
4.2 - Survey Findings  
In my main survey, I collected a total of 88 usable responses, representing a response rate 
of 22.8% (88/385). Of the 385 surveys mailed to community pharmacists I randomly 
selected in Barnet, London, and its surrounding area, Cardiff and Edinburgh, I initially 
received 49 responses (12.7%). After 3 weeks, I reminded non-respondents with another 
letter (sometimes with phone calls), together with another copy of the questionnaire. I 
received thirty-four more surveys, bringing the total to 83 (21.5%). This response rate meant 
that I did not meet my initial response rate target of 50-60%, even with the reminder letters 
and phone calls. Some pharmacists requested that I posted another questionnaire to them, 
while others promised to return their completed questionnaires as soon as possible. I 
received five more completed questionnaires by mail, bringing the total questionnaires 
collected from the main study to 88, a response rate of 22.8% (88/385).  
Seven questionnaires (from the main study) were returned to me incomplete for a number 
of reasons, that included wrong address, no reason stated, not having a pharmacist in the 
premises. When I put this into consideration in my calculation, my response rate for 
questionnaires received became 23.28% (88/378). 
4.2.1 – Pharmacists’ Characteristics 
Both men (39/44.3%) and women (49/55.7%) responded to the survey, C.I. ±10.37. Their 
age-range distribution, shown in Figure 5, indicate that the youngest and the highest 
number of respondents were aged between 20-29 years (30.7%, C.I. ±9.63), while the oldest 
and fewest number of respondents were aged between 70-79 years (2.3%, C.I. ±3.13). In 
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addition, I measured the experience level of respondents, which was determined by the 
number of years since qualification in the UK. The majority of respondents (56.3%, C.I. 
±10.41) qualified between 2000 and 2014. The role distribution of respondents, which is 
presented in Figure 6, indicated that the majority of my respondents were working as 
employee community pharmacists (77.3%, C.I. ±8.74), rather than as pharmacy owners or 
self-employed pharmacists. In terms of location (place of work), 36.5% of my respondents 
were working in Edinburgh, 34.1% in Cardiff, and 29.4% in Barnet and the surrounding areas 
(Figure 7). 
  
 Figure 5. Age of Participants 
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Figure 6. Respondent's Role in Pharmacy  
 
 
 
Figure 7. Location of Respondents 
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4.2.2 - Survey Responses   
4.2.2.1 - Involvement of Community Pharmacists in Public Health Services 
To ascertain the level of involvement of community pharmacists in public health services, 
my questionnaire began by asking community pharmacists if their involvement in public 
health services was in the form of offering over-the-counter advice; participating in a local 
authority-run scheme (e.g. Nicotine Replacement Therapy (NRT)) for pharmacists; or 
collaborating with a local practice in a shared care kind of scheme? Their Yes or No 
responses (see Table 4) showed that most of my respondents (98.9%, C.I. ±2.19) were 
offering over-the-counter (OTC) advice, 76.5% of respondents (C.I. ±9) participated in local 
authority-run schemes, while 33.7% of respondents (C.I. ±10.16) said they were 
collaborating with a local practice in a shared care kind of scheme.  
4.2.2.2 - Funding for Public Health Services from Community Pharmacies 
The majority of respondents (83.6%, C.I. ±8.49) indicated that the local authority fully 
funded the public health programme they were involved. Sixteen percent of the 
respondents said ‘No’.  
 
Table 4. Different forms of Public Health Services Provided by Respondents                      
Different forms of services                                                      Yes            No                        
                                                                                                   (%)           (%)               
Offering over-the-counter advice  (n = 87)                                 98.9            1.1              
 
Participating in local authority-run scheme  (n = 85)               76.5            23.5           
 
Collaborating in a shared care scheme  (n = 83)                        33.7            66.3            
 
Is programme fully funded by local authority?   (n = 73)         83.6            16.4 
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The next question asked, if not fully funded by your local authority, who else or which 
organisation is involved in the funding? The responses I received indicated that these 
programmes were funded through several sources. Four respondents indicated that the 
programme was privately funded, for example: 
“The patients through private payments – weight loss – ineligible for NHS (and) Flu 
jab.” [RC 196] 
 
In the case of another four respondents, they were getting some financial support from 
various health authorities: 
“Health Promotion Wales.” [RC 210] 
“NHS Board.” [E347] 
For another respondent, the company he/she was working for funded the costs of providing 
those services:  
 “Company.” [C168]  
4.2.2.3 - Strategies Enhancing the Public Health Role of Community Pharmacists 
Next, I asked several questions to ascertain the level of community pharmacists’ agreement, 
based on the findings of my review of the literature, on strategies enhancing the public 
health role of community pharmacists in the UK. I present their responses in Table 5. 
Notably, on changing the public health content of the UK undergraduate pharmacy 
curriculum, 64.8% (C.I. ±9.97) of respondents indicated that there was a need to increase 
the public health content of the UK pharmacy schools’ undergraduate curriculum. Four per 
cent of respondents rejected the idea. The majority of respondents (81.4%, C.I. ±8.21) 
indicated that they would like to see pharmacy students training closely with other 
healthcare students, with 93.1% of respondents (C.I. ±5.32) also indicating that they wanted 
to see pharmacy graduates working closely with other healthcare providers, e.g. GPs and 
nurses.  
Regarding communication skills, 79.3% of respondents (C.I. ±8.5) indicated that they would 
want UK undergraduate pharmacy students and pharmacists taught content-
specific/advanced communication techniques. In terms of other strategies needed to 
enhance the public health role of community pharmacists in the UK, 88.5% of respondents 
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(C.I. ±6.7) also felt that there was a need to develop good adherence strategies for patients; 
79.5% of respondents (C.I. ±8.42) would like community pharmacists’ role in preventing the 
spread of infections as well as managing antimicrobial resistance to be enhanced; 89.8% of 
respondents (C.I. ±6.32) would like community pharmacists to enhance patients’ self-
management capacities; while 78.5% of respondents (C.I. ±8.57) want pharmacists to 
enhance their safe medication disposal methods.  
In addition, the majority of the respondents indicated that they would like community 
pharmacists to enhance their skills in the management of polypharmacy and long-term 
conditions (87.5%, C.I. ±6.9); to manage the medication needs of athletes (66.6%, C.I. ±9.9); 
and to enhance their involvement in smoking cessation (80.6%, C.I. ±8.25). As well as these, 
the majority of respondents also indicated that they would like to see pharmacy students 
provided with advanced experience in public health (86.2%, C.I. ±7.24); pharmacists 
provided with advanced experience in public health (89.8%, C.I. ±6.32); and pharmacists 
remunerated directly for providing public health services (89.8%, C.I. ±6.32). However, in 
terms of UK universities offering dual MPharm (or even PharmD)/MPH degrees and 
community pharmacists adopting the use of new technologies and social media in practice, 
37.5% (C.I. ±10.1) and 43.2% (C.I. ±10.34) of respondents respectively indicated that they 
were in support of these. 
In addition to the above questions, the questionnaire also provided an option for 
respondents to supply other comments on what they considered necessary for enhancing 
the public health role of community pharmacists in the UK.  
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Table 5: Possible Ways to Enhance the Public Health role of Community Pharmacists  
 
Questions  
(Responses with significant agreement in bold) 
Disagree 
(%) 
Strongly 
disagree 
(%) 
Neither 
agree 
nor 
disagree 
(%) 
Agree 
(%) 
Strongly 
agree 
(%) 
Increase PH content of undergraduate curriculum? (n = 88) 3.4 1.1 30.7 52.3 12.5 
Offer dual MPharm (or even PharmD)/MPH degrees? (n = 88) 12.5 5.7 44.3 30.7 6.8 
Pharmacy students training with other HC students? (n = 86) 5.8 2.3 10.5 66.3 15.1 
Pharmacists working closely with HC practitioners? (n = 87) 2.3 1.1 3.4 62.1 31.0 
Teach advanced communication techniques? (n = 88) 1.1 1.1 18.4 56.3 23.0 
Adopt new technologies and social media? (n = 88) 17.0 9.1 30.7 34.1 9.1 
Develop good adherence strategies for patients? (n = 88) 0 0 11.5 73.6 14.9 
Enhancing role in preventing antimicrobial resistance? (n = 88)  2.3 1.1 17.0 60.2 19.3 
Enhance patients' self-management capacities? (n = 88) 0 0 10.2 61.4 28.4 
Enhance safe medication disposal methods? (n = 88) 5.7 2.3 13.6 58.0 20.5 
Enhance the management of polypharmacy? (n = 88) 1.1 1.1 10.2 52.3 35.2 
Managing the medication needs of athletes? (n = 87) 2.3 1.1 29.9 47.1 19.5 
Enhancing involvement in smoking cessation? (n = 88) 4.5 1.1 13.6 51.1 29.5 
Providing students with advanced experience in PH? (n = 88) 1.1 0 12.6 63.2 23.0 
Providing pharmacists with advanced experience in PH? (n = 88) 1.1 0 9.1 65.9 23.9 
Remunerate pharmacists directly for PH services? (n = 88) 1.1 3.4 5.7 48.9 40.9 
 
Role expansion 
A number of respondents cited role expansion and skill development (Knowledge and Skills) 
as strategies needed to enhance the role of community pharmacists in public health: 
“Expansion of minor ailments service – local arrangement. [Also, the] provision of 
vaccinations including Flu, travel, etc.” [E390]  
 “There is a need to develop both [the] consultation skills [and the] business skills [of 
pharmacists].” [B37] 
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In terms of the barriers to enhancing the public health role of community pharmacists in the 
UK (see Table 6), the majority of respondents identified insufficient training of pharmacists 
in public health (69.3%, C.I. ±9.63); insufficient skill of pharmacists in public health (51.1%, 
C.I. ± 10.43); lack of professional autonomy for pharmacists (64.8%, C.I. ±9.97); difficulties in 
recruiting patients (64.8%, C.I. ±9.97); lack of input from public health practitioners (64.8%, 
C.I. ±9.97); lack of support from public health practitioners (61.7%, C.I. ±10.26); and 
difficulty in communicating with other public health providers (72.4%, C.I. ±9.38), as 
significant barriers.  
As well as these, the majority of respondents also identified lack of support from GPs 
(61.4%, C.I. ±10.16); insufficient funding from the government (76.1%, C.I. ±8.9); time 
pressure and workload (90.9%, C.I. ±6); lack of patients' records (78.4%, C.I. ±8.59); lack of 
documentation of interventions (52.8%, C.I. ±10.48); lack of instrumentation (59.1%, C.I. 
±10.26); lack of understanding by the public of the training and skill-sets of pharmacists 
(72.1%, C.I. ±9.47); and lack of understanding by healthcare providers of the training and 
skill-sets of pharmacists (69.4%, C.I. ±9.79), as barriers to enhancing the public health role of 
community pharmacists in the UK. However, a number of respondents (majority) did not 
accept that lack of demand for public health services (45.5%, C.I. ±10.39); safety concerns by 
GPs (43.2%, C.I. ±10.34); language barrier (57.5%, C.I. ±10.38); and safety concerns of 
patients (57.9%, C.I. ±10.3) were barriers to enhancing the public health role of community 
pharmacists in the UK. 
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Table 6. Barriers to Enhancing the Public Health Role of Community Pharmacists  
Questions 
(Responses with significant agreement in bold) 
Disagree 
(%) 
Strongly 
disagree 
(%) 
Neither 
agree 
nor 
disagree 
(%) 
Agree 
(%) 
Strongly 
agree 
(%) 
Insufficient training of pharmacists in PH? (n = 88) 14.8 5.7 10.2 60.2 9.1 
Insufficient skill of pharmacists in PH? (n = 88) 20.5 10.2 18.2 46.6 4.5 
Lack of professional autonomy for pharmacists? (n = 88) 8.0 1.1 26.1 45.5 19.3 
Difficulties in recruiting patients? (n = 88) 13.6 2.3 19.3 48.9 15.9 
Lack of demand for public health services? (n = 88) 30.7 14.8 29.5 22.7 2.3 
High drop rates for public health services? (n = 88) 9.1 8.0 37.5 36.4 9.1 
Low success rates for public health services? (n = 87) 27.6 11.5 34.5 23.0 3.4 
Lack of input from public health practitioners? (n = 88) 9.1 0 26.1 52.3 12.5 
Lack of support from public health practitioners? (n = 86) 12.8 0 25.6 47.7 14.0 
Difficulty in communicating with other PH providers? (n = 87) 12.6 1.1 13.8 62.1 10.3 
Lack of support from GPs? (n = 88) 11.4 2.3 25.0 36.4 25.0 
Insufficient funding from the government? (n = 88) 9.1 1.1 13.6 35.2 40.9 
Difficulty in fee collection? (n = 88) 13.6 4.5 33.0 36.4 12.5 
Time pressure and workload? (n = 88) 2.3 1.1 5.7 36.4 54.5 
Safety concerns among pharmacists? (n = 88) 17.0 6.8 28.4 34.1 13.6 
Safety concerns by GPs? (n = 88) 27.3 15.9 28.4 18.2 10.2 
Safety concerns of patients? (n = 88) 40.9 17.0 25.0 11.4 5.7 
Lack of patients' records? (n = 88) 5.7 4.5 11.4 52.3 26.1 
Lack of documentation of interventions? (n = 87) 14.9 4.6 27.6 42.5 10.3 
Physical design of community pharmacies? (n = 88) 28.4 5.7 28.4 25.0 12.5 
Misperception that counselling is not needed? (n = 88) 26.1 6.8 20.5 31.8 14.8 
Lack of instrumentation? (n = 88) 17.0 3.4 20.5 52.3 6.8 
Language barrier? (n = 87) 41.4 16.1 24.1 10.3 8.0 
Lack of understanding by the public? (n = 86) 8.1 7.0 12.8 50.0 22.1 
Lack of understanding by HC providers? (n = 85) 10.6 4.7 15.3 51.8 17.6 
 
In addition, I provided an option for respondents to supply free text comments on what they 
considered as barriers to enhancing the public health role of community pharmacists in the 
UK. Barriers, which the respondents highlighted, were various and included funding issues 
and time pressure from employers:  
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Various [environmental context and resources and lack of knowledge] 
 “Lack of co-ordinated approach by utilising all parties; lack of understanding and 
 acceptance of health promotion before treatment; as well as ring-fenced funding 
 arrangements.” [E390] 
Follow-up [environmental context and resources] 
“Follow-up is difficult to find out why a patient hasn’t continued, e.g. NRT. Time 
constraints to phone, each individual patient who hasn’t returned.” [E454] 
Conflict of interest [social/professional role and identity] 
“GPs and GP practices don’t want pharmacies in their team – conflict of interest.” 
[B37] 
 “GPs think we are taking money from them by providing a service.” [RC185] 
Publicity [knowledge] 
 “Government/NHS should emphasise pharmacists’ roles more publicly – ever-likely 
 as mandatory for those using NHS services regularly, e.g. mandatory MUR for all on 
 long-term medications.” [P133] 
According to two respondents, ensuring consistency in service delivery across sectors 
and/or locations can also help to tackle some of the identified barriers:  
 “More nationally consistent strategies, that is, National Minor Ailment Scheme.” 
[B115] 
“Firstly, pharmacists themselves need to quantify and specify what they're able to do 
for the public and patients rather than just taking on what GPs don't want to do 
anymore for no more money.” [E382] 
On the other hand, five of my respondents highlighted the need for collaboration [social 
influences - team working] between healthcare professionals as well as with government 
bodies. For some, this would also mean various healthcare professionals seeing pharmacists 
more as colleagues and recognising each other’s roles and abilities:    
   “GPs and NHS need to recognise the ability of a pharmacist and collaborate and 
work together.” [RB27]  
“Better co-operation between pharmacies and GPs/nurses/carers to allow more 
seamless care.” [E448] 
“Training GPs, etc., and pharmacists together. All groups need to be aware of skills of 
other. Time – there’s a lot to do already!” [RE336]  
Two of my respondents would like pharmacies to employ more than one pharmacist 
(enhancing resources), which would, for example, allow pharmacists’ roles to be split 
between dispensing activities and clinical (and public health) activities:   
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“Have two pharmacists on duty at all times, [one] dispensing [and the other] clinical. 
Make it law, so pharmacy chains are forced into doing this.” [B63] 
“More pharmacists per branch.” [RE406] 
Another area of emphasis for many of my respondents was on improving funding for 
community pharmacy public health activities (resources), which five of them identified as a 
barrier to enhancing the role of pharmacists in public health: 
 “Money, education of healthcare professionals.” [RC185] 
“More funding.” [RC245] 
“More funding/training and better collaboration” [RC 280] 
“Funding.” [C210] 
At the same time, there were several and wide ranging suggestions for more support 
(minimising social influences) and training for pharmacists (knowledge and skills) (fourteen 
respondents); enhancing awareness (knowledge) for the services community pharmacists 
were providing (eight respondents); and community pharmacists becoming more proactive 
with public health (enhancing beliefs about capabilities). As well as, improving 
communication between healthcare professionals by encouraging team working; tackling 
the undervaluing of pharmacists [improving social support and identity] as well as reducing 
community pharmacists’ workload [through social support, enhanced resourcing and 
decreasing emotional stress].  
Support and training (knowledge, skills, and environmental context and resources)  
“The introduction of protected learning time such as how GPs [are] currently allowed 
to close the practice once a month for 2 hours to allow for training.” [B32] 
 “More funding/training and better collaboration.” [RC 280] 
“Better training for pharmacists and other healthcare professionals on public health 
and how pharmacists can get involved.” [RE411]  
“More training and greater understanding of problems and consequences.” [RB50] 
“Provide more training at suitable times and provide remuneration.” [B48]  
“More training with other healthcare professionals.” [B109] 
“Better training and communication/relationship building with other healthcare 
professionals.” [C157] 
“Adequate training of pharmacists; public health services campaigns to inform public 
co-operation between NHS and all contractors to pay and provide public health 
services.” [E444] 
 “Improve training in public health of qualified pharmacists – not at university level.” 
[E454] 
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“Increase knowledge of what pharmacists can/cannot do to patients and other 
healthcare professionals.” [E363] 
“Better education of public, higher profile for pharmacists.” [B30] 
“More training.” [B117] 
“Education, training and CPD.” [B35] 
“Improved education and training.” [E405] 
Awareness (education) 
  “Pharmacy to make its case effectively.” [B123] 
“An ‘ask your pharmacist’ campaign on Facebook, buses and newspapers.” [C257] 
 “Greater promotion of pharmacists’ role and qualifications.” [C272]  
“Better education of public, higher profile for pharmacists.” [B30] 
“Better advertising of our skills, to change patients’ perception of us.” [C239]  
“Educate public more on role of a pharmacist. Advertise services, e.g. on TV or in GP 
surgeries, that pharmacists carry out, for example, Nicotine Replacement Therapy 
(NRT).” [E310] 
“Better promotion of pharmacies by NHS.” [E347] 
“Public and health professional.” [C267] 
Proactive with public health activities (beliefs about capabilities) 
“It takes too long to dispense and check prescriptions. Due to clawbacks, I cannot 
employ an Accuracy Checking Technician (ACT). As I work for a multiple, our targets 
are not incentivised for services. I get paid either way with or without services. 
Currently, if I provide extra services it will not justify hiring extra staff, as payments 
are too low and not guaranteed income to employ full-time staff.” [RE442] 
“Pharmacists need to understand the bigger picture and must be proactive in 
promoting the services – public health.” [B121] 
“The barriers have gone down – pharmacists are no longer seen as just a dispensing 
machine – I think we are seen as healthcare practitioners.” [B77]  
“Government and health boards [CCGs] to accept health promotion as important 
part of clinical care that can save money in long term. Expansion of pharmacists’ 
clinical skills in this area.” [E390] 
Communication (education) 
“Better communication between healthcare professionals. Training together with 
other healthcare professionals.” [RC191]  
“Highlighting outcomes to other health professionals. Improved training.” [RE359] 
“Better communication with other healthcare professionals.” [RC244] 
“Better communication and funding.” [RE414] 
“Better communication and understanding of the skill set of pharmacists.” [RB148] 
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Undervalued (professional/social role & identity) 
“More discussion with NHS and various national bodies, i.e. GP; nurses; hospital; 
pharmacists. They need to understand how undervalued pharmacists are.” [B37] 
“The barriers have gone down – pharmacists are no longer seen as just a dispensing 
machine – I think we are seen as healthcare practitioners.” [B77] 
Workload (environmental context and resources) 
“Although I enjoy getting involved in public health services, the demands of 
workload and pressure mean that we don’t have the time to spend with patients. 
The amount of paperwork/electronic forms that need to be completed before 
registration/payment.” [RE362] 
 
When my questionnaire then asked community pharmacists how essential is it that patients 
get public health services from community pharmacies, 43.7% of respondents (C.I. ±10.41) 
indicated that this was ‘very essential’; 27.6% indicated ‘essential’ (C.I. ±9.38); 16.1% 
indicated ‘quite essential’ (C.I. ±7.71); and 12.6% said, ‘sometimes’ (C.I. ±6.96).  
I asked community pharmacists to provide in free text format what they considered the 
positive aspects/successes of the present public health services from the community 
pharmacy and how these can be strengthened. Their responses were diverse, with more 
than forty respondents highlighting the fact that community pharmacy was accessible. In 
addition, I also received responses that suggested that public health services offered from 
community pharmacies were a method of role extension [knowledge and skills] (seven 
respondents) and recognition/status for community pharmacists [social/professional role 
and identity]; enabled teamwork and collaboration between pharmacists and other 
healthcare professionals [social influences - team working]; however, more funding 
[resources] and training [knowledge and skills] were needed to boost outcomes. 
Various (environmental context and resources, and beliefs about capabilities) 
 “Accessible, infrastructure and logistical support to deliver these services. Need to 
reduce pressure on A & E and GPs, by utilising pharmacists’ skills. Acceptance on part 
of all stakeholders that this is cost-effective to do.” [E390] 
Role extension (professional/social role & identity) 
 “Smoking cessation – referral from GPs. Weight management – (needs) funding.” 
[B83] 
 “Extends job role.” [E374]  
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“Minor Ailment Service; Nicotine Replacement; EHC; Needle Exchange; Flu 
Vaccination; AAH Services; Malarial Tablet Prescribing; and Travel Vaccinations.” 
[E405] 
“Smoking cessation; weight clinic.” [RE406] 
 “Medicine interventions. Better access to medical records.” [RC191] 
 “Uptake is great, but outcomes depend on how strong is the willingness of the 
patient.” [RB144] 
“Many aspects of health are covered by services, which is very good in who wants to 
get improvement.” [RE354] 
Recognition (beliefs about capabilities and reinforcement) 
“By recognition from government of the role played by pharmacists, by keeping 
people healthy in many ways.” [B123] 
Status (professional/social role & identity) 
“Strengthens the standing of the profession with patients and other healthcare 
professionals.” [C157] 
“Less waiting time for patients, improving the image of pharmacists.” [C272]  
Teamwork/collaboration (social influences – team working)  
“Get the whole pharmacy team – counter assistants, dispensers and technicians 
involved in providing the services. Healthy living pharmacies/champions.” [B121] 
“Minor ailments – saves doctors’ time.” [B35] 
“Relieve pressure on GPs. [Develop] professional working relationship with other 
health practitioners.” [C255] 
 “Regular meetings with all pharmacists in [the] area.” [B60]   
Funding (environmental context and resources) 
“When funded by NHS, all pharmacies are involved, e.g. NRT, so funding is essential 
for universal service.” [E444] 
Accessibility (environmental context and resources) 
“Always visible and open to neighbours.” [B115] 
“Can be seen without an appointment, see both well and unwell people.” [B32] 
“Always available - weekends, late nights, etc. – accessible.” [RC185] 
“Quick and easy access to professional advice and services.” [RE411] 
“Easily accessible.” [RE372] 
“Long hours. See well people.” [C210] 
“Access, opening hours.” [RC196] 
“Easy access for patient to professional advice.” [RE359] 
 “Ease of access.” [RE442] 
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“Knowledge of customers. They are sometimes more likely to tell pharmacists what 
they are eating, etc. than GPs.” [RE362] 
“Easy instant access to pharmacists – no appointments, etc. [RB148] 
“Ease of access. Continued training and on-going training.” [RE336] 
  “Accessibility and local knowledge of patients.” [RC 280] 
“Familiarity with patients and ease of access can make it easy for patients.” [RE414] 
“Opening times and less waiting.” [RE385] 
“Don’t need an appointment to see us, so are available more readily than GPs.” 
[E448] 
“Ease of access, flexible access.” [B109] 
"Accessibility, cost effectiveness to NHS. Need strengthened by adapting pharmacy 
workforce, e.g. ACTs; move away from chasing items." [E347] 
  “Ease of access to pharmacy by public.” [C198] 
“Nationally commissioned services through NHS Scotland.” [E315] 
“Easy access/availability. Education and funding.” [C300] 
“Easy access, more funding.” [RB27] 
“Accessible, infrastructure and logistical support to deliver these services. Need to 
reduce pressure on A & E and GPs, by utilising pharmacists’ skills. Acceptance on part 
of all stakeholders that this is cost-effective to do.” [E390] 
“Saves time for GPs and patients - don’t need to make appointments for services 
such as NRT with pharmacists.” [E310] 
“Always visible and open to neighbours” [B115] 
“Localised services for smoking cessation, needle exchange, EHC, chlamydia 
screening, that is, services for local communities.” [B37] 
“Good access. Two pharmacists on duty.” [E446] 
“Accessible and non-threatening.” [C264] 
“Easy to access, qualified staff.” [C239] 
“Easy access.” [B86; RC245] 
"No appointment needed - accessible, non-judgemental and free." [E382] 
“Accessibility and approachability – patients know and trust pharmacy staff.” [C296] 
“Most accessible of health care professionals.” [E420] 
“More accessible through community pharmacy.” [B108] 
“Easy access.” [C243] 
“Accessibility.” [C257] 
“Easy to access, approachable but can improve by advertising campaign.” [B30] 
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“Ease of access for the public – don’t need an appointment to see a pharmacist.” 
[E454]  
“Easy access to services – no appointment needed.” [E363; C302] 
 “Easy accessibility”. [E357] 
"Location." [C267]. 
“Pharmacists have more time, so can offer better support than GPs.” [B77] 
The next free text question asked community pharmacists what they considered the 
negative aspects of public health services from community pharmacy and how these could 
be improved. I again received a number of diverse comments. Points raised included, 
commercial pressure from employers [due mainly to organisational climate/culture – social 
influences]; lack of training [knowledge and skills]; funding challenges [environmental 
context and resources]; and lack of privacy and premises arrangements [environmental 
context and resources]. As well as, distractions and lack of commitment from community 
pharmacists [environmental context and resources and behavioural regulation]; lack of 
awareness [knowledge] (ten respondents); lack of time [environmental context and 
resources] (seventeen respondents); workload and stress [environmental context and 
resources and emotion] (six respondents); inconsistency in service delivery [environmental 
context and resources]; and isolation [social influences - team working]:  
Various (environmental context and resources) 
 “Too much expected in a working day, funding is the major issue.” [B32] 
 Lack of training (knowledge and skills) 
 “Lack of training for certain services for pharmacists, for example, advising patients 
on Orlistat if diet and exercise not solely effective.” [E310]  
“Lack of training. Non-regular pharmacists.” [RC196] 
Funding (environmental context and resources) 
 “Not paid enough for services that are provided.” [B132] 
“Cost to patient.” [C257] 
 “Seen as an ‘add-on’ by staff, for which we are not directly remunerated.” [C296] 
“Too many free items and services available. Many people take just advantage of 
that without any real improvement.” [RE354]  
Privacy/Premises (environmental context and resources) 
 “Lack of discretion.” [B115] 
“Lack of privacy.” [E420] 
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“Small space and little time. Second pharmacist [is needed].” [RE406] 
Distraction/Lack of commitment (environmental context and resources, and intentions) 
“Lack of support by employers to deliver services.” [C157] 
“Pharmacist(s) too bogged down with dispensing and not focused on the other 
services.” [B121] 
“People can easily abuse the system – visit multiple pharmacies for free services. 
There should be electronic registration in place like Scottish Electronic Minor 
Ailments System (eMAS).” [E454] 
Lack of awareness (knowledge) 
 “Lack of knowledge from patients and others that services are offered.” [RC191].  
“Not enough advertising.” [B48] 
“Archaic mentality of what pharmacists do.” [C255] 
“Lack of understanding of pharmacists’ skills and capabilities by patients; and lack of 
engagement from GPs and other clinical disciplines. Media score stories, which 
represent only a small, tiny minority of profession.” [E390] 
 “Negative connotation, due to association with ‘commerce’, that is, ‘just a 
shopkeeper’.” [B30]  
 “Some essential services need to be more appreciated (e.g. MUR, NMS).” [B60] 
“Public reception.” [B108] 
“Perception as prescription providers; public awareness campaigns; national 
services.” [E347] 
 “Misconception we’re shopkeepers.” [B86] 
“Some people don’t want to be helped or have interference in their lives.” [E448] 
Lack of time (environmental context and resources) 
“Not implemented properly. No time for pharmacists to spend all day on front 
counter.” [RE442] 
 “Lack of time means services are done half-heartedly.” [RC244] 
“More time should be allocated to provide services.” [RB144] 
“Time constraints.” [RE372] 
“Time constraints and commercial pressure.” [RC185] 
  “Time restraints.” [RE414] 
“Time again!” [RE336] 
“Space and time.” [RE362] 
“Time pressure, lack of funding/resources.” [RC280] 
“Pharmacist has too many roles and too little time.” [RE385] 
“Lack of pharmacist’s time.” [C243] 
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“Pharmacists have too many tasks to do constantly.” [C169] 
“Time constraints and remuneration.” [C300] 
 “Not enough time to carry out all services.” [E374] 
“Lack of time/workload.” [E363] 
“Lack of time.” [E446] 
“Time-consuming.” [RC245] 
Workload/stress (environmental context and resources, and emotion) 
 “Extra workload on top of overcrowded daily work,” [C198] 
“Workload of pharmacists is dangerously high, so potential issues with more work,” 
[C239] 
 “Workload and insufficient staff,” [B35] 
“Pharmacists have too many tasks to do constantly,” [C169] 
"Because free and no appointments, patients come in together and expect to be 
seen right away, which isn't always possible," [E382] 
“Can be distraction from dealing with medication issues,” [RE359] 
Inconsistency (environmental context and resources) 
“Inconsistent – national programmes should be developed.” [B109] 
 “Sporadic services dependent on what a company offers and funds, no consistency 
due to lack of either funding or willingness of companies to fund services.” [E444] 
“We need to work as one – multiples and independents. Some service specification 
in every pharmacy you go to.” [B37] 
“Companies that own pharmacies should not be involved in activities which show 
conflict of interest, e.g. selling cigarettes.” [B123] 
Isolation (social influences – team working) 
“No mechanism for sharing with other members (of the healthcare profession) what 
we have done.” [C264] 
None 
“None.” [C267] 
Interestingly, 83.3% of my respondents (C.I., ±7.97) also agreed with the statement, ‘The 
public health role of community pharmacists in UK is still undeveloped in the 21st century’.  
For those respondents that said ‘yes’ to this question, some of the reasons they gave 
revolved around the quality of services provided from community pharmacies, hence, the 
problem of lack of consistency in service delivery [environmental context and resources]; 
and lack of time to deliver public health services [environmental context and resources]. In 
addition, lack of training [knowledge and skills]; lack of awareness [knowledge]; difficulty 
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adapting to changing needs [behavioural regulation]; feeling undervalued and unrecognised 
[social influences, lack of identity]; and lack of focus [inadequate behavioural regulation]. 
However, some of my respondents also highlighted the fact that community pharmacy 
practice is highly accessible. I listed these comments below: 
Consistency (environmental context and resources) 
 “Too much variation between areas, doesn’t allow us to build continuity of service.” 
[B115] 
 “Pharmacists’ role in medicine optimisation should be championed as this the 
mainstay of most treatments and concordance would help with prevention and 
wastage.” [B32] 
“People still visit their GP for minor ailments. One reason for this could be because 
prescriptions are free in Wales.” [C257] 
“By now pharmacists should be delivering National Minor Ailment Schemes across 
the UK. Pharmacists should be funded to deliver enhanced services beyond smoking 
cessation; EHC; methadone provision; and weight management.” [E390] 
“Pharmacists should interact more with patients/customers, as there are too many 
intermediate professional figures between pharmacist and customer/patient.” 
[RE354] 
Lack of time (environmental context and resources) 
 “Pharmacists have so much to do, all at once, it is difficult to spend time – devoted 
time – and concentrate on public health services.” [RE372]. 
“We have a lot of experience and knowledge but not the time to provide the 
services.” [RC244] 
 “No time.” [RE406] 
Training (knowledge and skills) 
 “Knowledge of public health varies within pharmacy due to lack of adequate 
training. So NHS seems to ignore the potential of health on the high street and tends 
to signpost to nurses or GPs.” [E444] 
"We are expected to provide a service without specific teaching or training – all we 
do is learning on our own or through one's own experiences.” [E382] 
“We need more scope to be able to discuss issues with patients.” [E448] 
Awareness (knowledge) 
 “Pharmacists can do a lot more to contribute to public health. Our biggest hurdle is 
educating the public that we are the first point of call and recognised by NHS.” 
[RB27] 
“Patients are still unaware of the extent of our role within the healthcare structure.” 
[C157] 
“Not enough publicity.” [B83] 
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“Still not perceived by many of the public that pharmacy has a role to play.” [C296] 
“The general public is still unaware of the role of a pharmacist. More advertising of 
these services would highlight role.” (E310) 
Adaptation (beliefs about capabilities) 
“Pharmacist(s) are not adapting to the changing needs of this service. Pharmacist(s) 
[are] really placed to provide public health services.” [B121] 
“Less checking of prescriptions and more time to counsel.” [RE385] 
“Can do more.” [RC245] 
Access (environmental context and resources) 
 “Easy access for the public.” [RB144] 
Undervalued/Recognition (professional/social role & identity, and reinforcement) 
   “The IT systems are a joke and in my opinion not enough is being actually done to 
free up pharmacist time. Our profession is being devalued constantly by reduced 
payments and ever increasing pressure to perform.” [RE442] 
 “There are good new examples such as the flu vaccination, but on the whole 
pharmacy is under-utilised or not remunerated for services done free.” [B123] 
“Look at the role of pharmacists in other countries. We are good, but not world 
leaders.” [RC185] 
“Many patients will still prefer to go to the doctor as they don’t fully understand the 
role of the pharmacist.” [RE411] 
“We seem to be 10 years behind everyone else. GPs have all the power.” [RC 196] 
“So much knowledge gone to waste.” [RC162] 
“Lack of funding/resources, poor collaboration with other healthcare professionals, 
poor understanding of pharmacists’ skills among public.” [RC280] 
“There are many services, e.g. vaccinations that can be handed over completely to 
pharmacies and haven’t.” [B29] 
“The pharmacist role isn’t seen as provider of this role, it’s seen as only provider of 
patients’ medication.” [B109] 
“Under-used.” [RE414] 
“Shopkeeper, not seen as a professional person.” [B86] 
“Massive, trained workforce, (but, are) criminally under-used and unpaid.” [B30] 
“Role of pharmacists not recognised, appreciated or remunerated.” [C198] 
“Public health bodies don’t seem to realise the potential pharmacists can offer.” 
[B37] 
“We are not used efficiently.” [C300] 
“Underdeveloped pharmacists; qualifications not advertised to public properly.” 
[C239] 
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“Not enough responsibilities given to pharmacists; too many hurdles to get 
accredited.” [B117] 
“Not even credit given to pharmacists.” [B108] 
“More can be done. Pharmacists are under-utilised.” [C267] 
Focus (intentions and goals) 
“Yes, pharmacy could do more but can’t do everything.” [C169] 
“Pharmacists do loads of work that doctors less do, which should be done by 
doctors.” [B60] 
“There is still too much focus on high volume dispensing.” [E347] 
 
In addition, my questionnaire also sought the opinion of UK community pharmacists on how 
community pharmacy-based public health services could be developed in the future (Table 
7). Their responses revealed that a minority of community pharmacists (34.1%, C.I. ±10.07) 
would like pharmacies to employ their own public health advisers. Thirty-four percent of 
respondents (C.I. ±10.07) indicated that they were unsure, with 31.7% (C.I. ±9.88) rejecting 
the idea. However, only 8.2% (C.I. ±5.83) of my respondents said they would like community 
pharmacies to devolve all such work to non-pharmacy-based public health practitioners. The 
majority of respondents (67.1%, C.I. ±9.98) rejected the suggestion. 
On the other hand, the majority of respondents also indicated that they would want 
community pharmacists to reach out to the community and run public health programmes 
in libraries or other community meeting places (53%, C.I. ±10.6); community pharmacies to 
develop into Healthy Living Pharmacies (68.7%, C.I. ±9.96); and pharmacists to develop their 
own expertise in public health (89.3%, C.I. ±6.6).  
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Table 7. Suggestions on How Community Pharmacy-based Public Health Services Could Be Developed in the 
Future  
 
Survey questions Disagree 
(%) 
Strongly 
disagree 
(%) 
Neither 
agree 
nor 
disagree 
(%) 
Agree 
(%) 
Strongly 
agree (%) 
Pharmacies employing their own PH advisers? (n = 140) 28.2 3.5 34.1 25.9 8.2 
Devolve all work to PH practitioners? (n = 139) 45.9 21.2 24.7 3.5 4.7 
Pharmacists reaching out to public places? (n = 140) 15.3 11.8 20.0 42.4 10.6 
Community pharmacies developing into HLPs? (n = 138) 3.6 6.0 21.7 43.4 25.3 
Pharmacists developing their own expertise? (n = 139) 2.4 2.4 6.0 63.1 26.2 
 
 
The provision made for other comments revealed many other suggestions:  
Opportunity (optimism) 
“One library in one local area, but many pharmacies in one local area. Uptake is 
great, far more than channelling the services to other places.” [RB144] 
Referral (social influences – team working) 
 “GPs and clinicians actively referring patients to pharmacists for intervention.” 
[E390] 
 
4.2.3 - Tests for Significance and Correlation of Variables 
4.2.3.1 - Tests for Significance of Variables 
I also performed tests for the significance of variables in my analysis (Significance level = p < 
0.05) (Appendix 5a-20). I noticed some significant differences in the manner my male and 
female respondents answered the questions on enhance patients’ self-management 
capacities (p = .012; η2 = .071) [see Appendix 5a-7], time pressure and workload (median = 
4.0; 5.0 respectively, p = .028; η2 = .055), insufficient funding from the government (5.0; 4.0, 
p = .007; η2 = .082) and how essential community pharmacists provide public health 
services (1.0; 2.0, p = .023, η2 = .060) (Appendix 5a-7)? This means that the likelihood of the 
result being a matter of chance is only 5 in 100. My male respondents were more likely to 
agree with the suggestion to enhance patients’ self-management capacities. 
On the question on low success rates for public health services, those aged 40-49 (median = 
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1.5), 50-59 (median = 2.5), 60-69 (median = 2.0) and 70-79 years (median = 2.0) were less 
likely than other age groups to agree that this was a barrier to enhancing the public health 
role of community pharmacists in the UK (total median = 3.0; p = .019; η2 = .152) (Appendix 
8c, 9 and 10). In addition, those respondents aged 60-69 (median = 5.0) were more likely to 
agree than other respondents (total mean = 4.0) that UK community pharmacies should 
develop into Healthy Living Pharmacies (p = .005; η2 = .191) (Appendix 8f, 9 and 10). 
Regarding the questions on safety, while ‘pharmacists’ (median = 4.0) were more likely, 
‘pharmacy managers’ (median = 2.0), ‘superintendent pharmacists’ (median = 2.5) and 
pharmacy contractors/superintendent pharmacists (median = 1.0) were less likely to agree 
than the rest of respondents that ‘Safety concerns by GPs’ was a barrier (p = .042; η2 = .146; 
total median = 3.0) (Appendix 14d, 15 and 16). At the same time, ‘pharmacists’ were more 
likely (median = 4.0), and ‘pharmacy contractors/supt. pharmacists’ (median = 1.0), ‘supt. 
pharmacists’ (median = 1.0) and ‘locum pharmacists’ (median = 2.0) less likely than other 
respondents (p = .016; η2 = .178; total median = 3.0) to agree with the suggestion that 
pharmacies should employ their own public health advisers (Appendix 14e, 15 and 16).  
Based on location, respondents from Cardiff (median = 2.0) were more likely to participate 
in local authority-run schemes than other respondents (p < .001; η2 = .296; total median = 
1.0) (Appendix 17a, 18 and 19). However, when it came to changing the UK undergraduate 
pharmacy curriculum, respondents from Cardiff (median = 3.0) were less likely than other 
respondents to agree that the public health content of the UK undergraduate curriculum 
should be increased (p = .024; η2 = .087; total median = 4.0) (Appendix 17a, 18 and 19). 
Respondents in Edinburgh (median = 5.0) were more likely than other respondents to agree 
to the suggestion that pharmacists should enhance their role in the management of 
polypharmacy (total median = 4.0). This difference was significant (p = .040; η2 = .076) 
(Appendix 17b, 18 and 19).  Moreover, I also found a significant difference on the question 
‘Lack of support from GPs’, with respondents from Edinburgh (median = 3.0) less likely than 
other respondents to agree that this was a barrier (p = .001; η2 = .155; total median = 4.0) 
(Appendix 17d, 18 and 19). However, respondents from Cardiff (median = 3.0) were more 
likely, and respondents from Barnet and the surrounding areas (median = 1.0) less likely to 
agree that it was essential that patients get public health services from community 
pharmacies (p < .001; η2 = .185; total median = 2.0) (Appendix 17f, 18 and 19).  Also 
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significant was the fact that respondents from Cardiff (median = 3.0) were less likely than 
other respondents to support community pharmacies developing into Healthy Living 
Pharmacies (p = .026; η2 = .090; total median = 4.0) (Appendix 17f, 18 and 19).  
4.2.3.2 Tests for Correlation of Variables 
At the same time, a number of variables also correlated to a significant level of p < .05 
(Spearman's rho, ρ) (see appendix 20). I found a correlation between the gender of 
respondents and the way respondents answered the question ‘Offer dual MPharm (or even 
PharmD)/MPH degrees?’ Spearman's correlation coefficient, ρ = -.247, significant to level (2-
tailed), p = .020 (Appendix 20). Male respondents were more likely than female respondents 
to support dual MPharm (or even PharmD)/MPH degrees. I found a similar pattern of 
significance with the question ‘Enhance patients’ self-management capacities?’ (ρ = -.268; p 
= .012) (Appendix 20).  
In addition, there were correlations between the age of respondents and the way they 
answered the questions on ‘is programme fully funded by local authority?’ (ρ = -.240; p = 
.041), pharmacy students training with other healthcare students (ρ = -.261; p = .015), and 
pharmacists working closely with healthcare practitioners (ρ = -.221; p = .040) (Appendix 
20)? In other words, as the age of respondents increased, their support decreased for 
students training with other healthcare students; pharmacists working closely with 
healthcare practitioners; and their ‘yes’ answer to the question, ‘is programme fully funded 
by local authority?’.  Still, there were correlations between the year of qualification and the 
way respondents answered the questions on, ‘enhancing community pharmacists’ 
involvement in smoking cessation’ (ρ = .243; p = .023) and ‘remunerate pharmacists directly 
for public health services’ (ρ = -.242; p = .024)? 
Regarding barriers, my male respondents were more likely to agree that 'Insufficient funding 
from the government’ was a barrier (ρ = -.269; p = .011). There were also negative 
correlations between age of respondents and their likelihood of agreeing that difficulties in 
recruiting patients (ρ = -.224; p = .036) (Appendix 20); low success rates for public health 
services (ρ = -.281; p = .008) (Appendix 20); and language barrier (ρ = -.212; p = .049) 
(Appendix 20) were barriers to enhancing the public health role of community pharmacists 
in the UK. Moreover, my female respondents were more likely to say ‘yes’ to the question, 
‘how essential is it that patients get public health services from community pharmacies?’ [ρ 
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= .216; p = .045]. 
4.2.4 - Strengths and limitation of the survey 
4.2.4.1 – Strengths 
This survey identified a number of strategies as well as barriers (which if tackled), could help 
enhance the role of UK community pharmacists in public health. Inclusion of free text 
comments in the report supported my survey findings. This study also incorporated effect 
size, which is relatively unaffected by the sample size (Clark-Carter 2003; Abelson 1995), in 
its calculations. This has an advantage in that it is possible to compare the findings of this 
survey with studies that have used different sample sizes (Clark-Carter 2003). In this study, I 
have also included p values as well as confidence intervals (C.I.) in the reports. Still, the test 
for correlation and significance of variables enabled me to determine any relationship or 
even association between variables. Finally, I maintained confidentiality throughout by 
ensuring that I did not identify informants by quotes from the data (Ford and Reutter 1990). 
 
4.2.4.2 – Limitations 
The response rate for my survey was very low (23.28%), with added limitation in that I 
selected respondents only from certain regions of the UK. This could have implications on 
the ability to generalise my findings to wider UK population. Highlighted above, are some 
the limitations associated with the measurement of correlation coefficient (section 3.4.4). 
Yet it is worth reiterating that correlation is a measure of association, not causation. Just 
because two variables are highly correlated, this does not imply that one causes the other. 
There are usually many factors involved (Reid 1996), particularly as there could be other 
variables affecting the relationship that the researchers may not know about (Jaffe 2010). 
  
4.2.5 - Conclusions      
My survey of UK community pharmacists helped confirm many of my key findings in the 
review of knowledge and information, particularly concerning increasing the public health 
content of the undergraduate curriculum (knowledge and skills); pharmacy students training 
closely with other healthcare students (social influences - team working); pharmacy 
graduates working closely with other healthcare providers (social influences -  team 
working); teaching students about content-specific/advanced communication techniques 
(developing communication skills and team working); and developing good adherence 
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strategies for patients (enhancing behavioural regulation). In addition, there were also 
indications that the majority of my respondents would want community pharmacists 
preventing the spread of infections and managing antimicrobial resistance (behavioural 
regulation), enhancing patients’ self-management capacities (behavioural regulation and 
beliefs about capabilities), and enhancing safe medication disposal methods (behavioural 
regulation). However, the majority of respondents would like community pharmacists to 
enhance their skills in the management of polypharmacy and long-term conditions and their 
involvement in smoking cessation (behavioural regulation), and for students to be provided 
with advanced experience in public health (knowledge and skills).  
Interestingly, the majority of my survey respondents also confirmed most of the barriers I 
identified in my review of knowledge and information. Notably they included insufficient 
funding from the government (environmental context and resources); time pressure and 
workload (environmental context and resources); lack of patients' records (memory, 
attention and decision processes); lack of understanding by the public of the training and 
skill-sets of pharmacists (knowledge); and lack of understanding by healthcare providers of 
the training and skill-sets of pharmacists (knowledge). In addition, I reconfirmed a number 
of these barriers in the survey’s free text comments. I also identified additional barriers 
from the free text comments, including commercial pressure (environmental context and 
resources), difficulty following up with patients (environmental context and resources), 
conflict of interest - notably, between GPs and community pharmacists (professional 
identity/boundaries/role), lack of publicity (knowledge) and the complaint that pharmacists 
are being under-utilised (beliefs about capabilities and identity).  
In addition, tests for significance indicated that there were a number of significant 
differences in the way respondents answered some of the questions, in terms of gender, 
age, role in the pharmacy and location of practice (p < .05). In some instances, the effective 
size magnitude of these differences (Eta squared, η2, with Anova), were ‘large’ (0.14) (Nandy 
2012). In addition, a number of these variables were significantly correlated (p < .05). There 
is therefore a need to put these differences into consideration when policies around the 
role of community pharmacists in public health are developed. 
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4.3 - Content Analysis 
The aim of my content analysis was to examine the pattern of the UK undergraduate 
pharmacy curricula, teaching and learning policy. Hence, I present below the characteristics 
of the 28 UK Schools of Pharmacy included in my analysis, as well as the nature of their 
curricula, in terms of the components (subject areas), with emphasis on how Public Health 
as a module, is taught in various schools.  
4.3.1 - Characteristics of UK Schools of Pharmacy 
At the time of my research activity, there were 29 Schools of Pharmacy in the UK (GPhC 
2015). Of these, 28 were included in my study. The only school that was not included in my 
study, the School of Pharmacy, University of Lincoln, was omitted because it was not fully 
functional at the time I started my analysis in May 2014. In 2014, the University of Sussex, 
was undergoing the GPhC accreditation, and was meant to begin its pharmacy programme 
in 2016 (Anon 2015b). Characteristics of the UK Schools of Pharmacy included in my content 
analysis (Figure 8 and 9) indicated that 12 of the 28 schools analysed (42.8%) were 
established after the year 2000. The remaining schools were established in 1800-1849 
(17.8%) [five]; 1850-1899 (14.3%) [four]; 1900-1949 (39.3%) [eleven]; and 1950-1999 (7.1%) 
[two]. In terms of location, two schools were located in Northern Ireland; one in Wales; two 
in Scotland, and twenty-three in England (Figure 9). All twelve pharmacy schools established 
after 2000 are located in England. 
Following my content analysis, I found that UK pharmacy schools were teaching a number of 
different subjects in the undergraduate pharmacy education. These included pharmacology, 
biochemistry, anatomy, physiology, pharmaceutics, pharmaceutical technology, 
pharmaceutical chemistry, microbiology, clinical pharmacy and pharmacy practice 
(dispensing, counselling, etc.), drug discovery and formulation, pharmacognosy, medicinal 
chemistry, business/management related topics, research, public health, etc. Often, some of 
these subjects were arranged or grouped together under different names and headings. 
According to the curriculum of one of the pharmacy schools I analysed (School of Pharmacy, 
King's College, London),  
 “... Staff-led ‘contact’ time includes timetabled classes such as lectures, lab 
practicals, tutorials, workshops, seminars and demonstrations.” (KCL 2015) 
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In addition to contact time, students are also expected to undertake directed private study, 
including independent work, such as lab reports, essays, assessments and project work, 
which could amount to approximately 2,000 hours over the four years’ training (knowledge 
and skills development) (KCL 2015).   
However, based on the Group Query and Visualisation results with NVivo, I was able to also 
confirm that the curricula of most UK pharmacy schools were more dominated by the 
sciences, clinical studies, modules on skills development (e.g. production (formulation) and 
dispensing activities), research and law and ethics. Some of these are presented in Appendix 
21-32. On the other hand, their emphasis on subject areas such as management/business 
studies and public health were often minimal, and in some cases optional. The fact that 
many aspects of the theoretical domains framework (Michie, et al. 2005), are not 
adequately covered in the curricula of UK Schools of Pharmacy is the most obvious impact.   
4.3.2 - Clinical Studies 
For clinical studies (knowledge and skills), some of the topics covered by UK Schools of 
Pharmacy included cancer care, case studies, diagnosis of illnesses, illnesses, infection 
control, one-to-one interactions with patients, patient-centred care, pharmacology of 
medicines, prescribing, psychiatry, treatment, etc.  
In particular, for ‘patient-care’, which was the most coded word under the main coding 
‘clinical’, I found statements in the pharmacy schools’ curricula, such as: 
“… Patient-based case studies to develop your patient-centred skills” “… and the use 
of medicines for individual patients.” (Aston SoP) 
In the case of the pharmacy curriculum at Durham University, I found patient-care 
statements such as, 
“You will meet patients during this level (Level 1) and will be exposed to various 
areas of practice as well as a range of healthcare settings outside of pharmacy.” 
4.3.3 - Skills Development 
Regarding skills development (skills), many of the UK Schools of Pharmacy felt that this was 
relevant to students’ employability and future career progression. Hence, some of their 
curriculum statements reflected this:  
“The curriculum is presented as integrated modules that develop your 
understanding of the pharmaceutical and biomedical sciences in ways that 
demonstrate their importance to problems encountered by pharmacists in practice – 
so that you understand the relevance of what you are learning for your future 
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practice.” [University of Bradford, School of Pharmacy]. 
4.3.4 - Sciences 
One of the criticisms against the UK undergraduate pharmacy curriculum has been its huge 
emphasis on the sciences (knowledge and skills) at the expense of public health (as well as 
clinical) modules, at a time when this has changed in many countries such as the USA, 
Canada, France, etc. (Agomo 2011, 2012c; Chapman 2014). According to pharmacist 
Mathew Smith from Cardiff School of Pharmacy and Pharmaceutical Sciences:  
“I would get rid of loads of the science … Around 99% of our students are going to be 
pharmacists and not going in to the pharmaceutical industry; if you look at those 
who do, it’s training on the job now, rather than at undergraduate [level].” 
(Chapman 2014) 
The curricula of most UK Schools of Pharmacy reflected this emphasis on the sciences, for 
example: 
“The first year develops your knowledge of the basic scientific principles 
underpinning pharmacy” and, “The second year extends your understanding of the 
pharmaceutical sciences – the chemistry of different drug groups …” [Aston SoP]. 
4.3.5 - Research  
As regards research (knowledge and skills), the curricula of UK pharmacy schools also 
revealed that this was an important component of the undergraduate pharmacy training. 
For example, at Birmingham SoP, its curriculum stated that: 
“In this year [Year 4], you’ll also be introduced to healthcare research methodology 
and undertake a substantial individual research project, which may have a 
laboratory-based scientific theme, or a professional or clinical focus in a healthcare 
environment.”  
4.3.6 - Law and Ethics 
Law and ethics have always been part of pharmacy practice (beliefs about consequences and 
behavioural regulation), particularly as it pertains to the use of medicines and the care of 
patients. The curricula of many UK pharmacy schools indicated this association. An example 
being the Level 2 curriculum at Durham SoP, which stated that: 
“Finally you will learn how the law relates to the practice of pharmacy and how we 
are involved in protecting the public from the potential harm associated with the use 
of medicines.” 
4.3.7 - Management 
Due to the commercial nature of the profession, particularly community pharmacy practice, 
I expected business and management studies to be important topics in the undergraduate 
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pharmacy curriculum. However, from the findings of my content analysis, there was nothing 
to suggest that this importance was widely reflected in the curricula of UK pharmacy 
schools. The exception may be the School of Pharmacy, University of Brighton, where a ten-
credit module in ‘Business Studies for Pharmacists’ is offered at Level 7 (final year). The 
school, however, provided no further information in their curriculum concerning the 
content of this module. 
4.3.8 - Public Health 
During my code development stage, I developed the following main codes for public health: 
accessibility; addiction; adherence; ageing; assessment; barriers; benefits; communicable 
disease; deficiency; definition; delivery; devices; emergency; empowerment; epidemiology; 
errors; evaluation; holistic; organisation; pharmacoeconomics; pharmacovigilance; poverty; 
prevention; risk factors; safety; self-care; surveillance; and well-being (see Figure 10 and 11). 
In addition, as revealed by another Group Query I conducted, in terms of coding, I noticed 
that there were a number of variations with the public health content of the curricula of UK 
pharmacy schools. Visually, the curricula of pharmacy schools such as the University of 
Portsmouth, Robert Gordon University and the University College London (UCL) seemed to 
contain more topics related to public health than those of the other UK pharmacy schools 
(see Figure 11). Regarding the specific topics covered in public health (see Figure 11), I also 
noticed that the emphasis of many UK pharmacy schools seem to be on safety (emotion – 
fear and threat), risk factors (emotion - threat), disease prevention (emotion - threat), 
adherence (behavioural regulation – goal priority) and addiction (behavioural regulation). 
Many of these fit within what Truong and Patterson (2010) describe as micro-level public 
health activities. On the other hand, there seems to be less teaching on public health areas 
such as assessment, pharmacovigilance (knowledge and skills), poverty alleviation (beliefs 
about capabilities – empowerment), surveillance (knowledge and skills), emergency 
preparedness (environmental context and resources (stressors) and emotion – threat), 
evaluation and epidemiology (knowledge and skills)- topics that represent more macro-level 
public health functions (Truong and Patterson 2010). 
4.3.9 - Word Frequency Query  
One activity with NVivo involved performing a Word Frequency List Query of the curricula of 
the 28 UK Schools of Pharmacy (for the 100 most frequent words, with a minimum word 
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length of three letters). A summary of the word frequency query results (Table 8) showed 
that the most frequently used words were: ‘pharmacy’ (count, 442; weighted percentage, 
1.25); ‘drug’ (count, 277; weighted percentage, 0.78); ‘course’ (count, 274; weighted 
percentage, 0.77); ‘students’ (count, 254; weighted percentage, 0.72); and ‘pharmaceutical’ 
(count, 247; weighted percentage, 0.70). Ranked much lower in the word frequency query 
results was the word, ‘public’, which may or may not necessarily be associated with the 
term of interest, ‘public health’ (count, 60; weighted percentage, 0.17). However, the word, 
‘health’ was ranked much higher in the table (count, 205; weighted percentage, 0.58). 
 
Table 8. Word Frequency Query Results (with 100 most frequent words; minimum word  
length of 3 letters) - Summary  
 
Word Length Count Weighted Percentage (%) 
pharmacy 8 442 1.25 
drug 4 277 0.78 
course 6 274 0.77 
students 8 254 0.72 
pharmaceutical 14 247 0.70 
year 4 231 0.65 
practice 8 223 0.63 
health 6 205 0.58 
module 6 204 0.58 
clinical 8 194 0.55 
skills 6 186 0.53 
medicines 9 176 0.50 
credits 7 174 0.49 
learning 8 171 0.48 
drugs 5 157 0.44 
describe 8 142 0.40 
understanding 13 141 0.40 
coursework 10 135 0.38 
patient 7 134 0.38 
professional 12 134 0.38 
knowledge 9 125 0.35 
study 5 125 0.35 
use 3 122 0.34 
based 5 120 0.34 
assessment 10 111 0.31 
research 8 111 0.31 
care 4 105 0.30 
also 4 104 0.29 
hours 5 103 0.29 
lectures 8 102 0.29 
level 5 101 0.29 
development 11 99 0.28 
 117 
 
disease 7 99 0.28 
including 9 99 0.28 
bradford 8 98 0.28 
modules 7 95 0.27 
pharmacology 12 94 0.27 
mpharm 6 93 0.26 
management 10 92 0.26 
teaching 8 92 0.26 
practical 9 89 0.25 
student 7 88 0.25 
chemistry 9 87 0.25 
programme 9 86 0.24 
pharmacist 10 85 0.24 
treatment 9 81 0.23 
studies 7 80 0.23 
university 10 80 0.23 
used 4 80 0.23 
patients 8 77 0.22 
pharmacists 11 77 0.22 
systems 7 75 0.21 
linked 6 74 0.21 
within 6 73 0.21 
demonstrate 11 72 0.20 
principles 10 72 0.20 
first 5 71 0.20 
semester 8 70 0.20 
structure 9 70 0.20 
formulation 11 69 0.19 
may 3 69 0.19 
medicine 8 69 0.19 
two 3 68 0.19 
methods 7 66 0.19 
aspects 7 65 0.18 
introduction 12 65 0.18 
therapeutics 12 65 0.18 
develop 7 64 0.18 
stage 5 64 0.18 
information 11 63 0.18 
science 7 63 0.18 
academic 8 62 0.18 
team 4 62 0.18 
work 4 62 0.18 
cancer 6 61 0.17 
design 6 61 0.17 
school 6 61 0.17 
able 4 60 0.17 
delivery 8 60 0.17 
physiology 10 60 0.17 
public 6 60 0.17 
role 4 60 0.17 
diseases 8 59 0.17 
provide 7 59 0.17 
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products 8 58 0.16 
time 4 58 0.16 
material 8 57 0.16 
action 6 56 0.16 
new 3 56 0.16 
review 6 56 0.16 
system 6 56 0.16 
issues 6 55 0.16 
case 4 54 0.15 
current 7 54 0.15 
outline 7 54 0.15 
mechanisms 10 53 0.15 
staff 5 53 0.15 
dosage 6 51 0.14 
understand 10 51 0.14 
one 3 50 0.14 
 
 
However, Weber (1990) argues that several assumptions underlie this mode of analysis, the 
salient one being that the most frequently appearing words indict the greatest concerns. 
While this is likely to be generally true, Weber (1990) warns about two cautions, which need 
not to be ignored. The first caution is that it is possible to use one word in a variety of 
contexts, and in some cases, one word may have different meanings. Word frequencies may 
indicate far greater uniformity in usage than actually exists; raising some questions about 
the validity of inferences from word frequency data (Weber 1990).  
The second caution is that the use of synonyms and/or pronouns for stylistic reasons can 
lead to the understating of actual concern with particular words or phrases (Weber 1990). 
While word frequency lists can disclose changes or differences in emphasis between 
documents, Weber (1990) also warns that they need to be used with caution, particularly as 
word frequencies do not disclose a lot about the associations among words. Instead, he 
advises that having employed ordered word frequency lists to flag up words of possible 
interest; the researcher should then use Key-Word-In-Context (KWIC) lists for retrievals 
from text to test hypotheses concerning the larger context of symbol usage. In my content 
analysis, I employed both the NVivo visualising method and the search for key words, based 
on the word frequency list and my coding, to collect some meaning regarding the pattern of 
UK undergraduate pharmacy curricula, teaching and learning policies. 
Next, I used NVivo to visualise the pattern of my coding for individual Schools of Pharmacy 
[with the source selected in List View: Right-click > Visualize > Chart Document Coding]. 
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Some of these representations are presented in Appendix 21-32, and revealed that in many 
of the Schools of Pharmacy, my most coded words were often ‘clinical’, ‘science’, 
‘dispensing’, ‘production’ and then ‘research’ (Knowledge and skills). The exceptions 
included, for example, the Schools of Pharmacy at Kingston, Huddersfield, Reading and De 
Montfort, where ‘experiential’, ‘public health issues’, ‘professionalism’ and ‘skills’ were the 
most coded words, respectively. In general, from both the word frequency search and visual 
representation of my coding, ‘public health’ was often a lesser priority in the curricula of UK 
pharmacy schools.  
When I investigated further some of the specific public health-related issues covered by UK 
pharmacy schools, I found that only a number of Schools of Pharmacy, namely, Bath, 
Bradford, De Montfort, Hertfordshire, Manchester, Portsmouth and UCL (all in England) 
mentioned the word ‘safety’ (beliefs about consequences – perceived risk/threat), in 
whatever form (including ‘public health safety’, ‘patient safety’, ‘health and safety’, etc.), in 
their curricula.  This was further confirmed when I performed a text search of the UK 
pharmacy schools’ curricula. There were also some indications from the content analysis 
that the older Schools of Pharmacy and those established in England between 1900 and 
1949, discussed ‘safety’ more in their curricula than other schools (see Figure 12). This query 
was performed by selecting the coding ‘safety’ from Nodes (NVivo), then Right-click > 
Visualize > Chart Document Coding by Attribute Value].  
An example of ‘public health safety’ being reflected in the school curriculum was in the 
‘Clinical Pharmaceutics module’ provided by the UCL SoP for Year 4 students. Here the 
university stated that one of the aims of the module was to enable students to “Appreciate 
safety, efficacy and quality of medicines for children”. In the University of Manchester, 
School of Pharmacy ‘Pharmaceutical Care’ module for Year 4 students, the curriculum stated 
that this was:  
“An integrated unit covering evidence-based practice, health economics, prescribing, 
patient safety and pharmaceutical care,” and aimed at, “develop(ing) students' core 
knowledge and problem-solving skills relating to patient safety, prescribing and 
pharmaceutical care.”  
Regarding my coding for ‘risk factors’, I realised that these were coded for programmes run 
by five universities: Hertfordshire, UCL, Queens University Belfast, Huddersfield and 
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Portsmouth. At the School of Pharmacy, University of Hertfordshire, the Year 4 module, 
‘Travel Health’ (optional) had the following description:  
“The aims of this module are to give the student advanced understanding of 
theoretical and practical knowledge in all elements of travel health. The module will 
cover the role of the pharmacist in travel health promotion and prevention of illness. 
... The course content will include risks of travel in different countries ...” 
At the School of Pharmacy, University of Portsmouth, the Year 1 Pharmacy Practice Syllabus 
Outline covered among other topics, ‘factors affecting the treatment process’. During the 
Year 2 module in ‘Public Health (Promoting Public Health)’, students were then taught 
‘Adverse Drug Reactions (ADRs) – their prevention, detection and management; the role of 
the pharmacist in minimising risk associated with drug therapy.’ Yet, the school taught 
students in the same module,  
 “Epidemiology of disease and determinants of public health, including lifestyle, 
employment status, air quality, crime, housing; health education and promotion 
roles for pharmacists in areas such as: child health, smoking cessation, exercise, diet 
and obesity, contraception and sexual health, alcohol consumption, vaccination, 
patients with long-term conditions, services for drug misuse and encouraging self-
care.” 
In addition to these, I also coded for the word ‘prevention’ against a number of pharmacy 
schools. However, it seems that the teaching of preventative care at different pharmacy 
schools, were in a variety of ways. For example, in the Year 1 programme of the School of 
Pharmacy, University of Wolverhampton, I found statements such as, “… you look at 
infection and immunity …” and in the final year, “… your studies will deal with treatment of 
infectious diseases, pharmaceutical public health and clinical pharmacy”. During the Level 2 
pharmacy programme at Durham University, the curriculum stated:  
“You will learn how medicines are preserved and the process that cause premature 
breakdown of medicinal products … and how we are involved in protecting the 
public from the potential harm associated with the use of medicines.” 
Other methods adopted by other UK Schools of Pharmacy to teach illness prevention 
included, for example, the ‘Pharmacy Practice’ module at Queen’s University Belfast, 
‘Promoting Healthy Lifestyle’; teaching to final year pharmacy students at Keele University 
about public health and health promotion; and a topic at Nottingham University that 
ensured that students,  
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“Appreciated the causes and systems of cardiovascular diseases ... [as well as] … 
patient counselling and lifestyle advice.”  
There were also indications from my content analysis of the curricula of UK pharmacy 
schools that some of the schools were also providing some level of training in issues 
surrounding ‘adherence’ and ‘addiction’. Regarding adherence, Cardiff University School of 
Pharmacy delivered this topic through a Year 3 module titled ‘Optimisation of 
Pharmaceutical Care’. At the UCL SoP, the ‘Pharmacy Practice’ module in Year 2 helped 
students to ‘distinguish the concepts of compliance, adherence and concordance’. The 
understanding of adherence was further enhanced during the Year 3 training at UCL SoP, in 
another pharmacy practice module, by enabling students to ‘undertake a basic medication 
review’. However, at the School of Pharmacy, University of Portsmouth, ‘adherence’ was 
introduced early to students in the Year 1 module, ‘Pharmacy Practice’. Some of the topics 
covered in the module included:  
“Factors affecting the treatment process. The function of medicines and the rational 
use of medicines. Sociological and behavioural aspects of the use of medicines. 
Medicines adherence. The placebo effect.” 
In addition, I also examined some of my less frequently coded words for public health 
further, e.g. surveillance, poverty, pharmacovigilance, evaluation, epidemiology, emergency 
and assessment, with some interesting findings. A unique module taught in the pharmacy 
programme at Robert Gordon University, Aberdeen, titled ‘Public Health for Pharmacists’ 
included the, 
“…Topics include: healthcare policy relating to pharmacy; health surveillance; health-
related data; health needs assessment; epidemiology; pharmacovigilance; 
pharmacoeconomics; application of evidence-based practice; health technology 
assessment; systematic review; pharmaceutical service development; service 
specification and implementation; business case; audit; evaluation; governance.”  
However, the need to tackle global poverty was the focus of the Year 4 module, at UCL SoP, 
‘Health Care, Drug Use and Pharmacy in Developing Countries’:  
“The World Health Organisation believes that pharmacists could make a greater 
contribution to health care in developing countries. This module will provide an 
overview of health care, disease patterns, the use of medicines in low-income 
countries ...” 
Interestingly, the module also highlighted the fact that: 
“Examination of these issues requires an interdisciplinary approach drawing on 
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material and research from a range of perspectives ...”   
Finally, while the role of pharmacists in ‘emergency preparedness’ is identified in my paper 
(Agomo 2012a), surprisingly this was not much reflected in the curriculum of UK pharmacy 
schools, as my content analysis identified the words ‘emergency’ and ‘emergencies’ in the 
curricula of only three Schools of Pharmacy: University of Hertfordshire, University of 
Portsmouth and University College London. I found for example that at the School of 
Pharmacy, University of Portsmouth, one of the topics taught in the Year 3 module, 
‘Pharmaceutical Care’, was on:  
“Dealing with medical emergencies and the provision of first aid.”  
The word ‘emergency’ when it appeared at UCL SoP was referring to hormonal replacement, 
taught under a pharmacology module, ‘Endocrinology and Associated Diseases’.  
However, Truong and Patterson (2010) argue that there is a need for pharmacists to 
contribute to macro-level public health functions (i.e., assessment, policy development and 
assurance at the population-based level). In my content analysis, I therefore determined the 
extent to which these macro-level public health activities were represented in the curricula 
of UK pharmacy schools.  
The word 'assessment', which I found in the curricula of some Schools of Pharmacy, for 
example, at Bath, Keele, Brighton, Durham and Ulster, was referring to coursework 
assessment(s), rather than to public health or health needs assessment. The only exception I 
identified was at the School of Pharmacy, Robert Gordon University, Aberdeen where the 
indicative module content for the Year 4 module, ‘Public Health for Pharmacists’ included,  
“Healthcare policy relating to pharmacy; health surveillance; health-related data; 
health needs assessment; epidemiology; pharmacovigilance; application of evidence-
based practice; health technology assessment; systematic review; pharmaceutical 
service development; service specification and implementation; 
pharmacoeconomics; business case; audit; evaluation; governance.” 
Again, the word 'policy', was often not related to public health policy development, but 
instead, was in many cases broadly associated with pharmacy practice, as I found at the 
School of Pharmacy, Medway University (‘Integrated Patient Care’): 
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 “The course will cover developments in pharmacy legislation taught in previous 
years and other legislation and policy relevant to the practising pharmacist.” 
Although I identified that polices as related to public health/health were being taught in 
Schools of Pharmacy such as, Huddersfield, Portsmouth and RGU, none of them seemed to 
be about influencing policy development in public health (behavioural regulation – action 
planning).    
Regarding assurance at the population level, when the word 'assurance' appeared in the 
curricula of UK pharmacy schools (e.g. at Brighton, UCL, Cardiff and Manchester), they were 
referring to the quality assurance of pharmaceutical products rather than to public health 
assurance:  
 "K11 - an appreciation of the principles of quality and quality assurance mechanisms 
 in appropriate aspects of scientific and professional activities." [Brighton SoP - Part 2 
 course details for CH143 and CH344] 
 "Design, Formulation and Quality Assurance of Medicinal Products" [Year 3 – Cardiff 
SoP]. 
4.3.10 – Strengths and limitations of my content analysis 
4.3.10.1 – Strengths 
I enhanced the reliability of my analysis by showing how well the results were linked with 
my data, linking references, describing clearly the context, selection and characteristics of 
my participants, as well as my process of data collection and analysis. Part of the process 
involved comparing codes within and across participants, noting patterns and discrepancies, 
and drawing conceptual maps to examine relationships between themes (see also 
Graneheim and Lundman 2004; Polit and Beck 2004). 
4.3.10.2 - Limitations 
My data analysis relied mostly on information available from Schools of Pharmacy websites.  
These curricula contents may not necessarily be an accurate reflection of the state of affairs 
in these institutions, in terms of completeness or being up-to-date, at the time the analysis 
was undertaken. I cannot therefore rule out the possibility of bias. Finally, the sheer 
quantity of the data analysed, was both daunting and overwhelming (Elo and Kyngäs 2008). 
4.3.11 - Conclusions 
In my content analysis of the curricula of UK Schools of Pharmacy, I found that the number 
of UK Schools of Pharmacy has more than doubled since the year 2000, to its present 
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number (> 29). There was however, no indication that this sharp increase in the number of 
pharmacy schools has had any massive impact on the way public health is taught to 
students in the UK, particularly as public health remains an optional module in many UK 
Schools of Pharmacy. In many UK pharmacy schools, several issues related to public health 
were often taught integrated with other modules. However, dominated in most of the 
curricula I analysed were traditional pharmacy modules designed to enhance students' 
knowledge and skills in the sciences, dispensing, production, research, law and ethics, and 
clinical pharmacy (see Figure 13). Nonetheless, as argued by Truong and Patterson (2010) on 
the US pharmacy system, there is also a need to develop the skill-sets of UK pharmacy 
students in macro-level public health activities.  
Reflecting on my content analysis process, the fact that a few number of UK pharmacy 
schools had a summarised version of their curricula on their websites hampered slightly its 
robustness. Some of these schools did however provide a more detailed curriculum when I 
approached them for assistance. A couple of pharmacy schools were, however, unwilling to 
provide further information about their curricula. 
 
 
Figure 8. Characteristics of UK Schools of Pharmacy - Year Established 
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Figure 9. UK Schools of Pharmacy - Location Versus Year Established 
 
 
 
Figure 10. Group Query Indicating Public Health, Clinical and Science Curricula of UK Schools of Pharmacy 
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Figure 11. Group Query Indicating the Public Health Curricula of UK Schools of Pharmacy 
 
 
 
Figure 12. Coding for ‘safety’ by Schools of Pharmacy (England) 
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Figure 13. Node Coding by University vs Country 
 
4.4 - Interviews with Healthcare Professionals 
4.4.1 - Introduction 
In my review of knowledge and information, I identified a wide range of strategies needed 
to enhance the public health role of community pharmacists in the UK (see Tables 1a and 
1b). The dominant themes included strategies enhancing the public health role of 
community pharmacists through the Expert Patients Programme, enhanced communication 
techniques, smoking cessation activities, advanced pharmacy practice experience in public 
health, and the enhancement of the public health content of pharmacy curricula.  
The findings of my survey of UK community pharmacists largely confirmed many of the key 
findings from my review of knowledge and information. At the same time, the majority of 
my survey respondents also confirmed most of the barriers identified in my review of 
knowledge and information. I confirmed various barriers or identified new ones in the free 
text comments, including commercial pressure, difficulty following up with patients, conflict 
of interest, lack of awareness, community pharmacists being under-utilised, etc. In my 
content analysis of the curricula of UK Schools of Pharmacy, I found that while many schools 
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discussed issues related to public health, traditional modules, designed to enhance 
students’ knowledge and skills in the sciences, dispensing, production, research, law and 
ethics and clinical pharmacy, dominated most curricula. Most of the studies I identified in 
my review of knowledge and information however originated from outside the UK, with 
findings that often could not be generalised to the UK, due to differences in health systems, 
practices and laws. Hence, to make some of these findings relevant to the UK, there was a 
need for me to conduct a survey of UK community pharmacists as well as interviewing 
healthcare professionals to identify strategies enhancing the public health role of 
community pharmacists in the UK. 
In my interviews with healthcare professionals, I explored further some of my findings by 
assessing the opinion of practitioners on: changing the UK undergraduate pharmacy 
curriculum to increase its public health content and UK pharmacy schools offering dual 
MPharm/MPH degrees; pharmacy students training closely with other healthcare students 
and, later, graduates working closely with other healthcare providers (for example GPs and 
nurses); teaching content-specific/advanced communication techniques to undergraduate 
pharmacy students and pharmacists; and the adoption of new technologies in community 
pharmacy practice. 
I conducted my interviews by telephone (supported by Skype) using the interview guide 
(Appendix 4), which I developed with the assistance of my academic adviser and academic 
consultant. My interview guide also explored some of the benefits of and barriers to 
enhancing the public health role of community pharmacists in the UK. I present below the 
characteristics of the healthcare professionals I interviewed and my interview findings. 
4.4.2 - Characteristics of Healthcare Professionals Interviewed 
Fifteen healthcare professionals were included in my interviews. Nine (60%) were female 
(Figure 14) and the majority of interview participants (seven [46.7%]) were aged 50-59 
(Figure 15). The following groups of healthcare professionals were included in my interviews 
(Figure 16): GP partner (1); pharmacy manager/superintendent pharmacist (1); 
pharmacist/PhD student (1); hospital pharmacists/tutor (1); nurse practitioner (1); GP locum 
(2); community intern pharmacist (1); community locum pharmacist (4); community relief 
pharmacist (1); pharmacy manager/pharmacist (1); and community pharmacist (1). 
Fourteen of the healthcare professionals I included in my interviews were based in the 
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United Kingdom, and one (a community pharmacist), was previously based in the UK, but 
had now relocated to the United States of America.  
Following my telephone interviews with the healthcare professionals, I identified a number 
of themes (categories) that emerged from my data analysis. The most frequently cited 
issues by interview participants regarding enhancing the public health role of community 
pharmacists in the UK were around accessibility of public health services, benefits in the 
public health role, barriers in the public health role, public health safety, and public health 
issues such as, illness prevention and empowerment (Figure 17). However, my interview 
participants said not much on public health issues such as managing risk factors, managing 
errors, communicable diseases, or public health topics such as epidemiology, assessment 
and ageing. 
 
 
Figure 14. Gender of Interview Participants 
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Figure 15. Age of Interview Participants 
 
 
Figure 16. Role of Interview Participants 
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Figure 17. Nvivo Group Query for Public Health Coding   
 
4.4.3 - Enhancing the Public Health Role of Community Pharmacists in the UK 
My participants suggested a number of strategies needed to enhance the public health role 
of community pharmacists in the UK.  
4.4.3.1 – Enhancing training in public health and clinical skills 
One of my participants highlighted the need to enhance the undergraduate and 
postgraduate training/awareness of pharmacists in public health (as well as clinical skills), as 
I identified in my survey of community pharmacists (Agomo and Ogunleye 2014) and the 
literature (Brown, et al. 2007; Patterson 2008; Truong and Patterson 2010; Whitley 2010; 
Eades, et al. 2011) [knowledge and skills]. Based on his experience from overseas, the US-
based pharmacist, who is also fairly experienced with the UK pharmacy practice, highlighted 
how the health system in the US, is presently utilising the skills as well as the accessibility of 
community pharmacists (environmental context and resources) in the delivery of public 
health services, particularly as it relates to flu, pneumonia and childhood immunisations.  
“I think then they're supposed to undertake a more in-depth training during the 
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under-graduation. If they were given to have more clinical skills, because at the 
moment, like if I take smoking cessation as an example, it's like we only do it like as 
impromptu service, and yes I know that they say that pharmacy people don't need 
appointments and things like that, but I feel that for the public to trust us more, we 
need to really do more clinical stuff, during our undergraduate training or even post-
graduation, to say to people who will be going into a public health role, be it smoking 
cessation, weight loss management, I think we need a bit more clinical knowledge.” 
[PR_FLY] 
4.4.3.2 – Creating awareness among pharmacists 
At least two other participants also highlighted the need to create more awareness 
(knowledge), as well as enhancing the public health training of pharmacists (knowledge and 
skills). One of these, a pharmacist, also suggested that pharmacists should also work with 
other healthcare professionals (social influences [Norms] – team working). The other 
participant, a GP partner, would like pharmacists to be more accessible to the public 
(environmental context and resources); particularly as this will help meet patients’ demand 
for greater choice and accessibility of healthcare (Por 2008). Another GP speaking from her 
experience, also reinforced the need for public awareness, in addition suggesting a referral 
system (social influences - team working), with the overall impact being that this could help 
minimise the present wastage of NHS resources (environmental context and resources). 
“I know from my own experience, we see a lot of patients with minor illnesses that 
come to the GP and I think this is a waste of time. A person says I have had fever 
yesterday; my nose is running … that's it. You see them, especially in the winter 
months; you see a lot of that. So, what can be done more is … patients can be 
educated more … like give them a list of conditions that, 'these things, you don't 
really need to see your GP, you don't really need to be crowding the A&E, go to your 
pharmacist’. Your pharmacist obviously is the one that will say, that thing is beyond 
me, and you go and see your GP. But, I think also, maybe providing, I don't know 
whether you can have like, triage services?” [GP-CHY] 
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4.4.3.3 – Empowering pharmacists in public health activities 
However, two other pharmacists who felt that not much could be achieved without the 
support of these very important groups also highlighted the wider issue of empowerment 
by the public, the commissioning and regulatory bodies (beliefs about capabilities). Yet, this 
might also mean enhancing the public health training of pharmacists [knowledge and skills] 
(Brown, et al. 2007; Eades, et al. 2011), remunerating pharmacists directly for providing 
public health services [environmental context and resources] (Trapskin, et al. 2009; The 
Scottish Government 2013), as well as enhancing the professional autonomy of pharmacists 
(social/professional role and identity), as also suggested by some respondents.  
“I think quite a lot can be done, but then again you know, this effort has to come 
from the top people really, people, government, pharmacists, or [those] shaping 
pharmacy into how it is … They say community pharmacists … have a major role to 
play in everything, but the way the pharmacy system works, this should come from 
the people, the governing bodies … so that it flows down to we, the pharmacists, and 
ultimately down to the communities.” [P-VI] 
   
A participant had specifically suggested that pharmacists should be remunerated directly 
(environmental context and resources; reinforcement) rather than their employers for 
providing public health services. According to him, as pharmacists are responsible for public 
health services from the pharmacy (skills), he reasoned that direct remuneration could be 
an incentive (reinforcement) for them to provide more of such services: 
“So, whoever is acting in the capacity of the function for today, is taking 
responsibility for every aspect of public health, they're responsible for and they 
should be remunerated accordingly and not the business. You understand? So, that 
is what I am saying. So, there are many, many roles pharmacists can do, if value is 
place on them to do it, if they're remunerated accordingly and they are able to fill 
the gap, they're going to be paid for the purpose.” [P-OL] 
 
4.4.4 – Enhancing public health through the use of new technologies and social media 
On the use of new technologies in public health, including some of the evolutions in social 
media (Cain, et al. 2010), the views were also varied, with some of my participants 
identifying beneficial impacts on the wider public health activities provided by pharmacists 
(skills) and a few highlighting concerns (emotion – fear and threat) about confidentiality and 
safety.  
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4.4.4.1 – Benefits associated with the use of new technologies and social media 
One participant talked about the use of popular software such as Twitter, Instant Messaging 
and Facebook in public health activities; citing an example where Instant Messaging is used 
in non-pharmacy organisations such as Currys®. On the other hand, the nurse practitioner 
saw the use of new technologies as an avenue, which community pharmacists could use to 
attract the younger population, who are often hard to reach, to the pharmacy (memory, 
attention and decision processes - attention). Yet, another of my participants saw the use of 
new technologies in public health as innovative and likely to bring benefits to community 
pharmacy public health campaigns (behavioural regulation – facilitator). Highlighting his 
experience in the United States of America, my US-based community pharmacist participant 
described other situations where the use of new technologies could help enhance the public 
health role of community pharmacists, for example, for recording public health activities 
from community pharmacies (memory, attention and decision processes), which could also 
be useful in emergency situations. He went on to describe the use of visual technologies to 
help patients learn how to use medical devices (beliefs about capabilities: self-efficacy), 
even from a distance. 
“I think it can only be a good thing isn't it? We are living in such a technologically 
advanced world, everything is online, and everything is on Twitter, Facebook, or 
whatever. I think if we can utilise that in some way for pharmacists that will be great. 
I know for instance, like some of our colleagues at [a named university], they work 
for online pharmacies, so people just submit their prescriptions online and it's all 
dispensed and ready to collect … so it's going that way, isn't it? … But in terms of 
public health, I do not know, maybe, if there was a number you could call that [had] 
more pharmacists at the other end. Then again, nurses, which is what the NHS 111 
often is or NHS direct, when you rang it … I mean it will be great to maybe have a line 
like, that that was more pharmacists … You could ask for help.” [P-NKT] 
 
While, one of the GP participants had also argued that not making use of new technologies 
could amount to a waste of time and resources (environmental context and resources), one 
of my pharmacist participants reckoned that the use of new technologies could also be 
extended to other pharmacy services, such as Medicines Use Reviews (MURs) in patients’ 
homes (knowledge, and beliefs about capabilities: self-efficacy), and linked to the GP 
practice (and maybe, pharmacy and hospital) computers [social influences - team working]. 
In addition, some participants also believed that the use of new technologies could also 
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serve as a useful tool for public awareness (knowledge; memory, attention and decision 
processes - attention). Although, Cain, et al. (2010) acknowledge that implementing health 
interventions via social media poses challenges, they also highlight the fact that several 
examples exist that display the potential for pharmacists to use social media in health 
initiatives.          
4.4.4.2 – Drawbacks Associated with the Use of New Technologies and Social Media 
On the negative side, one participant (a GP) revealed her concerns regarding confidentiality 
(emotion – fear and threat). While she was personally not too keen on the use new 
technologies, however, she did acknowledge that social media could be useful in hard-to-
reach groups. One pharmacist participant was however, against the use of new 
technologies, purely for the reason that he did not believe that the use of new technologies 
is the direction pharmacy should be heading; stressing that pharmacy is a personal service. 
Instead, he would prefer community pharmacies to be stocked with basic instruments for 
health checks, etc. (environmental context and resources). A similar comment on the use of 
new technologies was also expressed by another GP (an older GP Practice Partner), who saw 
their use in practice as a waste of resources by the government that desperately wants to 
save NHS money (manage resources). He seemed to agree with the pharmacist participant 
that there is nothing compared to personal service (skills – interpersonal skills). Although 
another older pharmacist participant (P-SOL), was not a friend of new technologies (emotion 
- fear), she did however see some benefits in the use of new technologies in practice, 
particularly as they reflected the changing times (environmental context and resources -
person x environmental interaction).  
“There is a plus side of it, but patient confidentiality is important that we protect 
that. So, it is one-to-one advice. Not so sure, I will be keen on the new technologies. 
However, in appealing to a broader and perhaps, harder to reach groups, who may 
not actually present to the health professionals, then I think social media will be 
useful in that respect.” [GP-NN] 
 4.4.4.3 – Suggestions on the use of new technologies and social media in public health 
When I asked my interview participants if they had any specific suggestions of new 
technologies that could be used in community pharmacy practice, I received a number of 
suggestions, including the “development of diagnostic tools” (P-PO), the use of the “EPS 2 
system” (P-VIV), “telephone systems”, social media tools such as “Smart Messaging Service 
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(SMS)”, “Twitter” and “Facebook” (P-JO), with one participant suggesting the use of 
“robots” (N-ART) as well as some of the implications associated with its use. For one of the 
participants, there is a need to extend the use of new technologies to include Patients’ 
Medication Records (PMR). This could then be linked to software on iPads (environmental 
context and resources). “The pharmacists must be able access that information [patients' 
medication record – PMR]” (P-NO). However, for one of my participants, what pharmacists 
need most are basic computer skills (skills), which will also help them adapt to Evidence-
Based Practice (behavioural regulation). There was however nothing to suggest from the 
interviews that participants themselves were making use of these tools in their practice. 
“Yes, obviously there are. Technology in diagnosis is important, because if you look 
at the minor ailment scheme, which we do, it is more or less guesswork. So, a 
technology that guarantees, that tells you that look, this is a bacteria sore throat and 
so should be referred to the doctor, or that is this cough, is reflective of cancer that 
should be referred or that knows that the cough is probably due to, dust inhalation 
or something like that. Yes.” [P-PO]    
 However, for one of my participants, what pharmacists need most are basic computer skills, 
which will also help them adapt to Evidence-Based Practice: 
“I mean examples of computing skills. People need to know things like Excel, Words 
and how to transfer information on Internet and how to check information quickly, 
for example, if somebody comes to the pharmacy with any disease that you don't 
know, people should be able to assess information online, it will be good to be able 
to check what some other people have written about that condition, without any 
problem. So, if you haven't either Googled before or you don't know how to log on 
to the Internet that will be a little difficult.” [P-SOL] 
 
4.4.4.4 – Benefits in teaching the Use of New Technologies and Social Media 
When it comes to teaching the use of new technologies for public health/pharmacy practice 
in UK pharmacy schools, most participants indicated that they were happy with this 
arrangement, even in situations where the same participants had earlier been sceptical 
about the use of new technologies in practice. One participant felt that teaching the use of 
new technologies in pharmacy schools will help bridge the gap that exists between what 
students are taught in pharmacy schools and the real pharmacy world (knowledge and 
skills), arguing also, that often you find that many of the UK pharmacy schools are not up-to-
date, technology-wise (environmental context and resources). For another participant, the 
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benefits of such teaching will be in the area of savings in costs and time (environmental 
context and resources).  
“… So this sort of saves costs, saves time, and it maximises benefits.” (USP-CHD) 
“Yes … it would really go a long way to open their mind-sets, into understanding how 
practical it is, a pharmacy is actually run. But unfortunately, what we actually see in 
most pharmacy schools today is the opposite of how a pharmacy and new 
technologies are being run …” [P-VIV] 
For yet another participant, it seems logical that UK pharmacy schools should include the 
use of new technologies in the undergraduate curriculum; bearing in mind that the 
pharmacists of today will have no choice, but to face the challenges of the computer age 
(skills – competence/ability/skill assessment, practice/skills development).  
“People need to know, because when they qualify they can't escape new 
technologies” (P-SOL).  
This need for pharmacists to embrace the use of new technologies was also reaffirmed by 
many other participants, who argued that there was no way the UK pharmacy profession 
could move forward (intentions) without pharmacists embracing modern technologies: 
   “Obviously, as we advance it seems like the computer is here to stay and the robot 
is here to stay. So, definitely, it needs to be on the curriculum.” [GP-NA] 
Welcoming the idea of the use of new technologies, another participant however argued 
that there was only so much you can teach in pharmacy schools, due to time and resource 
constraints (environmental context and resources). Instead, she suggested that some of 
these new technologies might be better taught during practice and experiential learning in 
pharmacies (skills – practice/skills development).  
“… There will be some things that the practitioners or pharmacy students can only 
learn in a simulated or real life practice environment …” (P-ART).  
In another case, one participant wanted the use of new technologies taught in pharmacy 
school, but he was also concerned about the impact such a move would have on 
pharmacists’ jobs (emotion – fear and threat).  
“New technologies are welcome, but we will have to be conscious of the fact that, 
inasmuch as new technologies are used, such technologies will not pose a threat to 
the job of pharmacists.” [P-PO] 
For another participant, these technologies will be relevant in the UK, however, this 
acceptance might be different in third world countries as well as in the elderly (social 
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influences [Norms]), particularly as these groups of people might be more concerned with 
other things (emotion - stress, fear, anxiety and tiredness) than how to use new 
technologies: 
“In a place like UK, for example, where you know that access to technology is easier, 
then it makes sense here. But if you're looking at a third world country, for example, 
where there are old people … a phone is the least of their worries. They're trying to 
feed themselves.” [P-CHY] 
While one pharmacist participant was against the use of new technologies in pharmacy 
practice, probably due to an earlier negative experience with robots (memory, attention and 
decision processes), he felt that this should not prevent UK pharmacy schools from teaching 
their use to students (skills). His reasoning was that it is the responsibility of the universities 
(social influences) to ensure they provide sound education to students (skills):   
“It is the role of the university to be robust in their teaching … they must consider 
every possible angle. The professional needs to be prepared. Even though I do not 
support the use of such in community practice, it doesn't mean that they shouldn't 
teach them … They should teach it, but not focused on it as a primary goal.” [P-OL] 
Interestingly, I did also capture the tendency of older professionals to be averse to the use 
of new technologies (emotion – fear, threat and anxiety) from the responses of another 
participant, who suggested that it is possible to manage this through further training 
(knowledge and skills): 
“Yes, I know, my view is a lot of new technologies … you know, some pharmacists 
who graduated many years ago, they may not be all that interested in handling these 
machineries, so it has to be a kind of organising workshops that would help many 
pharmacists to have that technological know-how in handling these new 
technologies in the pharmacy for public health enhancement.” [P-PK] 
Despite these benefits, Safdar argues that there is a possibility that pharmacy practice in 
general is not taking up the opportunity offered by social media (Safdar 2015). One 
challenge is that many pharmacy schools are failing to match theory with practice (Torjesen 
2015b). 
 
4.4.5 - Benefits of pharmacists’ involvement in public health 
In terms of benefits, one participant felt that pharmacists’ involvement in public health 
could help enhance their role in preventative care (professional identity/boundaries/role). 
This benefit, he continued, was not only for pharmacists, but also for every healthcare 
professional (social influences - team working): 
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“Yes, I think there is a benefit, I will say, not just for pharmacists, but for every 
healthcare professional, to be involved in public health. Because, it is a preventative 
measure. Why give people statins, when you can start by just educating them about 
health, about exercise, about not smoking?” [PR-FLY] 
Another benefit mentioned by some participants relates to accessibility (environmental 
context and resources - availability), particularly, as this will enable community pharmacists 
to be better trusted and respected by the public.  
“The benefits I would say, will include, the fact that community pharmacists are in 
regular contact with a wide majority of members of the community …” (P-PO).  
However, one of my participants also noted that there was a need to address the issue of 
target setting (intentions and goals; behavioural regulation – goal/target setting), which 
according to him defeated the whole purpose of public health service from community 
pharmacy (availability). 
 “I am not a community pharmacist, but speaking to my friends who are community 
pharmacists, it does seem like so much of their time is spent on meeting business 
targets and initiatives and things like that. Maybe, if they had a bit more time to 
focus on public health issues that will be great.” [HP/TP-NKT] 
There was also a belief from some participants that enhancing the role of community 
pharmacists in public health, will encourage collaboration between pharmacists and other 
healthcare professionals (social influences - team working), help enhance the profile of 
pharmacists and help extend the public health role of community pharmacists 
(social/professional role and identity).  
“And patients too will see, will begin to … see pharmacists as not just as 'the lazy 
workers' as they used to term us before, or as laid back workers, but begin to see us 
as more of professionals, who have more to take on board and be able to offer to 
their communities.” [P-VI] 
This might also mean creating more awareness (knowledge) to the public and other 
stakeholders about the role of community pharmacists in public health (Cain, et al. 2010; 
Agomo 2012a; Lam 2013). For one of my GP participants, this will also mean less pressure 
from patients over matters (emotion - stress), which could easily be resolved by 
pharmacists.  
  “Saves you listening to cough and cold, every minute! Every minute, cough and 
cold, coming to me, you know, when the pharmacist can just give advice for that.” 
[GP-CHY] 
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For some of my participants, the benefits were linked to financial savings to the NHS 
(environmental context and resources); enhancing the viability of community pharmacies 
and increasing POM (Prescription Only medicines) to P (Pharmacy Medicine) switches; 
reducing over-dependence on doctors and saving on doctors’ time, which can then be used 
for other serious matters (environmental context and resources – availability and 
management). However, for one of my participants, this was not just about treatment, it 
was also about preventing long-term diseases, which could then save lives through lifestyle 
changes, etc. (beliefs about capabilities). Again, this benefit was not for doctors alone, but 
also for other healthcare professionals and the entire health system (social influences – 
team working and organisational development). However, to enable community 
pharmacists to achieve these aims, it will also be necessary to enhance the undergraduate 
pharmacy curriculum, to enable pharmacists to identify disease patterns easily, even at a 
global level (skills). “… You could be part of the global team necessary to enhance global 
health.” (P-JO).    
“There is a lot of economic savings that will come out of that, in terms of saving 
doctor's time … for more serious issues, because the thing with public health is not 
just treatment, it also has to do with prevention … due to lifestyle choices, lifestyle 
adjustments … There is clearly gonna be a lot of benefits from there, in terms of the 
patients themselves, for the practitioners themselves, for the health profession as 
well, as a whole.” [P-ART] 
… You could be part of the global team necessary to enhance global health.” [P-JO]  
 
4.4.6 - Barriers to enhancing the public health role of community pharmacists  
As well as these benefits, my participants also highlighted several barriers (behavioural 
regulation), which they felt needed to be tackled in order to enhance the public health role 
of community pharmacists in the UK.  Nonetheless, I identified in the literature some of the 
factors affecting utilisation of pharmacy services to include, the community pharmacy 
environment, the pharmacist and support staff, service publicity, the public, GP services, 
and the healthcare system and policies (Saramunee, et al. 2012). There is also the 
perception of both the public and other health care providers of pharmacists’ competencies, 
privacy and confidentiality in pharmacies, the high dispensing workload and inadequate 
financial support (Saramunee, et al. 2012).  
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4.4.6.1 - Lack of awareness and education 
A number of participants raised the issue of lack of awareness and education about the 
public health role of the community pharmacists. Invariably, this hinges around social 
influences, such as, lack of social support, social pressure and feedback; hence, to what 
extent social influences hinder the public health role of community pharmacists (Michie, et 
al. 2005). 
“Yes, the barrier is that because health is free, people think that once they go to 
A&E, they will get free treatment ... This barrier is educating people. People are not 
aware that … they can access health in different ways, apart from going to the GP 
and A&E. So they need to create awareness and education.” [Nurse –CHM] 
 
“And a lot of these trivial cases, they can do it ... So, the barrier obviously is 
ignorance, and then that's where advertising, education, is to come into play. People 
are sitting in the waiting area; you have this advert all over the place, saying you can 
see your pharmacist first.” [GP-CHY] 
 
4.4.6.2 - Lack of empowerment 
There was also a call for the government to elevate the status of the pharmacist 
(professional role and identity), bearing in mind also that there are many health anxieties 
(emotion), especially among ethnic minorities. Interestingly, considered as a barrier were 
pharmacists also, in terms of their preparedness, willingness and desire to provide public 
health services (intentions and goals).  
“The barriers could also be the pharmacists themselves …” (GP-NN).  
According to one participant, there seems to be a culture within pharmacy whereby 
pharmacists are often reluctant to put themselves forward for new challenges (beliefs about 
capabilities, and emotion – anxiety and fear), unlike nurses, who continue to extend their 
roles into specialist areas. According to this participant, this way of practice seems to have 
been initiated right from the universities (knowledge, skills and social influences – 
organisational climate/culture), hence has made pharmacists focus more on minor things 
rather than the big picture, such as enhancing their diagnostic and consultation skills (skills). 
According to the theoretical domains framework (Michie, et al. 2005), it seems, there is here 
a lack of belief among pharmacists about their capabilities (beliefs about capabilities). This 
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raises the issue of how confident pharmacists are that they can provide public health roles, 
despite the challenges. (Michie, et al. 2005). In addition, it also seems that enabling 
community pharmacists to have access to patients’ medical records can empower them to 
engage more in public health activities.  
 “Pharmacists were maybe a little bit slow to do that or more focused on business, 
and how much money they can get from dispensing fees, and mix and match? So, we 
really lost out and we didn't add that value. I think going forward, our values really 
gonna be at diagnostic levels, so minor ailments, and things ... so we need to 
improve our communication and diagnostic skills, so that we actually have a 
presence in the public health minor ailment arena ... So, maybe it comes back to the 
degree, maybe at that point we need to start diagnosing minor ailments a bit more 
…” [HP/TP-NKT] 
 
4.4.6.3 - Commercial pressure 
Commercial pressure (due to lack of resources), with the resultant effect on emotions (stress 
and anxiety), which can also be considered as part of the social influences on pharmacists 
(Michie, et al. 2005) was also highlighted, with many participants identifying this as a barrier 
to enhancing the public health role of community pharmacists. Not only has this restricted 
pharmacists (unlike nurses) in terms of service provision, it seems also that some of the 
challenges faced by pharmacists lie with the undergraduate pharmacy education 
(knowledge and skills), lack of initiative (beliefs about capabilities and intentions) and 
culture (social influences). One participant also drew my attention to the way in which big 
chain community pharmacies were operating, with a concern that this was limiting the 
number or quality of activities that community pharmacies could offer. The same participant 
also highlighted the over-supply of pharmacists (resources) as a barrier.  
“Commercial pressure will be one. I think also, there is culture within the pharmacy I 
have noticed … nurses are very keen to forge out in different parts, so that they can 
be involved … I do not get that sense from pharmacy. I get the sense that our 
pharmacists are happy plodding along and doing what we are doing, and there 
hasn't really been, sort of, reaching out to get services for ourselves … In the hospital 
setting, there is respiratory nurse, she comes in and reviews asthma medication. 
There are diabetes nurse specialists, they come and review all the diabetic 
medications. I am looking at it and I am thinking … I am just saying, surely a 
pharmacist should be reviewing specialist diabetic medications, that kind of thing … 
this is something that was brought up in the universities. I think nurses were quicker 
to grab and say yes, we can put ourselves forward and do these things.” [HP/TP-NKT] 
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4.4.6.4 - Resistance to change  
Also highlighted was the difficulty associated with those pharmacists who were resistant to 
any form of change (beliefs about consequences), particularly as some of these changes will 
be new to many (due to lack of knowledge and skills, as well as, beliefs about capabilities). 
Closely related was a concern that other healthcare professionals often see community 
pharmacists as a threat – something which one of my participants described as ‘rivalries’ 
(social/professional role and identity; emotion – fear and threat). This can therefore affect 
community pharmacists’ ability to engage in collaborative and inter-professional public 
health roles (social influences - team working) (Michie, et al. 2005; Agomo and Ogunleye 
2014).  
“The barriers and I would say the major barrier is rivalries. I will put it that way, from 
other healthcare providers.” [P-PO] 
4.4.6.5 - Inadequate training and skills 
For some participants, there was also a need to enhance the training as well as the 
diagnostic skills of community pharmacists, with the benefit that this will help extend the 
public health role of community pharmacists to other areas. This is in line with Eades, et al. 
(2011) argument, that to improve public health services in community pharmacy, there will 
be a need to increase pharmacists’ confidence in providing public health services through 
enhanced training. 
“I think they [community pharmacists] should also expand in more areas, in the area 
of diagnosis and also training so that pharmacists can have access to medical history 
of patients.” [P-SOL] 
4.4.6.6 – Lack of time to provide public health activities 
In addition, tackling the issue of lack of time (environmental context and resources), which 
can be a big problem in very busy pharmacies, would help. Lack of time does not only affect 
pharmacists’ willingness to provide public health services, but can also affect the quality of 
service they are able to provide (Horsfield, et al. 2011; Gavaza, et al. 2011; Agomo, et al. 
2016a).   
“In community pharmacy, there isn't time. You only spend; I think a prescription can 
be dispensed in less than 5 minutes, that is it. There are so many people who will 
come into community pharmacy.” [PR-FLY]  
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4.4.6.7 – Lack of confidence 
There was also the issue of whether pharmacists have actually asserted themselves as 
primary care providers (beliefs about capabilities - perceived competence, self-
confidence/professional confidence), particularly when you consider the fact that many 
patients tend to visit GPs first before even remembering that community pharmacists are 
also available for minor ailments. 
 “I don't think community pharmacists have necessarily asserted themselves as 
people who can provide primary health care services … like treating common illness, 
like common cold and the rest of it.” [P-ART] 
 
4.4.6.8 – Government policy on the public health role of the pharmacist  
My US-based participant also identified the UK government’s policy around the public 
health role of the pharmacist (social/professional role and identity), as a barrier. This was 
important particularly as it relates to empowering and financing public health activities, as 
seen in the US, where almost every community pharmacy is involved with public health 
services, e.g. immunisation. Accordingly, this type of empowerment has not only raised the 
public health profile of US community pharmacists, but is also a time-saving strategy, which 
helps reduce the demand for doctor services. A number of participants did also highlight the 
need for UK government to develop enabling policies (reinforcement) that can support the 
public health role of the pharmacist. 
“Well, the barrier will have to do with the laid down policies of the government. The 
pharmacy profession will have to be given the opportunity to go into areas that will 
benefit the public and improve public health … In the US, almost every community 
pharmacist administers immunisation, and you have so many people that could not 
wait to make appointments to go to the doctors, going to the community pharmacist 
to administer immunisation. So, they should actually try to encourage the pharmacy 
profession by giving some incentives.” [USP-CHD]  
4.4.7 - The use of Independent Pharmacist Practitioners 
On the role of the Independent Pharmacist Practitioners (IPPs), that is, pharmacists who are 
independently employed, e.g. locums, pharmacist-visitors, etc., in public health, I received a 
mixture of comments, some of which were slightly confusing, as they were referring to 
Independent Prescribers rather than IPPs, until I explained the term further. A UK 
pharmacists’ organisation has argued that, enabling the development of IPPs who are not 
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attached to any employers (PDA 2013), could help change the status quo and at the same 
time motivate pharmacists to enhance their role in public health (APA 2008) 
4.4.7.1 - Independent pharmacist practitioners in GP surgeries 
From some of the responses, it was evident that at least one participant would like to see 
locum pharmacists working in GP surgeries (skills – practice/skills development; social 
influences - team working). My pre-registration participant was not familiar with 
pharmacists visiting patients’ homes for public health activities. However, from the 
comments of one of my GP participants, it was obvious that the use of independent 
practitioners was a common feature in general practice, as she reckoned that this group of 
practitioners can also have useful roles in public health activities.  
“They do, but they're pharmacists? Isn't it? Yes, they do. It is just like for us as 
doctors, it is not everybody that is affiliated to a practice … but, when they need us, 
because they know where we are, we go and help them out. So, in the same way, if 
there is a list of IPPs … saying look, we need this shift covered from this period to this 
period … Like right now, I'm not affiliated anywhere.” [GP-CHY] 
4.4.7.2 – Asserting ownership of qualifications 
On the other hand, one participant also raised the issue of ownership of public health 
qualifications (knowledge and skills), which he reckoned often belongs to the practitioner 
rather than the practice, and hence places IPPs at the centre of public health services. Using 
the recent Ebola outbreak in West Africa as an example, one of my participants described 
IPPs as ‘stakeholders in public health’, particularly as in this case, IPPs (not pharmacies) had 
to work collaboratively with other practitioners to contain the situation. He cited another 
example of the global Vitamin D deficiency, which he argued could also be tackled by IPPs, 
and hence the need for pharmacists and IPPs to take up leadership positions in public 
health.  
 “Every pharmacist, by virtue of their training, has a role to play in public health, 
whether employed by the chain, whether they are independent or whether 
employed by the hospital. Because, the training is such that if a pharmacist is trained 
on how to immunise, it is the individual pharmacist that immunises, it is he that has 
the qualification to immunise.” [USP-CHD] 
For another participant, the advantage with this model lies in the fact that practitioners will 
be working for the benefit of patients, rather than being constrained by some of the 
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limitations associated with commercially orientated pharmacy establishments (social 
influences – alienation/organisational commitment). 
“…I think that could intentionally be a good thing, because hopefully, they are 
actually working for the benefit of the patient, as opposed to maybe some sort of 
business.” [HP/TP-NKT].  
4.4.7.3 – Concern about the independent pharmacist practitioner role 
There was however some concern over how IPPs would be practising, with one participant 
also raising some questions regarding the quality of their training (knowledge and skills) and 
the kind of support they will be receiving (environmental context and resources; 
reinforcement), describing IPPs as ‘silo-practitioners’.  
“Well again, that is a very peculiar area, because, like I said before, it's more of, 
training for example of work force, is more of an employer-led initiative … so you 
find yourself wondering will these practitioners be that well-positioned to provide 
quality information, quality services, or not just quality, but in terms of relevance, 
essential services that are relevant to key and emerging needs … whether you like it 
or not, they're more or less silo-practitioners, because they're practising on their 
own.” [P-ART] 
For another participant, the role of IPPs in public health will only develop if the NHS is 
privatised (environmental context and resources): 
“I doubt it, because of the only time they will, is if the NHS is privatised. But for now, 
I do not think they have any role. I might be wrong.” [N-CHM] 
4.4.8 - Teaching communication methods to students and pharmacists 
A number of studies have identified the need for healthcare practitioners to improve their 
communication techniques (Schwartzberg, et al. 2007; Carter, et al. 2008; Sookaneknun, et 
al. 2009; Emmerton, et al. 2010; Roughead, et al. 2011; Rowlands 2012) (skills). None of my 
interview participants disagreed that that teaching communication method to UK pharmacy 
students and pharmacists could help enhance the role of community pharmacists in public 
health.  
4.4.8.1 - Developing professional skills through the teaching of communication methods  
In terms of benefits, I found from some of the responses that this would help develop the 
professional skills of pharmacists (skills), particularly with regard to teaching students and 
pharmacists on how to communicate with people from different ethnic groups and health 
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conditions. In addition, it will also help students and pharmacists develop skills in the use of 
pharmacy consultation tools in practice.  
“Oh yes, because I went to [named university], and communication was taught from 
Year 1 to Year 4, and it did help a lot, definitely. It helps on how you talk to people, 
not judging people, even according to the GPhC’s ethics, code of conduct. There is a 
way to communicate with people without demeaning them, because we meet 
people from different nationalities, different languages, different religion; how you 
approach them, putting aside my own faith and belief, everything, professionalism. 
So yes, communication does work, even when it comes to consultation ...” [PR-FLY]  
“Communication method is very important, just like saying bedside manner, isn't it, 
of a doctor? …The thing is this; they talked to us about communication skills as 
doctors, that we need to be empathetic …, a need for confidentiality, you know. And 
communication methods are very important, because you're looking at people from 
all kinds of life, religion, beliefs.” [GP-CHY] 
One participant recounted a time when she was a student at one of the popular UK 
pharmacy schools (about 10 years ago), stating that in those days, teaching of 
communication methods hardly existed, and left students graduating without any 
meaningful communication skills. According to her, this limitation was often obvious during 
pharmacy practice modules, with the effect being that interactions between students and 
their tutors were often one-way communication, rather than the desired two-way 
communication. She reckoned that the use of scenarios (case studies) in classes enabled 
enhanced communication skills to develop (skills), as it allowed interaction between 
students to occur (social influences - team working), which can then be further enhanced 
through feedback from tutors (behavioural regulation). This point was further reinforced by 
another participant (P-JO), who also supported the idea of developing a two-way 
communication method for students and pharmacists, supported with feedback:  
“… When I was in school … not a lot of our scenarios were done. It was more of 
reading and writing, reading and writing, reading articles and flipping the BNF and 
checking things. So, you find out those students, their communication levels were 
really limited, because they were not allowed to be part of that pharmacy practice … 
I do remember that it actually had a negative impact on most of us, obviously 
because in the pharmacy practice, you were not allowed to interact, in other words, 
you were not allowed to learn more … communication should be a two-way thing.” 
[P-VIV]       
The PhD student/pharmacist stated that teaching communication methods throughout the 
four-year undergraduate programme would enable pharmacists to interact better with 
patients as well as other healthcare professionals (social influences – team working). Other 
 148 
 
benefits lie in pharmacists’ positioning to prevent diseases, as well as the ability to provide 
patients with information on the use of medical equipment and devices when needed 
(knowledge and skills). Teaching communication methods to students and pharmacists can 
help develop some uniformity across healthcare professions (knowledge and skills), in terms 
of service delivery and information provision; help pharmacists reinforce public health 
messages from other healthcare practitioners; and help enhance the profile of pharmacists 
(professional identity): 
“That is one key area that needs to be really addressed, right from the beginning of 
undergraduate studies, because in the practice environment, pharmacy practice is 
about communication. I think it is an illusion to think communication has occurred 
when in reality it hasn't, and to be honest, communication is central to everything 
you do, and health practitioners for them to be effective, they have to be good 
communicators … It's not going to overburden or freeze the number of modules 
students are currently having to undergo to pass … that is something that can be 
negotiated …” [P-ART] 
 “Sometimes, you find in general practice that you give a patient advice on how to do 
something, how to take a particular medication and how to self-manage, and they 
forget it when they leave the door.” [GP-NN] 
4.4.8.2 - Improvement in the teaching of communication methods 
There seemed to have been some improvement in the teaching of communication methods 
in a named school lately. Another participant, [P-SOL], who attended the same school some 
years earlier, refuted the feedback from participant P-VIV on the lack of use of scenarios in 
communication methods: 
“When I was in the university … doing pharmacy practice, we normally do like role 
play about somebody coming into pharmacy and how we are going to phone the 
doctor and that kind of thing ... but, until you actually experience it real, when 
they're doing a role play, it doesn't actually stick to you.” [P-SOL]  
A teacher-practitioner from the same school, who qualified not too long ago, also confirmed 
this new trend of teaching. She however complained that the teaching of communication 
methods was more tailored towards community pharmacy practice than hospital pharmacy 
practice (knowledge and skills). A possible explanation could be that most of the teaching 
fellows in that school were originally from the community pharmacy background, hence, 
their default to tailor their teaching materials to practice in the community pharmacy 
setting:  
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“I think it's pretty good, because I gave two lectures on communication … when I was 
a student … I'm sure I did get lectures on communication or something, but I think 
it's certainly improved like now being involved in teaching … So it's certainly 
improving. So much more of an emphasis from community pharmacy than hospital 
pharmacy.” [HP/TP-NKT] 
 
4.4.9 - Integrating UK undergraduate healthcare programmes 
There is now an emphasis in the UK on interdisciplinary initiatives in the management of 
many causes of ill health (News Team 2012b). In terms of inter-professional education, in 
the USA, health professional education associations (AAMC 2012) drive it. At the University 
of Manchester, UK, health students have now developed an initiative to promote inter-
professional education (social influences [norms] – team working), by arranging numerous 
events each year, ranging from lectures to healthcare-based quizzes that focus on a variety 
of issues (Owen 2016). On the interview question that asked if UK pharmacy students 
should be educated with other health students, e.g. medical and nursing students, most 
participants thought that this was a good idea.  
4.4.9.1 - Benefits associated with integrated learning 
Some of their thoughts on this included the idea that this will help break down barriers and 
facilitate communication between healthcare practitioners (social influences – team 
working), as well as helping foster better understanding of roles and skill-sets. In addition, it 
can develop trust, widen the professional field of pharmacists and help enhance their 
knowledge base as well as their ability to pass on information easily (knowledge, skills and 
team working). “It would actually boost their field … makes it much easier to pass 
information around …” (P-VIV). Another reason to integrate the undergraduate teaching, 
according to one participant, rests on the fact that some of the modules taught to students 
are health-related, therefore, teaching can be across professions, with the added benefit of 
efficiency and savings (environmental context and resources): 
“So, it is good for all to understand what the physiotherapist does, what the special 
nurse does, what they do, how to communicate, what they do … Because even 
professions got their own case of pride, it is always good to hear them, students, to 
see their views and to hear their views about us, … so it's all good to get that even 
during education, so that when it happens in the real world, it doesn't get you by 
surprise, you're better prepared to deal with nurses, doctors, with physiotherapists, 
etc.” [PR-FLY] 
 150 
 
Related to this, one GP participant also mentioned that allowing undergraduate health 
students to study together (social influences - team working) would also enable graduates to 
appreciate some of the roles, responsibilities and boundaries of other health professionals 
(professional identity/boundaries/role), particularly as it relates to long-term management 
of chronic conditions:  
“You know; chronic condition is a drain in health care in this country? So, I feel like 
each person will have to play a part and respect each other… A lot of times when we 
go to college or university or whatever, we just learn about ourselves, our roles, and 
all what not … We are not intertwined with other people who are also health 
professionals, who play an important part. And then when you get to working with 
them, you have no clue how to handle them, so, taking certain courses together will 
help.” [GP-CHY] 
Some of the points raised by this GP participant supports the thoughts of a pharmacist 
participant, based on his experience with integrated teaching, as an undergraduate 
pharmacy student and as a PhD student in Russia and France respectively. For him, other 
advantages would come in terms of savings and ensuring that resources are used efficiently 
(environmental context and resources) in areas such as teaching, research and 
administration, as well as enabling lasting relationships to develop and flourish among 
future healthcare professionals (social influences – team working). 
"If you look at a number of countries, medical schools and pharmacy schools are 
together … you find that the basic subjects both parties need to know are always 
taught together in one class … I had background training where I spent together with 
medical students and dentists, so at a given stage, then we separated to different 
lines. So, you find that the basic understanding of what a pharmacist knows, that the 
doctor is aware, or that the dentist is aware … in practice, when there is a common 
problem, we could all be speaking on the same wavelength, rather than what you 
find at times in this country, they [pharmacists] are not even confident to speak to 
doctors … In some areas, doctors don't even know the role of pharmacists! So going 
back to education.” [P-JO] 
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Figure 18. Coding by Item for Collaboration 
Other than managing health outcomes, I noticed also from some participants’ responses 
that integrated work patterns can help pharmacists to get better career progression and 
fulfilment in practice (beliefs about capabilities – empowerment, optimism; and social 
influences - leadership), hence becoming the way forward (see Figure 18).  
“There should be more pharmacists linked to GP surgeries, in fact wouldn't it be 
great if each GP surgery had within it a pharmacy, because it makes sense, you 
know. What is the point having a pharmacy around the corner, when you can have it 
in-house? I think it is so much better. I think, that will be so good in the future. There 
was all these talk about polyclinics, back in the days, wasn't it? They were like, 
'everything going to be under one roof', GPs, pharmacists, nurses, and that, I don't 
know, didn't really sort of happen, did it?” [P-NKT] 
Notwithstanding this, the GP Partner participant also hinted that some of the benefits 
associated with integrated practice, particularly as it relates to financial rewards to GP 
practices, could be affected depending on where the practices are located – rural or urban 
(environmental context and resources – constraints). 
“They should be anyway … Rural GPs have pharmacists working within the same 
building, and the GPs are responsible for the financial aspects and they make a lot of 
money out of it. But GPs in urban areas, they are not allowed to. They will stop it.” 
[GPP-SIM]  
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This position is also confirmed by the views of a legal expert in pharmacy about the 
difficulties associated with establishing community pharmacies in GP practices (Reissner 
2015).  
Another participant also reminded me that GP practices that employ pharmacists seemed to 
make less prescribing errors (behavioural regulation – self-monitoring). This is due to the  
fact that, enhanced communication and transfer of information between healthcare 
providers and healthcare settings reduces medication and healthcare errors (Roughead, et 
al. 2011). Hence, being in-house meant that pharmacists were able to correct any errors 
before prescriptions left the GP practice to the pharmacies. In addition, these GP practices 
were also more likely to follow the NICE (National Institute for Clinical Excellence) guidance 
(behavioural regulation: moderators of intention - behaviour gap) in their prescribing 
patterns, hence helping to minimise harm to patients. Furthermore, they were also more 
likely to consider the price of medicines and other items in their prescribing habits 
(environmental context and resources), which can translate to large savings to GP practices 
and the wider NHS. Pharmacists employed in GP practices, particularly those with sound 
clinical knowledge and skills (knowledge and skills), I was also told, were often in a better 
position to advise doctors regarding the best therapeutic choices in complex clinical issues 
than GP practices without an in-house pharmacist (beliefs about capabilities – perceived 
competence). Having said that, not all practices are able to employ in-house pharmacists, 
due to financial constraints (environmental context and resources). 
“This is actually a good idea, because if you see doctors that have pharmacists inside 
their surgeries, they don't actually make a lot of mistakes, when it comes to 
[prescribing] and everything … So, it is difficult for the prescription to leave the 
surgery with any query, because the pharmacist inside would have checked it … Not 
a lot of doctors can afford to have a pharmacist, even though ...” [P-SOL]  
4.4.9.2 - Concerns with integrated learning 
Interestingly, while one of my participants highlighted also some of the advantages 
associated with integrated learning, for example, the ability to develop collaborative 
practices with other health professionals, she was however concerned about the logistics 
associated with this arrangement (material resources [availability and management], and 
social influences – crew resource management). Her concern was that often these other 
schools (e.g. medicine and nursing) tend to have large classes, which might be difficult to 
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manage across schools. There is also the issue of breaks, which she argued are not always 
aligned between schools and faculties:  
“The argument is neither here or there. It is not about, is it good or bad? … I think 
the argument has always been about the practicalities of this kind of inter-
professional learning, in terms of logistics, how this learning will take place, how it 
will occur, because when it comes to inter-professional learning for example, you're 
going to be talking about a large number class, a large class, including doctors, 
nurses, pharmacists and all of that ... sometimes the calendars are not the same. So 
it’s more about practicalities than benefits … But, having said that, I would say inter-
professional learning is important because students can begin to learn to work 
collaboratively … it makes it even far easier for them to be able to work in the health 
team as they graduate and as they go into real life practice.” [P-ART] 
Another concern from one participant was that integrated learning could lead to the 
dominance and the prioritisation of other healthcare students during lectures (professional 
role and identity), which could then put pharmacy students in a difficult situation (emotion – 
anticipated regret, fear and threat). 
“No, I really don't like that idea. I do not like that idea. One of the main reasons I 
choose [a named School of Pharmacy] back in the days, as supposed to something 
like [another named School of Pharmacy], is because I like the idea of being taught 
by pharmacists, only pharmacy students, the whole university was geared towards 
pharmacy. I realised that, because I think I was told there was a risk of when you're 
having lectures by medics and dentists, they take over and they prioritise and you 
won't want to be in that situation as a pharmacist. On the other hand, I know it is 
good to start integrating with other health disciplines, because then they respect us 
too and we can all work together as a team, we can all respect each other. So like 
maybe, certain lectures can be done jointly ...” [HP/TP-NKT]  
In terms of organisation, a pharmacist participant also suggested it was possible to teach 
communication methods at the same time to a group of healthcare professionals (social 
influences – team working): 
“There are elective courses that both pharmacy and the health sciences or the 
medical sciences, that they share together because somehow, both of them need … 
for example, the communication method you were talking about, we all need it, in 
the medical profession, isn't it?” [P-NO]  
While another participant also recognised the need for this integration, he was however, 
concerned that unlike in the hospital were such interactions seem to be natural, particularly 
during ward rounds, in the community this type of integration seems to be difficult with GPs 
(social influences: conflict – competing demands, conflicting roles). However, he also argued 
that enabling this integration through the development of closer relationships (social 
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influences – team working) between GPs and pharmacists was the only way to ensure 
optimum and guaranteed health outcomes for patients. I hope that the recent Royal 
Pharmaceutical Society and the Royal College of General Practitioner's plan for integrated 
practice will help to tackle this (Robinson 2015a; Anon 2015c). 
“There is a real need for it, but it has to start from the fundamental … let's start from 
the pharmacy school, from the medical school, and that will help everybody … In the 
hospital, it's a lot easier because there is interaction on the ward. I talk to your 
patients; you talk to my patients, on the ward … It is unlike the GP; I do not interact 
with the GP patients. The only thing I interact with is the prescription, which may not 
be brought to the pharmacy by the patients themselves, anyway. They will just 
collect the prescription and give it to somebody to bring in, and then I don't get a 
one-to-one with the patient ... I only see the prescription and because I'm so busy, I 
don't have the time to even talk to the patient … so, there isn't that much 
interaction, but there is a need for it.” [P-OL] 
 
4.4.10 - Changing the curriculum to increase its public health content 
In my review of knowledge and information, I identified that there was a need to enhance 
the public health content of pharmacy curriculum with one of the studies originating from 
the UK (Eades, et al. 2011). In my survey of UK community pharmacists, the majority of 
respondents (68.7%) agreed on this need. When I then asked the interview participants 
about their views on changing the UK undergraduate pharmacy curriculum to increase its 
public health content, I received a number of interesting responses.  
4.4.10.1 – Enhancing public health knowledge and skills   
The pre-registration pharmacist participant argued that many of the common chronic 
conditions we find today are interlinked with lifestyles (memory, attention and decision 
processes - decision making). Hence, there is a need to enhance both public health 
knowledge and the collaborative skills of healthcare professionals (knowledge and skills). 
This will also entail spending money (environmental context and resources) on the public 
health education of healthcare professionals, as a preventative measure, rather than on 
certain therapeutic medicines. Another participant also agreed that there was a need to 
ensure that undergraduate pharmacy students were well informed about public health 
before graduation (knowledge and skills), which could then be enhanced, depending on 
individual needs.  
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“I know there are postgraduate courses, I understand that, doctors, every healthcare 
professional want to do public health … but, these ailments are linked together. We 
are looking at diet and we are looking at smoking, smoking is linked to COPD or 
emphysema, as we used to know it in the day and chronic bronchitis and things like 
that. If we look at the lifestyle, exercise and the food we eat, that goes on into 
diabetes, and how many people are diabetic in this country? And how many people 
are overweight? And that's leading into those with heart conditions ... I will rather, 
instead of asking the money on simvastatin and things like that, can we not just train 
our healthcare professionals … from Day 1 ... No 1, we don't give drugs, No 2, we 
teach them how to live a healthy lifestyle. I know drug companies will not be happy 
with this [laughs], but if at the end of the day that will help the patient, it is a 
preventative measure.” [PR-FLY] 
The need became a lot clearer when one participant, a PhD student in pharmacy education 
(and an overseas pharmacist) in one of the Schools of Pharmacy, brought to my attention 
the recent review of the UK undergraduate pharmacy curriculum (knowledge and skills). The 
most recent undergraduate pharmacy curriculum discussion paper proposes a single five-
year integrated programme of pharmacy education and training, with joint responsibility 
from universities and employer (News Team 2011). The paper proposes that pharmacy 
students should receive a clinical supplement for at least 12 months of the five-year 
programme (News Team 2011). There is however, no indication that this curriculum reviews 
in any manner incorporated a significant amount of the macro-level public health activities, 
as described by Truong and Patterson (2010). 
“I think the question should be: should the curriculum be changed? I am aware that 
in the past two years, there has been a review of the curriculum and this review kind 
of incorporated and addressed some of the disparities and some of the deficiencies 
that were observed in terms of the lack of key modules or key trainings for 
pharmacists/pharmacy students. I think public health, in terms of health promotion, 
and the rest of it … I do not know the current content, what the percentage is, but I 
think pharmaceutical public health should be one of the core areas that need to be 
taught in pharmacy schools. Yeah, if this area is not properly captured in the 
curriculum, yes, it should be increased.” [P-ART]  
 
4.4.10.2 – Empowering pharmacists to provide public health activities   
Another participant also mentioned the need to be in line with the changing world 
(environmental context and resources - person X environmental interaction), as another 
reason why UK pharmacy schools ought to enhance the public health content of their 
curricula. According to him, enhancing the public health role of pharmacists will bring 
professional fulfilment (professional identity), empower pharmacists (beliefs about 
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capabilities) to provide public health services and produce financial savings for the NHS 
(environmental context and resources). It also seemed likely that enhancing and broadening 
the public health knowledge of pharmacists would help widen their role in public health 
(professional identity/boundaries/role), particularly when supported by education, 
awareness and the NHS triage system (knowledge and social influences - team working).  
“The world is a changing world … it is imperative that the pharmacy curriculum in the 
universities be modified to reflect such, so that graduates … are better equipped to 
deliver healthcare services to the public … That is … why the pharmacy curriculum 
should be tailored towards having more public health awareness and training … If it 
serves towards promotion of public health, it saves money, both for the government 
and for the public, and it brings professional satisfaction to pharmacists.” [USP-CHD] 
 
While one GP participant was not too sure about the nature of the undergraduate pharmacy 
curriculum (knowledge), other than that it was about medicines, however, she anticipated 
some of the advantages that could come with enhancing the public health knowledge of 
pharmacists (knowledge), particularly as it relates to preventative care and managing health 
demands and financial pressures. This becomes relevant when you consider that in some 
instances, community pharmacists are even nearer to patients than the GPs (Torjesen 
2015a), a point which was also raised by the GP participant.    
 
 “OK, if I understand your curriculum, normally is that you're dealing with medicines, 
whatever, whatever. It is just strictly on what you are doing. Isn't it? There is a need, 
because preventative medicine is better … Some patients are constantly in contact 
with pharmacists, and pharmacists have a broader knowledge of public health, it is 
going to be easier for them to give advice … So, if they do not talk about it in medical 
schools for pharmacists, they need to do it. Because, right now you know what's 
happening … because in some places, the pharmacist is even nearer than the GP 
surgery itself … and if they can get the answer from a pharmacy, then why are we 
stressing ourselves?” [GP-CHY] 
This lack of awareness of the nature of pharmacists’ undergraduate training by other health 
professionals was also evident from the responses of another GP participant, who also 
added that pharmacists of the 21st century would need to be independent practitioners 
(skills - competence), if they were to be taken seriously as public health practitioners. The GP 
emphasizing also that there is a lot of stress on healthcare professionals (emotion - stress), 
particularly, the general practitioners (GPs); with this apparently creating an opportunity for 
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pharmacists’ enhanced role in public health. However, this lack of awareness of the nature 
of the UK undergraduate pharmacy curriculum by GPs (and possibly, other healthcare 
professionals), can best be managed through inter-professional learning and practice (social 
influences - team working) (Baqir, et al. 2011; AAMC 2012; Watson, et al. 2014; Robinson 
2015a), as also highlighted by some of the participants.     
“This is really difficult for me to answer as a GP, as I don't know what the curriculum 
is, presently … from what we said already, it's quite important that the pharmacist of 
the 21st century is a pharmacist who's able to practice independently, safely and 
effectively in the 21st century … there is a lot of pressure on the other community 
health professionals, mainly the GPs. If the pharmacists are able to help and take the 
pressure off and have more education and training to be more relevant in health 
protection and health provision, that's all good … I can't see any reason why it 
wouldn't be a good idea personally.” [GP-NN]  
4.4.10.3 – Enhancing the public health content of pharmacy curriculum   
One participant also argued that changing the undergraduate pharmacy curriculum 
(knowledge and skills) would also help students and pharmacists keep abreast of the ever-
changing healthcare structure in the UK (social influences – organisational climate/culture, 
power/hierarchy). However, she reckoned that the onus lies with pharmacists to remain up 
to date with some of these changes (beliefs about capabilities: self-confidence/professional 
confidence). Supporting the need for change, another participant wanted this change to be 
in the area of Public Health Information.  
“Well, when I was at the School of Pharmacy, I had a whole module on public health, 
it was an option you choose, and I think I choose it and I really enjoyed it. It was 
looking at NHS policy, white papers, the structure of the NHS and healthcare in this 
country. I think that was fantastic. … It is always changing though, isn't it? I mean 
things like CCGs and all that are all coming now, as opposed to PCTs … I think it's up 
to the pharmacist, as well, to remain informed and read up around these topics 
themselves and keep abreast of changes … but I think it would be great to have more 
of it as well.” [HP/TP-NKT] 
On the type of change needed, one participant indicated that he was not happy with the 
dominance of science modules in the present UK undergraduate pharmacy curriculum, 
which he felt was at the expense of strong public health content. He would prefer that the 
public health module in UK pharmacy schools was the same as found in many medical 
schools (social influences – group conformity).   
“It should be the same in pharmacy schools as medical schools. There is a need to 
incorporate public health as a major part of the pharmacy curriculum. There is a 
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need for it. There are some things that might need to be reduced if there is need for 
it, like the pharmacist is trained to be an industrialist, at the same time, a public 
health worker … The pharmacy curriculum includes a lot of scientific training, as to 
discovery, invention of medications, drug development, drug design, and all of that. 
While those are important, there is also a need to bring in a strong public health 
curriculum, which is the way the practice is going … Then it has to be appreciated.” 
[P-OL]  
 
4.4.10.4 - Inadequate resources for public health activities 
My earlier participant [P-OL] also noted that public health services from community 
pharmacies were often affected by lack of basic health infrastructure (equipment) in some 
of the consultation rooms located in community pharmacies (environmental context and 
resources). There is also the issue of lack of comfortable waiting areas (environmental 
context and resources) and continued emphasis by pharmacy owners, most of them non-
pharmacists, on the profit and steady growth of the business (social influences – 
organisational development and commitment). A number of my participants did also 
highlight this limitation in the provision of public health services from community pharmacy.  
“To the effect, you must have a consultation room; all we need to do now is to give 
parameters to consultation rooms, in terms of dimension, in terms of what and what 
should be there. There are some basic things that are not there now which should be 
there … then the commercial aspect of it needs to be reduced. Because everybody is 
allowed to own a pharmacy, all these multiples, they are all after the profit and not 
after the patients' health and that is not doing well for the profession. So basically, 
there is somebody in the head office … all they are interested in is the money, 
money, and money. Oh, how many MURs have you done? How many … have you 
done? They are not thinking about, what have they provided for you to enhance the 
patient? Even the books they are providing, it is because the registration makes it 
compulsory for them to provide it, otherwise, they will cut it off as cost savings 
…Then, there must be a waiting area as well, for your customers. Some pharmacies 
don't have that at all, which is not good, where people can speak and be 
comfortable.” [P-OL]    
4.4.10.5 - The global nature of pharmacy practice 
For another participant, the global nature of pharmacy practice was another reason to 
change the undergraduate pharmacy curriculum, and this might also mean adopting good 
practices from other systems (environmental context and resources - person X 
environmental interaction), and maybe ensuring that community pharmacies engage more 
than one pharmacist at any time, as seen in Italy. Interestingly, a UK pharmacists’ 
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organisation is fully in support of this arrangement (PDA 2015a). Yet, other participants have 
earlier highlighted the global nature of pharmacy practice, particularly when it relates to the 
benefits of pharmacists’ enhanced role in public health.     
“The world is a global village. It is good for UK to change the undergraduate 
pharmacy curriculum and to match with other sectors, so that UK pharmacists will be 
able to work anywhere in the world, not only in the UK. It can also be matched with 
other countries … As in Italy, where I come from, if we are five, all five pharmacists 
working are qualified pharmacists. Therefore, a patient has enough time and a 
pharmacist has enough time to attend to each patient. Because they are many, and 
if a pharmacist is in difficulty, he asks somebody else, a colleague, to assist. Here, it is 
only one pharmacist in a large pharmacy. So I think they should try to do something 
about that.” [P-PKT] 
According to a GP Partner, there is a need to enhance the public health content of the 
undergraduate pharmacy curriculum, as pharmacy is often the first point of call,  
“I think there is a benefit because they are often the first persons that patients will 
go to … and if they understood public health issues; then they can guide patients 
better. Probably, it is good that it is on the curriculum.” [GP Partner – SIM] 
4.4.11 - Strengths and limitations of my interview  
4.4.11.1 – Strengths  
I have already covered above some of the strengths of my interview (please, see section 
3.5.2). However, interview is a method of naturalistic enquiry, which is normally less 
obtrusive than quantitative investigations and does not manipulate the research setting 
(Bowling 2002), and allows more detailed questions to be asked. By adopting this method, 
the findings of my survey were enhanced, as the qualitative study focused on the meanings 
that participants in the study setting placed on their social world (Bowling 2002), something 
that could not be achieved with quantitative research. I tried to enhance the reliability of my 
analysis by showing how well the results were linked with my data (Polit and Beck 2004), 
describing clearly the context, selection and characteristics of my participants, as well as my 
process of data collection and analysis (Graneheim and Lundman 2004). I tried also to 
enhance the trustworthiness of my analysis through authentic citations. I maintained 
confidentiality throughout by ensuring that informants were not identified by quotes from 
the data (Ford and Reutter 1990). 
4.4.11.2 - Limitations 
Some of the limitations included, my preconceptions about the findings (Weiss 1994), 
having done some work previously related to this project. In addition, the difficulty 
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associated with analysing interviews, which is very time-consuming. Some of the issues 
raised might be a reflection of interviewees’ pressing concerns at the time of the data 
collection (Cotter and Mckee 1997). The out-numbering of the group aged 50-59 years 
(seven [46.7%]) over the other age groups might have biased considerably the direction of 
my interview findings. Yet, only one nurse practitioner was included in my interviews of 
healthcare practitioners. I could have enhanced my study findings by including a wider 
range of healthcare practitioners, for example, hospital consultants, specialist public health 
practitioners/consultants, dieticians, even the public, etc. Finally, my pre-knowledge of 
some of the respondents may also have affected both the issues raised (Anderson 1998) and 
the respondents' willingness to share certain views (De Young 1996). 
 
4.4.12 - Conclusions 
My interviews with healthcare professionals revealed a number of interesting issues that 
can help enhance the public health role of community pharmacists in the UK. From the 
interviews, I gathered that enhancing the public health role of community pharmacists could 
make public health services from the community pharmacy more accessible to the public. 
Other benefits would include the ability to enhance public safety, enhancing public trust in 
pharmacists, encouraging collaboration between pharmacists, doctors and other healthcare 
providers and helping to save money for the NHS. Moreover, enhancing the public health 
role of community pharmacists could also help reduce stress levels among other healthcare 
professionals, as well as empowering and making community pharmacists more 
recognisable as important members of the healthcare team. Nonetheless, my interviews 
with healthcare professionals also revealed and confirmed a number of barriers that needed 
to be tackled to enhance the public health role of community pharmacists in the UK. These 
included free services, lack of awareness and education, lack of empowerment for 
pharmacists, pharmacists themselves, UK pharmacy education, and lack of support from GPs 
and other healthcare professionals. In addition, there was also the issue of lack of time and 
workload, lack of infrastructure, over-supply of pharmacists, commercialism of community 
pharmacy practice, and lack of clarity in the UK government’s policy on the role of the 
community pharmacist in public health. 
From my interviews, I could also confirm that UK pharmacists’ contribution to macro-level 
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public health activities were minimal: my interview participants hardly mentioned or 
discussed issues such as epidemiology, assessment, pharmacovigilance, policy development 
and assurance at the population-based level. I did also notice that although some of my 
participants highlighted issues such as managing risk factors, errors, communicable diseases 
and ageing, these discussions were often minimal when compared to, for example, to the 
need for empowerment or tackling some of the barriers associated with pharmacists’ role in 
public health. Interestingly, I captured in my interview all of the 14 domains of the 
theoretical domains framework and several of its constructs (Michie, et al. 2005). To 
enhance the public health role of community pharmacists in the UK, it seems there will also 
be a need to develop pharmacists’ capacity in several domain areas, notably, knowledge, 
skills, social/professional role and identity, optimism, intentions, goals, and beliefs about 
capabilities. As well as these, there seems to be also a need to manage social influences 
(Norms), reinforcement, emotion and the environmental context and resources available to 
pharmacists.   
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Chapter 5 - Discussion, Conclusions and Recommendations 
 
5.1 - Introduction 
A number of UK studies (Anderson 1998; Anderson and Blenkinsopp 2003; Blenkinsopp, et 
al. 2002; Agomo 2012a) confirm the role of pharmacists in public health. One of those 
studies (Agomo 2012a) also contributed to the conclusions of a recent Public Health England 
document on the role of community pharmacy in public health (PHE 2014). In the service-
focused study (Agomo 2012a), I identified that the main roles provided by community 
pharmacists in public health were in the areas of smoking cessation services; infection 
control and prevention; promoting cardiovascular health and blood pressure control; 
provision of emergency hormonal contraception; prevention and management of drug 
abuse, misuse and addiction; and healthy eating and lifestyle advice. These findings largely 
confirmed the findings of two other UK studies (Anderson and Blenkinsopp 2003; Anderson, 
et al. 2004).  
A white paper (DoH 2010a) proposes a higher priority and dedicated resources for public 
health, with community pharmacists expected to play greater roles than before. While some 
of the public health activities provided from the community pharmacy have been successful, 
several have been unsuccessful due to various factors (Agomo 2012a; Agomo and Ogunleye 
2014). Following my review of knowledge and information, I identified a wide range of 
strategies that could help to enhance the public health role of community pharmacists in 
the UK. The themes identified include strategies to enhance the public health role of 
community pharmacists through the following: the use of social media in public health 
education; developing good adherence strategies for patients; enhancing the public health 
content of pharmacy curricula; enhancing the effectiveness of the communication 
techniques of students and pharmacists; promoting interdisciplinary initiatives in pharmacy 
education and practice; and supporting efforts aimed at preventing the development of 
antimicrobial resistance and the spread of infections. Other themes included the need for 
promoting patients’ self-management capacities; strengthening patients’ education on safe 
medication disposal methods; enhancing the management of polypharmacy and long-term 
conditions; managing the legitimate medication needs of the public to prevent the 
accidental use of banned substances; remunerating pharmacists directly for providing public 
 163 
 
health services; innovating smoking cessation activities by pharmacists; and advancing the 
pharmacy practice experience of students in public health.  
Furthermore, in my review of knowledge and information, I also identified other papers that 
investigated community pharmacy-based services for alcohol misuse (Horsfield, et al. 2011), 
community pharmacy travel medicine services (Hind 2008) and the general public’s and 
health providers’ perspectives on public health utilisation from community pharmacies 
(Saramunee, et al. 2012). In terms of the limitations of the identified studies, there were 
instances where there were no indications that the studies were piloted (McDaniel and 
Malone 2011; Brown, et al. 2007; Roughead, et al. 2011; Lee, et al. 2009; Kurko, et al. 2010; 
Patterson 2008; Whitley 2010; Westrick, et al. 2009; Cerulli and Malone 2008; Saramunee, 
et al. 2012), where ethical considerations (Brown, et al. 2007; Patterson 2008; DiPietro, et 
al. 2011) and consent approval (Brown, et al. 2007; Hind 2008; Gavaza, et al. 2011; 
Schwartzberg, et al. 2007; Patterson 2008; Bush, et al. 2009; Westrick, et al. 2009; Kurko, et 
al. 2010; Whitley 2010; Baqir, et al. 2011; DiPietro, et al. 2011) were not discussed, as well 
as instances where the sample size was either not stated (Whitley 2010) or the response 
rate was low (Hind 2008; DiPietro, et al. 2011; Gavaza, et al. 2011; Saramunee, et al. 2012). 
In some of the papers, the outcome measures (Hind 2008; Bush, et al. 2009; Johnson, et al. 
2009; Emmerton, et al. 2010; Horsfield, et al. 2011; DiPietro, et al. 2011; McDaniel and 
Malone 2011; You, et al. 2011; Wong, et al. 2011b; Saramunee, et al. 2012), 
recommendations for further studies (Brown, et al. 2007; Hind 2008; Patterson 2008; Lee, et 
al. 2009; McDaniel and Malone 2011; Roughead, et al. 2011; Cerulli and Malone 2008) and 
limitations of the studies (Patterson 2008; Trapskin, et al. 2009; Whitley 2010; Wong, et al. 
2011b) were not discussed. These factors may therefore limit the generalisability of my 
findings. 
While each of the identified papers have contributed individually to the understanding of 
the strategies needed to enhance the public health role of community pharmacists, the 
main gap in the UK evidence base lies in the fact that none of the identified papers focused 
specifically on identifying or investigating strategies that can enhance the public health role 
of community pharmacists. There was also a significant gap in the quality of evidence in the 
papers reviewed, as I identified only one systematic review study in my review of knowledge 
and information (Eades, et al. 2011). However, the fact that most of the identified studies in 
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my review of knowledge and information originated from outside the UK, with findings that 
often could not be generalised to the UK due to differences in health systems, practices and 
laws, to some extent justified the need for my project. My project used mixed methods to 
develop an understanding of the strategies enhancing the public health role of community 
pharmacists in the UK.  
5.2 - Discussion 
My project has enabled me to identify some of the strategies needed to enhance the public 
health role of community pharmacists in the UK. Although most of the strategies identified 
in my review of knowledge and information were supported by the majority of my survey 
respondents, this support was however lower on issues such as offering dual MPharm (or 
even PharmD)/MPH degrees (37.5%) and community pharmacists adopting new 
technologies and social media in practice (43.2%). Dual degrees are popular in the USA, 
where some universities now run the dual PharmD/MPH (DiPietro, et al. 2011), even 
PharmD/MBA/Law, MD/MPH, MD/PhD, MD/MBA, etc., degrees (Flynn 2010). Dual medical 
degrees in particular have increased considerably in the US during the last decade or so 
(Flynn 2010). While obtaining a second degree needs a substantial investment of time, 
money or both, it can be highly rewarding and offer training and credentials leading to a 
specialised role within medicine as a physician-scientist, physician-executive or global health 
leader, as well as many other possibilities (Flynn 2010). The UK pharmacy profession has 
much to learn from this model, particularly as it concerns enhancing the public health role 
of pharmacists. Although dual degrees are not popular in the UK, a number of UK medical 
schools are however known to offer the dual MBBS BSc, MB PhD degrees (ICL 2015; UCL 
2015a, 2015b). I have discussed previously (Agomo 2012c, 2014) how the introduction of 
dual pharmacy degrees in the UK could empower pharmacists and, at the same time, create 
jobs for pharmacists, particularly now that the UK profession is experiencing an over-
production of pharmacists. My content analysis of the curricula of UK pharmacy schools 
confirmed that none of the UK pharmacy schools included in the study offered dual degrees.  
Regarding the adoption of new technologies and social media in practice, there was nothing 
to suggest in my content analysis that UK pharmacy schools were developing the skills of 
undergraduate pharmacy students in these new ways of providing public health services. In 
an article entitled 'Telemedicine', I describe how the public health (as well as the clinical) 
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role of UK community pharmacists could be enhanced (with the added benefit of financial 
savings), through the use of new technologies that allow pharmacists and other healthcare 
practitioners to diagnose conditions and give advice to patients at a distance with the help 
of a webcam, a computer and a broadband Internet connection (Agomo 2008b). Safdar 
(2015) also argues that social networks can be great tools to obtain professional knowledge 
and disseminate information globally. Moreover, platforms such as Twitter can offer real-
time access to news while allowing people to leave their opinions (Safdar 2015). On the 
other hand, it is possible to use LinkedIn to build a professional profile and get in contact 
with other professionals (Safdar 2015). Despite these benefits, Safdar argues that there is a 
minimal number of pharmacists using social media, raising the possibility that pharmacy 
practice in general is not taking up the opportunity offered by social media (Safdar 2015). 
With the increasing popularity of apps, with estimates in 2014 put at 138 billion downloads 
worldwide, there are signs that UK pharmacists are slowly catching up with these new 
technologies in practice (Andalo 2015). Some popular apps include the NHS four-week 
course in smoking cessation; the NHS app for depression assessment by the public; apps on 
how to prevent deep vein thrombosis and others to help patients track their blood sugar or 
blood pressure levels (Andalo 2015). In community pharmacy, a number of pharmacists are 
now using apps designed to calculate an individual’s chance of developing cardiovascular 
(CV) disease in the next ten years by recording information on height, weight, smoking 
history and family heart history. There is also, a Diabetes UK risk score app for calculating an 
individual’s risk of developing type 2 diabetes; a Diabetes UK app for type 1 or type 2 
diabetes daily blood glucose monitoring; an app for electrocardiograph (ECG) reading within 
30 seconds; an app designed as a game to test a person’s memory function; and another 
app which reminds patients when to take their medicine and prompts them if they forget. It 
seems reasonable to also consider the emotional impact (fear as well as threat) which the 
use of new technologies and social media could have on pharmacists, particularly when it 
comes to their job security (P-PO). Having said that, it also seems rational that UK pharmacy 
schools should also reflect the teaching of these new ways of delivering public health 
services strongly in their curricula. 
Concerning the present UK community pharmacy IT system, one of my survey respondents 
described it as a 'joke' and a time waster (environmental context and resources): 
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“The IT systems are a joke and in my opinion not enough is being actually done to 
free up pharmacist time.” [RE442] 
Maybe, delegating some of the dispensing roles to robotic dispensers and offsite dispensers 
(hub-and-spoke model), particularly with regards to electronic prescriptions, could be a way 
forward, in terms of minimising environmental constraints on pharmacists as well as 
resourcing them adequately. While most of my interview participants were in support of the 
use of new technologies and social media in practice (bearing in mind the need of younger 
service users), a few of them, particularly the older ones, were less supportive of their use in 
practice. Some of their concerns were around privacy, which is also an environmental 
constraint, and confidentiality – possibly due to lack of beliefs about capabilities of 
pharmacists and their staff. 
“I think it is rubbish … it is wrong, you can't beat the face-to-face consultation, for 
sure.” [GP Partner – SIM] 
However, the fact that some community pharmacies do not allow Internet access 
(environmental context and resources) to their staff might also be hindering pharmacists’ 
ability to provide public health services,  
“If somebody comes to the pharmacy with any disease that you don't know, people 
should be able to assess information online, it will be good to be able to check what 
some other people have written about that condition, without any problem.” (P-SOL) 
However, the fact that many UK pharmacy schools are failing to match theory (knowledge) 
with practice (skills) could also affect the public health role of community pharmacists:  
‘Unfortunately, what we actually see in most pharmacy schools today is the opposite 
of how a pharmacy and new technologies are being run’ [P-VIV].  
The fact that most lecturers in UK Schools of Pharmacy are non-pharmacist-practitioners, 
which is the opposite of what one finds in most medical, dental, nursing and other health 
institutions does not help much this mismatch of knowledge and skills (Agomo 2012d). 
Hence, you find that non-public health experts, e.g., health sociologists and psychologists, 
lead public health courses in some UK Schools of Pharmacy. Interestingly, Peter Noyce, 
professor of pharmacy practice at the University of Manchester, recently acknowledged this 
point in a Pharmaceutical Journal article (Torjesen 2015b): 
“In a number of schools the number of pharmacists would not be over half of the 
faculty, so that actually means the student can end up having quite a low exposure 
to practice but also low exposure to pharmacists … In comparison with other health 
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disciplines — whether it be medicine, nursing, physiotherapy or dietetics — many 
more of their practitioners are involved in education, whereas the majority of 
pharmacy practitioners are not.” [Prof. Peter Noyce] 
Although, the Modernising Pharmacy Careers Programme document (Smith and Darracott 
2011) aims to correct this by encouraging Schools of Pharmacy to produce more academic 
pharmacists, yet the challenges faced by pharmacy graduates is not just limited to 
undergraduate training as noted above, this anomaly continues into practice, with the 
majority of pharmacists today being managed directly by profit-orientated company non-
pharmacist managers, supervisors and directors. According to Michie, et al. (2005) this is a 
social influence, it has a direct link to organisational commitment and culture.  
However, when we also consider the fact that estimates indicate that medicine wastage in 
England is in the order of £300 million per year, the importance of developing good 
adherence strategies for patients, is further appreciated (Trueman, et al. 2010). Still, poor 
adherence by patients could also be associated with poor monitoring and reporting of 
serious adverse drug events (ADEs) by pharmacists (Gavaza, et al. 2011). The magnitude of 
the problem is also dependent on the condition being treated (Sukkar 2015), with a study 
showing that in type 2 diabetes, for instance, adherence rates have ranged from 60% to 
85%, for hypertension 26% to 51%, for asthma from 28% to 70% and for HIV adherence 
from 37% to 83% (Aitken and Gorokhovich 2012). Still, the cost of non-adherence is not just 
about the cost of wasted drugs but also include increased health costs to payers if a 
patient’s condition worsens (Sukkar 2015). 
Nonetheless, based on recent evidence that suggests that you would need to have 12 or 13 
different drugs to mimic all the effects of exercise, focus of good adherence may no longer 
be on patients taking their medicines correctly, but could soon shift to patients also 
adhering correctly to their exercise prescription regimens (Dolgin 2015). Eighty-eight per 
cent of my respondents indicated that they would want UK community pharmacists to be 
developing good adherence strategies for patients. However, the word 'adherence' was not 
widely featured in the curricula of UK Schools of Pharmacy (knowledge), as I found it only in 
the curricula of the School of Pharmacy, University of Portsmouth and UCL SoP (Year 2). A 
closely associated word, 'optimisation', appeared only in the curricula of the School of 
Pharmacy, Cardiff University and UCL SoP (Year 3). It seems to me therefore that the 
teaching of many of the issues concerning medicines adherence or optimisation to 
 168 
 
pharmacists is during postgraduate courses, such as, through continuous professional 
development programmes (CPDs) or in taught diploma and master’s programmes. Bringing 
some of these topics to the undergraduate pharmacy curriculum could help enhance 
students’ knowledge and skills in public health as well as prepare them for future public 
health roles in GP practices and community pharmacies.   
Regarding smoking cessation, several studies confirm the role of community pharmacists in 
this area (Anderson 1998; Anderson and Blenkinsopp 2003; Agomo, et al. 2006; Agomo 
2012a). In my review of knowledge and information, I identified a gap in the evidence base, 
particularly on the willingness of retail pharmacies to stop the sale of tobacco products. My 
survey of UK community pharmacists indicated that 80.6% of my respondents would want 
community pharmacists to enhance their involvement in smoking cessation. A free text 
comment by one respondent further amplified this point:  
“Companies that own pharmacies should not be involved in activities which show 
conflict of interest, e.g. selling cigarettes.” [B123]  
Not much was said in my interviews with UK health professionals regarding the role of 
community pharmacists in smoking cessation, with the exception being the pre-registration 
participant (PR-FLY), who cited smoking cessation as a good example of a service which 
community pharmacists could use to enhance their role in public health, through brief 
intervention (utilising, for example, the transtheoretical model and stages of change – tools 
for motivation). Surprisingly, my Text Search with NVivo revealed that the word 'smoking' 
appeared in the curricula of only three UK Schools of Pharmacy: Huddersfield, Portsmouth 
and UCL SoP (Year 4). I did not identify the related words 'smoke' or 'smoker' in the curricula 
of these schools. However, I found the word 'tobacco' at UCL SoP (Year 4). Although this 
may not necessarily indicate that the other UK Schools of Pharmacy were not teaching 
smoking cessation to their students, it does give some indication as to how this very 
important public health topic is prioritised in many UK pharmacy schools - (goal 
target/setting and goal priority). 
On effective communication, a number of studies identify the need for healthcare 
practitioners to improve their communication techniques (skills - interpersonal skills) 
(Schwartzberg, et al. 2007; Carter, et al. 2008; Sookaneknun, et al. 2009; Emmerton, et al. 
2010; Roughead, et al. 2011; Rowlands 2012). My survey of UK community pharmacists, 
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which indicated that majority of my respondents (79.3%) would want UK undergraduate 
pharmacy students and pharmacists taught content-specific/advanced communication 
techniques, further confirmed this need. I noticed the same trend both in the free text 
comments provided by my survey respondents and my interviews with healthcare 
participants.  
“If you have knowledge and you are not able to communicate, you will not be able to 
impact that knowledge to the person that needs it.” [USP-CHD] 
While there was nothing to suggest that UK Schools of Pharmacy were teaching advanced 
communication methods to students, from my content analysis of the curricula of UK 
pharmacy schools, it was obvious that many schools were developing students' skills in 
communication through written assignments, oral presentations, etc. However, it has been 
noted that in practice, little attempt is made by healthcare professionals to assess patients' 
understanding of any health advice given (Schwartzberg, et al. 2007). This could be due to 
lack of skills, beliefs about capabilities or environmental context and resources, particularly 
as it relates to competing tasks and time constraints. This is even more concerning when we 
also consider the findings of a recent study that assessed how 102 patients with an allergy 
used an epinephrine (adrenaline) auto-injector device and how a group of 44 patients used 
a metered-dose inhaler (MDI) to treat their asthma (Bonds, et al. 2015). In that study, the 
researchers found that only 7% of asthma patients used their MDI properly, and in the case 
of patients using an epinephrine auto-injector device, the success rate was only 16%. 
According to the study, there was a need for better patient training, including practical 
demonstrations, in the use of their devices (otherwise, enhancing patients’ beliefs about 
capabilities). The nurse participant [N-CHM] highlighted the same concern with community 
pharmacists, ‘At the moment now, most pharmacists … they just give you your usual supply 
of prescription. They don't advise any more’. However, pharmacists signposting patients to 
manufacturers' YouTube videos on good device techniques, which empower patients 
through knowledge or even using online tools such as Skype to teach patients (beliefs about 
capabilities), could further demonstrate pharmacists' ability to employ readily available new 
technologies and social media to enhance their role in public health.    
Nevertheless, within the UK’s NHS, there has been a steady transfer of care from specialist 
hospital doctors to primary care doctors, especially general practitioners (Martin, et al. 
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2011), mainly to take healthcare delivery nearer to patients as well as to contain and reduce 
the cost of treatment. However, this has further increased the workload of GPs (time 
constraints), and some of this work lies within the domain of public health practice (e.g. 
health education, immunisation, medicines use/clinical reviews, etc.). My review of 
knowledge and information (Baqir, et al. 2011; RPS 2014a; Watson, et al. 2014), survey of 
UK community pharmacists and interviews with healthcare professionals revealed that 
enhancing the public health role of community pharmacists can significantly reduce the cost 
of treatment as well as the workload of other healthcare professionals, by reducing GP and 
A&E appointments by patients for minor conditions that can easily be managed by 
pharmacists.  
 “I know from my own experience, we see a lot of patients with minor illnesses that 
come to the GP and I think this is a waste of time.” [GP-CHY] 
The easy access of community pharmacists to the public (environmental context – 
availability) was widely highlighted by both the survey respondents and interview 
participants.  
 “Easy access to services, no appointment needed” [C302]. 
However, as a pharmacist practitioner myself, I have also noticed that the main selling point 
of community pharmacy practice, 'easy access', with no need for appointments, also brings 
with it some challenges in terms of pharmacists’ ability to provide some services from the 
pharmacy. There is sometimes no time to provide some of these services. Meaning that, 
community pharmacists claim of availability, might actually be misleading due to time 
constraints. 
“The pharmacist then hasn't got time; you need two pharmacists.” [GP Partner-SIM] 
To enhance the public health role of community pharmacists in the UK, there is also a need 
to minimise environmental constraints (environmental context) and enhance resources by 
engaging more than one pharmacist in community pharmacies during opening hours, as 
highlighted for example by the GP Partner participant [SIM] above and also by a pharmacist 
participant [PKT].   
“Like in Italy where I come from, if we are five, all five pharmacists working are 
qualified pharmacists.” [P-PKT] 
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The Pharmacists’ Defence Association supports this initiative, which they believe will help 
enhance both the clinical and the public health roles of community pharmacists (PDA 
2015a). 
While it might seem logical that GPs should also transfer, some of their minor clinical and 
public health roles to pharmacists to enable them to focus on more complicated clinical and 
public health cases, this is not always an easy transition. The reason is that while it is a lot 
easier for GPs to take on some of the specialist doctors’ roles due to the uniformity of 
undergraduate training, this is not the case with pharmacists, whose undergraduate training 
has been developed traditionally as a science rather than a clinical/public health 
programme. My content analysis of curricula of UK pharmacy schools indicated that science-
orientated subjects, in most cases at the expense of public health modules, significantly 
dominated the UK undergraduate pharmacy programme – highlighting inadequacy of skills 
and knowledge of students in public health. In many UK pharmacy schools, the teaching of 
public health to students, has often been as an optional module or integrated with other 
topics. There is, therefore, a need to present Public Health as a core module in the curricula 
of UK Schools of Pharmacy, to broaden and advance the knowledge base and skills of 
pharmacists in public health. While I could argue that the public health module delivered at 
the School of Pharmacy, Robert Gordon University, Aberdeen, to a large extent closely 
resembled what one would expect, at least, in a Diploma in Public Health programme, based 
on the list of topics covered, it was difficult for me to ascertain how broadly or intensely 
these topics were delivered to students. 
My survey findings supported the need to increase the public health content of UK 
undergraduate pharmacy curriculum (knowledge), with 64.8% of my respondents indicating 
that they were happy with such an increase. The responses from my interview participants, 
many of whom saw this as the only way forward to enhance the public health role of 
community pharmacists support this finding.       
 "It will be important that before a pharmacist graduates, going into community 
 pharmacy, whatever, as a pharmacist, that they're aware of public health as a 
 discipline, and that in a way, they know what are involved..." [P-PO] 
Interestingly, respondents from Cardiff (median = 3.0) were less likely than other 
respondents (total median = 4.0) to agree that the public health content of the UK 
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undergraduate curriculum should be increased (p = .024; η2 = .087). This difference seems to 
suggest that the pharmacy profession in Cardiff might need more convincing (intentions) 
about the benefits of increasing the public health content of the undergraduate pharmacy 
curriculum. 
Regarding the dominance of the sciences in the undergraduate pharmacy curricula over 
public health, a pharmacist, Mathew Smith from Cardiff School of Pharmacy and 
Pharmaceutical Sciences, has questioned the wisdom in this (Chapman 2014). He threatens 
to get rid of a great deal of the science, as according to him, around 99% of students are 
going to be pharmacists rather than going into the pharmaceutical industry (Chapman 
2014). In the case of one of my interview participants (P-SOL), all of the chemistry she learnt 
during her undergraduate pharmacy training in the 1990s has made little contribution to her 
practice as a community pharmacist. More or less, highlighting the fact that she received 
wrong knowledge and skills during her undergraduate training, which has no relevance to 
her present role as a community pharmacist. She reckoned that, shifting the emphasis from 
the sciences to clinical studies would be more relevant to pharmacists in their clinical and 
public health roles, a point agreed by another participant.  
However, the need to broaden and enhance the public health (including clinical pharmacy) 
training of undergraduate students and then pharmacists (Agomo 2004, 2011, 2012c, 2015) 
supports the recent move in the UK to employ pharmacists in GP practices (Robinson 
2015a). I hope that pharmacists working in GP practices will help enhance the professional 
image of pharmacists, particularly as pharmacists’ association with the ‘shop environment’ 
seems not to be helping their public health role agenda.   
At the same time, it seems reasonable that community pharmacists should also be willing to 
transfer some aspects of their dispensing roles to well-trained and competent dispensers 
and technicians or even robotic dispensers (environmental context and resources), a point I 
have argued a number of times (Agomo 2008b, 2012b; Agomo and Ogunleye 2014), and 
reiterated recently in other articles (Bradley, et al. 2013; Torjesen 2015b).  
In order to enhance the public health role of community pharmacists, there will also be a 
need to advance the pharmacy practice experience (skills) of students in public health 
(Patterson 2008). Interestingly, Patterson (2008) also observes that students working behind 
a pharmacy counter may not give an accurate picture of health care beyond the pharmacy. 
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In one study, post-APPE discussion definitions were broader and more accurate in students 
who had the training; in addition, post-APPE reflections showed that students’ initial lack of 
knowledge base improved as well as their interest in participating in public health initiatives 
(Whitley 2010). Eighty-six per cent of my respondents were in favour of students getting 
advanced pharmacy practice experience in public health (skills - practical/skills 
development). There was no indication from my content analysis of the curricula, that UK 
pharmacy schools offered to students advanced pharmacy practice experience in public 
health. However, from my interviews with healthcare professionals, it was obvious that UK 
pharmacy students would benefit from additional experience in public health (including 
clinical pharmacy).   
Regarding promoting interdisciplinary initiatives in pharmacy education and later in practice 
(social influences - team working), these were widely supported by my survey respondents 
(81.4% and 93.1% respectively). The negative correlations that existed between the age of 
respondents and their support for the suggestions on pharmacy students training with other 
healthcare students (ρ = -.261; p = .015) and pharmacists working closely with healthcare 
practitioners (ρ = -.221; p = .040), tends to suggest that interdisciplinary initiatives might 
soon become the way forward for both UK pharmacy education and practice.  
My interview participants were also in support of interdisciplinary initiatives. The reflection 
of this in practice was however weak. For example, while most of my survey respondents 
(98.9%) indicated that they were offering over-the-counter (OTC) advice, with another 
76.5% participating in local authority-run schemes, when it came to collaboration with other 
healthcare providers, only 33.7% of my survey respondents said they were collaborating 
with a local practice in a shared care kind of scheme. Nonetheless, my observation that 
respondents from Cardiff (median = 2.0) were more likely to be participating in local 
authority-run schemes than other respondents (p < .001; η2 = .296; total median = 1.0) 
might necessitate further investigation, bearing in the mind the large effective size of the 
difference (η2 > .14). 
However, some of the benefits highlighted around integrated learning and practice included 
its ability to encourage inter-professional learning and practice, easy transfer of knowledge 
between practitioners (knowledge and skills enhancement), minimising wastage of 
resources and duplication of efforts in some institutions (reducing environmental 
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constraints through efficient resource management), facilitating patients’ care services 
(beliefs about capabilities and empowerment), as well as its ability to enhance the profile of 
pharmacists (social/professional role and identity). I have previously highlighted some of 
these benefits, which also include creating jobs for new pharmacy graduates and giving 
them the skills needed to work in various environments (Agomo 2006, 2012c). There was 
minimal evidence from my content analysis that interdisciplinary initiatives (social influences 
- team working) were being practised at the UK undergraduate pharmacy training level. 
Nonetheless, the programme at the School of Pharmacy, University of Birmingham may 
encourage other UK pharmacy schools to develop interdisciplinary initiatives, as it reflected 
Birmingham’s commitment to offering integrated medical training and education (News 
Team 2011). The system in most UK pharmacy schools, where students had little or no 
interaction with other healthcare students at the undergraduate level, was therefore, a 
deviation from the experience of some of my interview participants who had witnessed 
many of the benefits of integrated training overseas.    
Antibiotic resistance continues to be a global problem (WHO 2015b). In the UK, the National 
Institute for Health and Care Excellence (NICE) recommends that everyone engaged in 
providing healthcare should understand the standard principles of infection control (NICE 
2012). In both my service-focused study and my review of knowledge and information, I 
identified the role of community pharmacists in infection control (Agomo 2012a; Agomo 
and Ogunleye 2014). Other studies also discuss the role of community pharmacists in 
infection control (Bruce and Scott 1998; Watson, et al. 2003). In my survey of UK community 
pharmacists, 79.5% of respondents indicated that they would want community pharmacists 
to enhance their role in preventing the development of antimicrobial resistance and the 
spread of infections. My content analysis of the curricula of UK pharmacy schools revealed 
that various issues related to infection were taught in a number of schools, notably, at Bath, 
Brighton, UCL, De Montfort, Durham, Keele, Manchester and Wolverhampton. The curricula 
of the Schools of Pharmacy, Keele, Portsmouth and UCL indicated that their undergraduate 
pharmacy students received training in drug resistance. However, in my interviews with 
healthcare professionals, I noticed that my interview participants said hardly anything 
regarding infection control or drug resistance. The only mention of antibiotics by a 
participant [USP-CHD] was referring to pharmacists' role in preventing allergic reactions. 
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“A patient comes into the doctor's office, forgets to tell the doctor that he's allergic 
to maybe, a quinolone, gets Levaquin [a brand of levofloxacin]. He gets to the 
pharmacist, the pharmacist finds out that this patient is allergic to Levaquin, gives 
the doctor a call, that problem gets solved and then another medication that the 
patient is not allergic to is prescribed.” [USP-CHD] 
I also noticed that the only use of the word ‘infection’ in my interviews with healthcare 
professionals was by a pharmacist participant [P-PO] who was talking about the desire of 
GPs to have a diagnostic tool that will enable them to differentiate viral infections from 
bacterial infections easily, without the usual need to wait for laboratory results. 
Nevertheless, some of the challenges faced by Britain in areas such as sexually transmitted 
infections (STIs) have been highlighted (DoH 2010a); however, the role of community 
pharmacists in infection control is still limited mainly to advisory roles, as not many 
community pharmacists presently have prescribing qualifications or responsibilities. Maybe, 
there is a need for knowledge enhancement and skills development in this area as well as 
the use of motivational tools to enhance pharmacists’ interest in preventing the spread of 
infections as well as managing antimicrobial resistance. 
Still, promoting self-management capacities (beliefs about capabilities) is likely to empower 
patients and ensure better health outcomes and savings to the NHS (Taylor and Bury 2007). 
From my content analysis of the curricula of Schools of Pharmacy, I was able to confirm that 
the Schools of Pharmacy, University of Portsmouth and UCL were teaching self-management 
capacities to students. It is possible that other UK Schools of Pharmacy were teaching self-
management capacities as part of other modules. However, my survey of UK community 
pharmacists indicated that 89.8% of my respondents would want community pharmacists to 
be enhancing patients' self-management capacities, an idea further endorsed by a number 
of interview participants [N-CHM, PR-FLY, USP-CHD and GP-NN]. Again, from the comments 
I received from my US pharmacist participant [USP-CHM], it seemed reasonable to argue 
that the NHS could learn a few things from the practices of US health insurance companies, 
which minimise the need to make huge treatment payouts by paying community 
pharmacies/pharmacists to provide immunisation services to patients. In the UK, several 
insurance and utility companies do exactly the same by offering online self-care tips, which 
they hope will help reduce costs by limiting the need for call-outs. The recent call by the 
Royal Society of Public Health (RSPH) for pharmacists to join a wider public health workforce 
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(Kennedy 2015a), as well as the recent announcement for national flu service involving 
community pharmacists (Weinbren 2015), could therefore bring large savings to the NHS. 
On the strengthening of patients’ education on safe medication disposal methods (skills and 
beliefs about capabilities), there are indications that inappropriate medication disposal is 
still a problem, not just in the USA (Abrons, et al. 2010), but also in the UK (Fradgley and 
Smith 2012). In my survey of UK community pharmacists, 78.5% of respondents indicated 
that they would want community pharmacists to enhance their role in safe medication 
disposal methods. While none of my interview participants said anything regarding the need 
to enhance community pharmacists' role in medication disposal, there was also a lack of 
emphasis in the curricula of UK undergraduate pharmacy schools regarding medication 
disposal methods. This relates to lack of goal priority, particularly as it relates to behavioural 
regulation. It is possible that teachings on safe medication disposal methods occur with 
students after graduation.  
According to Munger (2010), the risks associated with polypharmacy and the potential for 
inappropriate therapy need to be considered and balanced against the possible benefits of 
multiple drug therapies. The Scottish Government has also identified the need for 
pharmacists' greater contribution in polypharmacy, to minimise risks to patients (NHS 
Scotland and The Scottish Government 2012). Interestingly, the position of The Scottish 
Government on polypharmacy was also reflected in the way respondents from Edinburgh 
more strongly supported pharmacists’ enhanced role in polypharmacy than did other 
respondents (p = .040; η2 = .076). While the majority of my interview respondents (87.5%) 
said they would want community pharmacists to enhance their skills in the management of 
polypharmacy and long-term conditions, to my surprise, I did not see the term 
'polypharmacy' in the curricula of any UK pharmacy schools. This could also highlight a 
mismatch between goal priority in terms of knowledge and skills. However, at the School of 
Pharmacy, University of Nottingham, there were indications that Year 4 students were 
receiving teaching on polypharmacy, in the ‘Integrated Pharmaceutical and Patient Care’ 
module.   
"Students will develop their problem-solving skills and their abilities in application of 
therapeutics to individual patients with complex medical conditions and multiple 
medicines use.”  
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There were also indications that in other UK Schools of Pharmacy, the teaching of issues 
pertaining to polypharmacy were often in modules related to medicines management and 
drug reconciliation. Although some of my interview participants made general statements 
regarding medicines use, none of them raised any specific issue about polypharmacy.   
Remunerating pharmacists directly for providing public health services can help enhance 
their role in public health (The Scottish Government 2013), as against the present system, 
where only pharmacists’ employers are remunerated for public health services provided by 
pharmacists. The majority of my survey respondents (89.8%) would like pharmacists to be 
remunerated directly for providing public health services (environmental context and 
resources).  
However, for one of these respondents, pharmacists are ‘seen as an “add-on” by staff, for 
which we are not directly remunerated’ [C296]. Supporting this initiative, one of my 
interview participants [P-OL] also argued that, ‘they (pharmacists) should be remunerated 
accordingly and not the business’. On the other hand, enabling the development of 
Independent Pharmacist Practitioners who are not attached to any employers, as proposed 
by a pharmacist organisation (PDA 2013), could help change the status quo and at the same 
time motivate pharmacists to enhance their role in public health (APA 2008). Another 
benefit of this model is that it limits some of the constraints often associated with 
employer-led public health services, such as targets and financial considerations (Bush, et al. 
2009; PDA 2013).   
As stated by the DoH (2010a), Britain has a relatively large population of problem drug users 
and increasing levels of harm from alcohol consumption. A number of studies have 
identified the role of pharmacists in drug addiction, substance abuse and misuse (Lee, et al. 
2009; Chaar, et al. 2011; Ambrose 2011). There were indications from my content analysis 
that many UK pharmacy schools, notably, Bath, Brighton, RGU, Nottingham, Portsmouth 
and UCL were teaching students issues related to drug addiction, substance abuse and 
misuse (behavioural regulation). While 66.6% of my survey respondents indicated that they 
would like community pharmacists to manage the medication needs of athletes to prevent 
them from accidentally using a banned substance, none of my interview participants 
highlighted the role of pharmacists in these areas. There was also a lack of information from 
my project findings that pharmacists and students were being made aware of the 
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educational opportunities and responsibilities of pharmacists in anti-doping activities 
(Ambrose 2011), highlighting once again lack of knowledge, skills and possibly, self-
confidence/professional confidence in this area. Moreover, Europe is considered to be the 
region that consumes the largest amount of alcohol in the world (Kaczmarek 2015), with 
consumption levels in some European countries estimated as twice the global average 
(WHO 2014). Not only is alcohol the third biggest risk factor in Europe for non-
communicable diseases (NCDs), ill health and premature death (WHO 2014), alcohol is also 
known to directly or indirectly induce over 60 different types of illness (WHO 2012). These 
include mental and behavioural disorders, gastrointestinal conditions, cancers, 
cardiovascular disease, immunological disorders, lung diseases, skeletal and muscular 
diseases, liver disease, reproductive disorders and prenatal harm (WHO 2012).  Alcohol 
consumption is also known to be associated with crime, violence, domestic abuse, child sex 
abuse and road traffic accidents (Kaczmarek 2015), with drink-driving being the second 
biggest killer on EU roads (European Commission 2014).  
While, there seems to be a potential for alcohol screening and brief intervention (SBI) 
services in community pharmacy (Horsfield 2011), still, there exists little empirical evidence 
of the effectiveness of community pharmacy-based services for alcohol misuse (Dhital 2004; 
Fitzgerald and Stewart 2006; Watson and Blenkinsopp 2009). In my survey of community 
pharmacists, a number of my respondents highlighted the role of community pharmacists in 
alcohol misuse (behavioural regulation). In addition, there was some evidence from the 
curricula of UK Schools of Pharmacy that alcohol misuse was one of the public health topics 
often discussed with students (knowledge - knowledge about condition/scientific rationale). 
There is however a need for UK Schools of Pharmacy to further develop their curricula, 
particularly as it relates to the use of motivational tools such as the Transtheoretical Model 
of Change (TTM) (Prochaska and DiClemente 1986; Prochaska 1994), Ajzen’s Theory of 
Planned Behaviour (Ajzen 1991) or even the Goal-setting theory (Locke and Latham 1990) in 
lifestyle and addictive behaviours (intentions and goals). I have also discussed some of these 
motivational tools in a commissioned continuing professional development (CPD) article 
(Agomo 2008a).  
Concerning travel medicines, Hind, et al. (2008) note that UK community pharmacists 
provide limited services in this area; highlighting, yet another area where community 
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pharmacists could be lacking self-confidence/professional confidence (beliefs about 
capabilities [Self-efficacy]). However, they have also argued that community pharmacists 
can enhance travel medicines service, by offering the travelling public general advice on 
various issues such as bite prevention, provision of immunisations and malaria prophylaxis, 
with the public in many cases also willing to pay for some services (Hind, et al. 2008). 
According to a recent study from Australia (Tudball, et al. 2015) there is more to travel 
medicine, which might also include community pharmacists managing patients’ medicines 
properly before they embark on any journey. Sadly, prior to travelling, patients seldom ask 
for advice regarding their regular medicines from healthcare professionals (Tudball, et al. 
2015). However, community pharmacists and other health professionals are well positioned 
to advise and assist patients with complex drug regimens who are planning to travel, and at 
the same time, provide general awareness regarding the need for maximum care with 
multiple medicines (Tudball, et al. 2015). 
As well as these, it is also imperative to address many of the identified barriers hindering the 
public health role of community pharmacists in the UK, such as the community pharmacy 
environment (environmental context and resources), which sometimes may not be suitable 
for the delivery of public health services; the perceptions of both the general public and 
other health providers of pharmacists’ competencies (beliefs about capabilities); privacy and 
confidentiality in pharmacies (environmental context and resources); time pressure; and 
high dispensing workload (environmental context and resources and social influences 
respectively). As well as,  address other barriers, such as, lack of awareness of the role of the 
pharmacist (social/professional role and identity [self-standards]); the UK healthcare system 
and its policies towards the public health role of the pharmacist (environmental context and 
resources and social influences); inadequate training of pharmacists in public health 
(knowledge and skills); lack of documentation of activities (memory, attention and decision 
processes); and inadequate financial support (environmental context and resources) (Bush, 
et al. 2009; Agomo 2012a; Saramunee, et al. 2012; Agomo and Ogunleye 2014). Other 
barriers that will also need to be tackled to enhance the public health role of community 
pharmacists include lack of professional autonomy for pharmacists (social/professional role 
and identity and beliefs about capabilities - empowerment), lack of input from public health 
practitioners (social influences - team working), lack of support from GPs and public health 
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practitioners (social influences - team working) and difficulty in communicating with other 
public health providers (social influences and skills), lack of patients’ records (environmental 
context and resources), and lack of understanding by the public and healthcare providers of 
the training and skill-sets of pharmacists (knowledge and social influences). 
In addition, it seems there is also a need to enhance professionalism in UK community 
pharmacy practice (social/professional role and identity), as highlighted previously (Agomo 
2012f), as well as tackling commercial pressure from employers (environmental context and 
resources, and social influences), difficulty following up with patients (social influences), the 
conflict of interest that exists between pharmacists and GPs and the underutilisation of 
pharmacists' skills (social influences and beliefs about capabilities).  
According to some of my survey respondents, some of these barriers could be tackled by, 
for example, getting rid of target-driven services (social influences and goal/target setting), 
opening up channels of engagement between pharmacists and stakeholders, reducing 
professional isolation (social influences – team working), tackling many of the barriers 
highlighted above, ensuring consistency in service delivery across sectors and localities 
(environmental context and resources), enhancing collaboration between community 
pharmacists and other healthcare providers (social influences – team working), and ensuring 
that more than one pharmacist works in community pharmacies at any one time 
(environmental context and resources), as seen in some European countries, for example, 
Italy. Besides this, role delegation between pharmacists and other healthcare professionals 
and pharmacy support staff will also be necessary. It seems there is also a need for better 
funding of public health services by the government (environmental context and resources); 
as well as direct remuneration of pharmacists for public health services and ensuring that 
the professional image of pharmacists (particularly in community pharmacy) is enhanced. 
Pharmacists themselves might also benefit from the application of motivational tools to 
make them more proactive, assertive and committed to public health activities.    
Other challenges faced by community pharmacists in their aspiration to provide public 
health services relate to the structure of community pharmacies (environmental constraints) 
(Agomo 2012f), lack of a well-defined career structure and progression channels in 
community pharmacy, unacceptable work-life balance (social influences) – leading to high 
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stress levels among community pharmacists (Agomo 2012g), the unavailability of 
individually contracted community pharmacists (environmental context and resources) (The 
Scottish Government 2013) and the declining ownership of community pharmacies by 
independent pharmacists (lack of empowerment) (Bush, et al. 2009; Agomo 2012e). The 
main implication of the declining ownership of community pharmacies by pharmacists is 
that we find that the role of the community pharmacist in public health is often shaped by 
the commercial interests of the organisations they work for rather than by their 
undergraduate pharmacy training or the aspiration of individual pharmacists to advance 
their public health roles. 
 "Because everybody is allowed to own a pharmacy, all these multiples, they are all 
after the profit and not after the patients' health and that's not doing well for the 
profession." [P-OL] 
The effect of workload (which can lead to stress and burn-out [emotion]) on community 
pharmacists’ ability to provide public health services seems to be huge, based on the 
number of comments I received from my survey respondents and interview participants. 
According to the same pharmacist respondent above (P-OL), ‘I only see the prescription and 
because I'm so busy, I don't have the time to even talk to the patient’. Such comments not 
only create doubt among patients about the seriousness of community pharmacists as 
public health providers, but can also defeat the whole perception of community pharmacists 
being readily accessible for public health services. 
On the conflict of interest which one of my respondents raised as a barrier to enhancing the 
public health role of community pharmacists in the UK – ‘GPs and GP practices don’t want 
pharmacies in their team – conflict of interest’ [B37], this might be managed through the 
development of Independent Pharmacist Practitioners, who could also work as group 
practitioners or partners, as well as encouraging GP practices to employ more pharmacists 
as recently proposed by the Royal Pharmaceutical Society (RPS) and the Royal College of 
General Practitioners (RPS) (Robinson 2015a) (social influences - team working). According 
to Butterfield (2015), closer ties with general practice – and primary, secondary, tertiary, 
mental health and social care (social influences - team working) – are essential to improve 
the contribution of pharmacist to patient care and to secure better prospects for the 
profession. Nonetheless, tackling comments such as, ‘Better funding. Remove services from 
GPs that are under-performing’ [RC196] also brings questions that require answers, for 
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example, do community pharmacists have the necessary education, skills and practice 
environment needed to provide such services?  
The underutilisation of pharmacists has often been described as a huge waste of resources 
and the intellectual skill of pharmacists (The Scottish Government 2013), particularly at a 
time when other healthcare professionals are barely coping with demands that can easily be 
provided by pharmacists. My survey of UK community pharmacists and interviews with 
healthcare professionals revealed that both pharmacists and other healthcare professionals 
would want this underutilisation of pharmacists to stop - minimising social influences 
(Norms) and enhancing social/professional role and identity of pharmacists.  
“Patients can be educated more … like give them a list of conditions that, 'these 
things, you don't really need to see your GP’.” [GP-CHY] 
To address some of these challenges, the profession might also need to consider a recent 
proposal to separate the dispensing role of pharmacists from the pharmacy/public health 
services role - creating professional identity/boundaries/role (Smith, et al. 2013), as well as 
promoting the establishment of Healthy Living Pharmacies (skills) (Kennedy 2015b). 
According to the Pharmaceutical Services Negotiating Committee,  
“The Healthy Living Pharmacy (HLP) framework is a tiered commissioning framework 
aimed at achieving consistent delivery of a broad range of high-quality services 
through community pharmacies to meet local need, improving the health and well-
being of the local population and helping to reduce health inequalities.” (PSNC 2015) 
Demonstrating the impact of HLPs, a recent Portsmouth study found that significantly more 
clients per pharmacy were seen in HLPs than non-HLPs for the following services: targeted 
respiratory medicine use reviews (medians: 29 vs 11; P = 0.0167); smoking cessation at 
initiation (62 vs 18; P < 0.001) and at 4-week (26 vs 10; P < 0.001) and 12-week (5 vs 1; 
P = 0.023) follow-ups (Browns, et al. 2014). Supporting the role of HLPs in enhancing the 
public health role of community pharmacists in UK, my survey of community pharmacists 
also revealed that the majority of my respondents (68.7%) would like to see UK community 
pharmacies developing into HLPs. Maybe creating an opportunity for more education and 
awareness is also behind the fact that respondents from Cardiff (median = 3.0) were less 
likely than other respondents to support community pharmacies developing into Healthy 
Living Pharmacies (p = .026; η2 = .090; Total median = 4.0). While three UK Schools of 
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Pharmacy (Huddersfield, Portsmouth and UCL) indicated that they were teaching about 
HLPs to students, none of my interview participants talked about HLPs.  
Public Health England has recently announced that it plans to ‘accelerate the role of HLPs’, 
by ensuring that they grew from ‘around 1,000’ to ‘more than 2,000 over the next three to 
five years’ (Kennedy 2015b). While this plan is likely to be slowed down due to the recent 
proposed £200m cuts to public health budgets for local authorities (Gidley 2015), it can be 
further accelerated and strengthened by enabling Independent Pharmacist Practitioners 
(IPPs) to establish HLPs in local communities. This seems reasonable as IPPs can operate 
without the dispensing burden sometimes highlighted as a barrier to the public health role 
in the community pharmacy. To support the role of healthy living pharmacists, there might 
also be a need for community pharmacists reaching out to the community and running 
public health programmes in libraries or other community meeting places, at the same time, 
developing their own expertise in public health. A good example of this reach out could be, 
pharmacists/pharmacy engaging in employee health fairs – defined as, services provided to 
employees at local businesses, including cholesterol screenings, blood pressure screenings, 
and height, weight, and body mass index measurement; (with) written results given to 
patients (Doucette, et al. 2012).  
In my survey analysis, I found that respondents aged 60-69 were more likely to agree than 
other respondents that UK community pharmacies should develop into Healthy Living 
Pharmacies (p = .005; η2 = .191). This calls for greater awareness among younger 
pharmacists about the benefits of HLPs compared to traditional models of community 
pharmacy practice.  Better awareness of these age-related and geographical differences will 
help policy-makers develop sustainable conditions for enhanced public health practice in UK 
community pharmacies.  
I considered two other free text comments from my survey of community pharmacists to be 
thought provoking: 
“Look at the role of pharmacists in other countries. We are good, but not world 
leaders.” [RC185]  
“GPs and clinicians actively referring patients to pharmacists for intervention.” 
[E390] 
The question might still be; why are the referrals not happening? Could the solution lie with 
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the undergraduate training of pharmacists, the public’s and other healthcare professionals' 
perception of pharmacists, the issue of trust, or even the commercial influence on 
pharmacists, which many of my survey respondents and interview participants highlighted 
as a barrier to enhancing the public health role of community pharmacists? As I have argued 
severally, introducing the undergraduate clinical pharmacy (PharmD programme) in the UK 
(knowledge and skills enhancement) might help enhance pharmacists’ role in public health 
as well as help change both the image and the perception of pharmacists (Agomo 2004, 
2006, 2011, 2012c, 2015).  
In a private conversation I had with a schoolmate who had qualified originally in Nigeria with 
the BPharm degree, before moving to the USA, where he then completed a further two-year 
part-time programme to obtain the PharmD degree (knowledge and skills enhancement), he 
revealed that the PharmD degree enabled him to run a HIV clinic in the state of Georgia - a 
consequence of enhanced beliefs about capabilities. According to him, there is no way he 
could have run the clinic, thereby supporting the public health agenda on HIV, without the 
extra knowledge and skills acquired through the PharmD degree. The main difference 
between the two qualifications was that the PharmD degree enhanced and broadened his 
public health/clinical knowledge and skills, as well as enabling him to become a pharmacist 
prescriber. My project tends to confirm that it might be impossible to enhance the public 
health role of community pharmacists in the UK without also enhancing both their clinical 
pharmacy and public health knowledge and skills. 
In a 2010, a document from the Association of Faculties of Pharmacy of Canada (AFPC) and 
the Association of Deans of Pharmacy of Canada (ADPC) titled, 'Position Statement and Joint 
Resolution on the Doctor of Pharmacy (PharmD) for the First Professional Degree at 
Universities in Canada February 2010' raised some concerns regarding the Canadian 
undergraduate pharmacy curriculum that could be of relevance to the UK undergraduate 
public health and clinical pharmacy education (AFPC/ADPC 2010). According to the 
document:  
 “The significant commitment the profession has made in recent years to a more 
 patient-focused role for pharmacists that is more responsive to the pressures on the 
 Canadian health care system will necessitate further changes to the curriculum and 
 structure of professional degree program in pharmacy. Specifically, professional 
 leaders and consensus reports have called for changes in the education of pharmacy 
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 students to include: more inter-professional experiences; greater attention to the 
 AFPC general attributes and outcomes; more ‘leadership’ and management training; 
 more readiness to handle the clinical use of complex biotechnology-derived drugs; 
 added skills in the documentation of care (especially in electronic health records); 
 prescribing skills and the monitoring of drug therapy outcomes; greater proficiency 
 in drug therapy management of chronic diseases; new skills in the technique of 
 vaccine immunisation; and several other curricular enhancements … However, the 
 explosive growth in the development and use of pharmaceuticals in recent years, 
 particularly drugs with narrow safety and therapeutic profiles, has raised the 
 public health protection responsibility role for pharmacists to a level that was 
 never contemplated when the current academic programme for pharmacy was 
 originally conceived … parties should make significant effort to ensure that all 
 pharmacy schools have a Doctor of Pharmacy curriculum in place by 2020.” 
 (AFPC/ADPC 2010) 
Interestingly, I made a similar case for the introduction of the PharmD programme in the UK 
in 2011 (Agomo 2011), without being aware of the existence of the AFPC/ADPC document.     
 "Maybe, when the MPharm was conceptualised, there was no immediate need for a 
 clinical pharmacy degree in the UK, but many of the changes that we are now 
 witnessing have made it necessary for pharmacy to position itself strategically or it 
 will be made irrelevant." 
The AFPC/ADPC document also talks about the need for public health protection, 
particularly when we also consider drugs with narrow safety and therapeutic profiles. 
Gavaza, et al. (2011) also note that poor adherence by patients could be associated with 
poor monitoring and reporting of serious adverse drug events (ADEs) by pharmacists. In my 
survey of healthcare professionals, I found that the majority of my respondents did not see 
‘safety concerns’ as a barrier to enhancing the public health role of community pharmacists. 
Only 28.4% of my respondents agreed that ‘safety concerns by GPs’, was a barrier. 
Supporting the notion that there exists a more cordial relationship between GPs and 
community pharmacists in Edinburgh (and possibly the whole of Scotland) is the revelation 
that respondents from Edinburgh were less likely than other respondents to agree that ‘lack 
of support from GPs’ was a barrier (p = .001; η2 = .155). 
However, it is concerning that ‘pharmacists’ were more likely and ‘pharmacy managers’, 
‘superintendent pharmacists’ and ‘pharmacy contractors/superintendent pharmacists’ less 
likely to agree that ‘safety concerns by GPs’ was a barrier (p = .042; η2 = .146). This 
difference probably highlights one of the disparities and challenges that often appear in 
community pharmacy practice between ordinary pharmacists at the “coal-face” of practice 
and community pharmacy leaders – many of who are non-practitioners (social influences). In 
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my content analysis of the curricula of UK Schools of Pharmacy, I identified the word 'safety' 
only in the curricula of a number of pharmacy schools, all in England (notably at Bath, 
Bradford, De Montfort, Hertfordshire, Manchester, Portsmouth and UCL). Strangely, none of 
my participants used the word 'safety' in the interview, however, a number of participants, 
for example, P-PKT and USP-CHD, did highlight the importance of pharmacists preventing 
harm to patients (beliefs about capabilities and behavioural regulation). 
However, the Blueprint for Pharmacy: The Vision for Pharmacy (2008) notes that the future 
education of pharmacists in Canada needs to emphasise foundational skills (such as 
communications, clinical decision-making, physical assessment, informatics, confidence 
building and research) and incorporate management, leadership, advocacy and change 
management skills (CPA 2008). I envisage these skills to be vital in this aspiration to enhance 
the public health role of community pharmacists in the UK. 
However, for some time, the Royal Pharmaceutical Society and the Pharmacists’ Defence 
Association have been working separately but collaboratively to further develop the clinical 
and public health role of community pharmacists, and hence have advocated that 
community pharmacists be given access to patients’ Summary Care Records (environmental 
context and resources) (RPS 2014b; PDA 2015b). According to the PDA, the availability of 
Summary Care Records will mean the application of highly developed clinical skills that only 
a pharmacist can perform (PDA 2015b). Hence, the recent announcement of the rolling out 
of SCR access to community pharmacists across the whole of England is therefore an 
encouraging development (HSCIC 2015). I hope that this will help enhance the public health 
skills of UK pharmacists. Interestingly, while the majority of my survey respondents felt that 
lack of patients' records (78.4%) was a barrier to enhancing their public health role, a much 
lower number of respondents (52.8%) identified lack of documentation of public health 
interventions as a barrier to enhancing this role. However, as described by the US-based 
pharmacist participant in the interview [USP-CHD], documentation of public health 
interventions, e.g., immunisation through a centralised online data system is a norm and 
enables other healthcare professionals including community pharmacists to track the 
immunisation status of patients/customers across the US; thereby helping to enhance 
memory, attention and decision processes of practitioners. None of my other interview 
participants said anything about the need to document interventions. In the curricula of UK 
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Schools of Pharmacy, the presence of the word, 'documentation' at UCL SoP (Year 4) and 
Hertfordshire was referring to documentation needs for manufactured products rather than 
the need to document public health/clinical pharmacy interventions. The related word, 
'record' that appeared at Bradford and UCL (Year 3) was not referring to the documentation 
of interventions.  
However, access to summary care health records is not risk-free. According to lawyer Noel 
Wardle, a partner at Charles Russell Speechlys (Sukkar 2014: 596): 
“It may not increase the risk of prosecution, but it could increase the risk of a civil 
claim for any injury caused by a dispensing error in certain circumstances. For a long 
time, the courts have told pharmacists they have to exercise an independent 
judgement when they are supplying medicine, so it is not good enough simply to do 
what the doctor says on a prescription. That duty implies that a pharmacist has to 
consider any information he [or she] has or ought to have. If a pharmacist has access 
to a wider care record, then the risk for a pharmacist is that not only are they 
deemed to know everything that is in the pharmacy's patient medication record, but 
they are also deemed to know everything in the summary care record.” 
Although pharmacists’ prescribing role is becoming an important element of pharmacy 
practice and public health (AFPC/ADPC 2010; Editorial 2015), surprisingly only a few UK 
Schools of Pharmacy, for example, Bath, Manchester, Birmingham and Portsmouth, 
described this role in their undergraduate pharmacy curricula (inadequacy of knowledge 
and skills). None of my interview participants indicated a desire to see UK pharmacists 
developing their prescribing skills. However, one of my survey respondents [P130] would 
like UK community pharmacists to go beyond OTC prescribing [P123] to full prescribing 
roles. 
 “More freedom in terms of prescribing.” [P130] 
Still, bearing in mind the global determinants of health as described by Hunter, et al. (2007), 
there are several factors that determine health. Hence, for community pharmacists to be 
effective public health practitioners, they will also need to be cognisant of the different 
variables that determine health and how to manipulate this to enhance patients’ health 
outcomes. This will therefore mean modifying the present UK undergraduate pharmacy 
curriculum, as evidenced by my project, to enhance both the knowledge base and the skills 
of students in public health and clinical pharmacy. While the UK pharmacy profession is on 
the path of evolving from product-orientated to patient-centred care, with pharmacists 
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contributing to micro-level public health activities (e.g., disease management, health and 
wellness screening), there is also a need to extend this role to macro-level public health 
functions (i.e., assessment, policy development, and assurance at the population-based 
level (Truong and Patterson 2010), and at the same time, tackling many of the barriers 
identified in my project.  
Another concern raised by one of my participants [P-ART] was the problem of logistics when 
it comes to integrating undergraduate pharmacy education with other healthcare 
professions (environmental context and resources). While integrated learning might be a 
challenge for those stand-alone Schools of Pharmacy without a nearby medical, dental or 
nursing school, these schools could liaise with nearby health facilities, for example GP 
practices, local health centres and hospitals, as a way forward. Again, exchange training 
programmes and internships with other schools and health institutions could also be 
helpful, as well as the use of online technologies, for example Skype or other conferencing 
software, to enhance communication skills, build rapport and understanding among 
professions and facilitate integrated learning and exchange of ideas. 
5.2.1 - How my Project met its Objectives 
In terms of how this project met its objectives, my review of the literature and information 
identified some of the strategies that could enhance the public health role of community 
pharmacists. I was able to incorporate most of these findings into the development of my 
survey questionnaire and interview guide. One of my project objectives was to determine 
why the public health role of community pharmacists in the UK remains basic in the 21st 
century. Eighty-three percent of my respondents agreed with the statement that ‘the public 
health role of community pharmacists in UK is still undeveloped in the 21st century’. The reasons 
they gave revolved around the quality of services provided from community pharmacies, hence, 
the problem of trust (beliefs about capabilities); lack of consistency in service delivery 
(environmental context and resources); lack of time to deliver public health services 
(environmental context and resources); community pharmacists not feeling empowered enough 
professionally to provide public health services (social and professional role and identity; beliefs 
about capabilities); lack of training (knowledge and skills); lack of awareness (knowledge); 
difficulty adapting to changing needs (behavioural regulation); feeling undervalued and 
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unrecognised (social and professional role and identity); and lack of focus (memory, attention 
and decision processes). 
The next objective of my project was to assess community pharmacists’ knowledge, attitudes 
and behaviour regarding enhancing their role in public health and determine the perceived 
barriers to enhancing this role. Community pharmacists’ knowledge about the public health 
role was diverse. The majority of my respondents were in support of pharmacists’ enhanced 
role in public health (skills). However, this project did also identify a number of barriers to 
the public health role of community pharmacists. The test of significance and correlation of 
variables revealed that there were a number of significant differences of variables in terms 
of the gender, age, role, years of qualification, and location of practice of the respondents. 
There is a need to consider some of these differences when developing any public health 
initiatives involving UK community pharmacists. 
The next objective assessed the opinion of practitioners on changing the UK undergraduate 
pharmacy curriculum to increase its public health content and, maybe, UK pharmacy schools 
offering dual MPharm/MPH degrees. The majority of my survey respondents (64.8%) 
indicated that they would like the public health content of the undergraduate pharmacy 
curriculum to be increased (knowledge and skills). There was a support for this in the 
interview with healthcare practitioners. However, there was no discussion by my interview 
participants about UK pharmacy schools offering dual MPharm/MPH degrees. This was 
probably due to the lack of awareness by participants of the existence of such degrees 
(knowledge). 
On the objective that assessed the opinion of practitioners on pharmacy students training 
closely with other healthcare students and, later, graduates working closely with other 
healthcare providers to enhance the public health role of community pharmacists in the UK 
(social influences - team working), most of the interview participants supported these 
initiatives. In same manner, this project was also able to assess the opinion of practitioners 
on the teaching of content-specific/advanced communication techniques to undergraduate 
pharmacy students and pharmacists, as well as the adoption of new technologies in 
community pharmacy practice to enhance the public health role of community pharmacists 
in the UK (skills). In this case, while most of the interview participants supported the need to 
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enhance the communication skills of students and pharmacists, when it came to the 
adoption of new technologies in community pharmacy practice, a few of the older interview 
participants were less in support of this, as they preferred face-to-face interaction with 
patients, with some also concerned about confidentiality (emotion - fear and threat). There 
was however, a possibility that their hidden lack of skills in the use of new technologies 
could also be a contributing factor.    
Finally, this project also achieved its last objective, which was to examine the pattern of UK 
undergraduate pharmacy curricula, teaching and learning policy. Through the content 
analysis of the curriculum of UK Schools of Pharmacy, I found that the pattern, teaching and 
learning policies of the UK pharmacy programme seemed to be in favour of the sciences 
(knowledge and skills), many of which are hardly used in routine community pharmacy 
practice, at the expense of public health topics – which in some schools were delivered as 
optional modules or in some cases integrated with other pharmacy topics (goal priority). 
Often these public health topics cover micro-level public health activities, at the expense of 
macro-level public health topics, which require the involvement of public health specialists. 
UK Schools of Pharmacy and the profession will need to work more closely with other 
healthcare professionals, as well as with various public health organisations, such as Public 
Health England, the Faculty of Public Health, etc. (social influences - team working), in order 
to enhance the public health role of community pharmacists in the UK. 
However, the application of the theoretical domains framework (TDF) (Michie, et al. 2005), 
in this project revealed that the majority of UK community pharmacists have a positive 
attitude towards enhancing their public health role, in terms of their perceived advantages 
and disadvantages of enhancing their public health role. In terms of knowledge and skills, 
my content analysis of the curricula of UK Schools of Pharmacy revealed that the public 
health knowledge and skills provided to students during the undergraduate pharmacy 
training were inadequate for the kind of role expected of them later as pharmacists, 
particularly as it relates to providing macro-level public health activities. Still, there were a 
number of challenges regarding the social/professional role and identity of pharmacists, as 
well as pharmacists’ beliefs about their capabilities - especially as it concerns self-efficacy 
and empowerment.  
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Their subjective norm (social pressure against engaging in public health) was variable, and 
their perceived behavioural control, low. While, there seems to be a need for motivation 
and goal setting pharmacists, to enable them to engage more with public health activities, 
any anticipated progress is likely to be hampered, particularly if social influences (Norms) 
and environmental constraints identified in the study are not tackled adequately. Yet, the 
perceived behavioural control was low because the perceived barriers associated with the 
public health role of community pharmacists outweighed the perceived facilitators. On the 
other hand, managing emotions associated with stress, fear and anxiety in the public health 
role and enhancing behavioural regulation, will enable pharmacists enhance their role in 
public health.  
Based on the application of the theoretical domains framework, it seems logical for me to 
argue that, based on the evidence from my project the intention of UK community 
pharmacists to enhance their public health role (behaviour) cannot be achieved unless their 
subjective norm (social influences or pressure) is reduced and their perceived behavioural 
control increased significantly. It is possible to enhance pharmacists’ perceived control 
(beliefs about capabilities) by reducing the perceived barriers, and enhancing the perceived 
facilitators. In order to enhance the role of pharmacists in public health, there is therefore a 
need to enhance students’/pharmacists’ knowledge and skills in public health; enhance their 
social/professional role and identity; enhance their beliefs about capabilities; manage their 
beliefs about consequences; enhance their intentions to engage in public health activities; as 
well as enhance their ability to maximise memory, attention and decision processes in 
practice. In addition, there is also a need to minimise some of the identified environmental 
constraints, adverse social influences (Norms) and negative emotions associated with the 
public health role; as well as, enhance pharmacists’ ability to manage favourably their 
behavioural regulations.     
5.3 - Implications of my Project Findings for UK Pharmacy Schools’ Curricula and Public 
Health Policy 
The implications of my project findings for UK pharmacy schools’ curricula and public health 
policy are huge. Regarding UK pharmacy schools’ curricula, there is a need to adapt their 
science content to reflect real practice as well as enhance their public health content, 
particularly as it concerns public health skills and knowledge in macro-level activities. At the 
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same time, it seems that UK pharmacy schools integrating their undergraduate training with 
other healthcare students, (team working), as well as teaching the use of new technologies 
and social media in practice, will enhance knowledge and skills of students and at the same 
time, prepare students and later graduates to engage more with public health activities. 
Moreover, there is a need to teach advanced communication techniques to students, which 
will further enhance their skills in public health, with pharmacy schools also enhancing 
students’ knowledge and skills in public health by providing advanced experience in public 
health. 
As regards public health policy, which can also help shape behavioural regulation of 
pharmacists, there is a need to minimise, among other things, the shopkeeper image often 
associated with community pharmacists. This can be achieved, for example, by enhancing 
the community pharmacy environment (minimising environmental constraints), motivating 
pharmacists adequately (enhancing intentions) by remunerating them directly for providing 
public health services (reinforcement), reducing the high stress level (negative emotion) 
often associated with community pharmacy practice and empowering Independent 
Pharmacist Practitioners to promote Healthy Living Pharmacies. Policy-makers must also 
continue to encourage team working by enabling pharmacists to work closely with other 
healthcare professionals in non-traditional places such as in GP practices, NHS 111 call 
centres, A&E departments, etc., as well as developing professional identity for pharmacists 
by enhancing professionalism in pharmacy practice. Awareness of the demographic 
differences of community pharmacists, in terms of gender, age, years of qualification, role of 
the pharmacist and location of practice, might help formulate the appropriate policies to 
enhance the role of UK community pharmacists in public health. Due to some of these 
complexities, it seems reasonable to develop students’ interest in advanced public health 
roles during undergraduate pharmacy education. 
5.4 - Conclusion 
There are numerous opportunities in public health for community pharmacists (Bjorkman, 
et al. 2008; DoH 2010a, 2010c). I used the theoretical domains framework (TDF) (Michie, et 
al. 2005) throughout in this project. It revealed that the majority of UK community 
pharmacists have a positive attitude towards enhancing their public health role. My project 
however confirmed that UK community pharmacy public health practice is still operating at 
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a basic level (Anderson 1998; Anderson and Blenkinsopp 2003; Agomo 2012a). While the UK 
pharmacy profession is gradually evolving from product-orientated to patient-centred care, 
with pharmacists now contributing to micro-level public health activities, there however 
remains an unmet need for pharmacists in macro-level public health functions (Truong and 
Patterson 2010). To achieve this desired objective, both in the UK and globally, there will be 
a need to enhance, among several matters discussed in this project, both the undergraduate 
and the postgraduate public health (including clinical pharmacy) (Robinson 2015b) training 
and skills of pharmacists and the career structure of community pharmacists. In addition, 
there will also be a need to enable the development of a mixed market in community 
pharmacy practice, encouraging pharmacists to be employed in GP practices, as well as the 
government contracting public health services directly to individual or group pharmacists. 
Pharmacists should also be encouraged to use newer technologies (Robinson 2015b), 
including social media, to enhance their public health practice. 
The tests for significance indicated that there were a number of significant differences in the 
way respondents answered some of the questions, in terms of gender, age, role in the 
pharmacy and location of practice (p < .05). In some instances, the effective size magnitude 
of these differences (Eta squared, η2, with Anova), were ‘large’ (0.14) (Nandy 2012). In 
addition, a number of these variables were significantly correlated (p < .05). There is 
therefore a need to put these differences into consideration when policies around the role 
of community pharmacists in public health are developed. 
5.4.1 - Recommendations for Further Studies 
My project identified strategies for enhancing the public health role of community 
pharmacists based on the findings of my review of the literature and information as well as 
on the perspectives of community pharmacists and healthcare professionals. I could have 
made my findings more illuminating by exploring the perspectives of healthcare users. In my 
survey of community pharmacists, I found that the majority of my respondents were less 
enthusiastic about UK Schools of Pharmacy offering dual MPharm (or even PharmD)/MPH 
degrees and community pharmacies adopting new technologies and social media in 
practice. None of my interview participants highlighted the need for a dual degree in the UK. 
On the use of new technologies and social media, my older interview participants were less 
interested in their use in community pharmacy practice. I might be a need for further 
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research in these areas, to identify how these could help enhance the public health role of 
community pharmacists in the UK. 
5.4.2 - Limitations  
There were several limitations in my project, some of which included my preconceptions 
about the findings (Weiss 1994), having done a great deal of work previously related to this 
project. I was also concerned that some of the issues raised in my interviews with 
healthcare professionals might be a reflection of interviewees’ pressing concerns at the time 
of the data collection (Cotter and Mckee 1997). Again, my pre-knowledge of some of the 
respondents may also have affected both the issues raised (Anderson 1998) and the 
respondents' willingness to share certain views (De Young 1996). For my survey of UK 
community pharmacists, the response rate was very low (23.28%). However, low response 
rates are not uncommon for health surveys (Cook, et al. 2009; Cline 2011; DiPietro, et al. 
2011). A major contributing factor for the low response rate might have been the length of 
my survey questionnaire, which listed 63 items (including free text options). However, the 
length of my questionnaire was important, as my project aimed at confirming or refuting 
themes I identified in my review of knowledge and information (Agomo and Ogunleye 
2014), at the same time enabling my project to uncover other strategies needed to enhance 
the public health role of community pharmacists in the UK. In addition, the fact that I did 
not have multiple contacts with respondents or offer any financial incentives might have 
negatively affected my survey response rate (Dillman 2000). However, the poor response 
rate recorded in this study could also be a reflection of how disengaged UK community 
pharmacists are with the profession. Often, past RPS elections have reflected this (Madlom 
2013; Cartwright 2015). 
For my content analysis and interviews, creating categories was challenging - empirically 
and conceptually, with the credibility of the research finding depending on how well the 
categories covered the data (Graneheim and Lundman 2004). Other limitations were the 
sheer quantity of the data I analysed, which was both daunting and overwhelming (Elo and 
Kyngäs 2008). Moreover, the fact that some of my categories were obtained from the very 
material I analysed might have limited the generalisability of my findings (Krippendorff 
1989). 
 195 
 
However, I tried to enhance the reliability of my analysis by showing how well the results 
were linked with my data (Polit and Beck 2004), describing clearly the context, selection and 
characteristics of my participants, as well as my process of data collection and analysis 
(Graneheim and Lundman 2004). I tried also to enhance the trustworthiness of my analysis 
through authentic citations that indicated to readers from where or from what kinds of 
original data my categories were contrived (Patton 1990; Sandelowski 1993). I maintained 
confidentiality throughout by ensuring that informants were not identified by quotes from 
the data (Ford and Reutter 1990). 
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Chapter 6 – A Reflexive Account of my Personal Learning and 
Professional Journey 
 
Reflecting on my ontology, values such as ethics (Fox, et al. 2007), accountability, hard work 
and perseverance are my guide. Although I am able to locate the source of my values mainly 
from my Christian and cultural upbringing, over the years my values have been influenced 
by both my formal and informal education and my empathy for the unwell. In my role as a 
community pharmacist, I strive to ensure that my values do not influence adversely the 
services I provide to the public. This is in line with the General Pharmaceutical Council's 
standards of conduct, ethics and performance that stipulate the behaviours, attitude and 
values expected of pharmaceutical professionals (GPhC 2012). Guiding these behaviours, 
attitude and values are the seven principles set out by GPhC. They include ensuring that 
patients are my first concern; using professional judgement in the interest of patients and 
the public; showing respect to others; encouraging patients and the public to participate in 
decisions about their care; developing my professional knowledge and competence; being 
honest and trustworthy; and taking responsibility for my working practices. 
However, I acknowledge that there are times when I find myself struggling with the GPhC’s 
principles, for example, in situations where patients or customers expect special treatments 
from me based on racial commonality. A good example would be when African visitors to 
the UK, asks for a prescription-only medicine (POM) without a doctor’s prescription (a 
practice that is normal in many third world countries). Many of these patients or customers 
are shocked and disappointed when I explain to them that I am not able to honour their 
demands. Again, I have found myself falling back on my values as a support when 
confronted with practice situations such as the provision of oral contraceptives to under-
aged girls (less than 16 years old) from the community pharmacy. What shaped my 
reluctance to engage in this service were not just by my religious or cultural considerations, 
but also by my belief that the provision of oral contraceptives to under-aged girls is best left 
in the hands of other healthcare professionals such as doctors and nurses, due to their 
situatedness to manage any accompanying social fallouts. These notwithstanding, living and 
working in the UK and experiencing a practice that is hugely different from what I 
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experienced in Nigeria (in terms of advanced practice), has also changed my practice and 
influenced my values in a positive way. 
In the Review of Learning (DPS 4520), I reflected on my role as an intern pharmacist in 
Nigeria, where I helped develop a clinical pharmacy forum for the pharmacy department at 
the Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife. In addition, I reflected 
on my role in Nigeria as a pharmacist and a medical representative, as well as my role in the 
UK as a community pharmacist, pharmaceutical writer, postgraduate student and teacher-
practitioner. Through my role as a medical representative and my study for the 
postgraduate diploma in marketing, I have been able to enhance my problem solving, 
communication, marketing, leadership and managerial skills. As a former pre-registration 
tutor and a current mentor, I have come to realise how much I love developing and 
supporting younger colleagues to become confident and successful practitioners. This desire 
to impact and share knowledge with colleagues also became the main motivating factor for 
my involvement in publications and teaching. 
On completion of the ‘Management and Decision-Making’ module of the MSc in Health 
Sciences, I was able to broaden my understanding, at a strategic level, of management 
practice and its impact on the provision of health care in the UK. Initially, I was not sure how 
the skills I developed during my medical representative role and the postgraduate studies 
linked to my later role in the UK as community pharmacist. However, as I reflected on my 
entire studies and career experiences, in my Review of Learning, I became aware of their 
connections and the fact that I am constantly using this learning in practice, particularly as it 
relates to engaging community pharmacy customers in public health services. These 
learnings have enabled me to develop transferable skills, many of which I have used in my 
project. Although these roles have helped in strengthening my leadership, management, 
marketing, communication and problem-solving skills, their impact in furthering my interest 
in the public health role of community pharmacists has been most illuminating. 
Also, in my RAL 7 claim for research and development project capability, I showed how my 
MSc in Health Sciences dissertation 'The current provision of smoking cessation services by 
community pharmacists in an inner-city area’ and my service-focused study at King's 
College, London, ‘The role of community pharmacists in public health’ helped develop my 
understanding of and my research capability in public health. Writing up the findings of both 
 198 
 
studies, as well as the findings of my review of knowledge and information for publication 
enabled me to develop other skills as well that included, collaboration and learning how to 
deal with comments from co-authors, peer reviewers and the editor. Publishing these 
studies also enabled me to develop lasting relationships with the publishers and co-authors. 
At the same time, I learnt how to critically assess research papers in professional journals, 
conduct research by employing appropriate methods of study design and tackle statistical 
analyses. Not only have I used these knowledge and skills in my project; they have also 
enabled me to become a member of the review panel for the Journal of Pharmaceutical 
Health Services Research (JPHSR).  
Developing my project proposal was a challenging but interesting process, which has 
enabled me to reflect on my professional and academic experiences and how these 
experiences could be used in my project on strategies enhancing the public health role of 
community pharmacists in the UK. Developing my project proposal and then conducting the 
actual project enabled me to fully appreciate my role as an insider-practitioner-researcher, 
and how this understanding can help me complete a project that was viable and coherent. I 
learnt that for my project to be viable, I needed to address both the quantitative and 
qualitative aspects, and by combining post-positivist and constructivist paradigms, the 
project would deliver results that are more meaningful. By using a mixed methods approach 
that incorporated both quantitative and qualitative elements, it was possible for me to 
create a significantly more coherent project which both analysed the past and developed 
solutions for the future in a sufficiently robust manner to represent a piece of work to be 
assessed at doctoral level. 
Conducting my project proposal has also enabled me to learn about the importance of a 
multi-disciplinary public health workforce for handling the main causes of ill health (DoH 
1999, 2010a). In this multi-disciplinary initiative, community pharmacists are expected to 
play greater roles than was previously the case (DoH 2010a; AFPC/ADPC 2010). Hence, in 
undertaking my project, I have also learnt about the health statistics of the UK (DoH 2010a). 
This information has helped me to appreciate better the importance of my project. 
Supporting my project is my role as a change agent. I have learnt that a change agent is a 
person who facilitates planned change or planned innovation (Havelock 1973). Change 
agents do not necessarily have the answers to problems, but they are usually dissatisfied 
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with things the way they are. By making their dissatisfaction known and by upsetting the 
“status quo”, they energise the problem-solving process, and hence get things started 
(Havelock 1973). Therefore, by conducting my project as an insider-practitioner-researcher, 
I was able to bring to the forefront my role as a change agent. 
By completing this project, I have also learnt more about my ontological position, and 
guided mainly by values such as ethics, accountability, hard work and perseverance. This 
project has also helped me to learn about the different definitions of public health and the 
determinants of health. At the same time, I have learnt how to tackle the various aspects of 
my project, such as the literature review; aims, objectives and outcomes; project design and 
methodologies; data collection, storage and analysis with online tools and software such as, 
Skype HD Call Recorder, NVivo and SPSS; in-depth interviews; justification of methodology; 
application of theory (TDF) to research; and how to deal with issues such as ethical 
considerations, project timescale, resources and the dissemination of findings in journals 
and conferences. 
I have published three papers based on my project findings. (Agomo, et al. 2016a, 2016b, 
2016c). Two other papers based on my content analysis of the curricula of UK pharmacy 
schools and my interviews will follow shortly.  
 
Word count: 64,162. 
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Appendices 
Appendix 1: Cronbach’s Alpha Reliability Test 
 
Item-Total Statistics 
 Scale 
Mean if 
Item 
Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if 
Item 
Deleted 
Sex of participant 183.5366 235.955 .183 .786 
Age of participant 182.1707 246.495 -.222 .802 
Year of qualification 182.2195 246.226 -.223 .801 
Respondent's role in pharmacy 182.1463 229.778 .137 .789 
Offering OTC advice? 183.8780 238.710 .043 .787 
Participating in local authority-run scheme? 183.7317 237.301 .127 .786 
Collaborating in shared care scheme? 183.2439 236.389 .157 .786 
Is programme fully funded by local authority? 183.6341 235.488 .236 .785 
Increase PH content of undergraduate curriculum? 181.0244 227.874 .353 .780 
Offer dual MPharm (or even PharmD)/MPH degrees? 181.8049 231.211 .172 .786 
Pharmacy students training with other HC students? 181.0000 222.550 .479 .776 
Pharmacists working closely with HC practitioners? 180.5122 230.256 .469 .780 
Teach advanced communication techniques? 180.6585 231.930 .376 .782 
Adopt new technologies and social media? 181.7317 229.001 .228 .784 
Develop good adherence strategies for patients? 180.6585 233.880 .201 .785 
Enhancing role in antimicrobial resistance? 180.6098 230.844 .315 .782 
Enhance patients' self-management capacities? 180.6585 227.730 .482 .778 
Enhance safe medication disposal methods? 180.9512 230.548 .303 .782 
Enhance the management of polypharmacy? 180.4146 230.999 .418 .781 
Managing the medication needs of athletes? 181.0976 227.990 .373 .780 
Reliability Statistics 
Cronbach's 
Alpha 
N of Items 
.787 56 
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Enhancing involvement in smoking cessation? 180.5854 234.399 .171 .785 
Providing students with advanced experience in PH? 180.7317 227.901 .395 .780 
Providing pharmacists with advanced experience in 
PH? 
180.8537 230.128 .368 .781 
Remunerate pharmacists directly for PH services? 180.5122 227.206 .423 .779 
Insufficient training of pharmacists in PH? 181.2439 231.789 .180 .785 
Insufficient skill of pharmacists in PH? 181.6829 224.672 .351 .779 
Lack of professional autonomy for pharmacists? 181.0976 223.590 .410 .778 
Difficulties in recruiting patients? 181.7073 225.862 .295 .782 
Lack of demand for public health services? 182.3902 228.794 .238 .784 
High drop rates for public health services? 181.7073 224.662 .354 .779 
Low success rates for public health services? 182.0976 224.040 .357 .779 
Lack of input from public health practitioners? 181.0244 229.024 .302 .782 
Lack of support from public health practitioners? 180.8780 229.460 .315 .782 
Difficulty in communicating with other PH providers? 181.3902 227.444 .296 .782 
Lack of support from GPs? 180.8293 230.495 .327 .782 
Insufficient funding from the government? 180.8537 236.278 .046 .790 
Difficulty in fee collection? 181.7317 227.001 .251 .783 
Time pressure and workload? 180.6341 230.938 .230 .784 
Safety concerns among pharmacists? 181.6585 226.580 .309 .781 
Safety concerns by GPs? 181.8537 230.028 .246 .783 
Safety concerns of patients? 182.3902 229.794 .238 .784 
Lack of patients' records? 180.9024 226.040 .338 .780 
Lack of documentation of interventions? 181.6585 232.580 .166 .786 
Physical design of community pharmacies? 181.8293 234.045 .089 .789 
Misperception that counselling is not needed? 181.7317 223.901 .349 .779 
Lack of instrumentation? 181.3902 235.494 .135 .786 
Language barrier? 182.3415 234.880 .076 .789 
Lack of understanding by the public? 181.2195 227.876 .320 .781 
Lack of understanding by HC providers? 181.0000 235.200 .162 .786 
How essential CPs provide PH services? 183.2927 235.262 .123 .787 
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PH role of CPs is still underdeveloped? 183.8049 239.761 -.098 .789 
Pharmacies employing their own PH advisers? 181.9268 226.970 .307 .781 
Devolve all work to PH practitioners? 182.7073 235.562 .067 .789 
Pharmacists reaching out to public places? 181.2195 236.476 .044 .790 
Community pharmacies developing into HLPs? 180.6098 236.744 .083 .787 
Pharmacists developing their own expertise? 180.4634 234.955 .171 .785 
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Appendix 2:  DProf Project Questionnaire  
            
   Ref number:  
'Identifying strategies than can enhance the public health role of community pharmacists in 
the UK.'  
Please tick boxes or provide answers as appropriate.  
1. How would you describe your gender? Female?  Male?   
2. Which of these age groups best represent your age?  
  [20-29]  [30-39]  [40-49]  [50-59]  [60-69]  [70-79]  [80 and over]  
3. Please state the year in which you qualified as a pharmacist …………………  
4. Which of the following best describes your role in pharmacy?  
 A pharmacy contractor?  A pharmacy manager?   
 Relief pharmacist?  Locum pharmacist?  Pharmacist?  Superintendent Pharmacist?   
 Pharmacy contractor/Supt. pharmacist?   
 Other …………………….  
5. Your involvement in public health services, is it in the form of:  
 (a) Offering over-the-counter advice? Yes  No   
 (b) Participating in a local authority-run scheme (e.g. NRT) for pharmacists? Yes  No   
 (c) Collaborating with a local practice in a shared care kind of scheme? Yes  No   
6. Is the public health programme you are involved in funded by your local authority? Yes  No   
7. If not funded by your local authority, who is funding it? ………………………………………  
8. The following have been identified as possible ways in which the public health role of 
community pharmacists could be enhanced in the UK. Please indicate your level of agreement 
with each of the following statements.  
 (a) Change the UK undergraduate pharmacy curriculum to increase its public health 
 content?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree                                                                              
(b) Change the UK undergraduate pharmacy curriculum to allow UK pharmacy schools to offer 
dual MPharm (or even PharmD)/MPH degrees?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(c) Pharmacy students training closely with other healthcare students?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(d) Pharmacy graduates working closely with other healthcare providers (for example GPs and 
nurses)?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(e) Teach content-specific/advanced communication techniques to undergraduate pharmacy 
students and pharmacists?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
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(f) Adopt new technologies, including social media (e.g. Facebook, Skype, Twitter, etc.) in 
practice?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(g) Develop good adherence strategies for patients?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(h) Enhance the role of pharmacists in preventing the spread of infections as well as managing 
antimicrobial resistance?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(i) Pharmacists engaging in programmes that can enhance patients’ self-management 
capacities?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(j) Enhance the safe medication disposal methods by pharmacists?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(k) Pharmacists enhancing their management of polypharmacy and long-term conditions?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree   
(l) Pharmacists managing legitimate medication needs of athletes to prevent them from 
accidentally using a banned substance?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(m) Pharmacists enhancing their involvement in smoking cessation activities?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(n) Provide pharmacy students with advanced pharmacy practice experience in public health?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(o) Provide pharmacists with advanced pharmacy practice experience in public health?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(p) Develop funding arrangements that allow employee pharmacists to be remunerated directly 
for providing public health services?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
9. The following have been identified as the major barriers to enhancing the public health role of 
community pharmacists in the UK. Please indicate your level of agreement with each of the 
following questions.  
(a) Insufficient training of pharmacists in public health?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(b) Insufficient skills of pharmacists in public health?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(c) Lack of professional autonomy and control for pharmacists for the jobs they do?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(d) Difficulties in recruiting patients for public health services?  
 228 
 
 Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree    
(e) Lack of demand for public health services?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(f) High dropout rates from community pharmacies for public health services (e.g. NRT, obesity 
management, etc.)?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(g) Low success rates of community pharmacy for public health services (e.g. NRT, obesity 
management, etc.)?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(h) Lack of input from public health practitioners and relevant stakeholders?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(i) Lack of support from public health practitioners and relevant stakeholders?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(j) Difficulty in communicating with other public health providers?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(k) Lack of support from GPs?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(l) Insufficient funding from the government for public health services?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(m) Difficulty in fee collection from funding authorities?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(n) Time pressure and workload?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(o) Safety concerns among pharmacists?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(p) Safety concerns of GPs?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(q) Safety concerns of patients?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(r) Lack of availability of patient records? 
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 Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(s) Lack of documentation of interventions?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(t) Physical design of community pharmacies?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(u) Misperception that counselling is not needed by pharmacists?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(v) Lack of instrumentation (technics and apparatuses) for community pharmacy public health 
practice?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(w) Language barrier between pharmacists and patients/carers?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(x) Underutilisation due to the lack of understanding of the training and skill-sets of pharmacists 
by the public?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(y) Underutilisation due to the lack of understanding of the training and skill-sets of pharmacists 
by other healthcare providers?  
  Disagree Strongly Disagree Neither agree nor disagree Agree Strongly Agree  
(z) Other (please state) …………………………………………  
------------------------------------  
------------------------------------  
10. What in your view can be done to overcome these difficulties?  
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………  
……………………………………………………………………………………………………………………………  
11. In your opinion how essential is it that patients get public health services from community 
pharmacies?  
  Very Essential  Essential  Quite Essential  Sometimes  Not at all essential  
12. What in your view are the positive aspects/successes of public health services from 
community pharmacies and how can they be strengthened?  
……………………………………………………………………………………………. 
….…………………………………………………………………………………………  
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13. What in your view are the negative aspects of public health services from community 
pharmacies and how can they be improved?  
……………………………………………………………………………………………. 
….…………………………………………………………………………………………  
14. Do you agree with the statement ‘that the public health role of community pharmacists in 
UK is still undeveloped in the 21st century?’  
 Yes  No   
15. If yes, please briefly state your reasons  
………………………………………………………………………………………………………………………  
………………………………………………………………………………………………………………………  
16. The following are some of the suggestions for how community pharmacy-based public 
health services could be developed in the future. Please indicate your level of agreement with 
each of the following questions.  
(a) Pharmacists employing their own public health advisers, based in the pharmacy?  
  Disagree  Strongly Disagree  Neither agree nor disagree  Agree  Strongly Agree  
(b) Devolve all such work to non-pharmacy-based public health practitioners?  
  Disagree  Strongly Disagree  Neither agree nor disagree  Agree  Strongly Agree  
 
(c) Reaching out to the community and running public health programmes in libraries or other 
community meeting places?  
  Disagree  Strongly Disagree  Neither agree nor disagree  Agree  Strongly Agree  
(d) Community pharmacies developing into Healthy Living Pharmacies?  
  Disagree  Strongly Disagree  Neither agree nor disagree  Agree  Strongly Agree  
(e) Pharmacists developing their own expertise?  
  Disagree  Strongly Disagree  Neither agree nor disagree  Agree  Strongly Agree  
(f) Other? (please state briefly) ……………..…………………………………………  
END.  
Thank you for completing the questionnaire. 
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Appendix 3:  Covering letter  
Mr. Chijioke O. Agomo. 
DProf. Student (Part 2), 
Institute of Work Based Learning, 
Middlesex University (Hendon Campus),  
London. 
Tel. 07576975753 
01/04/2013 
Dear Pharmacist, 
Identifying strategies that can enhance the public health role of community pharmacists in 
the UK (excluding Northern Ireland). 
 
Mr. C. O. Agomo is a part 2, DProf student at the Institute of Work Based Learning, 
Middlesex University (Hendon Campus), London. As part of his doctorate research project, 
we are conducting a survey to identify strategies that can enhance the public health role of 
community pharmacists in the UK. This project is under the guidance of Dr. James Ogunleye, 
(academic adviser) and Prof. Jane Portlock (academic consultant). 
We are seeking your assistance with the following questionnaire, which will require 
approximately 20 minutes to complete. Your response to this survey is crucial in providing 
the necessary information to formulate strategies that can enhance the public health role of 
community pharmacists in the UK. If you choose to participate in this project, please answer 
all questions as honestly as possible and return the completed questionnaires promptly. 
Your anonymity and confidentiality is guaranteed, and you may refuse to participate at any 
time. 
Please feel free to include any additional comments you consider necessary or relevant to 
enhancing the public health role of community pharmacists in the UK. Your response and 
time is greatly appreciated. Thank you! 
 
Sincerely, 
 
 
Mr. C. O. Agomo, MRPharmS, MSc. (student). 
 
 
Dr. James Ogunleye (academic adviser). 
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Appendix 4: DProf Project Interview Guide – Strategies enhancing the public health 
role of community pharmacists in the UK  
 
1. What can be done to enhance the public health role of community 
pharmacists in the UK? 
Prompt: any benefits or barriers?   
Prompt: do you see any role for Independent Pharmacist Practitioners? 
2.  What is your view on the use of new technologies to enhance the public 
health role of community pharmacists in the UK? 
Prompt: any suggestions on such technologies? 
3. What is your view on UK pharmacy schools teaching the use of new 
technologies in pharmacy/public health practice? 
Prompt: how would this benefit the public health role of community 
pharmacists in the UK? 
4. What are your thoughts on the teaching of communication methods to UK 
pharmacy students/pharmacists?  
Prompt: how would this benefit the public health role of community 
pharmacists in the UK? 
5.  What are your thoughts on pharmacy students being educated with other 
healthcare students?  
Prompt: e.g. medical and nursing students? 
Prompt: how would this benefit the public health role of community 
pharmacists in the UK? 
6.  What are your views on pharmacists working closely with other healthcare 
providers?  
Prompt: e.g. GPs, nurses and public health practitioners? 
Prompt: how would this benefit the public health role of community 
 pharmacists in the UK? 
7.  What are your thoughts on changing the UK undergraduate pharmacy 
curriculum to increase its public health content? 
8.  Any other comments/suggestions on enhancing the public health role of 
community pharmacists in the UK?
 233 
 
 
Appendix 5a - Means Table by Gender 
Report 
Gender of participant Offering O-T-C 
advice? 
Participating 
in local 
authority 
run scheme? 
Collaborating 
in shared care 
scheme? 
Is programme 
fully funded 
by local 
authority? 
Increase PH 
content of 
undergraduate 
curriculum? 
Offer dual 
MPharm (or 
even 
PharmD)/MPH 
degrees? 
Pharmacy 
students 
training with 
other HC 
students? 
Pharmacists 
working 
closely with 
HC 
practitioners? 
Teach 
advanced 
communicatio
n techniques? 
Male 
Mean 1.0000 1.1667 1.7353 1.1892 3.6923 3.4359 4.0270 4.3158 4.0000 
N 39 36 34 37 39 39 37 38 38 
Std. 
Deviation 
.00000 .37796 .44781 .39706 .76619 .94018 .44011 .52532 .73521 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
Female 
Mean 1.0208 1.2857 1.6122 1.1389 3.6939 2.8980 3.6735 4.0816 3.9796 
N 48 49 49 36 49 49 49 49 49 
Std. 
Deviation 
.14434 .45644 .49229 .35074 .89452 1.10387 1.14360 .88593 .77701 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
Total 
Mean 1.0115 1.2353 1.6627 1.1644 3.6932 3.1364 3.8256 4.1839 3.9885 
N 87 85 83 73 88 88 86 87 87 
Std. 
Deviation 
.10721 .42670 .47568 .37319 .83539 1.06330 .92281 .75527 .75474 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
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Appendix 5b - Means Table by Gender contd. 
 
Report 
Gender of participant Adopt new 
technologie
s and the 
social 
media? 
Develop good 
adherence 
strategies for 
patients? 
Enhancing role 
in 
antimicrobial 
resistance? 
Enhance 
patients' self-
managt 
capacities? 
Enhance safe 
medication 
disposal 
methods? 
Enhance the 
management of 
polypharmacy? 
Managing 
the 
medication 
needs of 
athletes? 
Enhancing 
involvement 
in smoking 
cessation? 
Providing 
students with 
advanced 
experience in 
PH? 
Male 
Mean 3.3333 4.1053 4.0000 4.3590 4.0000 4.2821 3.9487 4.1282 4.1053 
N 39 38 39 39 39 39 39 39 38 
Std. 
Deviation 
1.10818 .50881 .68825 .58432 1.00000 .64680 .72361 .86388 .79829 
Median 3.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Female 
Mean 2.8980 3.9796 3.8776 4.0408 3.7347 4.1224 3.6875 3.8980 4.0408 
N 49 49 49 49 49 49 48 49 49 
Std. 
Deviation 
1.27875 .52001 .85714 .57588 .93040 .83248 .92613 1.00509 .57588 
Median 3.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Total 
Mean 3.0909 4.0345 3.9318 4.1818 3.8523 4.1932 3.8046 4.0000 4.0690 
N 88 87 88 88 88 88 87 88 87 
Std. 
Deviation 
1.21897 .51598 .78485 .59780 .96537 .75594 .84687 .94686 .67846 
Median 3.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
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Appendix 5c - Means Table by Gender contd. 
Report 
Gender of participant Providing 
pharmacists 
with 
advanced 
experience 
in PH? 
Remunerate 
pharmacists 
directly for PH 
services? 
Insufficient 
training of 
pharmacists in 
PH? 
Insufficient 
skill of 
pharmacists in 
PH? 
Lack of 
professional 
autonomy for 
pharmacists? 
Difficulties in 
recruiting 
patients? 
Lack of 
demand for 
public 
health 
services? 
High drop 
rates for 
public health 
services? 
Low success 
rates for 
public health 
services? 
Male 
Mean 4.0769 4.3333 3.6667 2.8718 3.5128 3.6410 2.3333 3.1538 2.6923 
N 39 39 39 39 39 39 39 39 39 
Std. 
Deviation 
.77407 .77233 .95513 1.19603 1.18925 1.15820 1.17727 .98778 1.10391 
Median 4.0000 4.0000 4.0000 3.0000 4.0000 4.0000 2.0000 3.0000 3.0000 
Female 
Mean 4.1429 4.1837 3.2449 3.1837 3.7959 3.4082 2.6531 3.3878 2.5833 
N 49 49 49 49 49 49 49 49 48 
Std. 
Deviation 
.54006 .83350 1.34676 1.30182 .93496 1.24027 1.23408 1.09576 1.30194 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 4.0000 3.0000 
Total 
Mean 4.1136 4.2500 3.4318 3.0455 3.6705 3.5114 2.5114 3.2841 2.6322 
N 88 88 88 88 88 88 88 88 87 
Std. 
Deviation 
.65094 .80587 1.20149 1.25862 1.05832 1.20339 1.21290 1.04989 1.21152 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 
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Appendix 5d - Means Table by Gender contd. 
Report 
Gender of participant Lack of 
input from 
public 
health 
practitioner
s? 
Lack of 
support from 
public health 
practitioners? 
Difficulty in 
communicating 
with other PH 
providers? 
Lack of 
support 
from GPs? 
Insufficient 
funding from 
the 
government? 
Difficulty in fee 
collection? 
Time 
pressure 
and 
workload? 
Safety 
concerns 
among 
pharmacists? 
Safety 
concerns by 
GPs? 
Male 
Mean 3.5897 3.7027 3.6410 3.7692 4.3590 3.4359 4.1795 3.2308 2.6410 
N 39 37 39 39 39 39 39 39 39 
Std. 
Deviation 
.99255 .90875 1.08790 1.20222 .84253 1.11909 1.02268 1.34676 1.34726 
Median 4.0000 4.0000 4.0000 4.0000 5.0000 4.0000 4.0000 4.0000 3.0000 
Female 
Mean 3.5918 3.3469 3.5000 3.4898 3.6735 3.1837 4.5714 3.1837 2.7143 
N 49 49 48 49 49 49 49 49 49 
Std. 
Deviation 
1.05906 1.28373 1.14854 1.22683 1.34455 1.21918 .61237 1.21918 1.32288 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 
Total 
Mean 3.5909 3.5000 3.5632 3.6136 3.9773 3.2955 4.3977 3.2045 2.6818 
N 88 86 87 88 88 88 88 88 88 
Std. 
Deviation 
1.02426 1.14532 1.11753 1.21704 1.19364 1.17600 .83789 1.26998 1.32652 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 
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Appendix 5e - Means Table by Gender contd. 
Report 
Gender of participant Safety 
concerns 
of 
patients? 
Lack of 
patients' 
records? 
Lack of 
documentation 
of 
interventions? 
Physical 
design of 
community 
pharmacies? 
Misperception 
that 
counselling is 
not needed? 
Lack of 
instrumentation? 
Language 
barrier? 
Lack of 
understanding 
by the public? 
Lack of 
understanding 
by HC 
providers? 
Male 
Mean 2.2308 3.7436 3.4211 2.8462 2.8718 3.1282 2.2821 3.6486 3.6216 
N 39 39 38 39 39 39 39 37 37 
Std. 
Deviation 
1.32708 1.11728 1.10604 1.38675 1.30141 1.34124 1.25549 1.13569 1.08912 
Median 2.0000 4.0000 4.0000 3.0000 3.0000 4.0000 2.0000 4.0000 4.0000 
Female 
Mean 2.2449 4.0000 3.1837 2.8980 3.1429 3.4082 2.2708 3.7551 3.6042 
N 49 49 49 49 49 49 48 49 48 
Std. 
Deviation 
1.21673 .95743 1.25289 1.41782 1.52753 1.07855 1.37979 1.14620 1.21585 
Median 2.0000 4.0000 3.0000 3.0000 4.0000 4.0000 2.0000 4.0000 4.0000 
Total 
Mean 2.2386 3.8864 3.2874 2.8750 3.0227 3.2841 2.2759 3.7093 3.6118 
N 88 88 87 88 88 88 87 86 85 
Std. 
Deviation 
1.25940 1.03315 1.19015 1.39632 1.43019 1.20295 1.31794 1.13621 1.15567 
Median 2.0000 4.0000 4.0000 3.0000 3.0000 4.0000 2.0000 4.0000 4.0000 
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Appendix 5f - Means Table by Gender contd. 
Report 
Gender of participant How 
essential 
CPs provide 
PH services? 
The PH role of CPs 
is still 
underdeveloped? 
Pharmacies 
employing 
their own 
PH advisers? 
Devolve all 
work to PH 
practitioners? 
Pharmacists 
reaching out 
to public 
places? 
Community 
pharmacies 
developing 
into HLPs? 
Pharmacists 
developing 
their own 
expertise? 
Location 
Male 
Mean 1.6923 1.1053 2.9487 2.2051 3.0769 3.9231 4.1538 1.9444 
N 39 38 39 39 39 39 39 36 
Std. 
Deviation 
.83205 .31101 1.37551 1.19603 1.28523 .98367 .70854 .86005 
Median 1.0000 1.0000 3.0000 2.0000 3.0000 4.0000 4.0000 2.0000 
Female 
Mean 2.2083 1.2174 2.7174 1.8261 3.3261 3.7045 4.0222 2.1224 
N 48 46 46 46 46 44 45 49 
Std. 
Deviation 
1.16616 .41703 1.27651 1.06049 1.21206 1.02480 .86573 .75368 
Median 2.0000 1.0000 3.0000 1.0000 4.0000 4.0000 4.0000 2.0000 
Total 
Mean 1.9770 1.1667 2.8235 2.0000 3.2118 3.8072 4.0833 2.0471 
N 87 84 85 85 85 83 84 85 
Std. 
Deviation 
1.05629 .37492 1.31996 1.13389 1.24493 1.00557 .79469 .80039 
Median 2.0000 1.0000 3.0000 2.0000 4.0000 4.0000 4.0000 2.0000 
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Appendix 6 - Anova Table by Gender 
ANOVA Table 
 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Offering O-T-C advice? * Gender of participant 
Between Groups (Combined) .009 1 .009 .811 .370 
Within Groups .979 85 .012 
  
Total .989 86 
   
Participating in local authority run scheme? * Gender of participant 
Between Groups (Combined) .294 1 .294 1.627 .206 
Within Groups 15.000 83 .181 
  
Total 15.294 84 
   
Collaborating in shared care scheme? * Gender of participant 
Between Groups (Combined) .304 1 .304 1.349 .249 
Within Groups 18.250 81 .225 
  
Total 18.554 82 
   
Is programme fully funded by local authority? * Gender of participant 
Between Groups (Combined) .046 1 .046 .328 .568 
Within Groups 9.981 71 .141 
  
Total 10.027 72 
   
Increase PH content of undergraduate curriculum? * Gender of participant 
Between Groups (Combined) .000 1 .000 .000 .993 
Within Groups 60.716 86 .706 
  
Total 60.716 87 
   
Offer dual MPharm (or even PharmD)/MPH degrees? * Gender of participant 
Between Groups (Combined) 6.284 1 6.284 5.869 .018 
Within Groups 92.080 86 1.071 
  
Total 98.364 87 
   
Pharmacy students training with other HC students? * Gender of participant 
Between Groups (Combined) 2.635 1 2.635 3.174 .078 
Within Groups 69.748 84 .830 
  
Total 72.384 85 
   
Pharmacists working closely with HC practitioners? * Gender of participant 
Between Groups (Combined) 1.173 1 1.173 2.083 .153 
Within Groups 47.884 85 .563 
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Total 49.057 86 
   
Teach advanced communication techniques? * Gender of participant 
Between Groups (Combined) .009 1 .009 .015 .901 
Within Groups 48.980 85 .576 
  
Total 48.989 86 
   
Adopt new technologies and the social media? * Gender of participant 
Between Groups (Combined) 4.116 1 4.116 2.828 .096 
Within Groups 125.156 86 1.455 
  
Total 129.273 87 
   
Develop good adherence strategies for patients? * Gender of participant 
Between Groups (Combined) .338 1 .338 1.274 .262 
Within Groups 22.559 85 .265 
  
Total 22.897 86 
   
Enhancing role in antimicrobial resistance? * Gender of participant 
Between Groups (Combined) .326 1 .326 .526 .470 
Within Groups 53.265 86 .619 
  
Total 53.591 87 
   
Enhance patients' self-managt capacities? * Gender of participant 
Between Groups (Combined) 2.198 1 2.198 6.543 .012 
Within Groups 28.893 86 .336 
  
Total 31.091 87 
   
Enhance safe medication disposal methods? * Gender of participant 
Between Groups (Combined) 1.529 1 1.529 1.652 .202 
Within Groups 79.551 86 .925 
  
Total 81.080 87 
   
Enhance the management of polypharmacy? * Gender of participant 
Between Groups (Combined) .553 1 .553 .968 .328 
Within Groups 49.163 86 .572 
  
Total 49.716 87 
   
Managing the medication needs of athletes? * Gender of participant 
Between Groups (Combined) 1.468 1 1.468 2.073 .154 
Within Groups 60.210 85 .708 
  
Total 61.678 86 
   
Enhancing involvement in smoking cessation? * Gender of participant 
Between Groups (Combined) 1.151 1 1.151 1.288 .260 
Within Groups 76.849 86 .894 
  
Total 78.000 87 
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Providing students with advanced experience in PH? * Gender of participant 
Between Groups (Combined) .089 1 .089 .191 .663 
Within Groups 39.497 85 .465 
  
Total 39.586 86 
   
Providing pharmacists with advanced experience in PH? * Gender of participant 
Between Groups (Combined) .094 1 .094 .221 .640 
Within Groups 36.769 86 .428 
  
Total 36.864 87 
   
Remunerate pharmacists directly for PH services? * Gender of participant 
Between Groups (Combined) .486 1 .486 .747 .390 
Within Groups 56.014 86 .651 
  
Total 56.500 87 
   
Insufficient training of pharmacists in PH? * Gender of participant 
Between Groups (Combined) 3.863 1 3.863 2.729 .102 
Within Groups 121.728 86 1.415 
  
Total 125.591 87 
   
Insufficient skill of pharmacists in PH? * Gender of participant 
Between Groups (Combined) 2.112 1 2.112 1.339 .250 
Within Groups 135.706 86 1.578 
  
Total 137.818 87 
   
Lack of professional autonomy for pharmacists? * Gender of participant 
Between Groups (Combined) 1.740 1 1.740 1.564 .214 
Within Groups 95.703 86 1.113 
  
Total 97.443 87 
   
Difficulties in recruiting patients? * Gender of participant 
Between Groups (Combined) 1.178 1 1.178 .811 .370 
Within Groups 124.811 86 1.451 
  
Total 125.989 87 
   
Lack of demand for public health services? * Gender of participant 
Between Groups (Combined) 2.220 1 2.220 1.518 .221 
Within Groups 125.769 86 1.462 
  
Total 127.989 87 
   
High drop rates for public health services? * Gender of participant 
Between Groups (Combined) 1.188 1 1.188 1.079 .302 
Within Groups 94.710 86 1.101 
  
Total 95.898 87 
   
Low success rates for public health services? * Gender of participant Between Groups (Combined) .256 1 .256 .172 .679 
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Within Groups 125.974 85 1.482 
  
Total 126.230 86 
   
Lack of input from public health practitioners? * Gender of participant 
Between Groups (Combined) .000 1 .000 .000 .992 
Within Groups 91.273 86 1.061 
  
Total 91.273 87 
   
Lack of support from public health practitioners? * Gender of participant 
Between Groups (Combined) 2.668 1 2.668 2.059 .155 
Within Groups 108.832 84 1.296 
  
Total 111.500 85 
   
Difficulty in communicating with other PH providers? * Gender of participant 
Between Groups (Combined) .428 1 .428 .340 .561 
Within Groups 106.974 85 1.259 
  
Total 107.402 86 
   
Lack of support from GPs? * Gender of participant 
Between Groups (Combined) 1.696 1 1.696 1.147 .287 
Within Groups 127.168 86 1.479 
  
Total 128.864 87 
   
Insufficient funding from the government? * Gender of participant 
Between Groups (Combined) 10.205 1 10.205 7.715 .007 
Within Groups 113.750 86 1.323 
  
Total 123.955 87 
   
Difficulty in fee collection? * Gender of participant 
Between Groups (Combined) 1.381 1 1.381 .999 .320 
Within Groups 118.937 86 1.383 
  
Total 120.318 87 
   
Time pressure and workload? * Gender of participant 
Between Groups (Combined) 3.336 1 3.336 4.968 .028 
Within Groups 57.744 86 .671 
  
Total 61.080 87 
   
Safety concerns among pharmacists? * Gender of participant 
Between Groups (Combined) .048 1 .048 .030 .864 
Within Groups 140.270 86 1.631 
  
Total 140.318 87 
   
Safety concerns by GPs? * Gender of participant 
Between Groups (Combined) .117 1 .117 .066 .799 
Within Groups 152.974 86 1.779 
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Total 153.091 87 
   
Safety concerns of patients? * Gender of participant 
Between Groups (Combined) .004 1 .004 .003 .959 
Within Groups 137.984 86 1.604 
  
Total 137.989 87 
   
Lack of patients' records? * Gender of participant 
Between Groups (Combined) 1.428 1 1.428 1.343 .250 
Within Groups 91.436 86 1.063 
  
Total 92.864 87 
   
Lack of documentation of interventions? * Gender of participant 
Between Groups (Combined) 1.206 1 1.206 .850 .359 
Within Groups 120.610 85 1.419 
  
Total 121.816 86 
   
Physical design of community pharmacies? * Gender of participant 
Between Groups (Combined) .058 1 .058 .030 .864 
Within Groups 169.567 86 1.972 
  
Total 169.625 87 
   
Misperception that counselling is not needed? * Gender of participant 
Between Groups (Combined) 1.596 1 1.596 .778 .380 
Within Groups 176.359 86 2.051 
  
Total 177.955 87 
   
Lack of instrumentation? * Gender of participant 
Between Groups (Combined) 1.702 1 1.702 1.179 .281 
Within Groups 124.196 86 1.444 
  
Total 125.898 87 
   
Language barrier? * Gender of participant 
Between Groups (Combined) .003 1 .003 .002 .969 
Within Groups 149.377 85 1.757 
  
Total 149.379 86 
   
Lack of understanding by the public? * Gender of participant 
Between Groups (Combined) .239 1 .239 .183 .670 
Within Groups 109.494 84 1.303 
  
Total 109.733 85 
   
Lack of understanding by HC providers? * Gender of participant 
Between Groups (Combined) .006 1 .006 .005 .945 
Within Groups 112.182 83 1.352 
  
Total 112.188 84 
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How essential CPs provide PH services? * Gender of participant 
Between Groups (Combined) 5.730 1 5.730 5.398 .023 
Within Groups 90.224 85 1.061 
  
Total 95.954 86 
   
The PH role of CPs is still underdeveloped? * Gender of participant 
Between Groups (Combined) .262 1 .262 1.881 .174 
Within Groups 11.405 82 .139 
  
Total 11.667 83 
   
Pharmacies employing their own PH advisers? * Gender of participant 
Between Groups (Combined) 1.129 1 1.129 .645 .424 
Within Groups 145.224 83 1.750 
  
Total 146.353 84 
   
Devolve all work to PH practitioners? * Gender of participant 
Between Groups (Combined) 3.032 1 3.032 2.398 .125 
Within Groups 104.968 83 1.265 
  
Total 108.000 84 
   
Pharmacists reaching out to public places? * Gender of participant 
Between Groups (Combined) 1.310 1 1.310 .844 .361 
Within Groups 128.878 83 1.553 
  
Total 130.188 84 
   
Community pharmacies developing into HLPs? * Gender of participant 
Between Groups (Combined) .987 1 .987 .976 .326 
Within Groups 81.928 81 1.011 
  
Total 82.916 82 
   
Pharmacists developing their own expertise? * Gender of participant 
Between Groups (Combined) .362 1 .362 .570 .452 
Within Groups 52.055 82 .635 
  
Total 52.417 83 
   
Location * Gender of participant 
Between Groups (Combined) .658 1 .658 1.027 .314 
Within Groups 53.154 83 .640 
  
Total 53.812 84 
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Appendix 7 - Measures of Association by Gender 
Measures of Association 
 Eta Eta Squared 
Offering O-T-C advice? * Gender of participant .097 .009 
Participating in local authority run scheme? * Gender of participant .139 .019 
Collaborating in shared care scheme? * Gender of participant .128 .016 
Is programme fully funded by local authority? * Gender of participant .068 .005 
Increase PH content of undergraduate curriculum? * Gender of 
participant 
.001 .000 
Offer dual MPharm (or even PharmD)/MPH degrees? * Gender of 
participant 
.253 .064 
Pharmacy students training with other HC students? * Gender of 
participant 
.191 .036 
Pharmacists working closely with HC practitioners? * Gender of 
participant 
.155 .024 
Teach advanced communication techniques? * Gender of participant .013 .000 
Adopt new technologies and the social media? * Gender of 
participant 
.178 .032 
Develop good adherence strategies for patients? * Gender of 
participant 
.122 .015 
Enhancing role in antimicrobial resistance? * Gender of participant .078 .006 
Enhance patients' self-managt capacities? * Gender of participant .266 .071 
Enhance safe medication disposal methods? * Gender of participant .137 .019 
Enhance the management of polypharmacy? * Gender of participant .105 .011 
Managing the medication needs of athletes? * Gender of participant .154 .024 
Enhancing involvement in smoking cessation? * Gender of 
participant 
.121 .015 
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Providing students with advanced experience in PH? * Gender of 
participant 
.047 .002 
Providing pharmacists with advanced experience in PH? * Gender of 
participant 
.051 .003 
Remunerate pharmacists directly for PH services? * Gender of 
participant 
.093 .009 
Insufficient training of pharmacists in PH? * Gender of participant .175 .031 
Insufficient skill of pharmacists in PH? * Gender of participant .124 .015 
Lack of professional autonomy for pharmacists? * Gender of 
participant 
.134 .018 
Difficulties in recruiting patients? * Gender of participant .097 .009 
Lack of demand for public health services? * Gender of participant .132 .017 
High drop rates for public health services? * Gender of participant .111 .012 
Low success rates for public health services? * Gender of participant .045 .002 
Lack of input from public health practitioners? * Gender of 
participant 
.001 .000 
Lack of support from public health practitioners? * Gender of 
participant 
.155 .024 
Difficulty in communicating with other PH providers? * Gender of 
participant 
.063 .004 
Lack of support from GPs? * Gender of participant .115 .013 
Insufficient funding from the government? * Gender of participant .287 .082 
Difficulty in fee collection? * Gender of participant .107 .011 
Time pressure and workload? * Gender of participant .234 .055 
Safety concerns among pharmacists? * Gender of participant .019 .000 
Safety concerns by GPs? * Gender of participant .028 .001 
Safety concerns of patients? * Gender of participant .006 .000 
Lack of patients' records? * Gender of participant .124 .015 
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Lack of documentation of interventions? * Gender of participant .099 .010 
Physical design of community pharmacies? * Gender of participant .019 .000 
Misperception that counselling is not needed? * Gender of 
participant 
.095 .009 
Lack of instrumentation? * Gender of participant .116 .014 
Language barrier? * Gender of participant .004 .000 
Lack of understanding by the public? * Gender of participant .047 .002 
Lack of understanding by HC providers? * Gender of participant .008 .000 
How essential CPs provide PH services? * Gender of participant .244 .060 
The PH role of CPs is still underdeveloped? * Gender of participant .150 .022 
Pharmacies employing their own PH advisers? * Gender of 
participant 
.088 .008 
Devolve all work to PH practitioners? * Gender of participant .168 .028 
Pharmacists reaching out to public places? * Gender of participant .100 .010 
Community pharmacies developing into HLPs? * Gender of 
participant 
.109 .012 
Pharmacists developing their own expertise? * Gender of participant .083 .007 
Location * Gender of participant .111 .012 
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Appendix 8a - Means Table by Age of Respondent 
Report 
Age of participant Offering O-T-C 
advice? 
Participating 
in local 
authority run 
scheme? 
Collaborating 
in shared care 
scheme? 
Is programme 
fully funded 
by local 
authority? 
Increase PH 
content of 
undergraduate 
curriculum? 
Offer dual 
MPharm (or 
even 
PharmD)/MPH 
degrees? 
Pharmacy students 
training with other 
HC students? 
Pharmacists 
working 
closely with 
HC 
practitioners? 
Teach 
advanced 
communicatio
n techniques? 
Adopt new 
technologies 
and the social 
media? 
20-29 
Mean 1.0000 1.2593 1.6296 1.2609 3.7778 3.2963 4.0385 4.2963 4.1111 3.3704 
N 26 27 27 23 27 27 26 27 27 27 
Std. 
Deviation 
.00000 .44658 .49210 .44898 .84732 1.06752 .77360 .82345 .93370 1.18153 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 4.0000 
30-39 
Mean 1.0000 1.3333 1.6667 1.2000 3.5556 3.1111 4.0000 4.3889 3.9444 3.0000 
N 18 18 18 15 18 18 18 18 18 18 
Std. 
Deviation 
.00000 .48507 .48507 .41404 1.09664 1.18266 .90749 .50163 .72536 1.18818 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
40-49 
Mean 1.0588 1.1765 1.7059 1.1667 3.6471 3.3529 3.7647 4.2353 4.0588 2.5882 
N 17 17 17 12 17 17 17 17 17 17 
Std. 
Deviation 
.24254 .39295 .46967 .38925 .70189 1.05719 .90342 .43724 .74755 1.37199 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 
50-59 
Mean 1.0000 1.2308 1.7692 1.0769 3.6250 2.6250 3.6000 3.6000 3.8125 3.1250 
N 16 13 13 13 16 16 15 15 16 16 
Std. 
Deviation 
.00000 .43853 .43853 .27735 .80623 .95743 .98561 1.05560 .54391 1.02470 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
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60-69 
Mean 1.0000 1.0000 1.4286 1.0000 4.0000 3.2500 3.3750 4.3750 3.8571 3.2500 
N 8 8 7 8 8 8 8 8 7 8 
Std. 
Deviation 
.00000 .00000 .53452 .00000 .53452 1.03510 1.30247 .51755 .69007 1.48805 
Median 1.0000 1.0000 1.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 4.0000 
70-79 
Mean 1.0000 1.5000 2.0000 1.0000 3.5000 3.0000 3.5000 4.0000 4.0000 3.5000 
N 2 2 1 2 2 2 2 2 2 2 
Std. 
Deviation 
.00000 .70711 . .00000 .70711 .00000 .70711 .00000 .00000 .70711 
Median 1.0000 1.5000 2.0000 1.0000 3.5000 3.0000 3.5000 4.0000 4.0000 3.5000 
Total 
Mean 1.0115 1.2353 1.6627 1.1644 3.6932 3.1364 3.8256 4.1839 3.9885 3.0909 
N 87 85 83 73 88 88 86 87 87 88 
Std. 
Deviation 
.10721 .42670 .47568 .37319 .83539 1.06330 .92281 .75527 .75474 1.21897 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
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Appendix 8b - Means Table by Age of Respondent contd. 
 
Age of participant Develop good 
adherence 
strategies for 
patients? 
Enhancing role 
in 
antimicrobial 
resistance? 
Enhance 
patients' self-
managt 
capacities? 
Enhance safe 
medication 
disposal 
methods? 
Enhance the 
management 
of 
polypharmacy
? 
Managing the 
medication 
needs of 
athletes? 
Enhancing 
involvement in 
smoking 
cessation? 
Providing 
students with 
advanced 
experience in 
PH? 
Providing 
pharmacists 
with advanced 
experience in 
PH? 
Remunerate 
pharmacists 
directly for PH 
services? 
20-29 
Mean 4.1481 4.0370 4.2593 3.7407 4.2593 3.9630 3.8148 4.2222 4.2222 4.4444 
N 27 27 27 27 27 27 27 27 27 27 
Std. 
Deviation 
.53376 .64935 .65590 1.28879 .90267 .80773 1.21012 .64051 .50637 .64051 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 5.0000 
30-39 
Mean 4.0556 3.7778 4.1667 3.7778 4.2222 3.5000 3.6111 3.8889 4.1111 4.3333 
N 18 18 18 18 18 18 18 18 18 18 
Std. 
Deviation 
.53930 1.16597 .38348 .64676 .54832 .61835 1.03690 .58298 .58298 .84017 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 4.0000 4.0000 4.0000 4.5000 
40-49 
Mean 4.0588 4.1176 4.1765 3.8235 4.2941 3.5882 4.3529 4.1176 4.0588 4.2941 
N 17 17 17 17 17 17 17 17 17 17 
Std. 
Deviation 
.42875 .60025 .52859 .63593 .58787 1.12132 .60634 .48507 .55572 .58787 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
50-59 
Mean 3.7333 3.6250 3.9375 3.8750 3.8750 4.0667 4.1875 3.8000 3.8750 3.9375 
N 15 16 16 16 16 15 16 15 16 16 
Std. 
Deviation 
.45774 .80623 .77190 1.08781 .88506 .70373 .54391 .94112 1.02470 .92871 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
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60-69 
Mean 4.1250 4.1250 4.5000 4.3750 4.3750 4.0000 4.3750 4.5000 4.3750 4.0000 
N 8 8 8 8 8 8 8 8 8 8 
Std. 
Deviation 
.64087 .35355 .53452 .74402 .74402 .92582 .74402 .53452 .51755 1.30931 
Median 4.0000 4.0000 4.5000 4.5000 4.5000 4.0000 4.5000 4.5000 4.0000 4.0000 
70-79 
Mean 4.0000 4.0000 4.0000 4.0000 4.0000 3.5000 4.0000 3.5000 4.0000 4.0000 
N 2 2 2 2 2 2 2 2 2 2 
Std. 
Deviation 
.00000 .00000 .00000 .00000 .00000 .70711 .00000 .70711 .00000 .00000 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.5000 4.0000 3.5000 4.0000 4.0000 
Total 
Mean 4.0345 3.9318 4.1818 3.8523 4.1932 3.8046 4.0000 4.0690 4.1136 4.2500 
N 87 88 88 88 88 87 88 87 88 88 
Std. 
Deviation 
.51598 .78485 .59780 .96537 .75594 .84687 .94686 .67846 .65094 .80587 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
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Appendix 8c - Means Table by Age of Respondent contd. 
 
Age of participant Insufficient 
training of 
pharmacists in 
PH? 
Insufficient 
skill of 
pharmacists in 
PH? 
Lack of 
professional 
autonomy for 
pharmacists? 
Difficulties in 
recruiting 
patients? 
Lack of 
demand for 
public health 
services? 
High drop 
rates for 
public health 
services? 
Low success rates 
for public health 
services? 
Lack of input 
from public 
health 
practitioners? 
Lack of 
support from 
public health 
practitioners? 
Difficulty in 
communicating 
with other PH 
providers? 
20-29 
Mean 3.6667 3.0370 3.7407 3.8889 2.6667 3.4815 3.0741 3.7778 3.6154 3.8077 
N 27 27 27 27 27 27 27 27 26 26 
Std. 
Deviation 
.96077 1.22416 .98421 1.18754 1.24035 .93522 1.10683 .69798 1.02282 1.05903 
Median 4.0000 3.0000 4.0000 4.0000 3.0000 3.0000 3.0000 4.0000 4.0000 4.0000 
30-39 
Mean 3.2778 3.0556 3.5000 3.3889 2.3889 3.6111 3.0000 3.4444 3.2222 3.3889 
N 18 18 18 18 18 18 18 18 18 18 
Std. 
Deviation 
1.27443 1.10997 1.15045 1.19503 1.09216 .97853 1.02899 1.24722 1.39560 1.19503 
Median 4.0000 3.5000 4.0000 4.0000 2.5000 4.0000 3.0000 4.0000 3.5000 4.0000 
40-49 
Mean 3.5294 3.2353 3.7059 3.2941 2.0588 2.8824 1.8750 3.6471 3.5294 3.4706 
N 17 17 17 17 17 17 16 17 17 17 
Std. 
Deviation 
1.23073 1.30045 1.21268 1.40378 1.34493 1.16632 .95743 1.22174 1.37467 1.28051 
Median 4.0000 4.0000 4.0000 4.0000 1.0000 3.0000 1.5000 4.0000 4.0000 4.0000 
50-59 
Mean 3.2500 2.8125 3.6250 3.3750 3.0000 3.3125 2.5000 3.6875 3.6000 3.5625 
N 16 16 16 16 16 16 16 16 15 16 
Std. 
Deviation 
1.29099 1.51520 .95743 1.02470 1.15470 1.13835 1.41421 .47871 .50709 1.03078 
Median 4.0000 3.5000 4.0000 4.0000 3.0000 4.0000 2.5000 4.0000 4.0000 4.0000 
60-69 
Mean 3.3750 3.3750 3.8750 3.2500 2.3750 2.7500 2.2500 2.8750 3.3750 3.2500 
N 8 8 8 8 8 8 8 8 8 8 
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Std. 
Deviation 
1.50594 1.18773 1.24642 1.28174 1.06066 1.03510 1.28174 1.64208 1.50594 1.16496 
Median 4.0000 4.0000 4.0000 3.5000 2.5000 3.0000 2.0000 3.5000 4.0000 4.0000 
70-79 
Mean 2.5000 2.0000 3.5000 3.5000 2.0000 3.0000 2.0000 4.0000 4.0000 4.0000 
N 2 2 2 2 2 2 2 2 2 2 
Std. 
Deviation 
2.12132 1.41421 .70711 .70711 1.41421 .00000 1.41421 .00000 .00000 .00000 
Median 2.5000 2.0000 3.5000 3.5000 2.0000 3.0000 2.0000 4.0000 4.0000 4.0000 
Total 
Mean 3.4318 3.0455 3.6705 3.5114 2.5114 3.2841 2.6322 3.5909 3.5000 3.5632 
N 88 88 88 88 88 88 87 88 86 87 
Std. 
Deviation 
1.20149 1.25862 1.05832 1.20339 1.21290 1.04989 1.21152 1.02426 1.14532 1.11753 
Median 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 4.0000 4.0000 4.0000 
 
 
Appendix 8d - Means Table by Age of Respondent contd. 
 
Age of participant Lack of 
support from 
GPs? 
Insufficient 
funding from 
the 
government? 
Difficulty in 
fee collection? 
Time pressure 
and workload? 
Safety 
concerns 
among 
pharmacists? 
Safety 
concerns by 
GPs? 
Safety concerns of 
patients? 
Lack of 
patients' 
records? 
Lack of 
documentatio
n of 
interventions? 
Physical design 
of community 
pharmacies? 
20-29 
Mean 3.3704 3.8889 3.4815 4.2593 3.4444 2.9259 2.5926 4.0000 3.3333 3.4815 
N 27 27 27 27 27 27 27 27 27 27 
Std. 
Deviation 
1.39085 1.28103 1.28214 .90267 1.25064 1.38469 1.50024 1.03775 1.33012 1.39698 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 2.0000 4.0000 4.0000 4.0000 
30-39 Mean 3.6111 3.8889 3.1667 4.6111 3.1111 2.6111 1.8889 4.2222 3.3333 2.4444 
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N 18 18 18 18 18 18 18 18 18 18 
Std. 
Deviation 
1.24328 1.23140 1.24853 .77754 1.32349 1.19503 .96338 .42779 .97014 1.54243 
Median 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 2.0000 4.0000 4.0000 2.0000 
40-49 
Mean 3.6471 3.8824 3.2941 4.5294 3.4118 2.3529 2.1765 3.7059 3.1176 2.5294 
N 17 17 17 17 17 17 17 17 17 17 
Std. 
Deviation 
1.22174 1.26897 1.15999 1.00733 1.06412 1.45521 1.23669 1.31171 1.31731 1.32842 
Median 4.0000 4.0000 3.0000 5.0000 4.0000 2.0000 2.0000 4.0000 4.0000 3.0000 
50-59 
Mean 3.7500 4.5000 3.3750 4.4375 2.8125 2.7500 2.3750 3.6250 3.1333 2.6875 
N 16 16 16 16 16 16 16 16 15 16 
Std. 
Deviation 
1.06458 .63246 .88506 .51235 1.42449 1.34164 1.25831 .95743 1.24595 1.01448 
Median 4.0000 5.0000 3.0000 4.0000 3.0000 3.0000 3.0000 4.0000 3.0000 3.0000 
60-69 
Mean 4.0000 3.6250 2.7500 4.2500 3.1250 2.6250 1.7500 3.6250 3.7500 3.1250 
N 8 8 8 8 8 8 8 8 8 8 
Std. 
Deviation 
1.06904 1.59799 1.38873 .88641 1.24642 1.18773 .88641 1.50594 1.03510 1.45774 
Median 4.0000 4.0000 3.0000 4.5000 3.0000 3.0000 1.5000 4.0000 4.0000 3.5000 
70-79 
Mean 4.0000 4.0000 3.5000 3.5000 2.5000 2.5000 2.0000 4.0000 3.0000 2.0000 
N 2 2 2 2 2 2 2 2 2 2 
Std. 
Deviation 
.00000 .00000 .70711 .70711 2.12132 2.12132 1.41421 .00000 .00000 1.41421 
Median 4.0000 4.0000 3.5000 3.5000 2.5000 2.5000 2.0000 4.0000 3.0000 2.0000 
Total 
Mean 3.6136 3.9773 3.2955 4.3977 3.2045 2.6818 2.2386 3.8864 3.2874 2.8750 
N 88 88 88 88 88 88 88 88 87 88 
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Std. 
Deviation 
1.21704 1.19364 1.17600 .83789 1.26998 1.32652 1.25940 1.03315 1.19015 1.39632 
Median 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 2.0000 4.0000 4.0000 3.0000 
 
 
 
Appendix 8e - Means Table by Age of Respondent contd. 
 
Age of participant Misperception 
that counselling is 
not needed? 
Lack of 
instrumentation? 
Language 
barrier? 
Lack of 
understanding by 
the public? 
Lack of 
understanding by 
HC providers? 
How essential CPs 
provide PH 
services? 
The PH role of CPs is 
still underdeveloped? 
Pharmacies 
employing their 
own PH advisers? 
20-29 
Mean 3.1111 3.5185 2.7778 3.3462 3.5769 1.8889 1.1923 3.0000 
N 27 27 27 26 26 27 26 26 
Std. Deviation 1.47631 1.05139 1.45002 1.16421 1.10175 .97402 .40192 1.41421 
Median 4.0000 4.0000 3.0000 3.5000 4.0000 2.0000 1.0000 3.0000 
30-39 
Mean 2.6111 3.2778 1.9412 3.8889 3.5556 1.9444 1.1765 2.8333 
N 18 18 17 18 18 18 17 18 
Std. Deviation 1.33456 1.31978 1.08804 1.40958 1.58011 .99836 .39295 1.15045 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 2.0000 1.0000 3.0000 
40-49 
Mean 3.2353 3.1176 2.4118 3.9412 3.8235 1.8235 1.0625 2.6667 
N 17 17 17 17 17 17 16 15 
Std. Deviation 1.56243 1.36393 1.54349 .96635 .95101 1.28624 .25000 1.34519 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 1.0000 1.0000 3.0000 
50-59 
Mean 3.1875 3.1250 1.7500 4.0000 3.5333 2.2667 1.2667 2.5625 
N 16 16 16 15 15 15 15 16 
Std. Deviation 1.27639 1.08781 .93095 .53452 .91548 .88372 .45774 1.26326 
Median 4.0000 3.0000 1.0000 4.0000 4.0000 2.0000 1.0000 3.0000 
60-69 Mean 3.1250 3.3750 2.3750 3.3750 3.4286 2.1250 1.1250 2.8750 
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N 8 8 8 8 7 8 8 8 
Std. Deviation 1.64208 1.30247 1.06066 1.50594 1.39728 1.35620 .35355 1.72689 
Median 3.5000 4.0000 2.5000 4.0000 4.0000 1.5000 1.0000 3.0000 
70-79 
Mean 2.0000 2.5000 1.0000 4.0000 4.0000 2.0000 1.0000 3.5000 
N 2 2 2 2 2 2 2 2 
Std. Deviation 1.41421 2.12132 .00000 .00000 .00000 1.41421 .00000 .70711 
Median 2.0000 2.5000 1.0000 4.0000 4.0000 2.0000 1.0000 3.5000 
Total 
Mean 3.0227 3.2841 2.2759 3.7093 3.6118 1.9770 1.1667 2.8235 
N 88 88 87 86 85 87 84 85 
Std. Deviation 1.43019 1.20295 1.31794 1.13621 1.15567 1.05629 .37492 1.31996 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 2.0000 1.0000 3.0000 
 
 
Appendix 8f - Means Table by Age of Respondent contd. 
Report 
Age of participant Community 
pharmacies 
developing into 
HLPs? 
Pharmacists 
developing their 
own expertise? 
Location 
20-29 
Mean 4.1538 4.3846 1.9615 
N 26 26 26 
Std. Deviation .73170 .49614 .77360 
Median 4.0000 4.0000 2.0000 
30-39 
Mean 3.1667 3.9412 2.2941 
N 18 17 17 
Std. Deviation 1.24853 .74755 .77174 
Median 3.0000 4.0000 2.0000 
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40-49 
Mean 3.9286 4.0667 2.1765 
N 14 15 17 
Std. Deviation .91687 .96115 .72761 
Median 4.0000 4.0000 2.0000 
50-59 
Mean 3.5333 3.8125 2.0000 
N 15 16 16 
Std. Deviation .91548 .91059 .81650 
Median 4.0000 4.0000 2.0000 
60-69 
Mean 4.5000 4.0000 1.5714 
N 8 8 7 
Std. Deviation .75593 1.06904 .97590 
Median 5.0000 4.0000 1.0000 
70-79 
Mean 3.5000 4.0000 2.0000 
N 2 2 2 
Std. Deviation .70711 .00000 1.41421 
Median 3.5000 4.0000 2.0000 
Total 
Mean 3.8072 4.0833 2.0471 
N 83 84 85 
Std. Deviation 1.00557 .79469 .80039 
Median 4.0000 4.0000 2.0000 
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Appendix 9 - Anova Table by Age of Respondent 
ANOVA Table 
 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Offering O-T-C advice? * Age of participant 
Between Groups (Combined) .047 5 .009 .815 .543 
Within Groups .941 81 .012 
  
Total .989 86 
   
Participating in local authority run scheme? * Age of participant 
Between Groups (Combined) .831 5 .166 .907 .481 
Within Groups 14.463 79 .183 
  
Total 15.294 84 
   
Collaborating in shared care scheme? * Age of participant 
Between Groups (Combined) .707 5 .141 .610 .693 
Within Groups 17.848 77 .232 
  
Total 18.554 82 
   
Is programme fully funded by local authority? * Age of participant 
Between Groups (Combined) .603 5 .121 .857 .515 
Within Groups 9.425 67 .141 
  
Total 10.027 72 
   
Increase PH content of undergraduate curriculum? * Age of participant 
Between Groups (Combined) 1.472 5 .294 .408 .842 
Within Groups 59.243 82 .722 
  
Total 60.716 87 
   
Offer dual MPharm (or even PharmD)/MPH degrees? * Age of participant 
Between Groups (Combined) 
5.824 5 1.165 1.03
2 
.404 
Within Groups 92.540 82 1.129 
  
Total 98.364 87 
   
Pharmacy students training with other HC students? * Age of participant 
Between Groups (Combined) 
4.388 5 .878 1.03
3 
.404 
Within Groups 67.995 80 .850 
  
Total 72.384 85 
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Pharmacists working closely with HC practitioners? * Age of participant 
Between Groups (Combined) 
6.616 5 1.323 2.52
5 
.036 
Within Groups 42.441 81 .524 
  
Total 49.057 86 
   
Teach advanced communication techniques? * Age of participant 
Between Groups (Combined) 1.142 5 .228 .387 .857 
Within Groups 47.847 81 .591 
  
Total 48.989 86 
   
Adopt new technologies and the social media? * Age of participant 
Between Groups (Combined) 7.109 5 1.422 .954 .451 
Within Groups 122.164 82 1.490 
  
Total 129.273 87 
   
Develop good adherence strategies for patients? * Age of participant 
Between Groups (Combined) 
1.795 5 .359 1.37
8 
.241 
Within Groups 21.101 81 .261 
  
Total 22.897 86 
   
Enhancing role in antimicrobial resistance? * Age of participant 
Between Groups (Combined) 
3.127 5 .625 1.01
6 
.414 
Within Groups 50.464 82 .615 
  
Total 53.591 87 
   
Enhance patients' self-managt capacities? * Age of participant 
Between Groups (Combined) 
1.998 5 .400 1.12
6 
.353 
Within Groups 29.093 82 .355 
  
Total 31.091 87 
   
Enhance safe medication disposal methods? * Age of participant 
Between Groups (Combined) 2.688 5 .538 .562 .729 
Within Groups 78.392 82 .956 
  
Total 81.080 87 
   
Enhance the management of polypharmacy? * Age of participant 
Between Groups (Combined) 2.265 5 .453 .783 .565 
Within Groups 47.451 82 .579 
  
Total 49.716 87 
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Managing the medication needs of athletes? * Age of participant 
Between Groups (Combined) 
4.664 5 .933 1.32
5 
.262 
Within Groups 57.014 81 .704 
  
Total 61.678 86 
   
Enhancing involvement in smoking cessation? * Age of participant 
Between Groups (Combined) 
7.453 5 1.491 1.73
3 
.136 
Within Groups 70.547 82 .860 
  
Total 78.000 87 
   
Providing students with advanced experience in PH? * Age of participant 
Between Groups (Combined) 
4.477 5 .895 2.06
6 
.078 
Within Groups 35.109 81 .433 
  
Total 39.586 86 
   
Providing pharmacists with advanced experience in PH? * Age of participant 
Between Groups (Combined) 1.853 5 .371 .868 .506 
Within Groups 35.011 82 .427 
  
Total 36.864 87 
   
Remunerate pharmacists directly for PH services? * Age of participant 
Between Groups (Combined) 
3.366 5 .673 1.03
9 
.400 
Within Groups 53.134 82 .648 
  
Total 56.500 87 
   
Insufficient training of pharmacists in PH? * Age of participant 
Between Groups (Combined) 4.370 5 .874 .591 .707 
Within Groups 121.221 82 1.478 
  
Total 125.591 87 
   
Insufficient skill of pharmacists in PH? * Age of participant 
Between Groups (Combined) 4.539 5 .908 .559 .731 
Within Groups 133.279 82 1.625 
  
Total 137.818 87 
   
Lack of professional autonomy for pharmacists? * Age of participant 
Between Groups (Combined) 1.104 5 .221 .188 .966 
Within Groups 96.340 82 1.175 
  
Total 97.443 87 
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Difficulties in recruiting patients? * Age of participant 
Between Groups (Combined) 5.765 5 1.153 .786 .562 
Within Groups 120.224 82 1.466 
  
Total 125.989 87 
   
Lack of demand for public health services? * Age of participant 
Between Groups (Combined) 
8.895 5 1.779 1.22
5 
.305 
Within Groups 119.094 82 1.452 
  
Total 127.989 87 
   
High drop rates for public health services? * Age of participant 
Between Groups (Combined) 
8.177 5 1.635 1.52
9 
.190 
Within Groups 87.721 82 1.070 
  
Total 95.898 87 
   
Low success rates for public health services? * Age of participant 
Between Groups (Combined) 
19.128 5 3.826 2.89
3 
.019 
Within Groups 107.102 81 1.322 
  
Total 126.230 86 
   
Lack of input from public health practitioners? * Age of participant 
Between Groups (Combined) 
5.967 5 1.193 1.14
7 
.342 
Within Groups 85.306 82 1.040 
  
Total 91.273 87 
   
Lack of support from public health practitioners? * Age of participant 
Between Groups (Combined) 2.525 5 .505 .371 .867 
Within Groups 108.975 80 1.362 
  
Total 111.500 85 
   
Difficulty in communicating with other PH providers? * Age of participant 
Between Groups (Combined) 3.413 5 .683 .532 .752 
Within Groups 103.989 81 1.284 
  
Total 107.402 86 
   
Lack of support from GPs? * Age of participant 
Between Groups (Combined) 3.407 5 .681 .445 .815 
Within Groups 125.456 82 1.530 
  
Total 128.864 87 
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Insufficient funding from the government? * Age of participant 
Between Groups (Combined) 5.870 5 1.174 .815 .542 
Within Groups 118.084 82 1.440 
  
Total 123.955 87 
   
Difficulty in fee collection? * Age of participant 
Between Groups (Combined) 3.798 5 .760 .535 .750 
Within Groups 116.520 82 1.421 
  
Total 120.318 87 
   
Time pressure and workload? * Age of participant 
Between Groups (Combined) 3.444 5 .689 .980 .435 
Within Groups 57.636 82 .703 
  
Total 61.080 87 
   
Safety concerns among pharmacists? * Age of participant 
Between Groups (Combined) 5.944 5 1.189 .725 .606 
Within Groups 134.375 82 1.639 
  
Total 140.318 87 
   
Safety concerns by GPs? * Age of participant 
Between Groups (Combined) 3.704 5 .741 .407 .843 
Within Groups 149.387 82 1.822 
  
Total 153.091 87 
   
Safety concerns of patients? * Age of participant 
Between Groups (Combined) 
7.972 5 1.594 1.00
6 
.420 
Within Groups 130.017 82 1.586 
  
Total 137.989 87 
   
Lack of patients' records? * Age of participant 
Between Groups (Combined) 4.598 5 .920 .854 .515 
Within Groups 88.266 82 1.076 
  
Total 92.864 87 
   
Lack of documentation of interventions? * Age of participant 
Between Groups (Combined) 2.818 5 .564 .384 .859 
Within Groups 118.998 81 1.469 
  
Total 121.816 86 
   
Physical design of community pharmacies? * Age of participant 
Between Groups (Combined) 
17.892 5 3.578 1.93
4 
.098 
Within Groups 151.733 82 1.850 
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Total 169.625 87 
   
Misperception that counselling is not needed? * Age of participant 
Between Groups (Combined) 6.639 5 1.328 .636 .673 
Within Groups 171.316 82 2.089 
  
Total 177.955 87 
   
Lack of instrumentation? * Age of participant 
Between Groups (Combined) 3.656 5 .731 .491 .782 
Within Groups 122.242 82 1.491 
  
Total 125.898 87 
   
Language barrier? * Age of participant 
Between Groups (Combined) 
16.779 5 3.356 2.05
0 
.080 
Within Groups 132.600 81 1.637 
  
Total 149.379 86 
   
Lack of understanding by the public? * Age of participant 
Between Groups (Combined) 
7.254 5 1.451 1.13
3 
.350 
Within Groups 102.479 80 1.281 
  
Total 109.733 85 
   
Lack of understanding by HC providers? * Age of participant 
Between Groups (Combined) 1.479 5 .296 .211 .957 
Within Groups 110.709 79 1.401 
  
Total 112.188 84 
   
How essential CPs provide PH services? * Age of participant 
Between Groups (Combined) 2.064 5 .413 .356 .877 
Within Groups 93.890 81 1.159 
  
Total 95.954 86 
   
The PH role of CPs is still underdeveloped? * Age of participant 
Between Groups (Combined) .412 5 .082 .571 .722 
Within Groups 11.255 78 .144 
  
Total 11.667 83 
   
Pharmacies employing their own PH advisers? * Age of participant 
Between Groups (Combined) 3.207 5 .641 .354 .878 
Within Groups 143.146 79 1.812 
  
Total 146.353 84 
   
Devolve all work to PH practitioners? * Age of participant Between Groups (Combined) 6.292 5 1.258 .977 .437 
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Within Groups 101.708 79 1.287 
  
Total 108.000 84 
   
Pharmacists reaching out to public places? * Age of participant 
Between Groups (Combined) 5.657 5 1.131 .718 .612 
Within Groups 124.532 79 1.576 
  
Total 130.188 84 
   
Community pharmacies developing into HLPs? * Age of participant 
Between Groups (Combined) 
15.869 5 3.174 3.64
5 
.005 
Within Groups 67.047 77 .871 
  
Total 82.916 82 
   
Pharmacists developing their own expertise? * Age of participant 
Between Groups (Combined) 
3.951 5 .790 1.27
2 
.285 
Within Groups 48.466 78 .621 
  
Total 52.417 83 
   
Location * Age of participant 
Between Groups (Combined) 3.136 5 .627 .978 .437 
Within Groups 50.676 79 .641 
  
Total 53.812 84 
   
 
Appendix 10 - Measures of Association by Age of Respondent 
Measures of Association 
 Eta Eta Squared 
Offering O-T-C advice? * Age of participant .219 .048 
Participating in local authority run scheme? * Age of participant .233 .054 
Collaborating in shared care scheme? * Age of participant .195 .038 
Is programme fully funded by local authority? * Age of participant .245 .060 
Increase PH content of undergraduate curriculum? * Age of 
participant 
.156 .024 
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Offer dual MPharm (or even PharmD)/MPH degrees? * Age of 
participant 
.243 .059 
Pharmacy students training with other HC students? * Age of 
participant 
.246 .061 
Pharmacists working closely with HC practitioners? * Age of 
participant 
.367 .135 
Teach advanced communication techniques? * Age of participant .153 .023 
Adopt new technologies and the social media? * Age of participant .235 .055 
Develop good adherence strategies for patients? * Age of participant .280 .078 
Enhancing role in antimicrobial resistance? * Age of participant .242 .058 
Enhance patients' self-managt capacities? * Age of participant .253 .064 
Enhance safe medication disposal methods? * Age of participant .182 .033 
Enhance the management of polypharmacy? * Age of participant .213 .046 
Managing the medication needs of athletes? * Age of participant .275 .076 
Enhancing involvement in smoking cessation? * Age of participant .309 .096 
Providing students with advanced experience in PH? * Age of 
participant 
.336 .113 
Providing pharmacists with advanced experience in PH? * Age of 
participant 
.224 .050 
Remunerate pharmacists directly for PH services? * Age of 
participant 
.244 .060 
Insufficient training of pharmacists in PH? * Age of participant .187 .035 
Insufficient skill of pharmacists in PH? * Age of participant .181 .033 
Lack of professional autonomy for pharmacists? * Age of participant .106 .011 
Difficulties in recruiting patients? * Age of participant .214 .046 
Lack of demand for public health services? * Age of participant .264 .069 
High drop rates for public health services? * Age of participant .292 .085 
Low success rates for public health services? * Age of participant .389 .152 
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Lack of input from public health practitioners? * Age of participant .256 .065 
Lack of support from public health practitioners? * Age of participant .150 .023 
Difficulty in communicating with other PH providers? * Age of 
participant 
.178 .032 
Lack of support from GPs? * Age of participant .163 .026 
Insufficient funding from the government? * Age of participant .218 .047 
Difficulty in fee collection? * Age of participant .178 .032 
Time pressure and workload? * Age of participant .237 .056 
Safety concerns among pharmacists? * Age of participant .206 .042 
Safety concerns by GPs? * Age of participant .156 .024 
Safety concerns of patients? * Age of participant .240 .058 
Lack of patients' records? * Age of participant .223 .050 
Lack of documentation of interventions? * Age of participant .152 .023 
Physical design of community pharmacies? * Age of participant .325 .105 
Misperception that counselling is not needed? * Age of participant .193 .037 
Lack of instrumentation? * Age of participant .170 .029 
Language barrier? * Age of participant .335 .112 
Lack of understanding by the public? * Age of participant .257 .066 
Lack of understanding by HC providers? * Age of participant .115 .013 
How essential CPs provide PH services? * Age of participant .147 .022 
The PH role of CPs is still underdeveloped? * Age of participant .188 .035 
Pharmacies employing their own PH advisers? * Age of participant .148 .022 
Devolve all work to PH practitioners? * Age of participant .241 .058 
Pharmacists reaching out to public places? * Age of participant .208 .043 
Community pharmacies developing into HLPs? * Age of participant .437 .191 
Pharmacists developing their own expertise? * Age of participant .275 .075 
Location * Age of participant .241 .058 
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Appendix 11a - Means Table by Year of Qualification 
 
Report 
Year of qualification Offering O-
T-C advice? 
Participating 
in local 
authority run 
scheme? 
Collaborating 
in shared care 
scheme? 
Is 
programme 
fully funded 
by local 
authority? 
Increase PH 
content of 
undergraduate 
curriculum? 
Offer dual 
MPharm (or 
even 
PharmD)/MPH 
degrees? 
Pharmacy 
students 
training with 
other HC 
students? 
Pharmacists 
working closely 
with HC 
practitioners? 
Teach advanced 
communication 
techniques? 
Adopt new 
technologies 
and the social 
media? 
2010-2014 
Mean 1.0000 1.3077 1.6154 1.1667 3.6154 3.0769 3.7500 4.0769 3.8462 3.3077 
N 13 13 13 12 13 13 12 13 13 13 
Std. Deviation .00000 .48038 .50637 .38925 .96077 1.11516 .96531 1.03775 1.14354 1.03155 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
2000-2009 
Mean 1.0286 1.2778 1.6389 1.2414 3.6389 3.3056 4.0556 4.4167 4.1389 3.0556 
N 35 36 36 29 36 36 36 36 36 36 
Std. Deviation .16903 .45426 .48714 .43549 .93052 1.09073 .75383 .50000 .68255 1.28607 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
1990-1999 
Mean 1.0000 1.1818 1.6364 1.2222 3.8182 3.0909 3.4545 4.0909 4.1818 3.0000 
N 11 11 11 9 11 11 11 11 11 11 
Std. Deviation .00000 .40452 .50452 .44096 .60302 1.13618 1.29334 .53936 .40452 1.48324 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 4.0000 
1980-1989 
Mean 1.0000 1.0909 1.7273 1.0000 3.6923 3.0000 3.8333 4.2500 3.7692 2.9231 
N 13 11 11 10 13 13 12 12 13 13 
Std. Deviation .00000 .30151 .46710 .00000 .63043 .81650 .83485 .62158 .92681 1.32045 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
1970-1979 
Mean 1.0000 1.2500 1.7273 1.0833 3.7692 2.8462 3.5385 3.6923 3.7500 3.2308 
N 13 12 11 12 13 13 13 13 12 13 
Std. Deviation .00000 .45227 .46710 .28868 .83205 1.21423 1.05003 1.10940 .45227 1.09193 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
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1960-1969 
Mean 1.0000 1.0000 
 
1.0000 3.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
N 1 1 
 
1 1 1 1 1 1 1 
Std. Deviation . . 
 
. . . . . . . 
Median 1.0000 1.0000 
 
1.0000 3.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
Total 
Mean 1.0116 1.2381 1.6585 1.1644 3.6782 3.1264 3.8235 4.1860 3.9884 3.0920 
N 86 84 82 73 87 87 85 86 86 87 
Std. Deviation .10783 .42848 .47712 .37319 .82820 1.06536 .92809 .75944 .75917 1.22600 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
 
 
Appendix 11b - Means Table by Year of Qualification contd. 
Report 
Year of qualification Develop good 
adherence 
strategies for 
patients? 
Enhancing role 
in 
antimicrobial 
resistance? 
Enhance 
patients' self-
managt 
capacities? 
Enhance 
safe 
medication 
disposal 
methods? 
Enhance the 
management of 
polypharmacy? 
Managing the 
medication 
needs of 
athletes? 
Enhancing 
involvement 
in smoking 
cessation? 
Providing 
students with 
advanced 
experience in 
PH? 
Providing 
pharmacists 
with advanced 
experience in 
PH? 
Remunerate 
pharmacists 
directly for PH 
services? 
2010-2014 
Mean 3.9231 3.8462 4.0000 3.7692 4.3077 3.7692 3.6923 4.1538 4.0769 4.4615 
N 13 13 13 13 13 13 13 13 13 13 
Std. Deviation .49355 .68874 .57735 1.01274 .63043 .83205 1.10940 .68874 .49355 .66023 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 5.0000 
2000-2009 
Mean 4.1667 4.0833 4.3056 3.7500 4.2500 3.7500 3.7778 4.0556 4.2222 4.4444 
N 36 36 36 36 36 36 36 36 36 36 
Std. Deviation .56061 .80623 .52478 1.07902 .80623 .87423 1.12405 .62994 .54043 .60684 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.5000 
1990-1999 
Mean 4.0000 3.7273 4.0909 3.8182 4.1818 3.8182 4.3636 4.0909 4.0909 3.9091 
N 11 11 11 11 11 11 11 11 11 11 
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Std. Deviation .44721 1.00905 .53936 .40452 .40452 .60302 .50452 .30151 .30151 1.04447 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
1980-1989 
Mean 3.7500 3.8462 4.1538 3.9231 4.0000 3.7692 4.3077 4.1667 4.1538 4.3077 
N 12 13 13 13 13 13 13 12 13 13 
Std. Deviation .45227 .89872 .80064 1.18754 .91287 1.16575 .75107 .71774 .89872 .63043 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
1970-1979 
Mean 4.0769 3.8462 4.1538 4.1538 4.1538 4.0000 4.3077 3.9231 3.8462 3.7692 
N 13 13 13 13 13 12 13 13 13 13 
Std. Deviation .49355 .55470 .68874 .80064 .89872 .73855 .48038 1.03775 .98710 1.16575 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
1960-1969 
Mean 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
N 1 1 1 1 1 1 1 1 1 1 
Std. Deviation . . . . . . . . . . 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Total 
Mean 4.0349 3.9310 4.1839 3.8506 4.1954 3.8023 4.0000 4.0698 4.1149 4.2529 
N 86 87 87 87 87 86 87 86 87 87 
Std. Deviation .51900 .78936 .60094 .97084 .76003 .85157 .95235 .68240 .65460 .81009 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
 
 
Appendix 11c - Means Table by Year of Qualification contd. 
Report 
Year of qualification Insufficient 
training of 
pharmacists in 
PH? 
Insufficient 
skill of 
pharmacists in 
PH? 
Lack of 
professional 
autonomy for 
pharmacists? 
Difficulties 
in recruiting 
patients? 
Lack of demand 
for public health 
services? 
High drop 
rates for 
public health 
services? 
Low success 
rates for 
public health 
services? 
Lack of input 
from public 
health 
practitioners? 
Lack of 
support from 
public health 
practitioners? 
Difficulty in 
communicating 
with other PH 
providers? 
2010-2014 Mean 3.6923 2.9231 3.1538 3.3077 2.6154 3.3846 2.9231 3.6154 3.2500 3.8462 
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N 13 13 13 13 13 13 13 13 12 13 
Std. Deviation .63043 1.25576 .89872 1.31559 1.12090 1.04391 .95407 .50637 .86603 .68874 
Median 4.0000 3.0000 3.0000 4.0000 3.0000 3.0000 3.0000 4.0000 3.0000 4.0000 
2000-2009 
Mean 3.3889 3.1111 3.8611 3.8889 2.6111 3.5833 3.0286 3.6944 3.5556 3.5429 
N 36 36 36 36 36 36 35 36 36 35 
Std. Deviation 1.27117 1.11555 1.01848 1.11555 1.22539 .93732 1.07062 1.06421 1.25230 1.29121 
Median 4.0000 3.0000 4.0000 4.0000 3.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
1990-1999 
Mean 3.6364 3.0909 3.4545 2.6364 2.2727 3.0909 1.8182 3.6364 3.3636 3.4545 
N 11 11 11 11 11 11 11 11 11 11 
Std. Deviation 1.12006 1.37510 1.36848 1.36182 1.48936 1.13618 1.25045 1.43337 1.62928 1.12815 
Median 4.0000 4.0000 4.0000 3.0000 1.0000 3.0000 1.0000 4.0000 4.0000 4.0000 
1980-1989 
Mean 3.6154 3.5385 4.0769 3.3846 2.4615 2.9231 2.9231 3.5385 3.5000 3.2308 
N 13 13 13 13 13 13 13 13 12 13 
Std. Deviation 1.12090 1.33012 .49355 .96077 1.05003 1.18754 1.03775 .96742 .90453 1.30089 
Median 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 4.0000 4.0000 4.0000 
1970-1979 
Mean 3.0769 2.5385 3.3846 3.4615 2.6154 2.9231 1.9231 3.2308 3.6154 3.6923 
N 13 13 13 13 13 13 13 13 13 13 
Std. Deviation 1.49786 1.39137 1.32530 1.19829 1.26085 1.11516 1.32045 1.09193 .96077 .85485 
Median 4.0000 3.0000 3.0000 4.0000 3.0000 3.0000 1.0000 4.0000 4.0000 4.0000 
1960-1969 
Mean 1.0000 1.0000 4.0000 4.0000 1.0000 3.0000 1.0000 4.0000 4.0000 4.0000 
N 1 1 1 1 1 1 1 1 1 1 
Std. Deviation . . . . . . . . . . 
Median 1.0000 1.0000 4.0000 4.0000 1.0000 3.0000 1.0000 4.0000 4.0000 4.0000 
Total 
Mean 3.4253 3.0345 3.6667 3.5057 2.5287 3.2874 2.6512 3.5862 3.4941 3.5581 
N 87 87 87 87 87 87 86 87 85 86 
Std. Deviation 1.20688 1.26167 1.06385 1.20920 1.20887 1.05553 1.20555 1.02924 1.15081 1.12307 
Median 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 4.0000 4.0000 4.0000 
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Appendix 11d - Means Table by Year of Qualification contd. 
Report 
Year of qualification Lack of 
support from 
GPs? 
Insufficient 
funding from 
the 
government? 
Difficulty in 
fee collection? 
Time 
pressure 
and 
workload? 
Safety concerns 
among 
pharmacists? 
Safety 
concerns by 
GPs? 
Safety 
concerns of 
patients? 
Lack of patients' 
records? 
Lack of 
documentatio
n of 
interventions? 
Physical design 
of community 
pharmacies? 
2010-2014 
Mean 3.6923 3.4615 3.2308 4.4615 3.0000 2.6923 2.4615 3.7692 3.6154 3.4615 
N 13 13 13 13 13 13 13 13 13 13 
Std. Deviation 1.10940 1.61325 1.42325 .66023 1.22474 1.25064 1.45002 .92681 .96077 1.05003 
Median 4.0000 4.0000 4.0000 5.0000 3.0000 3.0000 2.0000 4.0000 4.0000 3.0000 
2000-2009 
Mean 3.4722 4.0556 3.4167 4.4444 3.4722 2.8056 2.2778 4.0833 3.1944 2.8889 
N 36 36 36 36 36 36 36 36 36 36 
Std. Deviation 1.36248 1.14504 1.18019 .90851 1.27584 1.34843 1.32258 .93732 1.28329 1.61737 
Median 4.0000 4.0000 4.0000 5.0000 4.0000 3.0000 2.0000 4.0000 3.5000 3.0000 
1990-1999 
Mean 3.5455 3.8182 3.3636 4.2727 3.2727 2.6364 2.2727 3.8182 3.0909 2.6364 
N 11 11 11 11 11 11 11 11 11 11 
Std. Deviation 1.21356 .87386 1.12006 1.19087 1.10371 1.43337 1.19087 1.40130 1.22103 1.43337 
Median 3.0000 4.0000 4.0000 5.0000 4.0000 2.0000 2.0000 4.0000 4.0000 3.0000 
1980-1989 
Mean 3.9231 3.9231 2.8462 4.5385 3.1538 2.6154 2.0769 3.6923 3.6667 2.5385 
N 13 13 13 13 13 13 13 13 12 13 
Std. Deviation 1.18754 1.49786 .98710 .66023 .98710 1.32530 1.25576 1.10940 .77850 1.33012 
Median 4.0000 5.0000 3.0000 5.0000 3.0000 3.0000 2.0000 4.0000 4.0000 3.0000 
1970-1979 
Mean 3.6154 4.4615 3.3846 4.3077 2.7692 2.6923 2.0769 3.6923 3.2308 2.9231 
N 13 13 13 13 13 13 13 13 13 13 
Std. Deviation 1.12090 .66023 1.26085 .63043 1.58923 1.37747 1.11516 1.10940 1.36344 1.03775 
Median 4.0000 5.0000 4.0000 4.0000 3.0000 3.0000 2.0000 4.0000 3.0000 3.0000 
1960-1969 Mean 4.0000 4.0000 3.0000 3.0000 1.0000 1.0000 1.0000 4.0000 3.0000 1.0000 
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N 1 1 1 1 1 1 1 1 1 1 
Std. Deviation . . . . . . . . . . 
Median 4.0000 4.0000 3.0000 3.0000 1.0000 1.0000 1.0000 4.0000 3.0000 1.0000 
Total 
Mean 3.6092 3.9770 3.2874 4.4023 3.1954 2.7011 2.2299 3.8851 3.3140 2.8736 
N 87 87 87 87 87 87 87 87 86 87 
Std. Deviation 1.22338 1.20055 1.18034 .84165 1.27443 1.32169 1.26400 1.03907 1.17084 1.40435 
Median 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 2.0000 4.0000 4.0000 3.0000 
 
 
Appendix 11e - Means Table by Year of Qualification contd. 
Report 
Year of qualification Misperception 
that 
counselling is 
not needed? 
Lack of 
instrumentation? 
Language 
barrier? 
Lack of 
understanding 
by the public? 
Lack of 
understanding 
by HC 
providers? 
How essential 
CPs provide 
PH services? 
The PH role of CPs 
is still 
underdeveloped? 
Pharmacies 
employing 
their own PH 
advisers? 
Devolve all 
work to PH 
practitioners? 
Pharmacists 
reaching out to 
public places? 
2010-2014 
Mean 3.3077 3.4615 2.3077 3.1667 3.5385 2.0000 1.2308 2.9231 2.1538 3.4615 
N 13 13 13 12 13 13 13 13 13 13 
Std. Deviation 1.10940 .87706 1.03155 1.11464 .96742 1.00000 .43853 1.49786 1.28103 .96742 
Median 4.0000 4.0000 3.0000 3.0000 4.0000 2.0000 1.0000 3.0000 2.0000 4.0000 
2000-2009 
Mean 3.0556 3.3611 2.5714 3.7500 3.7143 1.9167 1.1765 2.9706 2.0294 3.0000 
N 36 36 35 36 35 36 34 34 34 34 
Std. Deviation 1.56651 1.29069 1.48097 1.29560 1.31890 1.05221 .38695 1.19304 1.11424 1.34840 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 2.0000 1.0000 3.0000 2.0000 3.5000 
1990-1999 
Mean 2.6364 3.0000 2.3636 3.9091 3.7000 1.7273 1.0909 2.3000 1.8000 3.8000 
N 11 11 11 11 10 11 11 10 10 10 
Std. Deviation 1.50151 1.34164 1.50151 .83121 1.05935 1.10371 .30151 1.33749 1.03280 1.03280 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 1.0000 1.0000 2.0000 1.5000 4.0000 
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1980-1989 
Mean 2.7692 3.1538 2.0769 3.5000 3.1667 2.4615 1.2727 3.3077 1.7692 3.0769 
N 13 13 13 12 12 13 11 13 13 13 
Std. Deviation 1.53590 1.21423 1.25576 1.24316 1.40346 1.19829 .46710 1.25064 .92681 1.44115 
Median 3.0000 3.0000 2.0000 4.0000 4.0000 3.0000 1.0000 3.0000 1.0000 3.0000 
1970-1979 
Mean 3.3846 3.3846 1.7692 4.0769 3.6923 2.0000 1.0769 2.3077 2.3077 3.0769 
N 13 13 13 13 13 12 13 13 13 13 
Std. Deviation 1.19293 1.12090 .92681 .75955 .75107 .95346 .27735 1.37747 1.37747 1.18754 
Median 4.0000 4.0000 1.0000 4.0000 4.0000 2.0000 1.0000 3.0000 2.0000 3.0000 
1960-1969 
Mean 1.0000 1.0000 1.0000 4.0000 4.0000 1.0000 1.0000 4.0000 1.0000 4.0000 
N 1 1 1 1 1 1 1 1 1 1 
Std. Deviation . . . . . . . . . . 
Median 1.0000 1.0000 1.0000 4.0000 4.0000 1.0000 1.0000 4.0000 1.0000 4.0000 
Total 
Mean 3.0230 3.2759 2.2907 3.7059 3.6071 1.9884 1.1687 2.8452 2.0119 3.2024 
N 87 87 86 85 84 86 83 84 84 84 
Std. Deviation 1.43848 1.20743 1.31834 1.14251 1.16182 1.05712 .37674 1.31254 1.13535 1.24938 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 2.0000 1.0000 3.0000 2.0000 4.0000 
 
 
Appendix 11f - Means Table by Year of Qualification contd. 
Report 
Year of qualification Community 
pharmacies 
developing into 
HLPs? 
Pharmacists 
developing their 
own expertise? 
Location 
2010-2014 
Mean 4.0769 4.3077 2.0833 
N 13 13 12 
Std. Deviation .49355 .48038 .79296 
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Median 4.0000 4.0000 2.0000 
2000-2009 
Mean 3.7576 4.0909 2.0857 
N 33 33 35 
Std. Deviation 1.14647 .87905 .78108 
Median 4.0000 4.0000 2.0000 
1990-1999 
Mean 3.6000 4.2000 2.0909 
N 10 10 11 
Std. Deviation 1.26491 .42164 .83121 
Median 4.0000 4.0000 2.0000 
1980-1989 
Mean 3.7692 3.7692 2.1538 
N 13 13 13 
Std. Deviation 1.01274 1.16575 .89872 
Median 4.0000 4.0000 2.0000 
1970-1979 
Mean 3.8333 4.0769 1.8333 
N 12 13 12 
Std. Deviation .93744 .64051 .83485 
Median 4.0000 4.0000 2.0000 
1960-1969 
Mean 4.0000 4.0000 1.0000 
N 1 1 1 
Std. Deviation . . . 
Median 4.0000 4.0000 1.0000 
Total 
Mean 3.8049 4.0843 2.0476 
N 82 83 84 
Std. Deviation 1.01153 .79946 .80518 
Median 4.0000 4.0000 2.0000 
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Appendix 12 - Anova Table by Year of Qualification 
ANOVA Table 
 
Sum of Squares df Mean 
Square 
F Sig. 
Offering O-T-C advice? * Year of qualification 
Between Groups (Combined) .017 5 .003 .279 .923 
Within Groups .971 80 .012 
  
Total .988 85 
   
Participating in local authority run scheme? * Year of qualification 
Between Groups (Combined) .451 5 .090 .476 .793 
Within Groups 14.787 78 .190 
  
Total 15.238 83 
   
Collaborating in shared care scheme? * Year of qualification 
Between Groups (Combined) .147 4 .037 .155 .960 
Within Groups 18.292 77 .238 
  
Total 18.439 81 
   
Is programme fully funded by local authority? * Year of qualification 
Between Groups (Combined) .578 5 .116 .820 .540 
Within Groups 9.449 67 .141 
  
Total 10.027 72 
   
Increase PH content of undergraduate curriculum? * Year of qualification 
Between Groups (Combined) .893 5 .179 .249 .939 
Within Groups 58.096 81 .717 
  
Total 58.989 86 
   
Offer dual MPharm (or even PharmD)/MPH degrees? * Year of qualification 
Between Groups (Combined) 2.446 5 .489 .416 .836 
Within Groups 95.163 81 1.175 
  
Total 97.609 86 
   
Pharmacy students training with other HC students? * Year of qualification 
Between Groups (Combined) 4.589 5 .918 1.070 .383 
Within Groups 67.764 79 .858 
  
Total 72.353 84 
   
Pharmacists working closely with HC practitioners? * Year of qualification 
Between Groups (Combined) 5.422 5 1.084 1.990 .089 
Within Groups 43.601 80 .545 
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Total 49.023 85 
   
Teach advanced communication techniques? * Year of qualification 
Between Groups (Combined) 2.796 5 .559 .969 .442 
Within Groups 46.192 80 .577 
  
Total 48.988 85 
   
Adopt new technologies and the social media? * Year of qualification 
Between Groups (Combined) 1.375 5 .275 .174 .971 
Within Groups 127.889 81 1.579 
  
Total 129.264 86 
   
Develop good adherence strategies for patients? * Year of qualification 
Between Groups (Combined) 1.799 5 .360 1.365 .246 
Within Groups 21.096 80 .264 
  
Total 22.895 85 
   
Enhancing role in antimicrobial resistance? * Year of qualification 
Between Groups (Combined) 1.577 5 .315 .491 .782 
Within Groups 52.009 81 .642 
  
Total 53.586 86 
   
Enhance patients' self-managt capacities? * Year of qualification 
Between Groups (Combined) 1.125 5 .225 .609 .693 
Within Groups 29.933 81 .370 
  
Total 31.057 86 
   
Enhance safe medication disposal methods? * Year of qualification 
Between Groups (Combined) 1.748 5 .350 .357 .876 
Within Groups 79.309 81 .979 
  
Total 81.057 86 
   
Enhance the management of polypharmacy? * Year of qualification 
Between Groups (Combined) .830 5 .166 .275 .925 
Within Groups 48.848 81 .603 
  
Total 49.678 86 
   
Managing the medication needs of athletes? * Year of qualification 
Between Groups (Combined) .638 5 .128 .167 .974 
Within Groups 61.002 80 .763 
  
Total 61.640 85 
   
Enhancing involvement in smoking cessation? * Year of qualification 
Between Groups (Combined) 6.925 5 1.385 1.578 .176 
Within Groups 71.075 81 .877 
  
Total 78.000 86 
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Providing students with advanced experience in PH? * Year of qualification 
Between Groups (Combined) .501 5 .100 .205 .959 
Within Groups 39.080 80 .489 
  
Total 39.581 85 
   
Providing pharmacists with advanced experience in PH? * Year of qualification 
Between Groups (Combined) 1.412 5 .282 .645 .666 
Within Groups 35.439 81 .438 
  
Total 36.851 86 
   
Remunerate pharmacists directly for PH services? * Year of qualification 
Between Groups (Combined) 6.331 5 1.266 2.047 .081 
Within Groups 50.106 81 .619 
  
Total 56.437 86 
   
Insufficient training of pharmacists in PH? * Year of qualification 
Between Groups (Combined) 9.394 5 1.879 1.313 .267 
Within Groups 115.870 81 1.430 
  
Total 125.264 86 
   
Insufficient skill of pharmacists in PH? * Year of qualification 
Between Groups (Combined) 11.047 5 2.209 1.422 .225 
Within Groups 125.849 81 1.554 
  
Total 136.897 86 
   
Lack of professional autonomy for pharmacists? * Year of qualification 
Between Groups (Combined) 8.608 5 1.722 1.572 .177 
Within Groups 88.725 81 1.095 
  
Total 97.333 86 
   
Difficulties in recruiting patients? * Year of qualification 
Between Groups (Combined) 14.569 5 2.914 2.123 .071 
Within Groups 111.178 81 1.373 
  
Total 125.747 86 
   
Lack of demand for public health services? * Year of qualification 
Between Groups (Combined) 3.556 5 .711 .472 .796 
Within Groups 122.122 81 1.508 
  
Total 125.678 86 
   
High drop rates for public health services? * Year of qualification 
Between Groups (Combined) 7.234 5 1.447 1.323 .263 
Within Groups 88.582 81 1.094 
  
Total 95.816 86 
   
Low success rates for public health services? * Year of qualification Between Groups (Combined) 24.158 5 4.832 3.889 .003 
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Within Groups 99.377 80 1.242 
  
Total 123.535 85 
   
Lack of input from public health practitioners? * Year of qualification 
Between Groups (Combined) 2.304 5 .461 .420 .833 
Within Groups 88.800 81 1.096 
  
Total 91.103 86 
   
Lack of support from public health practitioners? * Year of qualification 
Between Groups (Combined) 1.486 5 .297 .214 .956 
Within Groups 109.761 79 1.389 
  
Total 111.247 84 
   
Difficulty in communicating with other PH providers? * Year of qualification 
Between Groups (Combined) 3.027 5 .605 .465 .801 
Within Groups 104.182 80 1.302 
  
Total 107.209 85 
   
Lack of support from GPs? * Year of qualification 
Between Groups (Combined) 2.244 5 .449 .287 .919 
Within Groups 126.469 81 1.561 
  
Total 128.713 86 
   
Insufficient funding from the government? * Year of qualification 
Between Groups (Combined) 7.044 5 1.409 .976 .438 
Within Groups 116.910 81 1.443 
  
Total 123.954 86 
   
Difficulty in fee collection? * Year of qualification 
Between Groups (Combined) 3.444 5 .689 .479 .791 
Within Groups 116.372 81 1.437 
  
Total 119.816 86 
   
Time pressure and workload? * Year of qualification 
Between Groups (Combined) 2.618 5 .524 .727 .605 
Within Groups 58.301 81 .720 
  
Total 60.920 86 
   
Safety concerns among pharmacists? * Year of qualification 
Between Groups (Combined) 10.524 5 2.105 1.320 .264 
Within Groups 129.154 81 1.594 
  
Total 139.678 86 
   
Safety concerns by GPs? * Year of qualification 
Between Groups (Combined) 3.430 5 .686 .379 .862 
Within Groups 146.800 81 1.812 
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Total 150.230 86 
   
Safety concerns of patients? * Year of qualification 
Between Groups (Combined) 2.921 5 .584 .352 .880 
Within Groups 134.481 81 1.660 
  
Total 137.402 86 
   
Lack of patients' records? * Year of qualification 
Between Groups (Combined) 2.618 5 .524 .470 .798 
Within Groups 90.233 81 1.114 
  
Total 92.851 86 
   
Lack of documentation of interventions? * Year of qualification 
Between Groups (Combined) 3.924 5 .785 .558 .732 
Within Groups 112.599 80 1.407 
  
Total 116.523 85 
   
Physical design of community pharmacies? * Year of qualification 
Between Groups (Combined) 10.124 5 2.025 1.028 .407 
Within Groups 159.486 81 1.969 
  
Total 169.609 86 
   
Misperception that counselling is not needed? * Year of qualification 
Between Groups (Combined) 9.366 5 1.873 .900 .485 
Within Groups 168.588 81 2.081 
  
Total 177.954 86 
   
Lack of instrumentation? * Year of qualification 
Between Groups (Combined) 7.074 5 1.415 .969 .442 
Within Groups 118.306 81 1.461 
  
Total 125.379 86 
   
Language barrier? * Year of qualification 
Between Groups (Combined) 8.616 5 1.723 .991 .429 
Within Groups 139.117 80 1.739 
  
Total 147.733 85 
   
Lack of understanding by the public? * Year of qualification 
Between Groups (Combined) 6.398 5 1.280 .979 .436 
Within Groups 103.249 79 1.307 
  
Total 109.647 84 
   
Lack of understanding by HC providers? * Year of qualification 
Between Groups (Combined) 3.126 5 .625 .448 .814 
Within Groups 108.910 78 1.396 
  
Total 112.036 83 
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How essential CPs provide PH services? * Year of qualification 
Between Groups (Combined) 4.826 5 .965 .856 .514 
Within Groups 90.163 80 1.127 
  
Total 94.988 85 
   
The PH role of CPs is still underdeveloped? * Year of qualification 
Between Groups (Combined) .376 5 .075 .514 .765 
Within Groups 11.263 77 .146 
  
Total 11.639 82 
   
Pharmacies employing their own PH advisers? * Year of qualification 
Between Groups (Combined) 11.456 5 2.291 1.359 .249 
Within Groups 131.532 78 1.686 
  
Total 142.988 83 
   
Devolve all work to PH practitioners? * Year of qualification 
Between Groups (Combined) 3.648 5 .730 .551 .737 
Within Groups 103.340 78 1.325 
  
Total 106.988 83 
   
Pharmacists reaching out to public places? * Year of qualification 
Between Groups (Combined) 6.883 5 1.377 .875 .502 
Within Groups 122.677 78 1.573 
  
Total 129.560 83 
   
Community pharmacies developing into HLPs? * Year of qualification 
Between Groups (Combined) 1.520 5 .304 .284 .921 
Within Groups 81.358 76 1.071 
  
Total 82.878 81 
   
Pharmacists developing their own expertise? * Year of qualification 
Between Groups (Combined) 2.082 5 .416 .637 .672 
Within Groups 50.327 77 .654 
  
Total 52.410 82 
   
Location * Year of qualification 
Between Groups (Combined) 1.882 5 .376 .565 .726 
Within Groups 51.928 78 .666 
  
Total 53.810 83 
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Appendix 13 - Measures of Association by Year of Qualification 
Measures of Association 
 Eta Eta Squared 
Offering O-T-C advice? * Year of qualification .131 .017 
Participating in local authority run scheme? * Year of qualification .172 .030 
Collaborating in shared care scheme? * Year of qualification .089 .008 
Is programme fully funded by local authority? * Year of qualification .240 .058 
Increase PH content of undergraduate curriculum? * Year of 
qualification 
.123 .015 
Offer dual MPharm (or even PharmD)/MPH degrees? * Year of 
qualification 
.158 .025 
Pharmacy students training with other HC students? * Year of 
qualification 
.252 .063 
Pharmacists working closely with HC practitioners? * Year of 
qualification 
.333 .111 
Teach advanced communication techniques? * Year of qualification .239 .057 
Adopt new technologies and the social media? * Year of qualification .103 .011 
Develop good adherence strategies for patients? * Year of 
qualification 
.280 .079 
Enhancing role in antimicrobial resistance? * Year of qualification .172 .029 
Enhance patients' self-managt capacities? * Year of qualification .190 .036 
Enhance safe medication disposal methods? * Year of qualification .147 .022 
Enhance the management of polypharmacy? * Year of qualification .129 .017 
Managing the medication needs of athletes? * Year of qualification .102 .010 
Enhancing involvement in smoking cessation? * Year of qualification .298 .089 
Providing students with advanced experience in PH? * Year of 
qualification 
.113 .013 
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Providing pharmacists with advanced experience in PH? * Year of 
qualification 
.196 .038 
Remunerate pharmacists directly for PH services? * Year of 
qualification 
.335 .112 
Insufficient training of pharmacists in PH? * Year of qualification .274 .075 
Insufficient skill of pharmacists in PH? * Year of qualification .284 .081 
Lack of professional autonomy for pharmacists? * Year of 
qualification 
.297 .088 
Difficulties in recruiting patients? * Year of qualification .340 .116 
Lack of demand for public health services? * Year of qualification .168 .028 
High drop rates for public health services? * Year of qualification .275 .075 
Low success rates for public health services? * Year of qualification .442 .196 
Lack of input from public health practitioners? * Year of qualification .159 .025 
Lack of support from public health practitioners? * Year of 
qualification 
.116 .013 
Difficulty in communicating with other PH providers? * Year of 
qualification 
.168 .028 
Lack of support from GPs? * Year of qualification .132 .017 
Insufficient funding from the government? * Year of qualification .238 .057 
Difficulty in fee collection? * Year of qualification .170 .029 
Time pressure and workload? * Year of qualification .207 .043 
Safety concerns among pharmacists? * Year of qualification .274 .075 
Safety concerns by GPs? * Year of qualification .151 .023 
Safety concerns of patients? * Year of qualification .146 .021 
Lack of patients' records? * Year of qualification .168 .028 
Lack of documentation of interventions? * Year of qualification .184 .034 
Physical design of community pharmacies? * Year of qualification .244 .060 
Misperception that counselling is not needed? * Year of qualification .229 .053 
 283 
 
Lack of instrumentation? * Year of qualification .238 .056 
Language barrier? * Year of qualification .241 .058 
Lack of understanding by the public? * Year of qualification .242 .058 
Lack of understanding by HC providers? * Year of qualification .167 .028 
How essential CPs provide PH services? * Year of qualification .225 .051 
The PH role of CPs is still underdeveloped? * Year of qualification .180 .032 
Pharmacies employing their own PH advisers? * Year of 
qualification 
.283 .080 
Devolve all work to PH practitioners? * Year of qualification .185 .034 
Pharmacists reaching out to public places? * Year of qualification .230 .053 
Community pharmacies developing into HLPs? * Year of 
qualification 
.135 .018 
Pharmacists developing their own expertise? * Year of qualification .199 .040 
Location * Year of qualification .187 .035 
 
Appendix 14a - Means Table by Respondent's Role in Pharmacy 
 
Report 
Respondent's role in pharmacy Offering 
O-T-C 
advice? 
Participating 
in local 
authority run 
scheme? 
Collaborating 
in shared care 
scheme? 
Is programme 
fully funded 
by local 
authority? 
Increase PH 
content of 
undergraduate 
curriculum? 
Offer dual 
MPharm (or 
even 
PharmD)/MPH 
degrees? 
Pharmacy 
students 
training with 
other HC 
students? 
Pharmacists 
working 
closely with 
HC 
practitioners? 
Teach advanced 
communication 
techniques? 
Adopt new 
technologies 
and the social 
media? 
Pharmacy Contractor 
Mean 1.0000 1.0909 1.8000 1.1000 3.6923 2.8462 3.5833 3.8462 3.6923 3.0000 
N 13 11 10 10 13 13 12 13 13 13 
Std. 
Deviation 
.00000 .30151 .42164 .31623 .75107 .80064 .79296 .68874 .75107 1.22474 
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Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
Pharmacy Manager 
Mean 1.0000 1.2708 1.5833 1.2093 3.6735 3.1633 3.7551 4.1875 4.0612 3.1837 
N 48 48 48 43 49 49 49 48 49 49 
Std. 
Deviation 
.00000 .44909 .49822 .41163 .85117 1.12448 .96890 .86679 .80125 1.20197 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
Relief Pharmacist 
Mean 1.0000 1.4000 2.0000 1.2500 3.6000 2.8000 4.0000 4.2000 4.0000 2.6000 
N 5 5 5 4 5 5 4 5 5 5 
Std. 
Deviation 
.00000 .54772 .00000 .50000 .54772 1.09545 .00000 .44721 .70711 1.51658 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
Locum Pharmacist 
Mean 1.0000 1.1667 1.8333 1.0000 3.8333 3.1667 3.8333 4.1667 4.1667 3.0000 
N 6 6 6 4 6 6 6 6 6 6 
Std. 
Deviation 
.00000 .40825 .40825 .00000 .75277 1.16905 1.47196 .40825 .75277 1.09545 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.5000 4.0000 4.0000 4.0000 3.0000 
Pharmacist 
Mean 1.1250 1.2500 1.5714 1.1667 3.7500 3.3750 4.2500 4.6250 4.0000 3.0000 
N 8 8 7 6 8 8 8 8 8 8 
Std. 
Deviation 
.35355 .46291 .53452 .40825 .70711 .91613 .70711 .51755 .75593 1.30931 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 5.0000 4.0000 3.5000 
Superintendent Pharmacist 
Mean 1.0000 1.1667 1.6667 1.0000 3.8333 3.5000 4.3333 4.3333 4.0000 3.5000 
N 6 6 6 5 6 6 6 6 5 6 
Std. 
Deviation 
.00000 .40825 .51640 .00000 1.47196 1.37840 .51640 .51640 .00000 1.22474 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Pharmacy Contractor/Supt. Pharmacist 
Mean 1.0000 1.0000 2.0000 1.0000 3.0000 3.0000 3.0000 4.0000 3.0000 1.0000 
N 1 1 1 1 1 1 1 1 1 1 
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Std. 
Deviation 
. . . . . . . . . . 
Median 1.0000 1.0000 2.0000 1.0000 3.0000 3.0000 3.0000 4.0000 3.0000 1.0000 
Total 
Mean 1.0115 1.2353 1.6627 1.1644 3.6932 3.1364 3.8256 4.1839 3.9885 3.0909 
N 87 85 83 73 88 88 86 87 87 88 
Std. 
Deviation 
.10721 .42670 .47568 .37319 .83539 1.06330 .92281 .75527 .75474 1.21897 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 3.0000 
 
 
Appendix 14b - Means Table by Respondent's Role in Pharmacy contd. 
Report 
Respondent's role in pharmacy Develop 
good 
adherence 
strategies 
for 
patients? 
Enhancing role 
in 
antimicrobial 
resistance? 
Enhance 
patients' 
self-managt 
capacities? 
Enhance 
safe 
medication 
disposal 
methods? 
Enhance the 
management 
of 
polypharmacy
? 
Managing 
the 
medication 
needs of 
athletes? 
Enhancing 
involvement 
in smoking 
cessation? 
Providing 
students 
with 
advanced 
experience 
in PH? 
Providing 
pharmacists 
with 
advanced 
experience 
in PH? 
Remunerate 
pharmacists 
directly for 
PH services? 
Pharmacy Contractor 
Mean 3.7500 4.0000 4.0769 3.6154 3.7692 3.8462 4.3846 4.0769 4.0000 4.2308 
N 12 13 13 13 13 13 13 13 13 13 
Std. 
Deviation 
.45227 .40825 .49355 1.12090 .92681 .68874 .50637 .64051 .70711 .83205 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Pharmacy Manager 
Mean 4.0612 3.8367 4.2245 3.8367 4.2857 3.7083 3.8980 4.0625 4.1633 4.2653 
N 49 49 49 49 49 48 49 48 49 49 
Std. 
Deviation 
.55558 .94311 .62133 .96495 .73598 .87418 1.02561 .59809 .55328 .75761 
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Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Relief Pharmacist 
Mean 4.0000 4.0000 4.4000 3.8000 4.0000 3.4000 4.2000 4.2000 4.2000 4.4000 
N 5 5 5 5 5 5 5 5 5 5 
Std. 
Deviation 
.70711 .70711 .54772 .83666 .70711 1.51658 .83666 .83666 .44721 .89443 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 5.0000 
Locum Pharmacist 
Mean 4.0000 4.0000 4.0000 3.8333 4.3333 3.6667 4.0000 4.1667 4.0000 4.1667 
N 6 6 6 6 6 6 6 6 6 6 
Std. 
Deviation 
.00000 .00000 .00000 .75277 .51640 .51640 .89443 .40825 .00000 .40825 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Pharmacist 
Mean 4.1250 4.2500 4.2500 4.5000 4.3750 4.5000 4.1250 4.2500 4.5000 4.5000 
N 8 8 8 8 8 8 8 8 8 8 
Std. 
Deviation 
.35355 .70711 .70711 .53452 .51755 .53452 .83452 .70711 .53452 .53452 
Median 4.0000 4.0000 4.0000 4.5000 4.0000 4.5000 4.0000 4.0000 4.5000 4.5000 
Superintendent Pharmacist 
Mean 4.3333 4.1667 4.1667 3.6667 4.3333 4.1667 3.6667 3.6667 3.6667 4.0000 
N 6 6 6 6 6 6 6 6 6 6 
Std. 
Deviation 
.51640 .40825 .75277 1.36626 .81650 .40825 1.36626 1.36626 1.36626 1.54919 
Median 4.0000 4.0000 4.0000 4.0000 4.5000 4.0000 4.0000 4.0000 4.0000 4.5000 
Pharmacy Contractor/Supt. Pharmacist 
Mean 4.0000 3.0000 3.0000 4.0000 3.0000 3.0000 4.0000 4.0000 3.0000 3.0000 
N 1 1 1 1 1 1 1 1 1 1 
Std. 
Deviation 
. . . . . . . . . . 
Median 4.0000 3.0000 3.0000 4.0000 3.0000 3.0000 4.0000 4.0000 3.0000 3.0000 
Total Mean 4.0345 3.9318 4.1818 3.8523 4.1932 3.8046 4.0000 4.0690 4.1136 4.2500 
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N 87 88 88 88 88 87 88 87 88 88 
Std. 
Deviation 
.51598 .78485 .59780 .96537 .75594 .84687 .94686 .67846 .65094 .80587 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
 
 
Appendix 14c - Means Table by Respondent's Role in Pharmacy contd. 
Report 
Respondent's role in pharmacy Insufficient 
training of 
pharmacists 
in PH? 
Insufficient 
skill of 
pharmacists 
in PH? 
Lack of 
professional 
autonomy 
for 
pharmacists
? 
Difficulties 
in recruiting 
patients? 
Lack of 
demand for 
public 
health 
services? 
High drop 
rates for 
public 
health 
services? 
Low success 
rates for 
public 
health 
services? 
Lack of input 
from public 
health 
practitioners
? 
Lack of 
support from 
public health 
practitioners? 
Difficulty in 
communicating 
with other PH 
providers? 
Pharmacy Contractor 
Mean 3.1538 2.6923 3.7692 3.2308 2.2308 2.9231 2.2308 3.4615 3.4615 3.6923 
N 13 13 13 13 13 13 13 13 13 13 
Std. 
Deviation 
1.40512 1.37747 1.01274 1.09193 1.16575 .95407 1.16575 .87706 1.12660 .85485 
Median 4.0000 3.0000 4.0000 4.0000 2.0000 3.0000 2.0000 4.0000 4.0000 4.0000 
Pharmacy Manager 
Mean 3.3469 2.8980 3.6327 3.4286 2.6122 3.4082 2.7708 3.6939 3.4894 3.4694 
N 49 49 49 49 49 49 48 49 47 49 
Std. 
Deviation 
1.23408 1.24574 1.09343 1.27475 1.33567 1.05906 1.25883 1.02478 1.24887 1.24335 
Median 4.0000 3.0000 4.0000 4.0000 3.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
Relief Pharmacist 
Mean 3.8000 3.4000 3.6000 3.8000 2.4000 3.4000 2.8000 3.8000 3.2000 3.8000 
N 5 5 5 5 5 5 5 5 5 5 
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Std. 
Deviation 
.83666 1.51658 .54772 .83666 .89443 .54772 1.09545 .44721 .44721 .83666 
Median 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 4.0000 3.0000 4.0000 
Locum Pharmacist 
Mean 3.8333 3.1667 4.1667 4.1667 2.3333 3.1667 1.8333 4.1667 4.0000 4.1667 
N 6 6 6 6 6 6 6 6 6 6 
Std. 
Deviation 
.40825 1.16905 .75277 .75277 1.21106 1.32916 .98319 .75277 .63246 .40825 
Median 4.0000 3.5000 4.0000 4.0000 2.5000 3.0000 1.5000 4.0000 4.0000 4.0000 
Pharmacist 
Mean 3.6250 4.0000 4.0000 4.1250 3.0000 3.7500 3.0000 3.0000 3.3750 3.6250 
N 8 8 8 8 8 8 8 8 8 8 
Std. 
Deviation 
1.18773 .53452 .75593 .83452 .75593 .88641 1.19523 1.41421 1.18773 1.18773 
Median 4.0000 4.0000 4.0000 4.0000 3.0000 3.5000 3.0000 3.0000 3.5000 4.0000 
Superintendent Pharmacist 
Mean 3.8333 3.1667 2.8333 3.0000 2.1667 2.5000 2.5000 3.1667 3.5000 3.0000 
N 6 6 6 6 6 6 6 6 6 5 
Std. 
Deviation 
1.47196 1.47196 1.60208 1.67332 .98319 1.22474 1.22474 1.16905 1.37840 1.22474 
Median 4.0000 3.5000 3.0000 3.5000 2.5000 3.0000 3.0000 3.5000 4.0000 3.0000 
Pharmacy Contractor/Supt. Pharmacist 
Mean 3.0000 4.0000 4.0000 4.0000 1.0000 3.0000 3.0000 3.0000 4.0000 4.0000 
N 1 1 1 1 1 1 1 1 1 1 
Std. 
Deviation 
. . . . . . . . . . 
Median 3.0000 4.0000 4.0000 4.0000 1.0000 3.0000 3.0000 3.0000 4.0000 4.0000 
Total 
Mean 3.4318 3.0455 3.6705 3.5114 2.5114 3.2841 2.6322 3.5909 3.5000 3.5632 
N 88 88 88 88 88 88 87 88 86 87 
Std. 
Deviation 
1.20149 1.25862 1.05832 1.20339 1.21290 1.04989 1.21152 1.02426 1.14532 1.11753 
 289 
 
Median 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 4.0000 4.0000 4.0000 
 
 
Appendix 14d - Means Table by Respondent's Role in Pharmacy contd. 
Report 
Respondent's role in pharmacy Lack of 
support 
from GPs? 
Insufficient 
funding 
from the 
government
? 
Difficulty in 
fee 
collection? 
Time 
pressure 
and 
workload? 
Safety 
concerns 
among 
pharmacists? 
Safety 
concerns by 
GPs? 
Safety 
concerns of 
patients? 
Lack of 
patients' 
records? 
Lack of 
documentation 
of 
interventions? 
Physical 
design of 
community 
pharmacies? 
Pharmacy Contractor 
Mean 3.6923 4.3846 3.0769 4.3077 3.0000 3.0769 2.2308 3.6154 3.1538 2.3846 
N 13 13 13 13 13 13 13 13 13 13 
Std. 
Deviation 
1.10940 .65044 .86232 .63043 1.22474 1.25576 1.01274 1.12090 .98710 1.12090 
Median 4.0000 4.0000 3.0000 4.0000 3.0000 3.0000 2.0000 4.0000 3.0000 3.0000 
Pharmacy Manager 
Mean 3.4286 3.9796 3.4082 4.4286 3.0204 2.4694 2.1020 3.8980 3.1667 2.9184 
N 49 49 49 49 49 49 49 49 48 49 
Std. 
Deviation 
1.32288 1.18127 1.27342 .86603 1.29887 1.29264 1.26235 .98414 1.32622 1.39697 
Median 4.0000 4.0000 4.0000 5.0000 3.0000 2.0000 2.0000 4.0000 3.5000 3.0000 
Relief Pharmacist 
Mean 3.6000 2.8000 3.2000 4.6000 4.2000 2.2000 2.2000 3.2000 3.4000 2.6000 
N 5 5 5 5 5 5 5 5 5 5 
Std. 
Deviation 
.89443 1.78885 .44721 .54772 .83666 1.09545 1.09545 1.30384 .54772 1.51658 
Median 3.0000 3.0000 3.0000 5.0000 4.0000 3.0000 3.0000 4.0000 3.0000 3.0000 
Locum Pharmacist 
Mean 3.6667 4.0000 3.3333 4.5000 3.5000 2.6667 2.5000 4.3333 3.0000 2.5000 
N 6 6 6 6 6 6 6 6 6 6 
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Std. 
Deviation 
.81650 .89443 1.21106 .54772 1.37840 1.50555 1.22474 .51640 1.09545 1.76068 
Median 3.5000 4.0000 4.0000 4.5000 4.0000 3.0000 3.0000 4.0000 3.0000 2.0000 
Pharmacist 
Mean 4.0000 3.6250 3.0000 4.2500 4.1250 4.0000 3.2500 4.5000 4.1250 4.0000 
N 8 8 8 8 8 8 8 8 8 8 
Std. 
Deviation 
1.41421 1.76777 1.06904 1.38873 .64087 .92582 1.58114 .75593 .64087 .75593 
Median 4.5000 4.5000 3.0000 5.0000 4.0000 4.0000 3.5000 5.0000 4.0000 4.0000 
Superintendent Pharmacist 
Mean 4.3333 4.5000 3.1667 4.1667 2.8333 2.5000 2.0000 3.6667 3.6667 3.0000 
N 6 6 6 6 6 6 6 6 6 6 
Std. 
Deviation 
.81650 .54772 1.72240 .75277 1.47196 1.37840 1.26491 1.50555 1.36626 1.67332 
Median 4.5000 4.5000 4.0000 4.0000 3.5000 2.5000 1.5000 4.0000 4.0000 3.5000 
Pharmacy Contractor/Supt. Pharmacist 
Mean 4.0000 4.0000 4.0000 5.0000 3.0000 1.0000 1.0000 4.0000 3.0000 1.0000 
N 1 1 1 1 1 1 1 1 1 1 
Std. 
Deviation 
. . . . . . . . . . 
Median 4.0000 4.0000 4.0000 5.0000 3.0000 1.0000 1.0000 4.0000 3.0000 1.0000 
Total 
Mean 3.6136 3.9773 3.2955 4.3977 3.2045 2.6818 2.2386 3.8864 3.2874 2.8750 
N 88 88 88 88 88 88 88 88 87 88 
Std. 
Deviation 
1.21704 1.19364 1.17600 .83789 1.26998 1.32652 1.25940 1.03315 1.19015 1.39632 
Median 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 2.0000 4.0000 4.0000 3.0000 
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Appendix 14e - Means Table by Respondent's Role in Pharmacy contd. 
Report 
Respondent's role in pharmacy Misperception 
that 
counselling is 
not needed? 
Lack of 
instrumentation? 
Language 
barrier? 
Lack of 
understanding 
by the public? 
Lack of 
understanding 
by HC 
providers? 
How 
essential 
CPs provide 
PH services? 
The PH role 
of CPs is still 
under-
developed? 
Pharmacies 
employing 
their own 
PH advisers? 
Devolve 
all work 
to PH 
practition
ers? 
Pharmacists 
reaching out 
to public 
places? 
Pharmacy Contractor 
Mean 2.9231 3.0000 1.7692 4.0000 3.5833 2.0000 1.2500 2.8462 1.8462 3.3077 
N 13 13 13 12 12 13 12 13 13 13 
Std. 
Deviation 
1.25576 1.15470 1.23517 .42640 .90034 1.08012 .45227 1.14354 .89872 .75107 
Median 3.0000 3.0000 1.0000 4.0000 4.0000 2.0000 1.0000 3.0000 2.0000 3.0000 
Pharmacy Manager 
Mean 2.8367 3.4082 2.3750 3.6531 3.5000 1.8542 1.1875 2.8723 2.1277 3.2128 
N 49 49 48 49 48 48 48 47 47 47 
Std. 
Deviation 
1.43392 1.11651 1.29853 1.18235 1.27162 .96733 .39444 1.37710 1.20897 1.28429 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 2.0000 1.0000 3.0000 2.0000 4.0000 
Relief Pharmacist 
Mean 3.0000 2.2000 1.8000 3.2000 3.5000 3.0000 1.4000 3.6000 2.2000 3.4000 
N 5 5 5 5 4 5 5 5 5 5 
Std. 
Deviation 
1.87083 1.64317 1.09545 1.30384 .57735 1.00000 .54772 .89443 1.09545 1.34164 
Median 4.0000 1.0000 1.0000 4.0000 3.5000 3.0000 1.0000 3.0000 3.0000 4.0000 
Locum Pharmacist 
Mean 3.5000 3.5000 1.8333 4.4000 4.3333 2.1667 1.0000 2.0000 1.6667 3.5000 
N 6 6 6 5 6 6 6 6 6 6 
Std. 
Deviation 
1.51658 1.37840 1.32916 .54772 .51640 1.47196 .00000 1.09545 1.03280 1.37840 
Median 3.5000 4.0000 1.0000 4.0000 4.0000 1.5000 1.0000 2.0000 1.0000 4.0000 
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Pharmacist 
Mean 4.1250 3.8750 3.0000 3.8750 3.8750 1.6250 1.0000 3.8571 2.1429 3.2857 
N 8 8 8 8 8 8 7 7 7 7 
Std. 
Deviation 
1.12599 .64087 1.30931 1.45774 1.45774 1.06066 .00000 .69007 1.57359 1.70434 
Median 4.5000 4.0000 3.0000 4.5000 4.5000 1.0000 1.0000 4.0000 1.0000 4.0000 
Superintendent Pharmacist 
Mean 3.1667 2.6667 2.6667 3.1667 3.6667 2.0000 1.0000 1.6667 1.5000 2.8333 
N 6 6 6 6 6 6 6 6 6 6 
Std. 
Deviation 
1.32916 1.63299 1.63299 1.47196 1.03280 .89443 .00000 1.03280 .54772 1.16905 
Median 3.0000 2.5000 2.5000 3.5000 4.0000 2.0000 1.0000 1.0000 1.5000 3.0000 
Pharmacy Contractor/Supt. Pharmacist 
Mean 1.0000 4.0000 1.0000 4.0000 3.0000 4.0000 
 
1.0000 1.0000 1.0000 
N 1 1 1 1 1 1 
 
1 1 1 
Std. 
Deviation 
. . . . . . 
 
. . . 
Median 1.0000 4.0000 1.0000 4.0000 3.0000 4.0000 
 
1.0000 1.0000 1.0000 
Total 
Mean 3.0227 3.2841 2.2759 3.7093 3.6118 1.9770 1.1667 2.8235 2.0000 3.2118 
N 88 88 87 86 85 87 84 85 85 85 
Std. 
Deviation 
1.43019 1.20295 1.31794 1.13621 1.15567 1.05629 .37492 1.31996 1.13389 1.24493 
Median 3.0000 4.0000 2.0000 4.0000 4.0000 2.0000 1.0000 3.0000 2.0000 4.0000 
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Appendix 14f - Means Table by Respondent's Role in Pharmacy contd. 
Report 
Respondent's role in pharmacy Community 
pharmacies 
developing 
into HLPs? 
Pharmacists 
developing their 
own expertise? 
Location 
Pharmacy Contractor 
Mean 3.5385 4.0000 2.0000 
N 13 13 13 
Std. Deviation .96742 .40825 .91287 
Median 4.0000 4.0000 2.0000 
Pharmacy Manager 
Mean 3.8043 4.0652 2.0833 
N 46 46 48 
Std. Deviation 1.12782 .90436 .76724 
Median 4.0000 4.0000 2.0000 
Relief Pharmacist 
Mean 3.8000 4.2000 1.8000 
N 5 5 5 
Std. Deviation .83666 .44721 .83666 
Median 4.0000 4.0000 2.0000 
Locum Pharmacist 
Mean 3.6667 4.3333 2.3333 
N 6 6 6 
Std. Deviation .51640 .51640 .81650 
Median 4.0000 4.0000 2.5000 
Pharmacist 
Mean 4.1667 4.0000 2.1250 
N 6 7 8 
Std. Deviation .98319 1.00000 .83452 
Median 4.5000 4.0000 2.0000 
Superintendent Pharmacist Mean 4.3333 4.1667 1.2500 
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N 6 6 4 
Std. Deviation .51640 .98319 .50000 
Median 4.0000 4.5000 1.0000 
Pharmacy Contractor/Supt. Pharmacist 
Mean 3.0000 4.0000 3.0000 
N 1 1 1 
Std. Deviation . . . 
Median 3.0000 4.0000 3.0000 
Total 
Mean 3.8072 4.0833 2.0471 
N 83 84 85 
Std. Deviation 1.00557 .79469 .80039 
Median 4.0000 4.0000 2.0000 
 
Appendix 15 - Anova Table by Respondent's Role in Pharmacy 
ANOVA Table 
 
Sum of 
Squares 
df Mean 
Square 
F Sig. 
Offering O-T-C advice? * Respondent's role in pharmacy 
Between Groups (Combined) .114 6 .019 1.730 .125 
Within Groups .875 80 .011 
  
Total .989 86 
   
Participating in local authority run scheme? * Respondent's role in pharmacy 
Between Groups (Combined) .539 6 .090 .475 .825 
Within Groups 14.755 78 .189 
  
Total 15.294 84 
   
Collaborating in shared care scheme? * Respondent's role in pharmacy 
Between Groups (Combined) 1.407 6 .234 1.039 .407 
Within Groups 17.148 76 .226 
  
Total 18.554 82 
   
Is programme fully funded by local authority? * Respondent's role in pharmacy Between Groups (Combined) .428 6 .071 .490 .813 
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Within Groups 9.600 66 .145 
  
Total 10.027 72 
   
Increase PH content of undergraduate curriculum? * Respondent's role in 
pharmacy 
Between Groups (Combined) .805 6 .134 .181 .981 
Within Groups 59.911 81 .740 
  
Total 60.716 87 
   
Offer dual MPharm (or even PharmD)/MPH degrees? * Respondent's role in 
pharmacy 
Between Groups (Combined) 2.969 6 .495 .420 .864 
Within Groups 95.395 81 1.178 
  
Total 98.364 87 
   
Pharmacy students training with other HC students? * Respondent's role in 
pharmacy 
Between Groups (Combined) 4.739 6 .790 .922 .484 
Within Groups 67.645 79 .856 
  
Total 72.384 85 
   
Pharmacists working closely with HC practitioners? * Respondent's role in 
pharmacy 
Between Groups (Combined) 3.211 6 .535 .934 .476 
Within Groups 45.846 80 .573 
  
Total 49.057 86 
   
Teach advanced communication techniques? * Respondent's role in pharmacy 
Between Groups (Combined) 2.570 6 .428 .738 .620 
Within Groups 46.419 80 .580 
  
Total 48.989 86 
   
Adopt new technologies and the social media? * Respondent's role in pharmacy 
Between Groups (Combined) 7.226 6 1.204 .799 .573 
Within Groups 122.047 81 1.507 
  
Total 129.273 87 
   
Develop good adherence strategies for patients? * Respondent's role in 
pharmacy 
Between Groups (Combined) 1.622 6 .270 1.016 .421 
Within Groups 21.275 80 .266 
  
Total 22.897 86 
   
Enhancing role in antimicrobial resistance? * Respondent's role in pharmacy 
Between Groups (Combined) 2.564 6 .427 .678 .668 
Within Groups 51.027 81 .630 
  
Total 53.591 87 
   
Enhance patients' self-managt capacities? * Respondent's role in pharmacy 
Between Groups (Combined) 2.104 6 .351 .980 .444 
Within Groups 28.987 81 .358 
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Total 31.091 87 
   
Enhance safe medication disposal methods? * Respondent's role in pharmacy 
Between Groups (Combined) 4.342 6 .724 .764 .600 
Within Groups 76.737 81 .947 
  
Total 81.080 87 
   
Enhance the management of polypharmacy? * Respondent's role in pharmacy 
Between Groups (Combined) 4.867 6 .811 1.465 .201 
Within Groups 44.849 81 .554 
  
Total 49.716 87 
   
Managing the medication needs of athletes? * Respondent's role in pharmacy 
Between Groups (Combined) 6.703 6 1.117 1.626 .151 
Within Groups 54.976 80 .687 
  
Total 61.678 86 
   
Enhancing involvement in smoking cessation? * Respondent's role in pharmacy 
Between Groups (Combined) 3.425 6 .571 .620 .714 
Within Groups 74.575 81 .921 
  
Total 78.000 87 
   
Providing students with advanced experience in PH? * Respondent's role in 
pharmacy 
Between Groups (Combined) 1.384 6 .231 .483 .819 
Within Groups 38.202 80 .478 
  
Total 39.586 86 
   
Providing pharmacists with advanced experience in PH? * Respondent's role in 
pharmacy 
Between Groups (Combined) 4.036 6 .673 1.660 .142 
Within Groups 32.827 81 .405 
  
Total 36.864 87 
   
Remunerate pharmacists directly for PH services? * Respondent's role in 
pharmacy 
Between Groups (Combined) 2.608 6 .435 .653 .687 
Within Groups 53.892 81 .665 
  
Total 56.500 87 
   
Insufficient training of pharmacists in PH? * Respondent's role in pharmacy 
Between Groups (Combined) 4.455 6 .742 .496 .809 
Within Groups 121.136 81 1.496 
  
Total 125.591 87 
   
Insufficient skill of pharmacists in PH? * Respondent's role in pharmacy 
Between Groups (Combined) 11.692 6 1.949 1.252 .289 
Within Groups 126.126 81 1.557 
  
Total 137.818 87 
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Lack of professional autonomy for pharmacists? * Respondent's role in pharmacy 
Between Groups (Combined) 6.881 6 1.147 1.026 .415 
Within Groups 90.562 81 1.118 
  
Total 97.443 87 
   
Difficulties in recruiting patients? * Respondent's role in pharmacy 
Between Groups (Combined) 9.173 6 1.529 1.060 .393 
Within Groups 116.816 81 1.442 
  
Total 125.989 87 
   
Lack of demand for public health services? * Respondent's role in pharmacy 
Between Groups (Combined) 6.682 6 1.114 .744 .616 
Within Groups 121.307 81 1.498 
  
Total 127.989 87 
   
High drop rates for public health services? * Respondent's role in pharmacy 
Between Groups (Combined) 8.105 6 1.351 1.246 .292 
Within Groups 87.793 81 1.084 
  
Total 95.898 87 
   
Low success rates for public health services? * Respondent's role in pharmacy 
Between Groups (Combined) 8.310 6 1.385 .940 .472 
Within Groups 117.920 80 1.474 
  
Total 126.230 86 
   
Lack of input from public health practitioners? * Respondent's role in pharmacy 
Between Groups (Combined) 7.167 6 1.195 1.150 .341 
Within Groups 84.106 81 1.038 
  
Total 91.273 87 
   
Lack of support from public health practitioners? * Respondent's role in 
pharmacy 
Between Groups (Combined) 2.350 6 .392 .283 .943 
Within Groups 109.150 79 1.382 
  
Total 111.500 85 
   
Difficulty in communicating with other PH providers? * Respondent's role in 
pharmacy 
Between Groups (Combined) 4.921 6 .820 .640 .698 
Within Groups 102.482 80 1.281 
  
Total 107.402 86 
   
Lack of support from GPs? * Respondent's role in pharmacy 
Between Groups (Combined) 6.228 6 1.038 .686 .662 
Within Groups 122.636 81 1.514 
  
Total 128.864 87 
   
Insufficient funding from the government? * Respondent's role in pharmacy Between Groups (Combined) 11.723 6 1.954 1.410 .221 
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Within Groups 112.232 81 1.386 
  
Total 123.955 87 
   
Difficulty in fee collection? * Respondent's role in pharmacy 
Between Groups (Combined) 2.592 6 .432 .297 .937 
Within Groups 117.726 81 1.453 
  
Total 120.318 87 
   
Time pressure and workload? * Respondent's role in pharmacy 
Between Groups (Combined) 1.277 6 .213 .288 .941 
Within Groups 59.803 81 .738 
  
Total 61.080 87 
   
Safety concerns among pharmacists? * Respondent's role in pharmacy 
Between Groups (Combined) 15.330 6 2.555 1.656 .143 
Within Groups 124.988 81 1.543 
  
Total 140.318 87 
   
Safety concerns by GPs? * Respondent's role in pharmacy 
Between Groups (Combined) 22.330 6 3.722 2.305 .042 
Within Groups 130.760 81 1.614 
  
Total 153.091 87 
   
Safety concerns of patients? * Respondent's role in pharmacy 
Between Groups (Combined) 11.391 6 1.899 1.215 .307 
Within Groups 126.597 81 1.563 
  
Total 137.989 87 
   
Lack of patients' records? * Respondent's role in pharmacy 
Between Groups (Combined) 7.830 6 1.305 1.243 .293 
Within Groups 85.033 81 1.050 
  
Total 92.864 87 
   
Lack of documentation of interventions? * Respondent's role in pharmacy 
Between Groups (Combined) 8.049 6 1.341 .943 .469 
Within Groups 113.767 80 1.422 
  
Total 121.816 86 
   
Physical design of community pharmacies? * Respondent's role in pharmacy 
Between Groups (Combined) 18.175 6 3.029 1.620 .152 
Within Groups 151.450 81 1.870 
  
Total 169.625 87 
   
Misperception that counselling is not needed? * Respondent's role in pharmacy 
Between Groups (Combined) 17.129 6 2.855 1.438 .210 
Within Groups 160.825 81 1.985 
  
 299 
 
Total 177.955 87 
   
Lack of instrumentation? * Respondent's role in pharmacy 
Between Groups (Combined) 13.553 6 2.259 1.629 .150 
Within Groups 112.345 81 1.387 
  
Total 125.898 87 
   
Language barrier? * Respondent's role in pharmacy 
Between Groups (Combined) 12.855 6 2.142 1.255 .287 
Within Groups 136.524 80 1.707 
  
Total 149.379 86 
   
Lack of understanding by the public? * Respondent's role in pharmacy 
Between Groups (Combined) 6.922 6 1.154 .887 .509 
Within Groups 102.810 79 1.301 
  
Total 109.733 85 
   
Lack of understanding by HC providers? * Respondent's role in pharmacy 
Between Groups (Combined) 4.730 6 .788 .572 .751 
Within Groups 107.458 78 1.378 
  
Total 112.188 84 
   
How essential CPs provide PH services? * Respondent's role in pharmacy 
Between Groups (Combined) 11.267 6 1.878 1.774 .115 
Within Groups 84.688 80 1.059 
  
Total 95.954 86 
   
The PH role of CPs is still underdeveloped? * Respondent's role in pharmacy 
Between Groups (Combined) .904 5 .181 1.311 .268 
Within Groups 10.763 78 .138 
  
Total 11.667 83 
   
Pharmacies employing their own PH advisers? * Respondent's role in pharmacy 
Between Groups (Combined) 26.036 6 4.339 2.813 .016 
Within Groups 120.317 78 1.543 
  
Total 146.353 84 
   
Devolve all work to PH practitioners? * Respondent's role in pharmacy 
Between Groups (Combined) 4.583 6 .764 .576 .748 
Within Groups 103.417 78 1.326 
  
Total 108.000 84 
   
Pharmacists reaching out to public places? * Respondent's role in pharmacy 
Between Groups (Combined) 6.585 6 1.097 .693 .656 
Within Groups 123.603 78 1.585 
  
Total 130.188 84 
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Community pharmacies developing into HLPs? * Respondent's role in pharmacy 
Between Groups (Combined) 4.146 6 .691 .667 .677 
Within Groups 78.770 76 1.036 
  
Total 82.916 82 
   
Pharmacists developing their own expertise? * Respondent's role in pharmacy 
Between Groups (Combined) .646 6 .108 .160 .986 
Within Groups 51.771 77 .672 
  
Total 52.417 83 
   
Location * Respondent's role in pharmacy 
Between Groups (Combined) 4.387 6 .731 1.154 .340 
Within Groups 49.425 78 .634 
  
Total 53.812 84 
   
 
Appendix 16 - Measures of Association by Respondent's Role in Pharmacy 
Measures of Association 
 Eta Eta Squared 
Offering O-T-C advice? * Respondent's role in pharmacy .339 .115 
Participating in local authority run scheme? * Respondent's role in 
pharmacy 
.188 .035 
Collaborating in shared care scheme? * Respondent's role in 
pharmacy 
.275 .076 
Is programme fully funded by local authority? * Respondent's role in 
pharmacy 
.207 .043 
Increase PH content of undergraduate curriculum? * Respondent's 
role in pharmacy 
.115 .013 
Offer dual MPharm (or even PharmD)/MPH degrees? * 
Respondent's role in pharmacy 
.174 .030 
Pharmacy students training with other HC students? * Respondent's 
role in pharmacy 
.256 .065 
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Pharmacists working closely with HC practitioners? * Respondent's 
role in pharmacy 
.256 .065 
Teach advanced communication techniques? * Respondent's role in 
pharmacy 
.229 .052 
Adopt new technologies and the social media? * Respondent's role 
in pharmacy 
.236 .056 
Develop good adherence strategies for patients? * Respondent's 
role in pharmacy 
.266 .071 
Enhancing role in antimicrobial resistance? * Respondent's role in 
pharmacy 
.219 .048 
Enhance patients' self-managt capacities? * Respondent's role in 
pharmacy 
.260 .068 
Enhance safe medication disposal methods? * Respondent's role in 
pharmacy 
.231 .054 
Enhance the management of polypharmacy? * Respondent's role in 
pharmacy 
.313 .098 
Managing the medication needs of athletes? * Respondent's role in 
pharmacy 
.330 .109 
Enhancing involvement in smoking cessation? * Respondent's role 
in pharmacy 
.210 .044 
Providing students with advanced experience in PH? * 
Respondent's role in pharmacy 
.187 .035 
Providing pharmacists with advanced experience in PH? * 
Respondent's role in pharmacy 
.331 .109 
Remunerate pharmacists directly for PH services? * Respondent's 
role in pharmacy 
.215 .046 
Insufficient training of pharmacists in PH? * Respondent's role in 
pharmacy 
.188 .035 
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Insufficient skill of pharmacists in PH? * Respondent's role in 
pharmacy 
.291 .085 
Lack of professional autonomy for pharmacists? * Respondent's role 
in pharmacy 
.266 .071 
Difficulties in recruiting patients? * Respondent's role in pharmacy .270 .073 
Lack of demand for public health services? * Respondent's role in 
pharmacy 
.228 .052 
High drop rates for public health services? * Respondent's role in 
pharmacy 
.291 .085 
Low success rates for public health services? * Respondent's role in 
pharmacy 
.257 .066 
Lack of input from public health practitioners? * Respondent's role in 
pharmacy 
.280 .079 
Lack of support from public health practitioners? * Respondent's role 
in pharmacy 
.145 .021 
Difficulty in communicating with other PH providers? * Respondent's 
role in pharmacy 
.214 .046 
Lack of support from GPs? * Respondent's role in pharmacy .220 .048 
Insufficient funding from the government? * Respondent's role in 
pharmacy 
.308 .095 
Difficulty in fee collection? * Respondent's role in pharmacy .147 .022 
Time pressure and workload? * Respondent's role in pharmacy .145 .021 
Safety concerns among pharmacists? * Respondent's role in 
pharmacy 
.331 .109 
Safety concerns by GPs? * Respondent's role in pharmacy .382 .146 
Safety concerns of patients? * Respondent's role in pharmacy .287 .083 
Lack of patients' records? * Respondent's role in pharmacy .290 .084 
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Lack of documentation of interventions? * Respondent's role in 
pharmacy 
.257 .066 
Physical design of community pharmacies? * Respondent's role in 
pharmacy 
.327 .107 
Misperception that counselling is not needed? * Respondent's role in 
pharmacy 
.310 .096 
Lack of instrumentation? * Respondent's role in pharmacy .328 .108 
Language barrier? * Respondent's role in pharmacy .293 .086 
Lack of understanding by the public? * Respondent's role in 
pharmacy 
.251 .063 
Lack of understanding by HC providers? * Respondent's role in 
pharmacy 
.205 .042 
How essential CPs provide PH services? * Respondent's role in 
pharmacy 
.343 .117 
The PH role of CPs is still underdeveloped? * Respondent's role in 
pharmacy 
.278 .078 
Pharmacies employing their own PH advisers? * Respondent's role 
in pharmacy 
.422 .178 
Devolve all work to PH practitioners? * Respondent's role in 
pharmacy 
.206 .042 
Pharmacists reaching out to public places? * Respondent's role in 
pharmacy 
.225 .051 
Community pharmacies developing into HLPs? * Respondent's role 
in pharmacy 
.224 .050 
Pharmacists developing their own expertise? * Respondent's role in 
pharmacy 
.111 .012 
Location * Respondent's role in pharmacy .286 .082 
 
 304 
 
Appendix 17a - Means Table by Location 
Means 
Report 
Location Offering 
O-T-C 
advice? 
Participating 
in local 
authority run 
scheme? 
Collaborating 
in shared care 
scheme? 
Is 
programme 
fully 
funded by 
local 
authority? 
Increase PH 
content of 
undergraduate 
curriculum? 
Offer dual 
MPharm (or 
even 
PharmD)/MPH 
degrees? 
Pharmacy 
students 
training with 
other HC 
students? 
Pharmacists 
working 
closely with 
HC 
practitioners
? 
Teach advanced 
communication 
techniques? 
Barnet 
Mean 1.0000 1.1200 1.6522 1.0526 3.6800 3.4000 3.7600 4.2083 4.1667 
N 25 25 23 19 25 25 25 24 24 
Std. 
Deviation 
.00000 .33166 .48698 .22942 .69041 .95743 1.05198 .65801 .56466 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
Edinburgh 
Mean 1.0333 1.0333 1.6000 1.1111 4.0000 3.1613 4.0645 4.2258 3.9032 
N 30 30 30 27 31 31 31 31 31 
Std. 
Deviation 
.18257 .18257 .49827 .32026 .85635 1.12833 .77182 .80456 .94357 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
Cardiff 
Mean 1.0000 1.5556 1.8148 1.3333 3.4483 2.7586 3.6296 4.1034 3.8966 
N 29 27 27 24 29 29 27 29 29 
Std. 
Deviation 
.00000 .50637 .39585 .48154 .73612 .98761 .96668 .81700 .67320 
Median 1.0000 2.0000 2.0000 1.0000 3.0000 3.0000 4.0000 4.0000 4.0000 
Total 
Mean 1.0119 1.2317 1.6875 1.1714 3.7176 3.0941 3.8313 4.1786 3.9762 
N 84 82 80 70 85 85 83 84 84 
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Std. 
Deviation 
.10911 .42452 .46644 .37960 .79600 1.05361 .93469 .76301 .76009 
Median 1.0000 1.0000 2.0000 1.0000 4.0000 3.0000 4.0000 4.0000 4.0000 
 
 
Appendix 17b - Means Table by Location contd. 
Report 
Location Adopt new 
technologies 
and the 
social 
media? 
Develop 
good 
adherence 
strategies 
for 
patients? 
Enhancing 
role in 
antimicrobial 
resistance? 
Enhance 
patients' 
self-managt 
capacities? 
Enhance 
safe 
medication 
disposal 
methods? 
Enhance the 
management of 
polypharmacy? 
Managing 
the 
medication 
needs of 
athletes? 
Enhancing 
involvement 
in smoking 
cessation? 
Providing 
students 
with 
advanced 
experience 
in PH? 
Barnet 
Mean 3.3600 4.0800 4.0000 4.2400 4.1600 4.1200 4.1200 4.1200 4.1667 
N 25 25 25 25 25 25 25 25 24 
Std. 
Deviation 
1.15036 .40000 .70711 .66332 .98658 .78102 .60000 1.01325 .63702 
Median 3.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
Edinburgh 
Mean 2.6774 4.0323 4.0323 4.2258 3.7742 4.4516 3.6129 3.8710 4.1290 
N 31 31 31 31 31 31 31 31 31 
Std. 
Deviation 
1.30095 .54674 .70635 .56034 1.08657 .85005 1.08558 1.17592 .88476 
Median 3.0000 4.0000 4.0000 4.0000 4.0000 5.0000 4.0000 4.0000 4.0000 
Cardiff 
Mean 3.3103 3.9286 3.6897 4.0345 3.6552 3.9655 3.6786 4.0000 3.9310 
N 29 28 29 29 29 29 28 29 29 
Std. 
Deviation 
1.07250 .53945 .89056 .56586 .81398 .56586 .66964 .59761 .45756 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
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Total 
Mean 3.0941 4.0119 3.9059 4.1647 3.8471 4.1882 3.7857 3.9882 4.0714 
N 85 84 85 85 85 85 84 85 84 
Std. 
Deviation 
1.21129 .50286 .78108 .59456 .98205 .76367 .85124 .95735 .69048 
Median 3.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 
 
 
Appendix 17c - Means Table by Location contd. 
Report 
Location Providing 
pharmacists 
with 
advanced 
experience 
in PH? 
Remunerate 
pharmacists 
directly for 
PH services? 
Insufficient 
training of 
pharmacists 
in PH? 
Insufficient 
skill of 
pharmacists 
in PH? 
Lack of 
professional 
autonomy for 
pharmacists? 
Difficulties 
in 
recruiting 
patients? 
Lack of 
demand for 
public 
health 
services? 
High drop 
rates for 
public 
health 
services? 
Low success 
rates for 
public health 
services? 
Barnet 
Mean 4.3200 4.2800 3.3600 2.7600 3.9600 3.5200 2.3600 3.0000 2.2500 
N 25 25 25 25 25 25 25 25 24 
Std. 
Deviation 
.47610 1.02144 1.35031 1.33167 .97809 1.15902 1.18603 .91287 1.15156 
Median 4.0000 5.0000 4.0000 3.0000 4.0000 4.0000 2.0000 3.0000 2.0000 
Edinburgh 
Mean 4.1290 4.1935 3.3871 2.9677 3.5484 3.0968 2.2581 3.3548 2.7097 
N 31 31 31 31 31 31 31 31 31 
Std. 
Deviation 
.84624 .70329 1.25638 1.32876 1.15004 1.53525 1.31574 1.33037 1.41877 
Median 4.0000 4.0000 4.0000 3.0000 4.0000 4.0000 2.0000 4.0000 3.0000 
Cardiff 
Mean 3.9655 4.2414 3.4828 3.4138 3.6552 3.9655 2.9310 3.4483 2.7931 
N 29 29 29 29 29 29 29 29 29 
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Std. 
Deviation 
.49877 .73946 1.08958 1.05279 .93640 .62580 1.06674 .82748 1.01346 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 
Total 
Mean 4.1294 4.2353 3.4118 3.0588 3.7059 3.5176 2.5176 3.2824 2.6071 
N 85 85 85 85 85 85 85 85 84 
Std. 
Deviation 
.65079 .81133 1.21786 1.25691 1.03307 1.22097 1.22097 1.06471 1.22246 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 3.0000 3.0000 
 
 
Appendix 17d - Means Table by Location contd. 
Report 
Location Lack of input 
from public 
health 
practitioners? 
Lack of 
support from 
public health 
practitioners? 
Difficulty in 
communicating 
with other PH 
providers? 
Lack of 
support 
from 
GPs? 
Insufficient 
funding from the 
government? 
Difficulty in 
fee 
collection? 
Time 
pressure 
and 
workload? 
Safety 
concerns 
among 
pharmacists? 
Safety 
concerns 
by GPs? 
Barnet 
Mean 3.5200 3.7500 3.3750 4.0800 4.2800 3.4000 4.2800 3.3600 3.0000 
N 25 24 24 25 25 25 25 25 25 
Std. 
Deviation 
1.15902 1.22474 1.24455 1.18743 1.06145 .86603 .84261 1.15036 1.41421 
Median 4.0000 4.0000 4.0000 4.0000 5.0000 4.0000 4.0000 3.0000 3.0000 
Edinburgh 
Mean 3.6774 3.2667 3.5806 2.9677 3.7419 3.1613 4.4839 3.1935 2.3226 
N 31 30 31 31 31 31 31 31 31 
Std. 
Deviation 
.90874 1.17248 1.25895 1.32876 1.29016 1.41649 .85131 1.37645 1.19407 
Median 4.0000 4.0000 4.0000 3.0000 4.0000 3.0000 5.0000 4.0000 2.0000 
Cardiff Mean 3.5862 3.5517 3.7241 3.8276 3.8966 3.2414 4.4483 3.0690 2.7931 
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N 29 29 29 29 29 29 29 29 29 
Std. 
Deviation 
1.08619 1.08845 .88223 .84806 1.20549 1.15434 .82748 1.33446 1.34641 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 
Total 
Mean 3.6000 3.5060 3.5714 3.5882 3.9529 3.2588 4.4118 3.2000 2.6824 
N 85 83 84 85 85 85 85 85 85 
Std. 
Deviation 
1.03740 1.16214 1.13313 1.22760 1.20422 1.17669 .83515 1.28915 1.32927 
Median 4.0000 4.0000 4.0000 4.0000 4.0000 3.0000 5.0000 3.0000 3.0000 
 
 
Appendix 17e - Means Table by Location contd. 
Report 
Location Safety 
concerns 
of 
patients? 
Lack of 
patients' 
records? 
Lack of 
documentation 
of 
interventions? 
Physical 
design of 
community 
pharmacies? 
Misperception 
that 
counselling is 
not needed? 
Lack of 
instrumentation? 
Language 
barrier? 
Lack of 
understanding 
by the public? 
Lack of 
understanding 
by HC 
providers? 
Barnet 
Mean 2.4400 3.5600 3.1667 2.5600 3.2800 2.9600 2.6000 3.6667 3.4545 
N 25 25 24 25 25 25 25 24 22 
Std. 
Deviation 
1.32539 1.22746 1.16718 1.44568 1.48661 1.33791 1.41421 1.04950 1.26217 
Median 2.0000 4.0000 3.0000 3.0000 4.0000 3.0000 3.0000 4.0000 4.0000 
Edinburgh 
Mean 2.0000 3.8387 3.1935 3.0323 2.6774 3.3226 2.2903 3.6129 3.6129 
N 31 31 31 31 31 31 31 31 31 
Std. 
Deviation 
1.15470 1.12833 1.37645 1.32876 1.51409 1.30095 1.29598 1.25638 1.17409 
Median 2.0000 4.0000 3.0000 3.0000 3.0000 4.0000 2.0000 4.0000 4.0000 
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Cardiff 
Mean 2.3793 4.1724 3.4483 3.0000 3.1724 3.5517 1.9643 3.9286 3.6897 
N 29 29 29 29 29 29 28 28 29 
Std. 
Deviation 
1.32055 .60172 1.05513 1.43925 1.33815 .82748 1.26146 .97861 1.10529 
Median 3.0000 4.0000 4.0000 3.0000 3.0000 4.0000 1.0000 4.0000 4.0000 
Total 
Mean 2.2588 3.8706 3.2738 2.8824 3.0235 3.2941 2.2738 3.7349 3.5976 
N 85 85 84 85 85 85 84 83 82 
Std. 
Deviation 
1.26447 1.03266 1.20592 1.40078 1.45550 1.18345 1.32947 1.10525 1.16386 
Median 2.0000 4.0000 4.0000 3.0000 3.0000 4.0000 2.0000 4.0000 4.0000 
 
 
Appendix 17f - Means Table by Location contd. 
Report 
Location How 
essential 
CPs provide 
PH 
services? 
The PH role of 
CPs is still 
underdeveloped? 
Pharmacies 
employing 
their own PH 
advisers? 
Devolve all 
work to PH 
practitioners? 
Pharmacists 
reaching out 
to public 
places? 
Community 
pharmacies 
developing into 
HLPs? 
Pharmacists 
developing 
their own 
expertise? 
Barnet 
Mean 1.5200 1.2083 3.0000 2.0400 3.1600 4.2000 4.0800 
N 25 24 25 25 25 25 25 
Std. 
Deviation 
.71414 .41485 1.38444 1.17189 1.24766 .81650 1.07703 
Median 1.0000 1.0000 3.0000 2.0000 3.0000 4.0000 4.0000 
Edinburgh 
Mean 1.8065 1.1667 2.7742 1.8710 3.3548 3.7333 4.2000 
N 31 30 31 31 31 30 30 
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Std. 
Deviation 
.94585 .37905 1.33441 1.20394 1.33037 1.01483 .55086 
Median 2.0000 1.0000 3.0000 1.0000 4.0000 4.0000 4.0000 
Cardiff 
Mean 2.6071 1.1481 2.7308 2.1538 3.1154 3.4400 3.9231 
N 28 27 26 26 26 25 26 
Std. 
Deviation 
1.16553 .36201 1.28243 1.08415 1.24344 1.08321 .68836 
Median 3.0000 1.0000 3.0000 2.5000 3.0000 3.0000 4.0000 
Total 
Mean 1.9881 1.1728 2.8293 2.0122 3.2195 3.7875 4.0741 
N 84 81 82 82 82 80 81 
Std. 
Deviation 
1.05846 .38046 1.32222 1.14928 1.26710 1.01500 .78705 
Median 2.0000 1.0000 3.0000 2.0000 4.0000 4.0000 4.0000 
 
Appendix 18 - Anova Table by Location 
ANOVA Table 
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
Offering O-T-C advice? * Location 
Between Groups (Combined) .021 2 .011 .898 .411 
Within Groups .967 81 .012   
Total .988 83    
Participating in local authority run scheme? * Location 
Between Groups (Combined) 4.324 2 2.162 16.626 .000 
Within Groups 10.273 79 .130   
Total 14.598 81    
Collaborating in shared care scheme? * Location 
Between Groups (Combined) .696 2 .348 1.625 .204 
Within Groups 16.491 77 .214   
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Total 17.188 79    
Is programme fully funded by local authority? * Location 
Between Groups (Combined) .995 2 .498 3.727 .029 
Within Groups 8.947 67 .134   
Total 9.943 69    
Increase PH content of undergraduate curriculum? * Location 
Between Groups (Combined) 4.611 2 2.306 3.889 .024 
Within Groups 48.612 82 .593   
Total 53.224 84    
Offer dual MPharm (or even PharmD)/MPH degrees? * Location 
Between Groups (Combined) 5.743 2 2.872 2.691 .074 
Within Groups 87.504 82 1.067   
Total 93.247 84    
Pharmacy students training with other HC students? * Location 
Between Groups (Combined) 2.911 2 1.456 1.694 .190 
Within Groups 68.727 80 .859   
Total 71.639 82    
Pharmacists working closely with HC practitioners? * Location 
Between Groups (Combined) .254 2 .127 .214 .808 
Within Groups 48.067 81 .593   
Total 48.321 83    
Teach advanced communication techniques? * Location 
Between Groups (Combined) 1.220 2 .610 1.057 .352 
Within Groups 46.733 81 .577   
Total 47.952 83    
Adopt new technologies and the social media? * Location 
Between Groups (Combined) 8.506 2 4.253 3.039 .053 
Within Groups 114.741 82 1.399   
Total 123.247 84    
Develop good adherence strategies for patients? * Location 
Between Groups (Combined) .323 2 .162 .633 .533 
Within Groups 20.665 81 .255   
Total 20.988 83    
Enhancing role in antimicrobial resistance? * Location 
Between Groups (Combined) 2.072 2 1.036 1.728 .184 
Within Groups 49.175 82 .600   
Total 51.247 84    
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Enhance patients' self-managt capacities? * Location 
Between Groups (Combined) .749 2 .375 1.061 .351 
Within Groups 28.945 82 .353   
Total 29.694 84    
Enhance safe medication disposal methods? * Location 
Between Groups (Combined) 3.681 2 1.840 1.951 .149 
Within Groups 77.331 82 .943   
Total 81.012 84    
Enhance the management of polypharmacy? * Location 
Between Groups (Combined) 3.705 2 1.853 3.355 .040 
Within Groups 45.283 82 .552   
Total 48.988 84    
Managing the medication needs of athletes? * Location 
Between Groups (Combined) 4.041 2 2.020 2.917 .060 
Within Groups 56.102 81 .693   
Total 60.143 83    
Enhancing involvement in smoking cessation? * Location 
Between Groups (Combined) .864 2 .432 .466 .629 
Within Groups 76.124 82 .928   
Total 76.988 84    
Providing students with advanced experience in PH? * Location 
Between Groups (Combined) .892 2 .446 .934 .397 
Within Groups 38.679 81 .478   
Total 39.571 83    
Providing pharmacists with advanced experience in PH? * 
Location 
Between Groups (Combined) 1.687 2 .844 2.041 .136 
Within Groups 33.889 82 .413   
Total 35.576 84    
Remunerate pharmacists directly for PH services? * Location 
Between Groups (Combined) .105 2 .053 .078 .925 
Within Groups 55.189 82 .673   
Total 55.294 84    
Insufficient training of pharmacists in PH? * Location 
Between Groups (Combined) .232 2 .116 .076 .926 
Within Groups 124.356 82 1.517   
Total 124.588 84    
Insufficient skill of pharmacists in PH? * Location Between Groups (Combined) 6.144 2 3.072 1.990 .143 
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Within Groups 126.562 82 1.543   
Total 132.706 84    
Lack of professional autonomy for pharmacists? * Location 
Between Groups (Combined) 2.458 2 1.229 1.156 .320 
Within Groups 87.189 82 1.063   
Total 89.647 84    
Difficulties in recruiting patients? * Location 
Between Groups (Combined) 11.308 2 5.654 4.070 .021 
Within Groups 113.915 82 1.389   
Total 125.224 84    
Lack of demand for public health services? * Location 
Between Groups (Combined) 7.666 2 3.833 2.674 .075 
Within Groups 117.558 82 1.434   
Total 125.224 84    
High drop rates for public health services? * Location 
Between Groups (Combined) 2.954 2 1.477 1.313 .275 
Within Groups 92.269 82 1.125   
Total 95.224 84    
Low success rates for public health services? * Location 
Between Groups (Combined) 4.390 2 2.195 1.486 .232 
Within Groups 119.646 81 1.477   
Total 124.036 83    
Lack of input from public health practitioners? * Location 
Between Groups (Combined) .351 2 .176 .160 .852 
Within Groups 90.049 82 1.098   
Total 90.400 84    
Lack of support from public health practitioners? * Location 
Between Groups (Combined) 3.208 2 1.604 1.193 .309 
Within Groups 107.539 80 1.344   
Total 110.747 82    
Difficulty in communicating with other PH providers? * Location 
Between Groups (Combined) 1.605 2 .802 .619 .541 
Within Groups 104.966 81 1.296   
Total 106.571 83    
Lack of support from GPs? * Location 
Between Groups (Combined) 19.643 2 9.821 7.530 .001 
Within Groups 106.946 82 1.304   
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Total 126.588 84    
Insufficient funding from the government? * Location 
Between Groups (Combined) 4.147 2 2.073 1.445 .242 
Within Groups 117.665 82 1.435   
Total 121.812 84    
Difficulty in fee collection? * Location 
Between Groups (Combined) .802 2 .401 .285 .753 
Within Groups 115.504 82 1.409   
Total 116.306 84    
Time pressure and workload? * Location 
Between Groups (Combined) .634 2 .317 .448 .640 
Within Groups 57.954 82 .707   
Total 58.588 84    
Safety concerns among pharmacists? * Location 
Between Groups (Combined) 1.139 2 .570 .337 .715 
Within Groups 138.461 82 1.689   
Total 139.600 84    
Safety concerns by GPs? * Location 
Between Groups (Combined) 6.891 2 3.445 1.996 .142 
Within Groups 141.533 82 1.726   
Total 148.424 84    
Safety concerns of patients? * Location 
Between Groups (Combined) 3.318 2 1.659 1.039 .359 
Within Groups 130.988 82 1.597   
Total 134.306 84    
Lack of patients' records? * Location 
Between Groups (Combined) 5.085 2 2.542 2.468 .091 
Within Groups 84.491 82 1.030   
Total 89.576 84    
Lack of documentation of interventions? * Location 
Between Groups (Combined) 1.358 2 .679 .461 .632 
Within Groups 119.344 81 1.473   
Total 120.702 83    
Physical design of community pharmacies? * Location 
Between Groups (Combined) 3.696 2 1.848 .940 .395 
Within Groups 161.128 82 1.965   
Total 164.824 84    
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Misperception that counselling is not needed? * Location 
Between Groups (Combined) 6.001 2 3.000 1.431 .245 
Within Groups 171.952 82 2.097   
Total 177.953 84    
Lack of instrumentation? * Location 
Between Groups (Combined) 4.740 2 2.370 1.721 .185 
Within Groups 112.907 82 1.377   
Total 117.647 84    
Language barrier? * Location 
Between Groups (Combined) 5.351 2 2.675 1.533 .222 
Within Groups 141.351 81 1.745   
Total 146.702 83    
Lack of understanding by the public? * Location 
Between Groups (Combined) 1.623 2 .812 .659 .520 
Within Groups 98.545 80 1.232   
Total 100.169 82    
Lack of understanding by HC providers? * Location 
Between Groups (Combined) .703 2 .352 .255 .776 
Within Groups 109.016 79 1.380   
Total 109.720 81    
How essential CPs provide PH services? * Location 
Between Groups (Combined) 17.231 2 8.615 9.212 .000 
Within Groups 75.757 81 .935   
Total 92.988 83    
The PH role of CPs is still underdeveloped? * Location 
Between Groups (Combined) .048 2 .024 .162 .851 
Within Groups 11.532 78 .148   
Total 11.580 80    
Pharmacies employing their own PH advisers? * Location 
Between Groups (Combined) 1.075 2 .538 .302 .740 
Within Groups 140.535 79 1.779   
Total 141.610 81    
Devolve all work to PH practitioners? * Location 
Between Groups (Combined) 1.159 2 .580 .433 .650 
Within Groups 105.828 79 1.340   
Total 106.988 81    
Pharmacists reaching out to public places? * Location Between Groups (Combined) .938 2 .469 .287 .751 
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Within Groups 129.111 79 1.634   
Total 130.049 81    
Community pharmacies developing into HLPs? * Location 
Between Groups (Combined) 7.361 2 3.680 3.828 .026 
Within Groups 74.027 77 .961   
Total 81.388 79    
Pharmacists developing their own expertise? * Location 
Between Groups (Combined) 1.069 2 .535 .860 .427 
Within Groups 48.486 78 .622   
Total 49.556 80    
 
Appendix 19 - Measures of Association by Location 
Measures of Association 
 Eta Eta Squared 
Offering O-T-C advice? * Location .147 .022 
Participating in local authority run scheme? * Location .544 .296 
Collaborating in shared care scheme? * Location .201 .040 
Is programme fully funded by local authority? * Location .316 .100 
Increase PH content of undergraduate curriculum? * Location .294 .087 
Offer dual MPharm (or even PharmD)/MPH degrees? * Location .248 .062 
Pharmacy students training with other HC students? * Location .202 .041 
Pharmacists working closely with HC practitioners? * Location .073 .005 
Teach advanced communication techniques? * Location .159 .025 
Adopt new technologies and the social media? * Location .263 .069 
Develop good adherence strategies for patients? * Location .124 .015 
Enhancing role in antimicrobial resistance? * Location .201 .040 
Enhance patients' self-managt capacities? * Location .159 .025 
Enhance safe medication disposal methods? * Location .213 .045 
Enhance the management of polypharmacy? * Location .275 .076 
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Managing the medication needs of athletes? * Location .259 .067 
Enhancing involvement in smoking cessation? * Location .106 .011 
Providing students with advanced experience in PH? * Location .150 .023 
Providing pharmacists with advanced experience in PH? * Location .218 .047 
Remunerate pharmacists directly for PH services? * Location .044 .002 
Insufficient training of pharmacists in PH? * Location .043 .002 
Insufficient skill of pharmacists in PH? * Location .215 .046 
Lack of professional autonomy for pharmacists? * Location .166 .027 
Difficulties in recruiting patients? * Location .301 .090 
Lack of demand for public health services? * Location .247 .061 
High drop rates for public health services? * Location .176 .031 
Low success rates for public health services? * Location .188 .035 
Lack of input from public health practitioners? * Location .062 .004 
Lack of support from public health practitioners? * Location .170 .029 
Difficulty in communicating with other PH providers? * Location .123 .015 
Lack of support from GPs? * Location .394 .155 
Insufficient funding from the government? * Location .185 .034 
Difficulty in fee collection? * Location .083 .007 
Time pressure and workload? * Location .104 .011 
Safety concerns among pharmacists? * Location .090 .008 
Safety concerns by GPs? * Location .215 .046 
Safety concerns of patients? * Location .157 .025 
Lack of patients' records? * Location .238 .057 
Lack of documentation of interventions? * Location .106 .011 
Physical design of community pharmacies? * Location .150 .022 
Misperception that counselling is not needed? * Location .184 .034 
Lack of instrumentation? * Location .201 .040 
Language barrier? * Location .191 .036 
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Lack of understanding by the public? * Location .127 .016 
Lack of understanding by HC providers? * Location .080 .006 
How essential CPs provide PH services? * Location .430 .185 
The PH role of CPs is still underdeveloped? * Location .064 .004 
Pharmacies employing their own PH advisers? * Location .087 .008 
Devolve all work to PH practitioners? * Location .104 .011 
Pharmacists reaching out to public places? * Location .085 .007 
Community pharmacies developing into HLPs? * Location .301 .090 
Pharmacists developing their own expertise? * Location .147 .022 
 
Appendix 20 – Test for Correlation  
  
Gender of 
participant 
Age of 
participant 
Year of 
qualification 
Respondent's 
role in 
pharmacy Location 
Spearman's 
rho 
Gender of 
participant 
Correlation 
Coefficient 
1.000 .061 -.030 .033 .107 
Sig. (2-
tailed) 
  .569 .781 .762 .329 
N 88 88 87 88 85 
Age of 
participant 
Correlation 
Coefficient 
.061 1.000 .891** -.201 -.055 
Sig. (2-
tailed) 
.569   .000 .061 .615 
N 88 88 87 88 85 
Year of 
qualification 
Correlation 
Coefficient 
-.030 .891** 1.000 -.218* -.081 
Sig. (2-
tailed) 
.781 .000   .043 .466 
N 87 87 87 87 84 
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Respondent's 
role in pharmacy 
Correlation 
Coefficient 
.033 -.201 -.218* 1.000 -.022 
Sig. (2-
tailed) 
.762 .061 .043   .839 
N 88 88 87 88 85 
Offering O-T-C 
advice? 
Correlation 
Coefficient 
.097 .040 -.057 .153 -.010 
Sig. (2-
tailed) 
.370 .715 .603 .156 .931 
N 87 87 86 87 84 
Participating in 
local authority 
run scheme? 
Correlation 
Coefficient 
.139 -.104 -.119 .037 .423** 
Sig. (2-
tailed) 
.206 .343 .281 .737 .000 
N 85 85 84 85 82 
Collaborating in 
shared care 
scheme? 
Correlation 
Coefficient 
-.128 .026 .078 .036 .148 
Sig. (2-
tailed) 
.249 .813 .485 .745 .189 
N 83 83 82 83 80 
Is programme 
fully funded by 
local authority? 
Correlation 
Coefficient 
-.068 -.240* -.152 -.060 .302* 
Sig. (2-
tailed) 
.568 .041 .198 .613 .011 
N 73 73 73 73 70 
Increase PH 
content of 
undergraduate 
curriculum? 
Correlation 
Coefficient 
.023 -.043 .005 .033 -.142 
Sig. (2-
tailed) 
.833 .691 .964 .757 .196 
N 88 88 87 88 85 
Offer dual 
MPharm (or even 
PharmD)/MPH 
degrees? 
Correlation 
Coefficient 
-.247* -.151 -.118 .143 -.243* 
Sig. (2-
tailed) 
.020 .161 .277 .184 .025 
N 88 88 87 88 85 
Pharmacy 
students training 
Correlation 
Coefficient 
-.109 -.261* -.140 .235* -.100 
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with other HC 
students? 
Sig. (2-
tailed) 
.319 .015 .200 .029 .369 
N 86 86 85 86 83 
Pharmacists 
working closely 
with HC 
practitioners? 
Correlation 
Coefficient 
-.107 -.221* -.198 .202 -.051 
Sig. (2-
tailed) 
.325 .040 .068 .061 .647 
N 87 87 86 87 84 
Teach advanced 
communication 
techniques? 
Correlation 
Coefficient 
-.004 -.168 -.140 .056 -.154 
Sig. (2-
tailed) 
.970 .119 .199 .604 .162 
N 87 87 86 87 84 
Adopt new 
technologies and 
the social 
media? 
Correlation 
Coefficient 
-.159 -.072 -.032 -.004 .020 
Sig. (2-
tailed) 
.140 .503 .772 .969 .854 
N 88 88 87 88 85 
Develop good 
adherence 
strategies for 
patients? 
Correlation 
Coefficient 
-.121 -.169 -.066 .199 -.121 
Sig. (2-
tailed) 
.263 .118 .544 .065 .274 
N 87 87 86 87 84 
Enhancing role in 
antimicrobial 
resistance? 
Correlation 
Coefficient 
-.055 -.075 -.074 .067 -.144 
Sig. (2-
tailed) 
.611 .485 .496 .537 .188 
N 88 88 87 88 85 
Enhance 
patients' self-
managt 
capacities? 
Correlation 
Coefficient 
-.268* -.061 .004 .003 -.150 
Sig. (2-
tailed) 
.012 .575 .969 .974 .172 
N 88 88 87 88 85 
Enhance safe 
medication 
disposal 
methods? 
Correlation 
Coefficient 
-.187 .088 .127 .131 -.295** 
Sig. (2-
tailed) 
.081 .414 .241 .225 .006 
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N 88 88 87 88 85 
Enhance the 
management of 
polypharmacy? 
Correlation 
Coefficient 
-.077 -.114 -.101 .112 -.145 
Sig. (2-
tailed) 
.473 .291 .354 .299 .184 
N 88 88 87 88 85 
Managing the 
medication 
needs of 
athletes? 
Correlation 
Coefficient 
-.125 .015 .079 .137 -.235* 
Sig. (2-
tailed) 
.247 .893 .471 .204 .032 
N 87 87 86 87 84 
Enhancing 
involvement in 
smoking 
cessation? 
Correlation 
Coefficient 
-.111 .167 .243* -.098 -.129 
Sig. (2-
tailed) 
.302 .119 .023 .365 .239 
N 88 88 87 88 85 
Providing 
students with 
advanced 
experience in 
PH? 
Correlation 
Coefficient 
-.096 -.054 -.011 .039 -.169 
Sig. (2-
tailed) 
.374 .617 .919 .720 .124 
N 87 87 86 87 84 
Providing 
pharmacists with 
advanced 
experience in 
PH? 
Correlation 
Coefficient 
.009 -.056 -.059 .040 -.249* 
Sig. (2-
tailed) 
.933 .603 .585 .713 .021 
N 88 88 87 88 85 
Remunerate 
pharmacists 
directly for PH 
services? 
Correlation 
Coefficient 
-.091 -.209 -.242* .000 -.078 
Sig. (2-
tailed) 
.400 .051 .024 .998 .477 
N 88 88 87 88 85 
Insufficient 
training of 
pharmacists in 
PH? 
Correlation 
Coefficient 
-.131 -.091 -.068 .140 .002 
Sig. (2-
tailed) 
.224 .399 .530 .192 .984 
N 88 88 87 88 85 
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Insufficient skill 
of pharmacists in 
PH? 
Correlation 
Coefficient 
.143 .005 -.015 .230* .211 
Sig. (2-
tailed) 
.183 .962 .893 .031 .052 
N 88 88 87 88 85 
Lack of 
professional 
autonomy for 
pharmacists? 
Correlation 
Coefficient 
.107 .025 .099 -.030 -.121 
Sig. (2-
tailed) 
.321 .820 .360 .779 .269 
N 88 88 87 88 85 
Difficulties in 
recruiting 
patients? 
Correlation 
Coefficient 
-.091 -.224* -.107 .169 .132 
Sig. (2-
tailed) 
.400 .036 .322 .116 .229 
N 88 88 87 88 85 
Lack of demand 
for public health 
services? 
Correlation 
Coefficient 
.137 -.022 -.055 .015 .190 
Sig. (2-
tailed) 
.204 .838 .615 .892 .081 
N 88 88 87 88 85 
High drop rates 
for public health 
services? 
Correlation 
Coefficient 
.159 -.177 -.204 .017 .163 
Sig. (2-
tailed) 
.138 .098 .059 .876 .136 
N 88 88 87 88 85 
Low success 
rates for public 
health services? 
Correlation 
Coefficient 
-.034 -.281** -.278** .039 .168 
Sig. (2-
tailed) 
.758 .008 .010 .722 .127 
N 87 87 86 87 84 
Lack of input 
from public 
health 
practitioners? 
Correlation 
Coefficient 
.031 -.059 -.064 -.060 .023 
Sig. (2-
tailed) 
.774 .586 .554 .579 .835 
N 88 88 87 88 85 
Lack of support 
from public 
Correlation 
Coefficient 
-.112 .016 .091 -.014 -.100 
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health 
practitioners? 
Sig. (2-
tailed) 
.306 .884 .407 .901 .370 
N 86 86 85 86 83 
Difficulty in 
communicating 
with other PH 
providers? 
Correlation 
Coefficient 
-.038 -.109 -.059 -.013 .087 
Sig. (2-
tailed) 
.730 .315 .591 .907 .429 
N 87 87 86 87 84 
Lack of support 
from GPs? 
Correlation 
Coefficient 
-.121 .116 .031 .129 -.123 
Sig. (2-
tailed) 
.261 .283 .778 .230 .264 
N 88 88 87 88 85 
Insufficient 
funding from the 
government? 
Correlation 
Coefficient 
-.269* .069 .126 -.082 -.145 
Sig. (2-
tailed) 
.011 .523 .244 .449 .184 
N 88 88 87 88 85 
Difficulty in fee 
collection? 
Correlation 
Coefficient 
-.114 -.145 -.080 .034 -.040 
Sig. (2-
tailed) 
.290 .179 .459 .753 .714 
N 88 88 87 88 85 
Time pressure 
and workload? 
Correlation 
Coefficient 
.201 -.026 -.102 .042 .085 
Sig. (2-
tailed) 
.060 .807 .347 .697 .442 
N 88 88 87 88 85 
Safety concerns 
among 
pharmacists? 
Correlation 
Coefficient 
-.040 -.158 -.117 .198 -.073 
Sig. (2-
tailed) 
.710 .141 .279 .064 .509 
N 88 88 87 88 85 
Safety concerns 
by GPs? 
Correlation 
Coefficient 
.029 -.083 -.052 .013 -.041 
Sig. (2-
tailed) 
.787 .441 .630 .908 .712 
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N 88 88 87 88 85 
Safety concerns 
of patients? 
Correlation 
Coefficient 
.021 -.111 -.101 .070 -.010 
Sig. (2-
tailed) 
.844 .304 .353 .515 .930 
N 88 88 87 88 85 
Lack of patients' 
records? 
Correlation 
Coefficient 
.122 -.165 -.082 .148 .188 
Sig. (2-
tailed) 
.257 .125 .450 .170 .085 
N 88 88 87 88 85 
Lack of 
documentation of 
interventions? 
Correlation 
Coefficient 
-.092 -.049 -.056 .164 .107 
Sig. (2-
tailed) 
.399 .649 .611 .128 .334 
N 87 87 86 87 84 
Physical design 
of community 
pharmacies? 
Correlation 
Coefficient 
.014 -.208 -.173 .156 .125 
Sig. (2-
tailed) 
.897 .052 .110 .148 .256 
N 88 88 87 88 85 
Misperception 
that counselling 
is not needed? 
Correlation 
Coefficient 
.117 .004 -.061 .152 -.038 
Sig. (2-
tailed) 
.277 .968 .578 .158 .733 
N 88 88 87 88 85 
Lack of 
instrumentation? 
Correlation 
Coefficient 
.076 -.133 -.089 .059 .170 
Sig. (2-
tailed) 
.482 .218 .413 .584 .121 
N 88 88 87 88 85 
Language 
barrier? 
Correlation 
Coefficient 
-.019 -.212* -.188 .126 -.196 
Sig. (2-
tailed) 
.863 .049 .084 .246 .074 
N 87 87 86 87 84 
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Lack of 
understanding by 
the public? 
Correlation 
Coefficient 
.059 .137 .155 -.020 .120 
Sig. (2-
tailed) 
.589 .207 .156 .858 .279 
N 86 86 85 86 83 
Lack of 
understanding by 
HC providers? 
Correlation 
Coefficient 
.005 -.014 -.047 .095 .072 
Sig. (2-
tailed) 
.966 .900 .673 .386 .521 
N 85 85 84 85 82 
How essential 
CPs provide PH 
services? 
Correlation 
Coefficient 
.216* .075 .037 .062 .391** 
Sig. (2-
tailed) 
.045 .487 .732 .568 .000 
N 87 87 86 87 84 
The PH role of 
CPs is still 
underdeveloped? 
Correlation 
Coefficient 
.150 -.033 -.088 -.177 -.062 
Sig. (2-
tailed) 
.174 .765 .428 .107 .581 
N 84 84 83 84 81 
Pharmacies 
employing their 
own PH 
advisers? 
Correlation 
Coefficient 
-.069 -.073 -.078 -.073 -.074 
Sig. (2-
tailed) 
.532 .508 .478 .505 .508 
N 85 85 84 85 82 
Devolve all work 
to PH 
practitioners? 
Correlation 
Coefficient 
-.171 -.038 -.038 -.078 .058 
Sig. (2-
tailed) 
.118 .729 .734 .475 .605 
N 85 85 84 85 82 
Pharmacists 
reaching out to 
public places? 
Correlation 
Coefficient 
.123 .031 -.013 -.021 -.023 
Sig. (2-
tailed) 
.264 .781 .905 .850 .837 
N 85 85 84 85 82 
Community 
pharmacies 
Correlation 
Coefficient 
-.126 -.065 -.069 .121 -.309** 
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developing into 
HLPs? 
Sig. (2-
tailed) 
.257 .557 .540 .275 .005 
N 83 83 82 83 80 
Pharmacists 
developing their 
own expertise? 
Correlation 
Coefficient 
-.055 -.210 -.134 .097 -.176 
Sig. (2-
tailed) 
.617 .055 .227 .378 .117 
N 84 84 83 84 81 
Location Correlation 
Coefficient 
.107 -.055 -.081 -.022 1.000 
Sig. (2-
tailed) 
.329 .615 .466 .839   
N 85 85 84 85 85 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Appendix 21: Visualisation of the Curriculum of School of Pharmacy, University of Brighton 
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Appendix 22: Visualisation of the Curriculum of School of Pharmacy, Liverpool John Moores University 
 
 
 
Appendix 23: Visualisation of the Curriculum of School of Pharmacy, University of Central Lancashire 
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Appendix 24: Visualisation of the Curriculum of School of Pharmacy, Kingston University 
 
 
 
 
Appendix 25: Visualisation of the Curriculum of School of Pharmacy, University of Wolverhampton 
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Appendix 26: Visualisation of the Curriculum of School of Pharmacy, University of Reading 
 
 
Appendix 27: Visualisation of the Curriculum of School of Pharmacy, University of Portsmouth 
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Appendix 28: Visualisation of the Curriculum of School of Pharmacy, University of Manchester 
 
 
Appendix 29: Visualisation of the Curriculum of School of Pharmacy, University of Hertfordshire 
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Appendix 30: Visualisation of the Curriculum of School of Pharmacy, Aston University 
 
 
 
Appendix 31: Visualisation of the Curriculum of School of Pharmacy, University of Bath 
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Appendix 32: Visualisation of the Curriculum of School of Pharmacy, University of Sunderland 
 
 
